Pesticidal proteins and strains
28 claims: 3 independent, 25 dependent
- 1Claims:1. A DNA molecule encoding a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp., said DNA molecule being complementary to a sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NO: 28. SEO ID NO: 30, SEQ ID NO: 31 and SEO ID NO: 51 at 65°C in a buffer comprising 7% SDS and 0,5 M sodium phosphate.
- 8An expression cassette comprising a DNA molecule according to any one of claims 1-7 operably linked to expression sequences including the transcriptional and translational regulatory signals necessary for expression of the associated DNA constructs in a host organism and optionally further regulatory sequences.
- 27A method of protecting plants against damage caused by an insect pest comprising transforming said plants with a DNA molecule encoding a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp., said DNA molecule being complementary to a sequence which hybridizes with a nucleotide selected from the group consisting of SEQ ID NO:28, SEQ ID NO: 30, SEQ ID NO: 31 and SEQ ID NO: 51 at 65°C in a buffer comprising 7% SDS and 0.5 M sodium phosphate.
Independent claims7
5,422 paragraphs in 1,682 sections, as filed
DNA MOLECULES ENCODING INSECTICIDAL PROTEINS SECRETED FROM VEGETATIVE GROWTH PHASE OF Bacillus spp., USES THEREOF AND TRANSGENIC ORGANISMS COMPRISING THE SAME
The present invention is drawn to methods and compositions for controlling plant and non-plant pests. Particularly, new pesticidal proteins are disclosed which are isolatable from the vegetative growth stage of Bacillus. Bacillus strains, proteins, and genes encoding the proteins are provided. The methods and compositions of the invention may be used in a variety of systems for controlling plant and non-plant pests.
Insect pests are a major factor in the loss of the world's commercially important agricultural crops. Broad spectrum chemical pesticides have been used extensively to control or eradicate pests of agricultural importance. There is, however, substantial interest in developing effective alternative pesticides.
Microbial pesticides have played an important role as alternatives to chemical pest control. The most extensively used microbial product is based on the bacterium Bacillus thuringiensis (Bt). Bt is a gram-positive spore forming Bacillus which produces an insecticidal crystal protein. (ICP) during sporulation.
Numerous varieties of Bt are known that produce more than 25 different but related ICP's. The majority of ICP's made by Bt are toxic to larvae of certain insects in the orders Lepidoptera, Diptera and Coleoptera. In general, when an ICP is ingested by a susceptible insect the crystal is solubilized and transformed into a toxic moiety by the insect gut proteases. None of the ICP's active against coleopteran larvae such as Colorado potato beetle (Leptinotarsa decemlineata) or Yellow mealworm (Tenebrio molitor) have demonstrated significant effects on members of the genus Diabrotica particularly Diabrotica virgifera virgifera^be western corn rootworm (WCRW) or Diabrotica longicornis barbori, the northern corn rootworm.
Bacillus cereus (Be) is closely related to Bt A major distinguishing characteristic is the absence of a parasporal crystal in Be. Be is a widely distributed bacterium that is commonly found in soil and has been isolated from a variety of foods and drugs. The organism has been implicated in the spoilage of food.
Although Bt has been very useful in controlling insect pests, there is a need to expand the number of potential biological control agents.
la
Shivakumar et al. [(1986) Plasmid, Vol. 16, No. 3, p.230] describe the cloning and characterization of two crystal protein genes expressed in B. subtilis during vegetative growth.
Walther et al. [(1986) Applied and Environmental Microbiology, Vol. 5, No. 4, pp.650-653] describe the induction of 100% mortality of the mosquito Aedes aegypti larvae upon infection by Bacillus thuringiensis subsp. israelensis. The larvicidal potential was localized within the cells, and was likely due to a heat-labile hemolysin which was immunologically distinct from the general cytolytic factor released during solubilization of Bacillus thuringiensis subsp. israelensis (Bti) crystals.
Ward et al. [(1986) J. Mol. Biol. Vol. 191, pp.13-22] cloned and characterized the pattern of expression of ®-endotoxin in sporogenic and asporogenic strains of Bacillus thuringiensis var. israelensis. The ®-endotoxin gene is expressed at a low level during vegetative growth in all three strains, but the synthesis of the toxin increases markedly during the third hour of stationary phase for both the sporogenic strain and an asporogenic mutant containing the OJ lesion.
Sekar V. [(1988) Current Microbiology, Vol. 17, pp.347-349] describe the expression of ICP transcript and the corresponding crystal antigen of the coleopteran-toxic Bacillus thuringiensis var. tenebrionis at detectable levels in vegetative cells. The expression of the ICP gene increases dramatically and reaches a plateau in early stationary cells.
WO 90/13651 describes the characterization of novel strains of B. thuringiensis, like JHCC 4835 and JHCC 4353, and their efficacy in the control of various pests. In particular a gene coding for a novel insecticidal endotoxin, of 81 kDa, was \ characterized from the recombinant strain MC1022/pJHll. This novel endotoxin is toxic to both Lepidoptera and Coleoptera.
Thanabalu et al. [(1992) Journal of Bacteriology, vol. 174, no. 15, pp.5051-5056] describe the cloning of a gene encoding a lOOkDa protein, designated mtx (mosquitocidal toxin) gene, from Bacillus sphaericusi SSII-1, and characterization of the Mtx protein. This study was followed by another publication by the same authors [Thanabalu et al. (1993) Journal of Bacteriology, vol. 175, no. 8, pp.23142320], where the Mtx protein was further characterized, and specific roles were assigned to trypsin-derived 27 kDa and 70 kDa Mtx peptides. The N-terminal 27 kDa peptide has homology with ADP-ribosyltransferase toxins, whereas the Cterminal 70 kDa peptide seems to cause morphological changes to certain mosquito cells in culture.
Yoshisue et al. [(1992) Biosci. Biotech. Biochem, Vol. 56(9), pp. 14291433־] investigated the effect of a 20-kDa protein of Bti, which is necessary for the efficient lb expression of the 27-kDa mosquitocidal protein in E. coll, when supplied in trans. A significant increase in the production of the fused CryIVA protein, supplied by a recombinant plasmid, was observed when in the presence of the 20-kDa protein gene.
Koziel et al. [(1993) Biotechnology, V01.ll, pp. 194-200] describe the generation of elite transgenic maize plants expressing a truncated version of the CryIA(b) protein derived from Bacillus thuringiensis. Plants expressing high levels of the insecticidal protein exhibited outstanding resistance to repeated heavy infestations of the European corn borer.
In US 5,262,158, novel isolates of Bacillus thuringiensis are described, which are active against acaride pests. The genes encoding novel toxins from Bacillus thuringiensis strains PS52A1 and PS69D1 were cloned and characterized. In addition, Bacillus thuringiensis isolates were tested for their activity against mites.
WO 94/21795 describes the characterization of pesticidal proteins and auxiliary proteins of Bacillus strains which are produced during vegetative growth. In particular, this publication describes the isolation, purification and characterization of Corn Rootworm active protein from strains AB78, AB81, AB6 and AB88. Other strains of Bacillus sp. were also isolated and characterized.
WO 95/15383 describes the characterization of a mosquitocidal toxin encoded by the B. sphaericus mtx gene.
All parts of the present description related to the following deposited strains: NRRL B-21221, NRRL B-21222<sub>A</sub>NRRL B-21223, NRRL B-21224, NRRL B-21225, NRRL B-21226, NRRL B-21227, NRRL B-21228, NRRL B-21229, NRRL B-21230, NRRL B-21058, NRRL B-21059, NRRL B-21060 and NRRL B-21061; and SEQ ID Nos. 118־ bearthe filing date of the Israeli application, i.e., September 21, 1995. These strains and sequences are physically post-dated herein.
All parts of the present description related to the following deposited strains: NRRL B-21422, NRRL B-21423, NRRL B-21438 and NRRL B-21439; and SEQ ID Nos. 19-50 bear the date of the second priority document, i.e., June 5,1995. These strains and sequences are physically post-dated herein.
All parts of the present description related to SEQ ID Nos. 51 and 52 bear their Israeli filing date, i.e., September 27,1995. These sequences are physically post-dated herein.
1c
Summary of the Invention
In a first aspect,׳ the present . invention provides a .DNA molecule encoding a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp., said DNA molecule being complementary to a- sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO. 31 and SEQ ID NO: 51 at 65°C in a buffer comprising 7% SDS and 0.5 M sodium phosphate.
In one embodiment, said DNA molecule encodes a protein as defined by SEQ ID NO: 29, SEQ ID NO: 32, and SEQ ID NO: 52, and said DNA molecule has the nucleotide sequence given in SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 31, or SEQ ID NO: <sup>51</sup>- . ' '
In another embodiment, said DNA molecule comprises a nucleotide sequence that has been wholly or partially synthesized using plant preferred codons, having the sequence given in SEQ ID NO: 30 or SEQ ID NO: 51.
In another embodiment, said DNA molecule comprises a nucleotide sequence that has been wholly or partially optimized synthesized using codons preferred by microorganisms.
In a further embodiment, said DNA molecule is obtainable by a process comprising the steps of: (i) obtaining a DNA molecule comprising a nucleotide sequence encoding a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp.; (ii) hybridizing said DNA molecule with a DNA. molecule complementary to a nucleotide sequence selected from the group consisting of SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 31 and SEQ ID NO:51; and (iii) isolating said.hybridized DNA.
, Id 115382/1
In another aspect, the present invention provides an expression cassette comprising a DNA molecule as described in the invention, operably linked to expression sequences including the transcriptional and translational regulatory signals necessary for expression of the associated DNA constructs in a host organism and optionally further regulatory sequences. Preferably, the host organism is a plant.
The present invention also provides a vector molecule comprising an expression cassette as described above.
In a further aspect, the present invention provides a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp. encoded by a DNA molecule as described in the invention, said protein having a molecular weight of about 60 to about 100 kDa,. and the amino acid sequence given in SEQ ID NO: 29 or SEQ ID NO: 32.
In one embodiment, said protein which may be isolated during the vegetative growth phase of Bacillus thuringiensis AB88 is deposited under the Accession Number NRRL B-21225, or Bacillus thuringiensis AB424 deposited under the Accession Number NRRL B-21439.
.In another further aspect, the present invention provides a host organism comprising a DNA molecule according to the invention, an expression cassette comprising said DNA molecule, or a vector molecule comprising said expression cassette, preferably stably incorporated into the genome of the host organism, said host organism being selected from the group consisting of plant and insect cells, bacteria, yeast, baculoviruses, protozoa, nematodes and algae.
In one particular embodiment, said host is a microorganism transformed with an expression cassette or.a vector molecule according to the invention, characterized in that said microorganism is preferably a microorganism that multiplies
I le ' ’ 115382/1 on plants. Preferably, characterized in that the microorganism is Bacillus thuringiensis AB88 deposited under the Accession Number NRRL B-21225, or Bacillus thuringiensis AB424 deposited under the Accession Number NRRL B-21439.
In another aspect, the present invention provides a transgenic plant expressing a vegetative . insecticidal protein according as described in the invention, including parts as well as progeny and seed thereof stably transformed with a DNA molecule or an expression cassette according to the invention. Said plant may further express Bt δ-endotoxm as a second distinct insect control principle. Preerably, said plant is a maize plant.
In one particular embodiment, said plant is a hybrid plant.
In yet another aspect the present invention provides a seed of a plant according to the invention, treated with a seed protecting coating.
In another even further aspect, the present invention provides a method for isolating a DNA molecule according to the invention, said method comprising:(i) obtaining a DNA molecule comprising a nucleotide sequence encoding a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp.; (ii) hybridizing said DNA molecule with a DNA molecule complementary to a nucleotide sequence selected from the group consisting of SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 31 or SEQ ID NO:51; and (iii)isolating hybridized DNA.
The invention further provides a method of increasing insect target range characterized in that an expression cassette as described in the invention is expressed in a plant together with at least . one second insecticidal protein that is different from the vegetative insecticidal protein encoded by said expression cassette.
If
115382/.1
In one embodiment of said method, the second insecticidal protein is selected from the group consisting of Bt δendotoxins, protease inhibitors, lectins, a-amylases and peroxidases.
In yet another aspect the present invention provides a method of protecting plants against damage caused by an insect pest comprising transforming said plants with a DNA molecule encoding a vegetative insecticidal protein secreted during the vegetative growth phase of Bacillus spp ., said DNA molecule being complementary to a sequence which hybridizes with a nucleotide selected from the group consisting of SED ID NO:28, SEQ ID NO: 30,.SEQ ID NO: 31 and SEQ ID NO: 51 at 65°C in a buffer comprising 7% SDS and 0.5 M sodium phosphate.
Finally, the present invention provides a method of producing a plant or plant cell expressing a vegetative insecticidal protein comprising transforming said plant or plant cell with an expression cassette or a vector-molecule according to the invention.
Detailed Description of the Invention
Within the present invention compositions and methods for controlling plant pests are provided. In particular, novel pesticidal proteins are provided which are produced during vegetative growth .of Bacillus strains. The proteins are useful as pesticidal agents.
More specifically, the present invention relates to a substantially purified Bacillus strain which produces a pesticidal protein during vegetative growth wherein said Bacillus is not B. sphaericus SSI 1-1. Preferred are a Bacillus cereus strain having Accession No. NRRL B-21058 and Bacillus thuringiensisstrain having Accession No. NRRL B-21060. Also preferred is a Bacillus strain selected from Accession Numbers NRRL B-21224, NRRL B-21225, NRRL B-21226, NRRL B-21227, NRRL B-21228, NRRL B-21229, NRRL B-21230, and NRRL B-21439.
The invention further relates to an insect-specific protein isolatable during the vegetative growth phase of Bacillus spp, but preferably of a Bacillus thuringiensis and
B. cereus strain, and components thereof, wherein said protein is not the mosquitocidal toxin from B. sphaericus SSII-1. The insect-specific protein of the invention is preferably toxic to Coleoptera or Lepidoptera insects and has a molecular weight of about 30 kDa or greater, preferably of about 60 to about 100 kDa, and more preferably of about 80 kDa.
More particularly, the insect-specific protein of the invention has a spectrum of insecticidal activity that includes an activity against Agrotis and/or Spodoptera species, but preferably a black cutworm [Agrotis ipsilon; BCW] and/or fall armyworm [Spodoptera frugiperda] and/or beet armyworm [Spodoptera exigua ] and/or tobacco budworm and/or.corn earworm [Helicoverpa zea] activity.
The insect-specific protein of the invention can preferably be isolated, for example, from Bacillus cereus having Accession No. NRRL B-21058, or from Bacillus thuringiensis having Accession No. NRRL B-21060.
The insect-specific protein of the invention can also preferably be isolated from a Bacillus spp strain selected from Accession Numbers NRRL B-21224, NRRL B21225, NRRL B-21226, NRRL B-21227, NRRL B-21228, NRRL B-21229, NRRL B21230, and NRRL B-21439.
The present invention especially encompasses an insect-specific protein that has the amino acid sequence selected from the group consisting of SEQ ID NO:5 and
SEQ ID N0:7, including any proteins that are structurally and/or functionally homologous thereto.
Further preferred is an insect-specific protein, wherein said protein has the sequence selected from the group consisting of SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:29SEQ ID NO:32 and SEQ ID<sup>;</sup>NO:2, including any proteins that are structurally and/or functionally homologous thereto.
Especially preferred is an insect-specific protein, wherein said protein has the sequence selected from the group consisting of SEQ ID NO:29 and SEQ ID NO:32, including any proteins that are structurally and/or functionally homologous thereto.
A further preferred embodiment of the invention comprises an insect-specific protein of the invention, wherein the sequences representing the secretion signal have been removed or inactivated.
The present invention further encompasses auxiliary proteins which enhance the insect-specific activity of an insect-specific protein. The said auxiliary proteins preferably have a molecular weight of about 50 kDa and can be isolated, for example, from the vegetative growth phase of a Bacillus cereus strain, but especially of Bacillus cereus strain AB78.
A preferred embodiment of the invention relates to an auxiliary protein, wherein the sequences representing the secretion signal have been removed or inactivated.
The present invention further relates to multimeric pesticidal proteins, which comprise more than one polypeptide chain and wherein at least one of the said polypeptide chains represents an insect-specific protein of the invention and at least one of the said polypeptide chains represents an auxiliary protein of the invention, which activates or enhances the pesticidal activity of the said insect-specific protein.
The multimeric pesticidal proteins according to the invention preferably have a molecular weight of about 50 kDa to about 200 kDa.
i
The invention especially encompasses a multimeric pesticidal protein, which comprises an insect-specific protein of the invention and an auxiliary protein according to the invention, which activates or enhances the pesticidal activity of the said insectspecific protein.
The present invention further relates to fusion proteins comprising several protein domains including at least an insect-specific protein of the invention and/or an auxiliary protein according to the invention produced by in frame genetic fusions, which, when translated by ribosomes, produce a fusion protein with at least the combined attributes of the insect-specific protein of the invention and/or an auxiliary protein according to the invention and, optionally, of the other components used in the fusion.
A specific embodiment of the invention relates to a fusion protein comprising a ribonuclease S־protein, an insect-specific protein of the invention and an auxiliary protein according to the invention.
A further specific embodiment of the invention relates to a fusion protein comprising an insect-specific protein according to the invention and an auxiliary protein according to the invention having either the insect-specific protein or the auxiliary protein at the N-terminal end of the said fusion protein.
Preferred is a fusion protein, which comprises an insect-specific protein as given in SEQ ID ׳NO:5 and an auxiliary protein as given in SEQ ID NO: 2 resulting in the protein given in SEQ ID NO: 23, including any proteins that are structurally and/or functionally homologous thereto.
Also preferred is a fusion protein, which comprises an insect-specific protein as given in SEQ ID NO:35 and an auxiliary protein as given in SEQ ID NO: 27 resulting in the protein given in SEQ ID NO: 50, including any proteins that are structurally and/or functionally homologous thereto.
The invention further relates to a fusion protein comprising an insect-specific protein of the invention and/or an auxiliary protein according to the invention fused to a signal sequence, preferably a secretion signal sequence or a targeting sequence that directs the transgene product to a specific organelle or cell compartment, which signal sequence is of herterologous origin with respect to the recipient protein.
Especially preferred within this invention is a fusion protein wherein the said, protein has a sequence as given in SEQ ID NO: 43, or in SEQ ID NO: 46, including any proteins 'that are structurally and/or functionally homologous thereto.
As used in the present application, substantial sequence homology means close structural relationship between sequences of amino acids. For example, substantially homologous proteins may be 40% homologous, preferably 50% and most preferably 60% or 80% homologous, or more. Homology also includes a relationship wherein one or several subsequences of amino acids are missing, or subsequences with additional amino acids are interdispersed.
A further aspect of the invention relates to a DNA molecule comprising a nucleotide sequence which encodes an insect-specific protein isolatable during the vegetative growth phase of Bacillus spp. and components thereof, wherein said protein is not the mosquitocidal toxin from B. sphaericus SSII-1. In particular, the present invention relates to a DNA molecule comprising a nucleotide sequence which encodes an insect-specific protein wherein the spectrum of insecticidal activity includes an activity against Agrot/s and/or Spodoptera species, but preferably a black cutworm [Agrotis ipsilon; BCW] and/or fall armyworm [Spodoptera frugiperda] and/or beet armyworm [Spodoptera exigua ] and/or tobacco budworm and/or corn earworm [Helicoverpa zea] activity.
Preferred is a DNA molecule, wherein the said molecule comprises a nucleotide sequence as given in SEQ, ID NO: 4, or SEQ ID NO: 6, including any DNA molecules that are structurally and/or functionally homologous thereto.
Also ;preferred is a DNA molecule, wherein the said molecule comprises a nucleotide sequence as given SEQ ID NO:19, SEQ ID NO:28, SEQ ID NO:31, or SEQ ID NO:1־, including any DNA molecules that are structurally and/or functionally homologous thereto.
The invention further relates to a DNA molecule comprising a nucleotide sequence which encodes an auxiliary protein according to the invention which enhances the insect-specific activity of an insect-specific protein.
Preferred is a DNA molecule, wherein the said molecule comprises a nucleotide sequence as given SEQ ID NO:19, including any DNA molecules that are structurally and/or functionally homologous thereto.
A further embodiment of the invention relates to a DNA molecule comprising a nucleotide sequence which encodes an insect-specific protein isolatable during the vegetative growth phase of Bacillus spp. and components thereof, wherein said protein is not the mosquitocidal toxin from B. sphaericus SSII-1, which nucleotide sequence has been optimized for expression in a microorganism or a plant.
Preferred is a DNA molecule, wherein the said molecule comprises a nucleotide sequence as given in SEQ ID NO:17 or SEQ ID NO:18, including any DNA molecules that are structurally and/or functionally homologous thereto.
Also preferred is a DNA molecule, wherein the said molecule comprises a nucleotide sequence as given in SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:27, or
SEQ ID NO:30, including any DNA molecules that are structurally and/or functionally homologous thereto.
The invention further relates to a DNA molecule which comprises a nucleotide sequence encoding a multimeric pesticidal protein, which comprises more than one polypeptide chains and wherein at least one of the said polypeptide chains represents an insect-specific protein of the invention and at least one of the said polypeptide chains represents an auxiliary protein according to the invention, which activates or enhances the pesticidal activity of the said insect-specific protein.
Preferred is a DNA molecule comprising a nucleotide sequence encoding an insect-specific protein of the invention and an auxiliary protein according to the invention, which activates or enhances the pesticidal activity of the said insect-specific protein.
Especially preferred is a DNA molecule, wherein said molecule comprises a nucleotide sequence as given in SEQ ID NO:1 or SEQ ID NO:19, including any nucleotide sequences that are structurally and/or functionally homologous thereto. A further embodiment of the invention relates to a DNA molecule which comprises a nucleotide sequence encoding a fusion protein comprising several protein domains including at least an insect-specific protein of the invention and/or an auxiliary protein according to the invention produced by in frame genetic fusions, which, when translated by ribosomes, produce a fusion protein with at least the combined attributes of the irisect-specific protein of the invention and/or an auxiliary protein according to the invention and, optionally, of the other components used in the fusion.
Preferred within the invention is a DNA molecule which comprises a nucleotide sequence encoding a fusion protein comprising an insect-specific protein according to the invention and an auxiliary protein according to the invention having either the insect-specific protein or the auxiliary protein at the N-terminal end of the said fusion protein.; Especially preferred is a DNA molecule, wherein the said molecule comprises a nucleotide sequence as given in SEQ ID NO:22, including any DNA molecules that are structurally and/or functionally homologous thereto.
The invention further relates to a DNA molecule which comprises a nucleotide sequence encoding a fusion protein comprising an insect-specific protein of the invention and/or an auxiliary protein of the invention fused to a signal sequence, preferably a secretion signal sequence or a targeting sequence that directs the transgene product to a specific organelle or cell compartment, which signal sequence is of herterologous origin with respect to the recipient DNA.
The present invention further encompasses a DNA molecule comprising a nucleotide sequence encoding a fusion protein or a mulitmeric protein according to the invention that has been optimized for expression in a microorganism or plant.
Preferred is an optimized DNA molecule, wherein the said molecule comprises a nucleotide sequence as given in SEQ ID NO:42, SEQ ID NO:45, or SEQ ID NO:49, including any DNA molecules that are structurally and/or functionally homologous thereto.
The invention further relates to an optimized DNA molecule, wherein the sequences encoding the secretion signal have been removed from its 5' end, but especially to an optimized DNA molecule, wherein the said molecule comprises a nucleotide sequence as given in SEQ ID NO: 35 or SEQ ID NO:39, including any DNA molecules that are structurally and/or functionally homologous thereto.
As used in the present application, substantial sequence homology means close structural relationship between sequences of nucleotides. For example, substantially homologous DNA molecules, may be 60% homologous, preferably 80% and most preferably 90% or 95% homologous, or more. Homology also includes a relationship wherein one or several subsequences of nucleotides or amino acids are missing, or subsequences with additional nucleotides or amino acids are interdispersed.
Also comprised by the present invention are DNA molecules which hybridizes to a DNA molecule according to the invention as defined hereinbefore, but preferably to an oligonucleotide probe obtainable from said DNA molecule comprising a contiguous portion of the coding sequence for the said insect-specific protein at least 10 nucleotides in length, under moderately stringent conditions and which molecules have insect-specific activity and also the insect-specific proteins being encoded by the said DNA molecules.
Preferred are DNA molecules, wherein hybridization occurs at 65°C in a buffer comprising 7% SDS and 0.5 M sodium phosphate.
Especially preferred is a DNA molecule comprising a nucleotide sequence which encodes an insect-specific protein according to the invention obtainable by a process comprising (a) obtaining a DNA molecule comprising a nucleotide sequence encoding an insectspecific protein; and (b) hybridizing said DNA molecule with an oligonucleotide probe acording to claim 107 obtained from a DNA molecule comprising a nucleotide sequence as given in SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 31; and (c) isolating said hybridized DNA.
The invention further relates to an insect-specific protein, wherein the said protein is encoded by a DNA molecule according to the invention.
Also encompassed by the invention is an expression cassette comprising a DNA molecule according to the invention operably linked to expression sequences including the transcriptional and translational regulatory signals necessary for expression of the associated DNA constructs in a host organism, preferably a microorganism or a plant, and optionally further regulatory sequences.
The invention further relates to a vector molecule comprising an expression cassette-according to the invention.
The expression cassette and/or the vector molecule according to the invention are preferably part of the plant genome.
A further embodiment of the invention relates to a host organism, preferably a host organism selected from the group consisting of plant and insect cells, bacteria, yeast, baculoviruses, protozoa, nematodes and algae, comprising a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette, preferably stably incorporated into the genome of the host organism.
The invention further relates to a transgenic plant, but preferably a maize plant, including parts as well as progeny and seed thereof comprising a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette, preferably stably incorporated into the plant genome.
Preferred is a transgenic plant including parts as well as progeny and seed thereof which has been stably transformed with a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette.
Also preferred is a transgenic plant including parts as well as progeny and seed thereof which expresses an insect-specific protein according to the invention.
The invention further relates to a transgenic plant, preferably a maize plant, according to the invention as defined hereinbefore, which further expresses a second distinct insect control principle, but preferably a Bt δ-endotoxin. The said plant is preferably a hybrid plant.
Parts of transgenic plants are to be understood within the scope of the invention to comprise, for example, plant cells, protoplasts, tissues, callus, embryos as well as flowers, stems, fruits, leaves, roots originating in transgenic plants or their progeny previously transformed with a DNA molecule according to the invention and therefore consisting at least in part of transgenic cells, are also an object of the present invention.
The invention further relates to plant propagating material of a plant according to the invention, which is treated with a seed protectant coating.
The invention further encompasses a microorganism transformed with a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette, wherein the said microorganism is preferably a microorganism that multiply on plants and more preferably a root colonizing bacterium.
A further embodiment of the invention relates to an encapsulated insect-specific protein which comprises a microorganism comprising an insect specific protein according to the invention.
The invention also relates to an entomocidal composition comprising a host organism of the invention, but preferably a purified Bacillus strain, in an insecticidallyeffective amount together with a suitable carrier.
Further comprised by the invention is an entomocidal composition comprising an isolated protein molecule according to the invention, alone or in combination with a host organism of the invention and/or an encapsulated insect-specific protein according to the invention, in an insecticidally-effective amount, together with a suitable carrier.
A further embodiment of the invention relates to a method of obtaining a purified insect-specific protein according to the invention, said method comprising applying a solution comprising said insect-specific protein to a NAD column and eluting bound protein.
Also comprised is a method for identifying insect activity of an insect-specific protein according to the invention, said method comprising:
growing a Bacillus strain in a culture;
obtaining supernatant from said culture;
allowing insect larvae to feed on diet with said supernatant; and, determining mortality.
Another aspect of the invention relates to a method for isolating an insect-specific protein according to the invention, said method comprising:
growing a Bacillus strain in a culture;
obtaining supernatant from said culture; and, isolating said insect-specific protein from said supernatant.
The invention also encompasses a method for isolating a DNA molecule comprising a nucleotide sequence encoding an insect-specific protein exhibiting the insecticidal activity of the proteins according to the invention, said method comprising: obtaining a DNA molecule comprising a nucleotide sequence encoding an insect-specific protein; and hybridizing said DNA molecule with DNA obtained from a Bacillus species; and isolating said hybridized DNA.
The invention further relates to a method of increasing insect target range by using an insect specific protein according to the invention in combination with at least one second insecticidal protein that is different from the insect specific protein according to the invention, but preferably with an insecticidal protein selected from the group consisting of Bt δ-endotoxins, protease inhibitors, lectins, a-amylases and peroxidases.
Preferred is a method for increasing insect target range within a plant by expressing within the said plant a insect specific protein according to the invention in combination with at least one second insecticidal protein that is different from the insect specific protein according to the invention, but preferably with an insecticidal protein selected from the group consisting of Bt δ-endotoxins, protease inhibitors, lectins, a-amylases and peroxidases.
Also comprised is a method of protecting plants against damage caused by an insect pest, but preferably by Spodoptera and/or Agrotis species, and more preferably by an insect pest selected from the group consisting of black cutworm [Agrotis ipsilon; BOW], fall armyworm [Spodoptera frugiperda], beet armyworm [Spodoptera exigua ], tobacco budworm and corn earworm [Helicoverpa zea] comprising applying to the plant or the growing area of the said plant an entomocidal composition or a toxin protein !according to the invention;
The invention further relates to method of protecting plants against damage caused by an insect pest, but preferably by Spodoptera and/or Agrotis species, and more preferably by an insect pest selected from the group consisting of black cutworm [Agrotis ipsilon; BOW], fall armyworm [Spodoptera frugiperda], beet armyworm [Spodoptera exigua ], tobacco budworm and corn earworm [Helicoverpa zea] comprising planting a transgenic plant expressing a insect-specific protein according to the invention within an area where the said insect pest may occur.
The invention also encompasses a method of producing a host organism which comprises stably integrated into its genome a DNA molecule according to the invention and preferably expresses an insect-specific protein according to the invention comprising transforming the said host organism with a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette.
A further embodiment of the invention relates to a method of producing a transgenic plant or plant cell which comprises stably integrated into the plant genome a DNA molecule according to the invention and preferably expresses an insectspecific<sup>1</sup> protein according to the invention comprising transforming the said plant and plant cell, respectively, with a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette.
The invention also relates to a method of producing an entomocidal composition comprising mixing an isolated Bacillus strain and/or a host organism and/or an isolated protein molecule, and/or an encapsulated protein according to the invention in an insecticidally-effective amount with a suitable carrier.
The invention also encompasses a method of producing transgenic progeny of a transgenic parent plant comprising stably incorporated into the plant genome a DNA molecule comprising a nucleotide sequence encoding an insect-specific protein according to the invention comprising transforming the said parent plant with a DNA molecule according to the invention, an expression cassette comprising the said DNA molecule or a vector molecule comprising the said expression cassette and transferring the pesticidal trait to the progeny of the said transgenic parent plant involving known plant breeding techniques.
Also encompassed by the invention is oligonucleotide probe capable of specifically hybridizing to a nucleotide sequence encoding a insect-specific protein isolatable during the vegetative growth phase of Bacillus spp. and components thereof, wherein said protein is not the mosquitocidal toxin from B. sphaericus SSII-1, wherein said probe comprises a contiguous portion of the coding sequence for the said insectspecific protein at least 10 nucleotides in length and the use of the said oligonucleotide probe for screening of any Bacillus strain or other organisms to determine whether the insect-specific protein is naturally present or whether a particular transformed organism includes the said gene
The present invention recognizes that pesticidal proteins are produced during vegetative growth of Bacillus strains. Having recognized that such a class exists, the present invention embraces all vegetative insecticidal proteins, hereinafter referred to as VIPs, except for the mosquitocidal toxin from B. sphaericus.
The present VIPs are not abundant after sporulation and are particularly expressed during log phase growth before stationary phase. For the purpose of the present invention vegetative growth is defined as that period of time before the onset of sporulation. Genes encoding such VIPs can be isolated, cloned and transformed into various delivery vehicles for use in pest management programs.
For purposes of the present invention, pests include but are not limited to insects, fungi, bacteria, nematodes, mites, ticks, protozoan pathogens, animal-parasitic liver flukes, and the like. Insect pests include insects selected from the orders Coleoptera, Diptera.iHymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera, Trichoptera, etc., particularly Coleoptera and Lepidoptera.
Tables 1 -10 gives a list of pests associated with major crop plants and pests of human and veterinary importance. Such pests are included within the scope of the present invention.
TABLE 1
Lepidootera (Butterflies and Moth)
Maize
Ostrinia nubilalis, European corn borer
Agrotis ipsilon, black cutworm
Helicoverpa zea, corn earworm
Spodoptera frugiperda, fall armyworm
Diatraea grandiosella, southwestern corn borer Elasmopalpus lignosellus, lesser cornstalk borer
Diatraea saccharalis, sugarcane borer
Sorghum
Chilo partellus, sorghum borer
Spodoptera frugiperda, fall armyworm
Helicoverpa zea, corn earworm
Elasmopalpus lignosellus, lesser cornstalk borer Feltia subterranea, granulate cutworm
Wheat
Pseudaletia unipunctata, army worm
Spodoptera frugiperda, fall armyworm
Elasmopalpus lignosellus, lesser cornstalk borer Agrotis orthogonia, pale western cutworm
Elasmopalpus lignosellus, lesser cornstalk borer
Sunflower
Suleima helianthana, sunflower bud moth
Homoeosoma electellum, sunflower moth
Cotton
Heliothis virescens, cotton boll worm
Helicoverpa zea, cotton bollworm
Spodoptera exigua, beet armyworm
Pectindphora gossypiella, pink bollworm
Rice
Diatraea saccharalis, sugarcane borer
Spodoptera frugiperda, fall armyworm
Helicoverpa zea, corn earworm
Soybean
Pseudoplusia includens, soybean looper
Anticarsia gemmatalis, velvetbean caterpillar
Plathypena scabra, green cloverworm
Ostrinia nubilalis, European corn borer
Agrotis ipsilon, black cutworm
Spodoptera exigua, beet armyworm
Heliothis virescens, cotton boll worm
Helicoverpa zea, cotton bollworm
Barley
Ostrinia nubilalis, European corn borer
Agrotis ipsilon, black cutworm
TABLE 2
Coleoptera (Beetles)
Maize
Diabrotica virgifera virgifera, western corn rootworm
Diabrptica longicornis barberi, northern corn rootworm
Diabrotica undecimpunctata howardi, southern corn rootworm
Melanotus spp., wireworms
Cyclocephala borealis, northern masked chafer (white grub)
Cycldcephala immaculata, southern masked chafer (white grub)
Popillia japonica, Japanese beetle
Chaetocnema pulicaria, corn flea beetle
Sphenophorus maidis, maize billbug
Sorghum
Phyllophaga crinita, white grub
Eleodes, Conoderus, and Aeolus spp., wireworms
Oulema melanopus, cereal leaf beetle
Chaetocnema pulicaria, corn flea beetle
Sphenophorus maidis, maize billbug
Wheat <sup>;</sup>
Oulema melanopus, cereal leaf beetle
Hypera punctata, clover leaf weevil
Diabrotica undecimpunctata howardi, southern corn rootworm
Sunflower
Zygogramma exclamationis, sunflower beetle Bothyrus gibbosus, carrot beetle
Cotton <sub>(</sub>
Anthonomus grandis, boll weevil
Rice
Colaspis brunnea, grape colaspis Lissorhoptrus oryzophilus, rice water weevil
Sitophilus oryzae, rice weevil
Soybean
Epilachna varivestis, Mexican bean beetle
TABLE 3
Homoptera (Whiteflies, Aphids etc.)
Maize
Rhopalosiphum maidis, corn leaf aphid Anuraphis maidiradicis, corn root aphid
Sorghum
Rhopalosiphum maidis, corn leaf aphid
Sipha flava, yellow sugarcane aphid
Wheat '
Russian wheat aphid
Schizaphis graminum, greenbug
Macrosiphum avenae, English grain aphid
Cotton
Aphis gossypii, cotton aphid
Pseudatomoscelis seriatus, cotton fleahopper
Trialeurodes abutilonea, bandedwinged whitefly
Rice
Nephptettix nigropictus, rice leafhopper i
Soybean
Myzus persicae, green peach aphid
Empoasca fabae, potato leafhopper
Barley
Schizaphis graminum, greenbug
Oil Seed Rape
Brevicoryne brassicae, cabbage aphid
TABLE 4
Hemiptera (Bugs)
Maize
Blissus leucopterus leucopterus, chinch bug
Sorghum
Blissus leucopterus leucopterus, chinch bug
Cotton
Lygus lineolaris, tarnished plant bug
Rice
Blissus leucopterus leucopterus, chinch bug
Acrosternum hilare, green stink bug
Soybean
Acrosternum hilare, green stink bug
Barley
Blissus leucopterus leucopterus, chinch bug
Acrosternum hilare, green stink bug Euschistus serves, brown stink bug
TABLE 5
Qrthoptera (Grasshoppers, Crickets, and Cockroaches)
Maize
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus sanguinipes, migratory grasshopper
Wheat
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus differentialis, differential grasshopper
Melanoplus sanguinipes, migratory grasshopper
Cotton
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus differentialis, differential grasshopper
Soybean
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus differentialis, differential grasshopper
Structural/Household
Periplaneta americana, American cockroach
Blattella germanica, German cockroach
Blatta orientalis, oriental cockroach
TABLE 6
Diptera (Flies and Mosquitoes)
Maize
Hylemya platura, seedcorn maggot
Agromyza parvicornis, corn blotch leafminer
Sorghum
Contarinia sorghicola, sorghum midge
Wheat
Mayetiola destructor, Hessian fly
Sitodiplosis mosellana, wheat midge
Meromyza americana, wheat stem maggot
Hylemya coarctata, wheat bulb fly
Sunflower
Neolasioptera murtfeldtiana, sunflower seed midge
Soybean
Hy/emya p/atura, seedcorn maggot
Barley
Hylemya platura, seedcorn maggot
Mayetiola destructor, Hessian fly
Insects attacking humans and animals and disease carriers
Aedes aegypti, yellowfever mosquito
Aedes albopictus, forest day mosquito
Phlebotomus papatasii, sand fly
Musca domestica, house fly
Tabanus atratus, black horse fly
Cochliomyia hominivorax, screwworm fly
TABLE 7
Thvsanoptera (Thrips)
Maize
Anaphothrips obscurus, grass thrips
Wheat
Frankliniella fusca, tobacco thrips
Cotton
Thrips tabaci, onion thrips
Frankliniella fusca, tobacco thrips
Soybean
Sericothrips variabilis, soybean thrips
Thrips tabaci, onion thrips
TABLE 8
Hymenoptera (Sawflies, Ants, Wasps, etc.)
Maize
Solenopsis milesta, thief ant
Wheat
Cephas cinctus, wheat stem sawfly
TABLE 9
Other Orders and Representative Species
Dermaptera (Earwigs)
Forficula auricularia, European earwig
Isoptera (Termites)
Reticulitermes flavipes, eastern subterranean termite
Mallophaga (Chewing Lice)
Cuclotogaster heterographa, chicken head louse
Bovicola bovis, cattle biting louse
Anoplura (Sucking Lice)
Pediculus humanus, head and body louse
Siphonaptera (Fleas)
Ctenocephalides felts, cat flea
TABLE 10
Acari (Mites and Ticks)
Maize
Tetranychus urticae, twospotted spider mite
Sorghum
Tetranychus cinnabarinus, carmine spider mite
Tetranychus urticae, twospotted spider mite
Wheat
Aceria tulipae, wheat curl mite
Cotton
Tetranychus cinnabarinus, carmine spider mite
Tetranychus urticae, twospotted spider mite
Soybean
Tetranychus turkestani, strawberry spider mite
Tetranychus urticae, twospotted spider mite
Barley
Petrobia latens, brown wheat mite
Important human and animal Acari
Demacentor variabilis, American dog tick
Argas persicus, fowl tick
Dermatophagoides farinae, American house dust mite
Dermatophagoides pteronyssinus, European house dust mite
Now that it has been recognized that pesticidal proteins can be isolated from the vegetative growth phase of Bacillus, other strains can be isolated by standard techniques and tested for activity against particular plant and non-plant pests. Generally Bacillus strains can be isolated from any environmental sample, including soil, plant, insect, grain elevator dust, and other sample material, etc., by methods known in the art. See, for example, Travers et al. (1987) Appl. Environ. Microbiol. 53:1263-1266; Saleh etal. (1969) Can J. Microbiol. 15:1101-1104; DeLucca et al. (1981) Can. J. Microbiol. 27:865-870; and Norris, etal. (1981) The genera Bacillus and Sporolactobacillus, In Starr et al. (eds.), The Prokaryotes: A Handbook on Habitats, Isolation, and Identification of Bacteria, Vol. II, Springer-Verlog Berlin Heidelberg. After isolation, strains can be tested for pesticidal activity during vegetative growth. In this manner, new pesticidal proteins and strains can be identified.
Such Bacillus microorganisms which find use in the invention include Bacillus cereus and Bacillus thuringiensis, as well as those Bacillus species listed in Table 11.
TABLE 11
List of Bacillus species
Morphological Group 1
B. megaterium
B. cereus*
B. cereus var. mycoides
B. thuringiensis*
B. licheniformis
B. subtilis*
B. pumilus
B. firmus*
B. coagulans
Morphological Group 2
B. polymyxa
B. macerans
B. circulans
B. stearothermophilus
B. alvei*
B. laterosporus*
B. brevis
B. pulvifaciens
B. popilliae*
B. lentimorbus*
B. larvae*
Morphological Group 3
B. sphaericus*
B. pasteurii
Unassigned Strains
Subgroup A
B. apiarus*
B. filicolonicus
B. thiaminolyticus
B. alcalophilus
Subgroup B
B. cirroflagellosus
B. chitinosporus
B. lentus
Subgroup 0
B. badius
B. aneurinolyticus
B. macroides
B. freundenreichii
Subgroup D
B. pantothenticus
B. epiphytus
Subgroup E1
B. aminovorans
B. globisporus
B. insolitus
B. psychrophilus
Subgroup E2
B. psychrosaccharolyticus
B. macquariensis ‘־Those Bacillus strains that have been previously found associated with insects Grouping according to Parry, J.M. etal. (1983) Color Atlas of Bacillus species, Wolfe
Medical Publications, London.
In accordance with the present invention, the pesticidal proteins produced during vegetative growth can be isolated from Bacillus. In one embodiment, insecticidal proteins produced during vegetative growth, can be isolated. Methods for protein isolation are known in the art. Generally, proteins can be purified by conventional chromatography, including gel-filtration, ion-exchange, and immunoaffinity chromatography, by high-performance liquid chromatography, such as reversed-phase high-performance liquid chromatography, ion-exchange high-performance liquid chromatography, size-exclusion high-performance liquid chromatography, high-performance chromatofocusing and hydrophobic interaction chromatography, etc., by electrophoretic separation, such as one-dimensional gel electrophoresis, two-dimensional gel electrophoresis, etc. Such methods are known in the art. See for example Current Protocols in Molecular Biology, Vols. 1 and 2, Ausubel et al. (eds.), John Wiley & Sons, NY (1988). Additionally, antibodies can be prepared against substantially pure preparations of the protein. See, for example, Radka et al. (1983) J. Immunol. 128:2804; and Radka et al. (1984) Immunogenetics 19:63. Any combination of methods may be utilized to purify protein having pesticidal properties. As the protocol is being formulated, pesticidal activity is determined after each purification step.
Such purification steps will result in a substantially purified protein fraction. By substantially purified or substantially pure is intended protein which is substantially free of any compound normally associated with the protein in its natural state. Substantially pure preparations of protein can be assessed by the absence of other detectable protein bands following SDS-PAGE as determined visually or by densitometry scanning. Alternatively, the absence of other amino-terminal sequences or N-terminal residues in a purified preparation can indicate the level of purity. Purity can be verified by rechromatography of pure preparations showing the absence of other peaks by ion exchange, reverse phase or capillary electrophoresis. The terms substantially pure or substantially purified are not meant to exclude artificial or synthetic !mixtures of the proteins with other compounds. The terms are also not meant to exclude the presence of minor impurities which do not interfere with the biological activity of the protein, and which may be present, for example, due to incomplete purification.
Once purified protein is isolated, the protein, or the polypeptides of which it is comprised, can be characterized and sequenced by standard methods known in the art. For example, the purified protein, or the polypeptides of which it is comprised, may be fragmented as with cyanogen bromide, or with proteases such as papain, chymotrypsin, trypsin, lysyl-C endopeptidase, etc. (Oike etal. (1982) J. Biol. Chem. 257:9751-9758; Liu et al. (1983) Int. J. Pept. Protein Res. 21:209-215). The resulting peptides are separated, preferably by HPLC, or by resolution of gels and electroblotting onto PVDF membranes, and subjected to amino acid sequencing. To accomplish this task, the peptides are preferably analyzed by automated sequenators. It is recognized that N-terminal, C-terminal, or internal amino acid sequences can be determined. From the amino acid sequence of the purified protein, a nucleotide sequence can be synthesized which can be used as a probe to aid in the isolation of the gene encoding the pesticidal protein.
It is recognized that the pesticidal proteins may be oligomeric and will vary in molecular weight, number of protomers, component peptides, activity against particular pests, and in other characteristics. However, by the methods set forth herein, proteins active against a variety of pests may be isolated and characterized.
Once׳the purified protein has been isolated and characterized it is recognized that it may be altered in various ways including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants of the pesticidal proteins can be prepared by mutations in the DNA. Such variants will possess the desired pesticidal activity. Obviously, the mutations that will be made in the DNA encoding the variant must not place the sequence out of reading frame and preferably will not create complementary regions that could produce secondary mRNA structure. See, EP Patent Application Publication No. 75,444.
In this<sup>;</sup> manner, the present invention encompasses the pesticidal proteins as well as components and fragments thereof. That is, it is recognized that component protomers, polypeptides or fragments of the proteins may be produced which retain pesticidal activity. These fragments include truncated sequences, as well as N-terminal, C-terminal, internal and internally deleted amino acid sequences of the proteins. <sub>־</sub>
Most deletions, insertions, and substitutions of the protein sequence are not expected to produce radical changes in the characteristics of the pesticidal protein.
However, when it is difficult to predict the exact effect of the substitution, deletion, or insertion in advance of doing so, one skilled in the art will appreciate that the effect will be evaluated by routine screening assays.
The proteins or other component polypeptides described herein may be used alone or in combination. That is, several proteins may be used to control different insect pests.
Some proteins are single polypeptide chains while many proteins consist of more than one polypeptide chain, i.e., they are oligomeric. Additionally, some VIPs are pesticidally active as oligomers. In these instances, additional protomers are utilized to enhance the pesticidal activity or to activate pesticidal proteins. Those protomers which enhance or activate are referred to as auxiliary proteins. Auxiliary proteins activate or enhance a pesticidal protein by interacting with the pesticidal protein to form an.oligomeric protein having increased pesticidal activity compared to that observed in the absence of the auxiliary protein.
Auxiliary proteins activate or increase the activity of pesticidal proteins such as the VIP1 protein from AB78. Such auxiliary proteins are exemplified by, but not limited to, the VIP2 protein from AB78. As demonstrated in the Experimental section of the application, auxiliary proteins can activate a number of pesticidal proteins. Thus, in one embodiment of the invention, a plant, Parent 1, can be transformed with an auxiliary protein. This Parent 1 can be crossed with a number of Parent 2 plants transformed with one or more pesticidal proteins whose pesticidal activities are activated by the auxiliary protein.
Amongst the pesticidal proteins of the invention a new class of insect-specific proteins could be surprisingly identified within the scope of the present invention. The said proteins, which are designated throughout this application as VIP3, can be obtained from Bacillus spp strains, but preferably from Bacillus thuringiensis strains and most preferably from Bacillus thuringiensis strains AB88 and AB424. The said VIPs are present mostly in the supernatants of Bacillus cultures amounting to at least 75% of the total in strain AB88. The VIP3 proteins are further characterized by their unique spectrum of insectical acitivity, which includes an activity against Agrotis and/or Spodoptera species, but especially a black cutworm [BCW] and/or fall armyworm and/or beet armyworm and/or tobacco budworm and/or corn earworm activity.
Black cutworm is an agronomically important insect quite resistant to δ-endotoxins. Macintosh et al (1990) J Invertebr Pathol 56,258-266 report that the δ-endotoxins CrylA(b) and CrylA(c) possesses insecticidal properties against BCW with LC<sub>50</sub> of more than 80 gg and 18 gg/ml of diet respectively. The vip3A insecticidal proteins according to the invention provide >50% mortality when added in an amount of protein at least 10 to 500, preferably 50 to 350, and more preferably 200 to 300 fold lower than the amount of Cry IA proteins needed to achieve just 50% mortality. Especially preferred within the invention are vip3A insecticidal proteins which provide 100% mortality when added in an amount of protein at least 260 fold lower than the amount of CrylA proteins needed to achieve just 50% mortality.
The vip3 insecticidal proteins according to the invention are present mostly in the supernatants of the cultures and are therefore are to be classified as secreted proteins. They preferably contain in the N-terminal sequence a number of positively charged residues followed by a hydrophobic core region and are not N-terminally processed during export.
As the other pesticidal proteins reported hereto within the scope of the invention, the VIP3 proteins can be detected in growth stages prior to sporulation establishing a further clear distinction from other proteins that belong to the δ-endotoxin family. Preferably, expression of the insect-specific protein starts during mid-log phase and continues during sporulation. Owing to the specific expression pattern in combination with the high stability of the VIP3 proteins, large amounts of the VIP3 proteins can be found in supernatants of sporulating cultures. Especially preferred are the VIP3 proteins identified in SEQ ID NO:29 and SEQ ID NO:32 and the corresponding DNA molecules comprising nucleotide sequences encoding the said proteins, but especially those DNA molecules comprising the nucleotide sequences given in SEQ ID NO:28, SEQ ID NQ:30 and SEQ ID NO:31.
The pesticidal proteins of the invention can be used in combination with Bt endotoxins or other insecticidal proteins to increase insect target range. Furthermore, the use of the VIPs of the present invention in combination with Bt δ-endotoxins or other insecticidal principles of a distinct nature has particular utility for the prevention and/or management of insect resistance. Other insecticidal principles include protease inhibitors (both serine and cysteine types), lectins, a-amylase and peroxidase. In one preferred embodiment, expression of VIPs in a transgenic plant is accompanied by the expression of one or more Bt δ-endotoxins. This co-expression of more than one insecticidal principle in the same transgenic plant can be achieved by genetically engineering a plant to contain and express all the genes necessary. Alternatively, a plant, Parent 1, can be genetically engineered for the expression of VIPs. A second plant, Parent 2, can be genetically engineered for the expression of Bt δ-endotoxin. By crossing Parent 1 with Parent 2, progeny plants are obtained which express all the genes introduced into Parents 1 and 2. Particularly preferred Bt δ-endotoxins are those disclosed in EP-A 0618976, herein incorporated by reference.
A substantial number of cytotoxic proteins, though not all, are binary in action. Binary toxins typically consist of two protein domains, one called the A domain and the other called the B domain (see Sourcebook of Bacterial Protein Toxins, J. E. Alouf and J. H. Freer eds.(1991) Academic Press). The A domain possesses a potent cytotoxic activity. The B domain binds an external cell surface receptor before being internalized. Typically, the cytotoxic A domain must be escorted to the cytoplasm by a translocation domain. Often the A and B domains are separate polypeptides or protomers, which are associated by a protein-protein interaction or a di-sulfide bond. However, the toxin can be a single polypeptide which is proteolytically processed within the cell into two domains as in the case for Pseudomonas exotoxin A. In summary binary toxins typically have three important domains, a cytotoxic A domain, a receptor binding B domain and a translocation domain. The A and B domain are often associated by protein-protein interacting domains.
The receptor binding domains of the present invention are useful for delivering any protein, toxin, enzyme, transcription factor, nucleic acid, chemical or any other factor into target insects having a receptor recognized by the receptor binding domain of the binary toxins described in this patent. Similarly, since binary toxins have translocation domains which penetrate phosopholipid bilayer membranes and escort cytotoxins across those membranes, such translocation domains may be useful in escorting any protein, toxin, enzyme, transcription factor, nucleic acid, chemical or any other factor across a phospholipid bilayer such as the plasma membrane or a vesicle membrane. The translocation domain may itself perforate membranes, thus having toxic or insecticidal properties. Further, all binary toxins have cytotoxic domains; such a
- <sup>28</sup>־ . !
i cytotoxic domain may be useful as a lethal protein, either alone or when delivered into any target cell(s)> by any means.
Finally, since binary toxins comprised of two polypeptides often form a complex, it is likely that there are protein-protein interacting regions within the components of the binary toxins of the invention. These protein-protein interacting domains may be useful in forming associations between any combination of toxins, enzymes, transcription factors, nucleic acids, antibodies, cell binding moieties, or any other chemicals, factors, proteins or protein domains.
Toxins, enzymes, transcription factors, antibodies, cell binding moieties or other protein domains can be fused to pesticidal or auxiliary proteins by producing in frame genetic fusions which, when translated by ribosomes, would produce a fusion protein with the combined attributes of the; VIP and the other component used in the fusion. Furthermore, if the protein domain fused to the VIP has an affinity for another protein, nucleic acid, carbohydrate, lipid, or other chemical or factor, then a three-component complex can be formed. This complex will have the attributes of all of its components. A similar rationale can be used for producing four or more component complexes. These complexes are useful as insecticidal toxins, pharmaceuticals, laboratory reagents, and diagnostic reagents, etc. Examples where such complexes are currently used are fusion toxins for,potential cancer therapies, reagents in ELISA assays and immunoblot analysis.
One strategy of altering pesticidal or auxiliary proteins is to fuse a 15-amino-acid “Si-tag” to the protein without destroying the insect cell binding domain(s), translocation domains or protein-protein interacting domains of the proteins. The Stag has a high affinity (K<sub>d</sub> = 10’<sup>9</sup> M) for a ribonuclease S-protein, which, when bound to the S-;tag, forms an active ribonuclease (See F. M. Richards and H. W. Wyckoff! (1971) iri <sup>,</sup>'The Enzymes, Vol. IV (Boyer, P.D. ed.). pp. 647-806. Academic Press,
I . <sup>!</sup> : -
New York). The fusion can be made in such a way as to destroy or remove the ! . <sup>:</sup> i . ׳ י. ’ cytotoxic activity of the pesticidal or auxiliary protein, thereby replacing the VIP cytotoxic activity with a new cytotoxic ribonuclease activity. The final toxin would be comprised of the S-protein, a pesticidal protein and an auxiliary protein, where either the pesti'cidal protein or the auxiliary protein is produced as translational fusions with the S-tag. Similar strategies can be used to fuse other potential cytotoxins to pesticidal or auxiliary proteins including (but not limited to) ribosome inactivating proteins, insect hormones, hormone receptors, transcription factors, proteases, phosphatases, Pseudomonas exotoxin A, or any other protein or chemical factor that is lethal’when delivered into cells. Similarly, proteins can be delivered into cells which are not lethal, but might alter cellular biochemistry or physiology.
The spectrum of toxicity toward different species can be altered by fusing domains to pesticidal or auxiliary proteins which recognize cell surface receptors from other species. Such domains might include (but are not limited to) antibodies, transferrin, hormones, or peptide sequences isolated from phage displayed affinity selectable libraries. Also, peptide sequences which are bound to nutrients, vitamins, hormones, or other chemicals that are transported into cells could be used to alter the spectrum of toxicity. Similarly, any other protein or chemical which binds a cell surface receptor or the membrane and could be internalized might be used to alter the spectrum of activity of VIP1 and VIP2.
The pesticidal proteins of the present invention are.those proteins which confer a specific pesticidal property. Such proteins may vary in molecular weight, having component polypeptides at least a molecular weight of 30 kDa or greater, preferably about 50 kDa or greater.
The auxiliary proteins of the invention may vary in molecular weight, having at least a molecular weight of about 15 kDa or greater, preferably about 20 kDa or greater; more preferably, about 30 kDa or greater. The auxiliary proteins themselves may have component polypeptides.
It is possible that the pesticidal protein and the auxiliary protein may be components of a multimeric, pesticidal protein. Such a pesticidal protein which includes the auxiliary proteins as one or more of its component polypeptides may vary in molecular weight, having at least a molecular weight of 50 kDa up to at least200 ׳ kDa, preferably about 100 kDa to 150 kDa.
An auxiliary protein may be used in combination with the pesticidal proteins of the invention to enhance activity or to activate the pesticidal protein. To determine whether the auxiliary protein will affect activity, the pesticidal protein can be expressed alone and in combination with the auxiliary protein and the respective activities compared in feeding assays for pesticidal activity.
It may be beneficial to screen strains for potential pesticidal activity by testing activity of the strain alone and in combination with the auxiliary protein. In some instances an auxiliary protein in combination with the native proteins of the strains yields pesticidal activity where none is seen in the absence of an auxiliary protein.
The auxiliary protein can be modified, as described above, by various methods known in the art. Therefore, for purposes of the invention, the term Vegetative Insecticidal Protein (VIP) encompasses those proteins produced during vegetative growth which alone or in combination can be used for pesticidal activity. This includes pesticidal proteins, auxiliary proteins and those proteins which demonstrate activity only in the presence of the auxiliary protein or the polypeptide components of these proteins.
It is recognized that there are alternative methods available to obtain the nucleotide and amino acid sequences of the present proteins. For example, to obtain the nucleotide sequence encoding the pesticidal protein, cosmid clones, which express the pesticidal protein, can be isolated from a genomic library. From larger active cosmid clones, smaller subclones can be made and tested for activity. In this manner, clones Vvhich express an active pesticidal protein can be sequenced to determine the nucleotide sequence of the gene. Then, an amino acid sequence can be deduced for the protein. For general molecular methods, see, for example, Molecular Cloning, A Laboratory Manual, Second Edition, Vols. 1-3, Sambrook et al. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989), and the references cited therein.
The present invention also encompasses nucleotide sequences from organisms other than Bacillus, where the nucleotide sequences are isolatable by hybridization with the Bacillus nucleotide sequences of the invention. Proteins encoded by such nucleotide sequences can be tested for pesticidal activity. The invention also: encompasses the proteins encoded by the nucleotide sequences. Furthermore, the invention encompasses proteins obtained from organisms other than Bacillus wherein the protein cross-reacts with antibodies raised against the proteins of the invention. Again the isolated proteins can be assayed for pesticidal activity by the methods disclosed herein or others well-known in the art.
Once the nucleotide sequences encoding the pesticidal proteins of the invention have behn isolated, they can be manipulated and used to express the protein in a variety of hosts including other organisms, including microorganisms and plants.
The pesticidal genes of the invention can be optimized for enhanced expression in plants. See, for example EP-A 0618976; EP-A 0359472; EP-A 0385962; WO 91/16432; Perlak et al. (1991) Proc. Natl Acad. Sei. USA 88:3324-3328; and Murray et al. (1989) Nucleic Acids Research 17:477-498. In this manner, the genes can be synthesized utilizing plant preferred codons. That is the preferred codon for a particular host is the single codon which most frequently encodes that amino acid in that host The maize preferred codon, for example, for a particular amino acid may be derived from known gene sequences from maize. Maize codon usage for 28 genes from maize plants is found in Murray etal. (1989), Nucleic Acids Research 17:477498, the disclosure of which is incorporated herein by reference. Synthetic genes can also be made based on the distribution of codons a particular host uses for a particular amino acid.
In this manner, the nucleotide sequences can be optimized for expression in any plant. It is recognized that all or any part of the gene sequence may be optimized or synthetic. That is, synthetic or partially optimized sequences may also be used.
In like manner, the nucleotide sequences can be optimized for expression in any microorganism. For Bacillus preferred codon usage, see, for example US Patent No. 5,024,837 and Johansen etal. (1988) Gene 65:293-304.
Methodologies for the construction of plant expression cassettes as well as the introduction of foreign DNA into plants are described in the art. Such expression cassettes may include promoters, terminators, enhancers, leader sequences, introns and other regulatory sequences operably linked to the pesticidal protein coding sequence. It is further recognized that promoters or terminators of the VIP genes can be used hn expression cassettes.
Generally, for the introduction of foreign DNA into plants Ti plasmid vectors have been utilized for the delivery of foreign DNA as well as direct DNA uptake, liposomes, electroporation, micro-injection, and the use of microprojectiles. Such methods had been published in the art. See, for example, Guerche et al., (1987) Plant Science 52:111-1.16; Neuhause etal., (1987) Theor, Appl. Genet. 75:30-36: Klein etal., (1987) Nature 327: 70-73; Howell etal., (1980) Science 208:1265: Horsch etal., (1985) Science 227:1229-1231; DeBlock et al., (1989) Plant Physiology 91:694-701; Methods for Plant Molecular Biology (Weissbach and Weissbach, eds.) Academic Press, ln‘c. (1988); and Methods in Plant Molecular Biology (Schuler and Zielinski, eds.) Academic Press, Inc. (1989). See also US patent application serial no.
08/008,374 herein incorporated by reference. See also, EP-A 0193259 and EP-A
0451878. It is understood that the method of transformation will depend upon the plant cell to be transformed.
It is further recognized that the components of the expression cassette may be modified to increase expression. For example, truncated sequences, nucleotide substitutions or other modifications may be employed. See, for example Perlak et al.
(1991) Proc. Natl. Acad. Sei. USA 88:3324-3328; Murray et al., (1989) Nucleic Acids Research 17:477-498; and WO 91/16432.
The construct may also include any other necessary regulators such as terminators, (Guerineau et al., (1991), Mol. Gen. Genet. 226:141-144; Proudfoot, (1991).,Cell, 64:671-674; Sanfacon etal., (1991). Genes Dev. 5:141-149: Mogen et al., (1990). Plant Cell. 2:1261-1272; Munroe etal., (1990). Gene. 91:151-158; Ballas etaletal., (1989). Nucleic Acids Res. 17:7891-7903; Joshi etal., (1987). Nucleic Acid Res., 15:9627-9639); plant translational consensus sequences (Joshi, C.P., (1987).׳Nucleic Acids Research, 15:6643-6653), introns (Luehrsen and Walbot,.
(1991). Mol. Gen. Genet., 225:81-93) and the like, operably linked to the nucleotide sequence. It may be beneficial to include 5' leader sequences in the expression cassette construct. Such leader sequences can act to enhance translation.
Translational leaders are known in the art and include:
Picornavirus leaders, for example, EMCV leader (encephalomyocarditis 5' noncoding region) (Elroy-Stein, 0., Fuerst, T.R., and Moss, B. (1989) PNAS USA 86:6126-6130);
Potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison etal., (1986); MDMV leader (Maize Dwarf Mosaic Virus); Virology, 154:9-20), and
Human immunoglobulin heavy-chain binding protein (BiP), (Macejak, D.G., and Sarnow, P1991) ״), Nature, 353:90-94;
Untranslated leader from the coat protein mRNA of alfalfa mosaic virus (AMV RNA 4), (Jobling, S.A., and Gehrke, L1987) ״), Nature. 325:622-625;
Tobacco mosaic virus leader (TMV), (Gallie, D.R. et al., (1989), Molecular Biology of RNA, pages 237-256; and
Maize Chlorotic Mottle Virus leader (MCMV) (Lommel, S.A. etal., (1991), Virology, 81:382-385. See also, Della-Cioppa etal., (1987), Plant Physiology, 84:965-968.
A plant terminator may be utilized in the expression cassette. See, Rosenberg et al., (1987), Gene. 56:125; Guerineau etal., (1991). Mol. Gen. Genet., 226:141-144; Proudfoot, (1991), Cell, 64:671674־; Sanfacon etal., (1991). Genes Dev. 5:141-149; Mogen eta/., (1990), Plant Cell. 2:1261-1272; Munroe eta/., (1990), Gene. 91:151158־; Ballas etal., (1989). Nucleic Acids Res. 17:7891-7903; Joshi etal., (1987). Nucleic Acid Res. 15:9627-9639.
For tissue specific expression, the nucleotide sequences of the invention can be operably linked to tissue specific promoters. See, for example, EP-A 0618976, herein incorporated by reference.
Further comprised within the scope of the present invention are transgenic plants, in particular transgenic fertile plants transformed by means of the aforedescribed processes and their asexual and/or sexual progeny, which comprise and preferably also express the pesticidal protein according to the invention. Especially preferred are hybrid plants.
The transgenic plant according to the invention may be a dicotyledonous or a monocotyledonous plant. Preferred are monocotyledonous plants of the Graminaceae family involving Lolium, Zea, Triticum, Triticale, Sorghum, Saccharum, Bromus, Oryzae, Avena, Hordeum, Secale and Setaria plants.
Especially preferred are transgenic maize, wheat, barley, sorghum, rye, oats, turf grasses and rice.
Among the dicotyledonous plants soybean, cotton, tobacco, sugar beet, oilseed rape, and sunflower are especially preferred herein.
The expression 'progeny' is understood to embrace both, asexually and sexually generated progeny of transgenic plants. This definition is also meant to include all mutants, and variants obtainable by means of known processes, such as for example cell fusion or mutant selection and which still exhibit the characteristic properties of the initially transformed parent plant, together with all crossing and fusion products of the transformed plant material.
Another object of the invention concerns the proliferation material of transgenic plants.
The proliferation material of transgenic plants is defined relative to the invention as any plant material that may be propagated sexually or asexually in vivo or in vitro. Particularly preferred within the scope of the present invention are protoplasts, cells, calli, tissues, organs, seeds, embryos, pollen, egg cells, zygotes, together with any other propagating material obtained from transgenic plants.
Parts of plants, such as for example flowers, stems, fruits, leaves, roots originating in transgenic plants or their progeny previously transformed by means of the process of the invention and therefore consisting at least in part of transgenic cells, are also an object of the present invention.
Before the plant propagation material [fruit, tuber, grains, seed], but expecially seed is sold as a commerical product, it is customarily treated with a protectant coating comprising herbicides, insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation to provide protection against damage caused by bacterial, fungal or animal pests.
In order to treat the seed, the protectant coating may be applied to the seeds either by impregnating the tubers or grains with a liquid formulation or by coating them with a combined wet or dry formulation. In addition, in special cases, other methods of application to.plants are possible, eg treatment directed at the. buds or the fruit.
The plant seed according to the invention comprising a DNA molecule comprising a nucleotide sequence encoding a pesticidal protein according to the invention may be treated with a seed protectant coating comprising a seed treatment compound, such as, for example, captan, carboxin, thiram (TMTD®), methalaxyl (Apron®) and pirimiphos-methyl (Actellic®) and others that are commonly used in seed treatment. Preferred within the scope of the invention are seed protectant coatings comprising an ehtomocidal composition according to the invention alone or in combination with one ׳ of the a seed protectant coating customarily used in seed treatment.
It is thus a further object of the present invention to provide plant propagation material for cultivated plants, but especially plant seed that is treated with a seed protectant coating as defined hereinbefore.
It is recognized that the genes encoding the pesticidal proteins can be used to transform insect pathogenic organisms. Such organisms include Baculoviruses, fungi, protozoa, bacteria and nematodes.
The Bacillus strains of the invention may be used for protecting agricultural crops and products from pests. Alternatively, a gene encoding the pesticide may be introduced via a suitable vector into a microbial host, and said host applied to the environment or plants or animals. Microorganism hosts may be selected which are known ,to occupy the phytosphere (phylloplane, phyllosphere, rhizosphere, and/or rhizoplana) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment with the wildtype microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation.
Such microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g., Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes׳, fungi, particularly yeast, e g., Saccharomyces, Cryptococcus, Kluyverpmyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular interest.are such phytosphere bacterial species as Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacteria, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus, Clavibacterxyli and Azotobacter vinlandir, and phytosphere yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Sporobolomyces rosues, S. odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms.
A number of ways are available for introducing a gene expressing the pesticidal protein into the microorganism host under conditions which allow for stable maintenance and expression of the gene. For example, expression cassettes can be constructed which include the DNA constructs of interest operably linked with the transcriptional and translational regulatory signals for expression of the DNA constructs, and a DNA sequence homologous with a sequence in the host organism, whereby integration will occur, and/or a replication system which is functional in the host, whereby integration or stable maintenance will occur.
Transcriptional and translational regulatory signals include but are not limited to promoter, transcriptional initiation start site, operators, activators, enhancers, other regulatory elements, ribosomal binding sites, an initiation codon, termination signals, and the like. See, for example, US Patent 5,039,523; US Patent No. 4,853,331; EPO
0480762A2; Sambrook et al. supra; Molecular Cloning, a Laboratory Manual, Maniatis etal. (eds) Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1982); Advanced
Bacterial Genetics, Davis et al. (eds.) Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY (1980); and the references cited therein.
Suitable host cells, where the pesticide-containing cells will be treated to prolong the activity of the toxin in the cell when the then treated cell is applied to the environment of the target pest(s), may include either prokaryotes or eukaryotes, normally being limited to those cells which do not produce substances toxic to higher organisms, such as mammals. However, organisms which produce substances toxic to higher organisms could be used, where the toxin is unstable or the level of application sufficiently low as to avoid any possibility of toxicity to a mammalian host. As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi. Illustrative prokaryotes, both Gram-negative and -positive, include Enterobacteriaceae, such as Escherichia, Erwinia, Shigella, Salmonella, and Proteus', Bacillaceae; Rhizobiceae, such as Rhizobium; Spirillaceae, such as photobacterium, Zymomonas, Serratia, Aeromonas, Vibrio, Desulfovibrio, Spirillum; Lactobacillaceae; Pseudomonadaceae, such as Pseudomonas and Acetobacter; Azotobacteraceae and Nitrobacteraceae. Among eukaryotes are fungi, such as Phycomycetes and Ascomycetes, which includes yeast, such a Saccharomyces and Schizosaccharromyces; and Basidiomycetes yeast, such as Rhodotorula, Aureobasidium, Sporobolomyces. and the like.
Characteristics of particular interest in selecting a host cell for purposes of production include ease of introducing the protein gene into the host, availability of expression systems, efficiency of expression, stability of the protein in the host, and the presence of auxiliary genetic capabilities. Characteristics of interest for use as a pesticide microcapsule include protective qualities for the pesticide, such as thick cell walls, pigmentation, and intracellular packaging or formation of inclusion bodies; leaf affinity; lack of mammalian toxicity; attractiveness to pests for ingestion; ease of killing and fixing without damage to the toxin; and the like. Other considerations include ease of formulation and handling, economics, storage stability, and the like.
Host organisms of particular interest include yeast, such as Rhodotorula sp., Aureobasidium sp., Saccharomyces sp., and Sporobolomyces sp.; phylloplane organisms such as Pseudomonas sp., Erwinia sp. and Flavobacterium sp.׳, or such other organisms as Escherichia, LactoBacillus sp., Bacillus sp., and the like. Specific organisms include Pseudomonas aeurginosa, Pseudomonas fluorescens,
Saccharomyces cerevisiae, Bacillus thuringiensis, Escherichia coli, Bacillus subtilis, and the like.
VIP genes can be introduced into micro-organisms that multiply on plants (epiphytes) to deliver VIP proteins to potential target pests. Epiphytes can be grampositive or gram-negative bacteria for example.
Root colonizing bacteria, for example, can be isolated from the plant of interest by methods known in the art. Specifically, a Bacillus cereus strain which colonizes roots could be isolated from roots of a plant (for example see J. Handelsman, S. Raffel, E. Mester; L. Wunderlich and C. Grau, Appl. Environ. Microbiol. 56:713-718, (1990)). VIP1 and/or V.IP2 and/or VIP3 could be introduced into a root colonizing Bacillus cereus by standard methods known in the art.
Specifically, VIP1 and/or VIP2 derived from Bacillus cereus strain AB78 can be introduced into a root colonizing Bacillus cereus by means of conjugation using standard methods (J. Gonzalez, B. Brown and B. Carlton, Proc. Natl. Acad. Sci. 79:6951-6955, (1982)).
Also, VIP1 and/or VIP2 and/or VIP3 or other VIPs of the invention can be introduced into the root colonizing Bacillus by means of electro-transformation. Specifically, VIPs can be cloned into a shuttle vector, for example, pHT3101 (D. Lereclus et al., FEMS Microbiol. Letts. 60:211-218 (1989)) as described in Example
10. The shuttle vector pHT3101 containing the coding sequence for the particular VIP can then be transformed into the root colonizing Bacillus by means of electroporation (D. Lereclus et al. 1989, FEMS Microbiol. Letts. 60:211 -218).
Expression systems can be designed so that VIP proteins are secreted outside the cytoplasm of gram negative bacteria, E. coli, for example. Advantages of having VIP proteins secreted are (1) it avoids potential toxic effects of VIP proteins expressed within the cytoplasm and (2) it can increase the level of VIP protein expressed and (3) can aid in efficient purification of VIP protein.
VIP proteins can be made to be secreted in E. coli, for example, by fusing an appropriate E. co//signal peptide to the amino-terminal end of the VIP signal peptide or replacing the VIP signal peptide with the E. co//signal peptide. Signal peptides recognized by E. colican be found in proteins already known to be secreted in E. coli, for example the OmpA protein (J. Ghrayeb, H. Kimura, M. Takahara, Y. Masui and M. Inouye, EMBO J., 3:24371984) 2442־)). OmpA is a major protein of the E. co//outer membrane and thus its signal peptide is thought to be efficient in the translocation process. Also, the OmpA signal peptide does not need to be modified before processing as may be the case for other signal peptides, for example lipoprotein signal peptide (G. Duffaud, P. March and M. Inouye, Methods in Enzymology, 153:492 (1987)).
Specifically, unique BamHI restriction sites can be introduced at the aminoterminal and carboxy-terminal ends of the VIP coding sequences using standard methods known in the art. These BamHI fragments can be cloned, in frame, into the vector pIN-lll-ompA 1, A2 or A3 (J. Ghrayeb, H. Kimura, M. Takahara, H. Hsiung, Y. Masui and M. Inouye, EMBO J. 3:24371984) 2442־)) thereby creating 0mpA:VIP fusion gene which is secreted into the periplasmic space. The other restriction sites in the polylinker of pIN-lll-ompA can be eliminated by standard methods known in the art so that the VIP amino-terminal amino acid coding sequence is directly after the ompA signal peptide cleavage site. Thus, the secreted VIP sequence in E. coliwoM then be identical to the native VIP sequence.
When the VIP native signal peptide is not needed for proper folding of the mature protein, such signal sequences can be removed and replaced with the ompA signal sequence. Unique BamHI restriction sites can be introduced at the amino-termini of the proprotein coding sequences directly after the signal peptide coding sequences of VIP and at the carboxy-termini of VIP coding sequence. These BamHI fragments can then be cloned into the pIN-lll-ompA vectors as described above.
General methods for employing the strains of the invention in pesticide control or in engineering other organisms as pesticidal agents are known in the art. See, for example US Patent No. 5,039,523 and EP 0480762A2.
VIPs can be fermented in a bacterial host and the resulting bacteria processed and used as a microbial spray in the same manner that Bacillus thuringiensis strains have been used as insecticidal sprays. In the case of a VIP(s) which is secreted from Bacillus, the secretion signal is removed or mutated using procedures known in the art. Such mutations and/or deletions prevent secretion of the VIP protein(s) into the growth medium during the fermentation process. The VIPs are retained within the cell and the cells are then processed to yield the encapsulated VIPs. Any suitable microorganism can be used for this purpose. Psuedomonas has been used to express
Bacillus thuringiensis endotoxins as encapsulated proteins and the resulting cells processed and sprayed as an insecticide. (H. Gaertner etal. 1993, In Advanced
Engineered Pesticides, L. Kim ed.)
Various strains of Bacillus thuringiensis are used in this manner. Such Bt strains produce endotoxin protein(s) as well as VIPs. Alternatively, such strains can produce only VIPs. A sporulation deficient strain of Bacillus subtilis has been shown to produce high levels of the Cry 111A endotoxin from Bacillus thuringiensis (Agaisse, H. and Lereclus, D., “Expression in Bacillus subtilis of the Bacillus thuringiensis CrylllA toxin gene is not dependent on a sporulation-specific sigma factor and is increased in a spoOA mutant”, J. Bacteriol., 176:4734-4741 (1994)). A similar spoOA mutant can be prepared in Bacillus thuringiensis and used to produce encapsulated VIPs which are not secreted into the medium but are retained within the cell.
To have VIPs maintained within the Bacillus cell the signal peptide can be disarmed so that it no longer functions as a secretion signal. Specifically, the putative signal peptide for VIP1 encompasses the first 31 amino acids of the protein with the putative consensus cleavage site, Ala-X-Ala, at the C-terminal portion of this sequence (G. von Heijne , J. Mol. Biol. 184:99-105 (1989)) and the putative signal peptide for VIP2 encompasses the first 40 amino acids of the protein with the putative cleavage site after Ala40. The cleavage sites in either VIP1 or VIP2 can be mutated with methods known in the art to replace the cleavage site consensus sequence with alternative amino acids that are not recognized by the signal peptidases.
Alternatively, the signal peptides of VIP1, V1P2 and/or other VIPs of the invention can be eliminated from the sequence thereby making them unrecognizable as secretion proteins in Bacillus. Specifically, a methionine start site can be engineered in front of the proprotein sequence in VIP1, starting at Asp32, or the proprotein sequence in VIP2, starting at Glu41 using methods known in the art.
VIP genes can be introduced into micro-organisms that mutiply on plants (epiphytes) to deliver VIP proteins to potential target pests. Epiphytes can be grampositive or gram-negative bacteria for example.
The Bacillus strains of the invention or the microorganisms which have been genetically altered to contain the pesticidal gene and protein may be used for
-‘40- :.
protecting agricultural crops and products from pests. In one aspect of the invention, whole, i.e., unlysed, cells of a toxin (pesticide)-producing organism are treated with reagents that prolong the activity of the toxin produced in the cell when the cell is applied to the environment of target pest(s).
Alternatively, the pesticides are produced by introducing a heterologous gene into a cellular host. Expression of the heterologous gene results, directly or indirectly, in the intracellular production and maintenance of the pesticide. These cells are then treated under conditions that prolong the activity of the toxin produced in the cell when the cell is applied to the environment Of target pest(s). The resulting product retains the toxicity of the toxin. These naturally encapsulated pesticides may then be formulated in accordance with conventional techniques for application to the environment hosting a target pest, e.g., soil, water, and foliage of plants. See, for example EPA 0192319, and the references cited therein.
The active ingredients of the present invention are normally applied in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession, with other compounds. These compounds can be both fertilizers or micronutrient donors or other preparations that influence plant growth. They can also be selective herbicides, insecticides, fungicides, bactericides, nematicides, mollusicides or mixtures of several of these preparations, if desired, together with further agriculturally acceptable carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation. Suitable carriers and adjuvants can be solid or liquid and correspond to the substances ordinarily employed in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, binders or fertilizers.
Preferred methods of applying an active ingredient of the present invention or an agrochemical composition of the present invention which contains at least one of the insect-specific proteins produced by the bacterial strains of the present invention are leaf application, seed coating and soil application. The number of applications and the rate of application depend on the intensity of infestation by the corresponding pest
The׳ present invention thus further provides an entomocidal composition comprising as an active ingrdient at least one of the novel insect-specific proteins according to the invention and/or a recombinant microorganism containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insectspecific proteins in recombinant form, but especially a recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus thuringiensis, containing at least one one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form, or a derivative or mutant thereof, together with an agricultural adjuvant such as a carrier, diluent, surfactant or application-promoting adjuvant. The composition may also contain a further biologically active compound. The said compound can be both a fertilizer or micronutrient donor or other preparations that influence plant growth. It can also be a selective herbicide, insecticide, fungicide, bactericide, nematicide, molluscide or mixtures of several of these preparations, if desired, together with further agriculturally acceptable carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation. Suitable carriers and adjuvants can be solid or liquid and correspond to the substances ordinarily employed in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, binders or fertilizers
The composition may comprise from .0.1 to 99% by weight of the active ingredient, from 1 to 99.9% by weight of a solid or liquid adjuvant, and from 0 to 25% by weight of a surfactant. The acitve ingredient comprising at least one of the novel insect-specific proteins according to the invention or a recombinant microorganism containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insectspecific proteins in recombinant form, but especially a recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus thuringiensis strain containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific; proteins in recombinant form, or a derivative or mutant thereof, or the composition containing the said acitve ingredient, may be administered to the plants or crops to be protected together with certain other insecticides or chemicals (1993 Crop Protection Chemicals Reference, Chemical and Pharmaceutical Press, Canada) without loss of potency. It is compatible with most other commonly used agricultural spray materials but should not be used in extremely alkaline spray solutions. It may be administered as a dust, a suspension, a wettable powder or in any other material form suitable for agricultural application.
The invention further provides methods for for controlling or inhibiting of insect pests by applying an active ingredient comprising at least one of the novel insectspecific proteins according to the invention or a recombinant microorganism containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form or a composition comprising the said active ingredient to (a) an environment in which the insect pest may occur, (b) a plant or plant part in order to protect said plant or plant part from damage caused by an insect pest, or (c) seed in order to protect a plant which develops from said seed from damage caused by an insect pest.
A preferred method of application in the area of plant protection is application to the foliage of the plants (foliar application), with the number of applications and the rate of application depending on the plant to be protected and the risk of infestation by the pest in question. However, the active ingredient may also penetrate the plants through the roots (systemic action) if the locus of the plants is impregnated with a liquid formulation or if the active ingredient is incorporated in solid form into the locus of the plants, for example into the soil, e.g. in granular form (soil application). In paddy rice crops, such granules may be applied in metered amounts to the flooded rice field.
The compositions according to the invention are also suitable for protecting plant propagating material, e.g. seed, such as fruit, tubers or grains, or plant cuttings, from insect pests. The propagation material can be treated with the formulation before planting: seed, for example, can be dressed before being sown. The acitve ingredient of the invention can also be applied to grains (coating), either by impregnating the grains with a liquid formulation or by coating them with a solid formulation. The formulation can also be applied to the planting site when the propagating material is being planted, for example to the seed furrow during sowing. The invention relates also to those methods of treating plant propagation material and to the plant propagation material thus treated.
The compositions according to the invention comprising as an active ingredient a recombinant microorganism containing at least one of the novel toxin genes in recombinant form, but especially a recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus thuringiensis strain containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form, or a derivative or mutant thereof may be applied in any method known for treatment of seed-or soil with bacterial strains. For example, see US Patent
N0.4,863,866. The strains are effective for biocontrol even if the microorganism is not living. Preferred is, however, the application of the living microorganism.
Target crops to be protected within the scope of the present invention comprise,
e.g., the following species of plants:
cereals (wheat, barley, rye, oats, rice, sorghum and related crops), beet (sugar beet and fodder beet), forage grasses (orchardgrass, fescue, and the like), drupes, pomes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries), leguminous plants (beans, lentils, peas, soybeans), oil plants (rape, mustard, poppy, olives, sunflowers, coconuts, castor oil plants, cocoa beans, groundnuts), cucumber plants (cucumber, marrows, melons) fiber plants (cotton, flax, hemp, jute), citrus fruit (oranges, lemons, grapefruit, mandarins), vegetables (spinach, lettuce, asparagus, cabbages and other Brassicae, onions, tomatoes, potatoes, paprika), lauraceae (avocados, carrots, cinnamon, camphor), deciduous trees and conifers (e.g. , linden-trees, yew-trees, oak-trees, alders, poplars, birch-trees, firs, larches, pines), or plants such as maize, tobacco, nuts, coffee, sugar cane, tea, vines, hops, bananas and natural rubber plants, as well as ornamentals (including composites).
A recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus thuringiensis strain, containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form is normally applied in the form of entomocidal compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession, with further biologically active compounds. These compounds may be both fertilizers or micronutrient donors or other preparations that influence plant growth. They may also be selective herbicides, insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several ׳of these preparations, if desired together with further carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation.
The active ingredient according to the invention may be used in unmodified form or together with any suitable agriculturally acceptable carrier. Such carriers are adjuvants conventionally employed in the art of agricultural formulation, and are therefore formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations, for example, in polymer substances. Like the nature of the compositions, the methods of application, such as spraying, atomizing, dusting, scattering or pouring, are chosen in accordance with the intended objective and the prevailing circumstances. Advantageous rates of application are normally from about 50 g to about 5 kg of active ingredient (a.i.) per hectare (ha, approximately 2.471 acres), preferably from about 100 g to about 2kg a.i./ha. Important rates of application are about 200 g to about 1kg a.i./ha and 200g to 500g
a.i./ha.
For seed dressing advantageous application rates are 0.5 g to 1000 g a.i.per 100 kg seed, preferably 3 g to 100 g a.i. per 100 kg seed or 10 g to 50 g a.i.per 100 kg seed.
Suitable carriers and adjuvants can be solid or liquid and correspond to the substances ordinarily employed in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, binders or fertilizers. The formulations, i.e. the entomocidal compositions, preparations or mixtures containing the recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus thuringiensis strain containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form as an active ingredient or combinations thereof with other active ingredients, and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e.g., by homogeneously mixing and/or grinding the active ingredients with extenders, e.g., solvents, solid carriers, and in some cases surface-active compounds (surfactants).
Suitable solvents are: aromatic hydrocarbons, preferably the fractions containing 8 to 12 carbon atoms, e.g. xylene mixtures or substituted naphthalenes, phthalates such as dibutyl phthalate or dioctyl phthalate, aliphatic hydrocarbons such as cyclohexane or paraffins, alcohols and glycols and their ethers and esters, such as ethanol, ethylene glycol monomethyl or monoethyl ether, ketones such as cyclohexanone, strongly polar solvents such as N-methyl-2-pyrrolidone, dimethylsulfoxide or dimethylformamide, as well as vegetable oils or epoxidised vegetable oils such as epoxidised coconut oil or soybean oil; or water.
The solid carriers used, e.g., for dusts and dispersible powders, are normally natural mineral fillers such as calcite, talcum, kaolin, montmorillonite or attapulgite. In order to improve the physical properties it is also possible to add highly dispersed silicic acid or highly dispersed absorbent polymers. Suitable granulated adsorptive carriers are porous types, for example pumice, broken brick, sepiolite or bentonite;
and suitable nonsorbent carriers are materials such as calcite or sand. In addition, a great number of pregranulated materials of inorganic or organic nature can be used,
e.g. especially dolomite or pulverized plant residues.
Depending on the nature of the active ingredients to be formulated, suitable surface-active compounds are non-ionic, cationic and/or anionic surfactants having good emulsifying, dispersing and wetting properties. The term surfactants will also be understood as comprising mixtures of surfactants. Suitable anionic surfactants can be both water-soluble soaps and water-soluble synthetic surface-active compounds. Suitable soaps are the alkali metal salts, alkaline earth metal salts or unsubstituted or substituted ammonium salts of higher fatty acids (C™ -C<sub>22</sub>), e.g. the sodium or potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which can be obtained, e.g. from coconut oil or tallow oil. Further suitable surfactants are also the fatty acid methyltaurin salts as well as modified and unmodified phospholipids.
More frequently, however, so-called synthetic surfactants are used, especially fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylarylsulfonates. The fatty sulfonates or sulfates are usually in the forms of alkali metal salts, alkaline earth metal salts or unsubstituted dr substituted ammonium salts and generally contain a C<sub>B</sub> -C<sub>22</sub> alkyl radical which also includes the alkyl moiety of acyl radicals, e.g. the sodium or calcium salt of lignosulfonic acid, of dodecylsulfate, or of a fixture of fatty alcohol sulfates obtained from natural fatty acids. These compounds also comprise the salts of sulfuric acid esters and sulfonic acids of fatty alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably contain 2 sulfonic acid groups and one fatty acid radical containing about 8 to 22 carbon atoms. Examples of alkylarylsulfonates are the sodium, calcium or triethanolamine salts of dodecylbenzenesulfonic acid, dibutylnaphthalenesulfonic acid, or of a naphthalenesulfonic acid/formaldehyde condensation product. Also suitable are corresponding phosphates, e.g. salts of the phosphoric acid ester of an adduct of p-nonylphenol with 4 to 14 moles of ethylene oxide.
Non-ionic surfactant are preferably polyglycol ether derivatives of aliphatic or cycloaliphatic alcohols, or saturated or unsaturated fatty acids and alkylphenols, said derivatives containing 3 to 30 glycol ether groups and 8 to 20 carbon atoms in the (aliphatic) hydrocarbon moiety and 6 to 18 carbon atoms in the alkyl moiety of the alkylphenols.
Further suitable non-ionic surfactants are the water-soluble adducts of polyethylene oxide with polypropylene glycol, ethylenediaminopolypropylene glycol and alkylpolypropylene glycol containing 1 to 10 carbon atoms in the alkyl chain, which adducts contain 20 to 250 ethylene glycol ether groups and 10 to 100 propylene glycol ether groups. These compounds usually contain 1 to 5 ethylene glycol units per propylene glycol unit. Representative examples of non-ionic surfactants are nonylphenolpolyethoxyethanols, castor oil polyglycol ethers, polypropylene/polyethylene oxide adducts, tributylphenoxypolyethoxyethanol, polyethylene glycol and octylphenoxypolyethoxyethanol. Fatty acid esters of polyoxyethylene sorbitan, such as polyoxyethylene sorbitan trioleate, are also suitable non-ionic surfactants.
Cationic surfactants are preferably quaternary ammonium salts which contain, as N־substituent, at least one C<sub>8</sub> -C<sub>22</sub> alkyl radical and, as further substituents, lower unsubstituted or halogenated alkyl, benzyl or hydroxyl-lower alkyl radicals. The salts are preferably in the form of halides, methylsulfates or ethylsulfates, e.g., stearyltrimethylammonium chloride or benzyldi-(2-chloroethyl)ethylammonium bromide.
The surfactants customarily employed in the art of formulation are described, e.g., in McCutcheon’s Detergents and Emulsifiers Annual, MC Publishing Corp. Ridgewood, N.J., 1979; Dr. Helmut Stache, Tensid Taschenbuch (Handbook of Surfactants), Carl Hanser Verlag, Munich/Vienna.
Another particularly preferred characteristic of an entomocidal composition of the present invention is the persistence of the active ingredient when applied to plants and soil. Possible causes for loss of activity include inactivation by ultra-violet light, heat, leaf exudates and pH. For example, at high pH, particularly in the presence of reductant, δ-endotoxin crystals are solubilized and thus become more accessible to proteolytic inactivation. High leaf pH might also be important, particularly where the leaf surface can be in the range of pH 8-10. Formulation of an entomocidal composition of the present invention can address these problems by either including additives to help prevent loss of the active ingredient or encapsulating the material in such a way that the active ingredient is protected from inactivation. Encapsulation
-Μ can be accomplished chemically (McGuire and Shasha, J Econ Entomol 85:14251433,1992) or biologically (Barnes and Cummings, 1986; EP-A 0 192 319). Chemical encapsulation involves a process in which the active ingredient is coated with a polymer while biological encapsulation involves the expression of the δ-endotoxin genes in a microbe. For biological encapsulation, the intact microbe containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form is used as the active ingredient in the formulation. The addition of UV protectants might effectively reduce irradiation damage. Inactivation due to heat could also be controlled by including an appropriate additive.
Preferred within the present application are formulations comprising living microorganisms as active ingredient either in form of the vegetative cell or more preferable in form of spores, if available. Suitable formulations may consist, for example, of polymer gels which are crosslinked with polyvalent cations and comprise these microorganisms. This is described, for example, by D.R. Fravel et al. in Phytopathology, Vol. 75, No. 7, 774-777,1985 for alginate as the polymer material. It is also known from this publication that carrier materials can be co-used. These formulations are as a rule prepared by mixing solutions of naturally occurring or synthetic gel-forming polymers, for example alginates, and aqueous salt solutions of polyvalent metal ions such that individual droplets form, it being possible for the microorganisms to be suspended in one of the two or in both reaction solutions. Gel formation starts with the mixing in drop form. Subsequent drying of these gel particles is possible. This process is called ionotropic gelling. Depending on the degree of drying, compact and hard particles of polymers which are structurally crosslinked via polyvalent cations and comprise the microorganisms and a carrier present predominantly uniformly distributed are formed. The size of the particles can be up to 5 mm.
Compositions based on partly crosslinked polysaccharides which, in addition to a microorganism, for example, can also comprise finely divided silicic acid as the carrier material, crosslinking taking place, for example, via Ca<sup>++</sup> ions, are described in EP-A1 -0 097 571. The compositions have a water activity of not more than 0.3. W.J. Cornick et al. describe in a review article [New Directions in Biological Control: Alternatives for Suppressing Agricultural Pests and Diseases, pages 345-372, Alan R.
Liss, Inc. (1990)] various formulation systems, granules with vermiculite as the carrier and compact alginate beads prepared by the ionotropic gelling process being mentioned. Such compositions are also disclosed by D.R.Fravel in Pesticide Formulations and Application Systems: 11th Volume, ASTM STP 1112 American Society for Testing and Materials, Philadelphia, 1992, pages 173 to 179 and can be used to formulate the recombinant microorganisms according to the invention.
The entomocidal compositions of the invention usually contain from about 0.1 to about ,99%, preferably about 0.1 to about 95%, and most preferably from about 3 to about90%־ of the active ingredient, from about 1 to about 99.9%, preferably from about 1 to about 99%, and most preferably from about 5 to about 95% of a solid or liquid Adjuvant, and from about 0 to about 25%, preferably about 0.1 to about 25%, and most preferably from about 0.1 to about 20% of a surfactant.
In a preferred embodiment of the invention the entomocidal compositions usually contain 0.1 to 99%, preferably 0.1 to 95%, of a recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus thuringiensis strain containing at least one DNA molecule comprising a nucleotide sequence encoding the novel insect-specific proteins in recombinant form, or combination thereof with other active ingredients, 1 to 99.9% of a solid or liquid adjuvant, and 0 to 25%, preferably 0.1 to 20%, of a surfactant.
Whereas commercial products are preferably formulated as concentrates, the end user will normally employ dilute formulations of substantially lower concentration. The entomocidal compositions may also contain further ingredients, such as stabilizers, antifoams, viscosity regulators, binders, tackifiers as well as fertilizers or other active ingredients in order to obtain special effects.
In one embodiment of the invention a Bacillus cereus microorganism has been isolated which is capable of killing Diabrotica virgifera virgifera, and Diabrotica longicornis barberi. The novel B. cereus strain AB78 has been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, IL 61604, USA and given Accession No. NRRL B-21058.
A fraction protein has been substantially purified from the B. cereus strain. This purification of the protein has been verified by SDS-PAGE and biological activity. The protein has a molecular weight of about 60 to about 100 kDa, particularly about 70 to about 90 kDa, more particularly about 80 kDa, hereinafter VIP.
Amino-terminal sequencing has revealed the N-terminal amino-acid sequence to Uc י <sup>NH</sup>2-Lys-Arg-Glu-ll<sub>e</sub>.<sub>As</sub>p.G|<sub>u</sub>A<sub>S</sub>p-Thr-Asp-Thr-<sub>As</sub>x-Gly-<sub>A</sub>sp-Ser-llo-Pro(SEQ ID NO:8) where Asx represents either Asp or As״. The entire amino acid sequence is given in SEQ ID NO:7. The DNA sequence which encodes the amino acid sequence of SEQ ID NO:7 is disclosed in SEQ ID NO6־
A״ oligonuleotide probe for the region of the gene encoding amino acids 3-9 of the NH<sub>2</sub>-ter״״,1״s has been generated. The probe was synthesized based on the codon ־״age of a Sac,־״/׳ <sub>tMngiensis (Bt) 5</sub>.<sub>en</sub>d<sub>10</sub>״xin <sub>gene Τή</sub>θ the oligonucleotide probe used lor Southern hybridizations was as follows:
5־ GAA ATT GATCAA GAT AON GAT-3’ (SEQIDNO-9) where N represents any base.
In addition, the DNA probe for the Be AB78 VIP1 gene described herein, permits e screening of any Baallus strain or other organisms to determine whether the VIP1 gene (or related gene) <sub>is</sub> ״aturatly θ organism includes the VIP1 gene.
The invention now being.generatly described, the same will be better understood y reference to the following detailed examples that are provided for the purpose of . ustration and are not to be considered limiting of the invention unless so specified
A standard nomenclature has been developed based on the sequence identity oi *he proteins encompassed by the present i״״e״,<sub>ion</sub>. <sub>The gene </sub>he detailed examples which fellow and their relationship to the names used in t e first priority document are shown below.
<td> Gene/Protein</td><td> Gene / Description of Protein</td>
<td> Name under</td><td> Protein</td>
<td> Standard</td><td> Name in</td>
<td> Nomenclature</td><td> Parent</td>
<td> VIP1A(a)</td><td> VIP 1 VIP1 from strain AB78 as disclosed in SEQ ID NO:5.</td>
<td> VIP2A(a)</td><td> VIP2 VIP2 from strain AB78 as disclosed in SEQ ID NO:2.</td>
<td> VIPIA(b)</td><td> VIP1 VIP1 from Bacillus thuringiensisvar. homolog tenebrionis as disclosed in SEQ ID NO:21.</td>
<td> VIP2A(b)</td><td> VIP2 VIP2 from Bacillus thuringiensisvar. homolog tenebrionis as disclosed in SEQ ID NQ:20.</td>
<td> VIP3A(a)</td><td> VIP from strain AB88 as disclosed in SEQ ID NO:28 of the present application</td>
<td> VIP3A(b)</td><td> VIP from strain AB424 as disclosed in SEQ ID NO:31 of the present application</td>
EXPERIMENTAL
Formulation Examples
The active ingredient used in the following formulation examples are Bacillus cereus strain AB78 having Accession No. NRRL B-21058; Bacillus thuringiensis strains having Accession Nos. NRRL B-21060, NRRL B-21224, NRRL B-21225, NRRL B21226, NRRL B-21227, and NRRL B-21439; and Bacillus spp strains having Accession Nos NRRL B-21228, NRRL B-21229, and NRRL B-21230. All the mentioned strains are natural isolates comprising the insect-specific proteins according to the invention.
Alternatively, the isolated insect-specific proteins are used as the active ingredient alone or in combination with the above-mentioned Bacillus strains.
A1. Wettable powders
<td></td><td> a)</td><td> b)</td><td> c)</td>
<td> Bacillus thuringiensis spores</td><td> 25%</td><td> 50%</td><td> 75%</td>
<td> sodium lignosufonate</td><td> 5%</td><td> 5%</td><td> —</td>
<td> sodium laurylsulfate</td><td> 3%</td><td> —</td><td> 5%</td>
<td> sodium diisobutylnaphthalenesulfonate</td><td> .</td><td> 6%</td><td> 10%</td>
<td> octylphenol polyethylene glycol ether</td><td> —</td><td> 2%</td><td> —</td>
<td> (7-8 moles of ethylene oxid) highly dispersed silicid acid</td><td> 5%</td><td> 10%</td><td> 10%</td>
<td> kaolin</td><td> 62%</td><td> 27%</td><td> --</td>
The spores are thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders which can be diluted with water to give suspensions of the desired concentrations.
A2. Emulsifiable concentrate
Bacillus thuringiensis spores 10% octylphenol polyethylene glycol ether (4:5 moles ethylene oxide) 3% clacium;dodecylbenzensulfonate 3% castor oil polyglycol ether (36 moles of ethylene oxide) 4% cyclohexanone 30% xylene mixture 50%
Emulsions of any required concentration can be obtained from this concentrate by dilution with water.
A3. Dusts
a) b)
Bacillus thuringiensis spores 5% 8% talcum 95% kaolin - 92%
Ready for use dusts are obtained by mixing the active ingredient with the carriers and grinding the mixture in a suitable mill.
A4. Extruder Granulate
Bacillus thuringiensis spores 10% sodium lignosulfonate 2% carboxymethylcellulose 1% kaolin 87%
The active ingredient or combination is mixed and ground with the adjuvants and the mixture is subsequently moistened with water. The mixture is extruded, granulated and the dried in a stream of air.
A5. Coated Granule
Bacillus thuringiensis spores 3% polyethylene glycol (mol wt 200) 3% kaolin 94%
The active ingredient or combination is uniformly applied in a mixer to the kaolin moistened with polyethylene glycol. Non-dusty coated granulates are obtained in this manner.
A6. Suspension Concentrate
Bacillus thuringiensis spores 40% ethyleneglycol 10% nonylphenol polyethylene glycol ether (15 moles of ethylene oxide) 6% sodium lignosulfonate 10% carboxymethylcellulose 1%
37% aqueous formaldehyde solution 0.2% silicone oil in the form of a 75% aqueous solution 0.8% water 32%
The active ingredient or combination is intimately mixed with the adjuvants giving a suspension concentrate from which suspensions of any desired concentration can be obtained by dilution with water.
EXAMPLE 1. AB78 ISOLATION AND CHARACTERIZATION
Bacillus cereus strain AB78 was isolated as a plate contaminant in the laboratory on T3 media (per liter: 3 g tryptone, 2 g tryptose, 1.5 g yeast extract, 0.05 M sodium phosphate (pH 6.8), and 0.005 g MnCI<sub>2</sub>; Travers, R.S. 1983). During log phase growth, AB78 gave significant activity against western corn rootworm. Antibiotic activity against gram-positive Bacillus spp. was also demonstrated (Table 12);
TABLE 12
Antibiotic activity of AB78 culture supernatant
Zone of inhibition(cm)
Bacteria tested AB78 Streptomycin
E. coli 0.0 3.0
<td> B. megaterium</td><td> 1.1</td><td> 2.2</td>
<td> B. mycoides</td><td> 1.3</td><td> 2.1</td>
<td> B. cereus CB</td><td> 1.0</td><td> 2.0</td>
<td> B. cereus 11950</td><td> 1.3</td><td> 2.1</td>
<td> B. cereus 14579</td><td> 1.0</td><td> 2.4</td>
<td> B. Cereus AB78</td><td> 0.0</td><td> 2.2</td>
<td> Btvar. israelensis</td><td> 1.1</td><td> 2.2</td>
<td> Btvar. tenebrionis</td><td> 0.9</td><td> 2.3</td>
Morphological characteristics of AB78 are as follows:
Vegetative rods straight, 3.1-5.0 mm long and 0.5-2.0 mm wide. Cells with rounded ends, single in short chains. Single subterminal, cylindrical-oval, endospore formed per cell. No parasporal crystal formed. Colonies opaque, erose, lobate and flat. No pigments produced. Cells motile. Flagella present.
Growth characteristics of AB78 are as follows:
Facultative anaerobe with optimum growth temperature of 21-30°C. Will grow at 15, 20, 25,30 and 37°C. Will not grow above 40°C. Grows in 5-7% NaCl.
Tabte 13 provides the biochemical profile of AB78.
TABLE 13
Biochemical characteristics of B. cereus strain AB78.
<td> Acid from L-arabinose</td><td> Methylene blue reoxidized</td><td> +</td>
<td> Gas from L-arabinose</td><td> Nitrate reduced</td><td> +</td>
<td> Acid from D-xylose</td><td> NO<sub>3</sub> reduced to NO<sub>2</sub></td><td> +</td>
<td> Gas from D-xylose -</td><td> VP</td><td> -ו-</td>
<td> Acid from D-glucose +</td><td> H<sub>2</sub>O<sub>2</sub> decomposed</td><td> -».</td>
<td> Gas from D-glucose</td><td> Indole</td><td> -</td>
<td> Acid from lactose</td><td> Tyrosine decomposed</td><td> +</td>
<td> Gas from lactose</td><td> Dihydroxiacetone</td><td> -</td>
<td> Acid from sucrose</td><td> Litmus milk acid</td><td> -</td>
<td> Gas from sucrose</td><td> Litmus milk coagulated</td><td> -</td>
<td> Acid from D-mannitol</td><td> Litmus milk alkaline</td><td> -</td>
<td> Gas from D-mannitol</td><td> Litmus milk peptonized</td><td> -</td>
<td> Proprionate utilization +</td><td> Litmus milk reduced</td><td> -</td>
<td> Citrate utilization +</td><td> Casein hydrolyzed</td><td> +</td>
<td> Hippurate hydrolysis w</td><td> Starch hydrolyzed</td><td> +</td>
<td> Methylene blue reduced + Lecithinase produced w</td><td> Gelatin liquidified</td><td> +</td>
w= weak reaction
EXAMPLE 2. BACTERIAL CULTURE
A subculture of Be strain AB78 was used to inoculate the following medium, known as TB broth:
<td> Tryptone Yeast Extract Glycerol kh<sub>2</sub>po<sub>4 </sub>k<sub>2</sub>hpo<sub>4 </sub>pH 7.4</td><td> 12 g/l 24 g/l 4 ml/l 2.1 g/l 14.7 g/l</td>
The potassium phosphate was added to the autoclaved broth after cooling.
Flasks were incubated at 30°C on a rotary shaker at 250 rpm for 24 h-36 h, which represents an early to mid-log growth phase.
The above procedure can be readily scaled up to large fermentors by procedures well known in the art.
During vegetative growth, usually 24-36 h. after starting the culture, which represents an early to mid-dog growth phase, AB78 bacteria were centrifuged from the culture supernatant. The culture supernatant containing the active protein was used in bioassays.
EXAMPLE 3. INSECT BIOASSAYS
B. cereus strain AB78 was tested against various insects as described below.
Western, Northern and Southern corn rootworm, Diabrotica virgifera virgifera, D. longcornis barberi and D. undecempunctata howardi, respectively: dilutions were made of AB78 culture supernatant grown 24-36 h., mixed with molten artificial diet (Marrone et al. (1985) J. of Economic Entomology 78:290-293) and allowed to solidify. Solidified diet was cut and placed in dishes. Neonate larvae were placed on the diet and held at 30 C. Mortality was recorded after 6 days.
£ ¢0//clone bioassav: E. colicells were grown overnight in broth containing 100 jig/ml ampicillin at 37°C. Ten ml culture was sonicated 3X for 20 sec each. 500 μΙ of sonicated culture was added to molten western corn rootworm diet.
Colorado potato beetle, Leptinotarsa decemlineata: dilutions in Triton X-100 (to give final concentration of 0.1% TX-100) were made of AB78 culture supernatant grown 24-36 h. Five cm<sup>2</sup> potato leaf pieces were dipped into these dilutions, air dried, and placed on moistened filter paper in plastic dishes. Neonate larvae were placed on the leaf pieces and held at 30°C. Mortality was recorded after 3-5 days.
Yellow mealworm, Tenebrio molitor dilutions were made of AB78 culture supernatant grown 24-36 h., mixed with molten artificial diet (Bioserv #F9240) and allowed to solidify. Solidified diet was cut and placed in plastic dishes. Neonate larvae were placed on the diet and held at 30°C. Mortality was recorded after 6-8 days.
European corn borer, black cutworm, tobacco budworm, tobacco hornworm and beet armyworm; Ostrinia nubilalis, Agrotis ipsilon, Heliothis virescens, Manduca sexta and Spodoptera exigua, respectively: dilutions, in TX-100 (to give final concentration of 0.1% TX-100), were made of AB78 culture supernatant grown 24-36 hrs. 100 μί was pipetted onto the surface of 18 cm of solidified artificial diet (Bioserv #F9240) and allowed to air dry. Neonate larvae were then placed onto the surface of the diet and held at 30°C. Mortality was recorded after 3-6 days.
Northern house mosquito, Culex p/p/ens:-dilutions were made of AB78 culture supernatant grown 24-36 h. 100 μΙ was pipetted into 10 ml water in a 30 ml plastic cup. Third instar larvae were added to the water and held at room temperature. Mortality was recorded after 24-48 hours. The spectrum of entomocidal activity of AB78 is given in Table 14.
TABLE 14
Activity of AB78 culture supernatant against various insect species
Insect species tested to date ________ Order___________Activity
<td></td><td></td>
<td> Western corn rootworm (Diabrotica virgifera virgifera) Northern corn rootworm</td><td> Col +++</td>
<td> (Diabrotica longicornis barbed) Southern corn rootworm (Diabrotica undecimpunctata howardi) Colorado potato beetle (Leptinotarsa decemlineata) Yellow mealworm</td><td> Col +++ Col Col</td>
<td> (Tenebrio molitoi)</td><td> Col</td>
<td colspan="2"> European corn borer</td>
<td> (Ostrinia nubilalis)</td><td> Lep</td>
<td> Tobacco budworm (Heliothis virescens) Tobacco hornworm</td><td> Lep</td>
<td> (Manduca sexta)</td><td> Lep</td>
<td> Beet armyworm (Spodoptera exigua) Black cutworm</td><td> Lep</td>
<td> (Agrotis ipsilon)</td><td> Lep</td>
<td> Northern house mosquito (Culex pipiens)</td><td> Dip</td>
The newly discovered B. cereus strain AB78 showed a significantly different spectrum of insecticidal activity as compared to known coleopteran active δ-endqtoxins from Bt. In particular, AB78 showed more selective activity against beetles than known coleopteran-active Bt strains in that it was specifically active against Diabrotica spp. More specifically, it was most active against D. virgifera virgifera and D. longicornis barberi but not D. undecimpunctata howardi.
A number of Bacillus strains were bioassayed for activity during vegetative growth (Table 15) against western corn rootworm. The results demonstrate that AB78 is unique in that activity against western corn rootworm is not a general phenomenon.
TABLE 15
Activity of culture supernatants from various Bacillus spp. against western corn rootworm
<td> Bacillus strain</td><td> Percent WCRW mortality</td>
<td> B. cereus AB78 (Bat.1)</td><td> 100</td>
<td> B: cereus AB78 (Bat.2)</td><td> 100</td>
<td> B. cereus (Carolina Bio.)</td><td> 12</td>
<td> B. cereus MCC 11950</td><td> 12</td>
<td> B. cereus ATCC 14579</td><td> 8</td>
<td> B. mycoides (Carolina Bio.)</td><td> 30</td>
<td> B. popilliae</td><td> 28</td>
<td> B. thuringiensis HD135</td><td> 41</td>
<td> B. thuringiensis H D191</td><td> 9</td>
<td> B. thuringiensis GC91</td><td> 4</td>
<td> B. thuringiensis isrealensis</td><td> 24</td>
<td> Water Control</td><td> 4</td>
Specific activity of AB78 against western corn rootworm is provided in Table 16.
TABLE 16
Activity of AB78 culture supernatant against neonate western corn rootworm
Culture supernatant Percent concentration (ul/ml)________WCRW mortality
<td> 100</td><td> 100</td>
<td> 25</td><td> 87</td>
<td> 10</td><td> 80</td>
<td> 5</td><td> 40</td>
<td> 2.5</td><td> 20</td>
<td> 1</td><td> 6</td>
<td> 0 .</td><td> 0</td>
The LC50 was calculated to be 6.2 μΙ of culture supernatant per ml of western corn rootworm diet.
The cell pellet was also bioassayed and had no activity against WCRW. Thus, the presence of activity only in the supernatant indicates that this VIP is an exotoxin.
EXAMPLE 4 ISOLATION AND PURIFICATION OF CORN ROOTWORM
ACTIVE PROTEINS FROM AB78.
Culture media free of cells and debris was made to 70% saturation by the addition of solid ammonium sulfate (472 g/L). Dissolution was at room temperature followed by cooling in an ice bath and centrifugation at 10,000 X g for thirty minutes to pellet the precipitated proteins. The supernatant was discarded and the pellet was dissolved i I in 1/10 the original volume of 20 mM TRIS-HCI at pH 7.5. The dissolved pellet was desalted either by dialysis in 20 mM TRIS-HCI pH 7.5, or passing through a desalting column;
.The desalted material was titrated to pH 3.5 using 20 mM sodium citrate pH 2.5. Following a thirty minute room temperature incubation the solution was centrifuged at
3000 X g for ten minutes. The supernatant at this stage contained the greatest amount of active protein.
Following neutralization of the pH to 7.0 the supernatant was applied to a Mono-Q, anion exchange, column equilibrated with 20 mM TRIS pH 7.5 at a flow rate of 300 mL/min. The column was developed with a stepwise and linear gradient employing 400 mM NaCl in 20 mM TRIS pH 7.5.
Bioassay of the column fractions and SDS-PAGE analysis were used to confirm the active fractions. SDS-PAGE analysis identified the biologically active protein as having components of a molecular weight in the range of about 80 kDa and 50 kDa.
EXAMPLE 5. SEQUENCE ANALYSIS OF THE CORN ROOTWORM ACTIVE PROTEIN
The 80 kDa component isolated by SDS-PAGE was transferred to PVDF membrane and was subjected to amino-terminal sequencing as performed by I repetitive Edman cycles on an ABI470 pulsed-liquid sequencer. Transfer was carried out in 10 mM CAPS buffer with 10% methanol pH 11.0 as follows:
Incubation of the gel following electrophoresis was done in transfer buffer for five minutes. ProBlott PVDF membrane was wetted with 100% MeOH briefly then equilibrated in transfer buffer. The sandwich was arranged between foam sponges and filter paper squares with the configuration of cathode-gel-membrane-anode.
Transfer was performed at 70 V constant voltage for 1 hour.
Following transfer, the membrane was rinsed with water and stained for two minuteis with 0.25% Coomassie Blue R-250 in 50% MeOH.
Destaining was done with several rinses with 50% MeOH 40% water 10% acetic acid.
Following destaining the membrane was air dried prior to excision of the bands for sequence analysis. A BlottCartridge and appropriate cycles were utilized to achieve maximum efficiency and yield. Data analysis was performed using model 610 Sequence Analysis software for identifying and quantifying the PTH-amino acid derivatives for each sequential cycle.
The N-terminal sequence was determined to be:
NH2-Lys-Arg־Glu-lle-Asp-Glu-Asp-Thr-Asp-Thr-Asx-Gly-Asp-Ser-lle־Pro1 1 5 3 82 /2 (SEQ ID N0:8) where Asx represents Asp er As״. The complete amino acid sequence for the 80 kDa component is disclosed in SEQ ID NO-7 The DNA sequence which encodes SEQ ID NO:7 is disclosed in SEQ ID NO-6
EXAMPLE 6 CONSTRUCTION OF DNA PRORF
An oligonucleotide probe lor the region of the gene encoding amino 3cids 3-9 of he N-termmal sequence (Example 5) was generated. Th־ probe was synthesized based on the codon usage of a <sub>8acfc lhumgiens1s (Bt) </sub>nucleotide sequence
5.- GAA ATT GAT CAA GAT ACN GAT -3' (SEQ ID NO:9) was used as a probe in Southern hybridizations. The oligonucleotide using standard procedures and equipment.
was synthesized
EXAMPLE 7. ISOEI FCTRIC PDINTpETERMINATION OF THE CORM .ROOTWORM ACTIVE PROTEIN
Purified protein from step 5 of the publication process was anaiyzed on a 3-9 pl ,־־electnc focus,ng gel using the Phastgel eiectrophoresis system (Pharmacia) Standard operate procedures for the unit were followed for both the separation and ver staining development procedures. The pl was approximated at about 4 9
EXAMPLE 8. PCR DATA ON AB78
PCR analysis (See, for example US Patent No. 5,506,099; and, <sup>Car</sup>°zz1 era/. (1991) AbqL Environ, M!crobipL57(11)3057-3061־ h<sub>P</sub>r<sub>P</sub><sup>Γ6</sup>^<sup>βΓ</sup>θ<sup>ηί:6</sup>^<sup>was use</sup>d<sup>t0</sup> verify that the β. cereus strain AB^TSd^dno?00013^30^ ׳nsecticidsl crystal protein genes 018. thun<sub>ngiensis or e</sub>. <sub>י ?)</sub>
TABLE 17
Sac/7/us insecticidal crystal protein gene primers tested by PCR against AB78
DNA.
<td colspan="2"> Primers Tested Product Produced</td>
<td> 2 sets specific for Cry 111A</td><td> Negative</td>
<td> CrylllB</td><td> Negative</td>
<td> 2 sets specific for CrylA</td><td> Negative</td>
<td> CrylA(a)</td><td> Negative</td>
<td> CrylA(b) specific</td><td> Negative</td>
<td> CrylB</td><td> Negative</td>
<td> CryIC specific</td><td> Negative</td>
<td> Cry IE specific</td><td> Negative</td>
<td> 2 sets specific for S. sphaericus</td><td> Negative</td>
<td> 2 sets specific for CryIV</td><td> Negative</td>
<td> Bacillus control (PI-PLC) ,</td><td> Positive</td>
EXAMPLE 9. COSMID CLONING OF TOTAL DNA FROM B. CEREUSSTRMN
AB78
The VIP1 A(a) gene was cloned from total DNA prepared from strain AB78 as follows:
Isolation of AB78 DNA was as follows:
1. Grow bacteria in 10 ml L־broth overnight. (Use 50 ml sterile centrifuge tube)
2. Add 25 ml of fresh L-broth and ampicillin (30 gg/ml).
3. Grow cells 2-6 h. at 30°C with shaking.
4. Spin cells in a 50 ml polypropylene orange cap tube in IEC benchtop clinical centrifuge at 3/4 speed.
5. Resuspend cell pellet in 10 ml TES (TES = 50 mM TRIS pH 8.0,100 mM EDTA, 15 mM NaCI).
6. Add 30 mg lysozyme and incubate 2 hrs at 37°C.
7. Add 200 μΙ 20% SDS and 400 μΙ Proteinase K stock (20 mg/ml). Incubate at 37°C.
8. Add 200 μΙ fresh Proteinase K. Incubate 1 hr. at 55°C. Add 5 ml TES to make 15 ml final volume.
9. Phenol extract twice (10 ml phenol, spin at room temperature at 3/4 speed in an IEC benchtop clinical centrifuge). Transfer supernatant (upper phase) to a clean tube using a wide bore pipette.
10. Extract once with 1:1 vol. phenokchloroform/isoamyl alcohol (24:1 ratio).
11. Precipitate DNA with an equal volume of cold isopropanol; Centrifuge to pellet DNA.
12. Resuspend pellet in 5 ml TE.
13. Precipitate DNA with 0.5 ml 3M NaOAc pH 5.2 and 11 ml 95% ethanol. Place at-20°C for 2 h.
14. Hook DNA from tube with a plastic loop, transfer to a microfuge tube, spin, pipette off excess ethanol, dry in vacuo.
15. , Resuspend in 0.5 ml TE. Incubate 90 min. at 65°C to help get. DNA back into solution.
16. Determine concentration using standard procedures.
Cosmid Cloning of AB78
All procedures, unless indicated otherwise, were performed according to Stratagene Protocol, Supercos 1 Instruction Manual, Cat. No. 251301.
Generally, the steps were as follows:
A. Sau 3A partial digestion of the AB78 DNA.
B. Preparation of vector DNA
C. Ligation and packaging of DNA
D. Tittering the cosmid library
1. Start a culture of HB101 cells by placing 50 ml of an overnight culture in mis of TB with 0.2% maltose. Incubate 3.5 hrs. at 37°C.
2. Spin out cells and resuspend in 0.5 ml 10 mM MgSO4.
<sup>1</sup> 3. Add together:
100 !cells
100 I diluted packaging mixture
100 110 mM MgSO4
ITB
4. Adsorb at room temperature for 30 minutes with no shaking.
5. Add 1 ml TB and mix gently. Incubate 30 minutes at 37°C.
6. Plate 200 I onto L־amp plates. Incubate at 37°C overnight.
At least 400 cosmid clones were selected at random and screened for activity against western corn rootworm as described in Example 3. DNA from 5 active clones and 5 non-active clones were used in Southern hybridizations. Results demonstrated that hybridization using the above described oligonucleotide probe correlated with western corn rootworm activity (Table 18).
Cosmid clones P3-12 and P5-4 have been deposited with the Agricultural Research Service Patent Culture Collection (NRRL) and given Accession Nos. NRRL B-21061 and NRRL B-21059 respectively.
TABLE 18
Activity of AB78 cosmid clones against western corn rootworm.
Mean
Clone percent mortality (N=4)
Clones which hybridize with probe
P1-7347
PT-8364
P2-269
P3-1285
P&497
Clones which do not hybridize with probe
P1-2
P3t8
P3-912
P3-18Ο
Ρ4-69
EXAMPLE 10. IDENTIFICATION OF A 6 KB REGION ACTIVE AGAINST WESTERN CORN ROOTWORM.
DNA from P3-12 was partially digested with restriction enzyme Sau 3A, and ligated into the E. coli vector pUC19 and transformed into E. coli. A DNA probe specific for the 80 kDa VIP1 A(a) protein was synthesized by PCR amplification of a portion of P3-12 DNA. Oligonucleotides MK113 and MK117, which hybridize to portions of VIP1 A(a), were synthesized using the partial amino acid sequence of the 80 kDa protein. Plasmid subclones were identified by colony hybridization to the PCR-generated probe, and tested for activity against western corn rootworm. One such clone, PL2, hybridized to the PCR-generated fragment, and was active against western com rootworm in the assay previously described.
A 6 kb Cla I restriction fragment from pL2 was cloned into the Sma I site of the E. co/<Bac///t/s shuttle vector pHT 3101 (Lereclus, D. etal., FEMS Microbiology Letters 60:211 -218 (1989)) to yield pCIB6201. This construct confers anti-western corn rootworm activity upon both Bacillus and E.colistrains, in either orientation. pCIB6022 contains this same 6 kb Cla I fragment in pBluescript SK(+) (Stratagene), produces equivalent VIP1A(a) protein (by western blot), and is also active against western corn rootworm.
The nucleotide sequence of pCIB6022 was determined by the dideoxy termination method of Sanger etal., Proc. Natl. Acad. Sci. USA, 74:5463-5467 (1977), using PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kits and PRISM Sequenase® Terminator Double-Stranded DNA Sequencing Kit and analyzed on an ABI 373 automatic sequencer. The sequence is given in SEQ ID NO:1. The 6 kb fragment encodes both VIP1 A(a) and VIP2A(a), as indicated by the open reading frames described in SEQ ID NO:1. The sequence encoding VIP2A(a) is further disclosed in SEQ ID NO:4. The relationship between VIP1 A(a) and VIP2A(a) within the 6 kb fragment found in pCIB6022 is depicted in Table 19. pCIB6022 was deposited with the Agricultural Research Service, Patent Culture Collection) (NRRL),
Northern Regional Research Center, 1815 North University Street, Peoria, Illinois
61604, USA, and given the Accession No. NRRL B-21222.
EXAMPLE 11. FUNCTIONAL DISSECTION OF THE VIP1 A(a) DNA REGION.
To confirm that the VIP1 A(a) open reading frame (ORF) is necessary for insecticidal activity a translational frameshift mutation was created in the gene. The restriction enzyme Bgl II recognizes a unique site located 857 bp into the coding region of VIP1 A(a). pCIB6201 was digested with Bgl II, and the single-stranded ends filled-ΐη with DNA polymerase (Klenow fragment) and dNTPS. The plasmid was religated and transformed into E. coli. The resulting plasmid, pCIB6203, contains a four nucleotide insertion in the coding region of VIP1A(a). pCIB6203 does not confer WCRW insecticidal activity, confirming that VIP1 A(a) is an essential component of western corn rootworm activity.
To further define the region necessary to encode VIP1 A(a), subclones of the VIP1 A(a) and VIP2A(a) (auxiliary protein) region were constructed and tested for their ability to complement the mutation in pCIB6203. pCIB6023 contains the 3.7kb Xba IEcoRV fragment in pBluescript SK(+) (Stratagene). Western blot analysis indicates that pCIB6023 produces VIP1 A(a) protein of equal size and quantity as clones PL2 and pCIB6022. pCIB6023 contains the entire gene encoding the 80 kD protein. pCIB6023 was deposited with the Agricultural Research Service, Patent Culture < Collection, (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA, and given the Accession No. NRRL B-21223N. pCIB6206 contains the 4.3 kb Xba l-Cla I fragment from pCIB6022 in pBluescript SK(+) (Stratagene). pCIB6206 was also deposited with the Agricultural Research Service, Patent Culture Collection, (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA, and given the Accession No. NRRL B21321.
pCIB6023, pCIB6206, and pCIB6203 do not produce detectable western corn rootworm activity when tested individually. However, a mixture of cells containing pCIB6203 (VIP1 A(a)-mutated, plus VIP2A(a)) and cells containing pCIB6023 (only
2/ 5382 ח
VIP.1 A(a)) ־hows high activity <sub>against westem com rootworm</sub>
To further define the limit־ of VIP2<sub>A</sub>(a), we constructed pCIB6024 which cont»־ <sup>theeatlrey0 V,P2A</sup>(<sup>a</sup>)׳b<sup>u</sup>t <sup>1</sup>acks most of the VIP1<sub>A</sub>(a) coding region pC!B6024was constnjcted by gel purifying the 2.2 kb Cla l-Sca I restriction fragment from pCIB6022 I ing in the single-stranded ends with DNA polymerase (Klpnnw f dNTPs. <sub>and</sub> 1i<sub>ga</sub>tin<sub>g</sub> this <sub>lragn1en</sub>, <sub>int0 pB|usscSK(+)</sub> enzyme Eco RV. Cells containing pCIB6024 exhibit no activity <sub>against</sub> western com rootworm. However, a mixture of celts containing <sub>pCIB6 24 and ells </sub>^<sup>n a,n,n9</sup> PC<sup>|B6023 sh</sup>°ws high activity against western corn rootworm .{See TaWe
Thus, PCIB6023 and p<sub>CI</sub>B6206 must produce a functional <sub>V</sub>|<sub>P1A(a) </sub>prod״״, while PCIB6203 and pCIB<sub>6</sub>024 must produce a functionai V.pX <sub>ene </sub>product These results suggest a requirement for a gene product(־) from the W2A(a) region. ,״ combination with VIPf <sub>A(a)</sub>, <sub>t0 confer maxima| </sub>rootworm activity. (See Figure 1). ״־״»״> com
־
In Figure 1, boxed regions represent the extent of VIPiA(a) and VIP2A(at Whi! >
P״ »״־, VIP1 encoding rhe 80 <sub>kDa</sub> pept,d־ ob״־־ed in 2L 0^^ ”
I
EXAMPLE 12. AB78 ANTIBODY PRODUCTION
Antibody production was initiated in 2 Lewis rats to allow for both the possibility of moving to production of hybridoma cell lines and also to produce enough serum for limited screening of genomic DNA library. Another factor was the very limited amount of antigen available and the fact that it could only be produced to purity by PAGE and subsequent electrotransfer to nitrocellulose.
Due to the limited availability of antigen on nitrocellulose, the nitrocellulose was emulsified in DMSO and injected into the hind footpads of the animals to elicit B-cell production in the popliteal lymph nodes just upstream. A strong reacting serum was produced as judged by western blot analysis with the first production bleed. Several subsequent injections and bleeds produced enough serum to accomplish all of the screening required.
Hybridoma production with one of the rats was then initiated. The popliteal lymph node was excised, macerated, and the resulting cells fused with mouse myeloma P3x63Ag8.653. Subsequent cell screening was accomplished as described below. Four initial wells were selected which gave the highest emulsified antigen reaction to be moved to limited dilution cloning. An additional 10 wells were chosen for expansion and cryoperservation.
Procedure to Emulsify AB78 on nitrocellulose in DMSO for ELISA screening:
After electrotransfer of AB78 samples run on PAGE to nitrocellulose, the reversible strain Ponceau S is used to visualize all protein transferred. The band corresponding to AB78 toxin, previously identified and N-terminal sequenced, was identified and excised from nitrocellulose. Each band is approximately 1 mm x 5 mm in size to minimize the amount of nitrocellulose emulsified. A single band is placed in a microfuge tube with 250 μΙ of DMSO and macerated using a plastic pestle (Kontes, Vineland, NJ). To aid in emulsification, the DMSO mixture is heated for 2-3 minutes at 37 C-45 C. Some further maceration might be necessary following heating; however, all of the nitrocellulose should be emulsified. Once the AB78 sample is emulsified, it is placed on ice. In preparation for microtiter plate coating with the emulsified antigen, the sample must be diluted in borate buffered saline as follows: 1:5,1:10,1:15,1:20, 1:30, 1:50, 1:100, and 0. The coating antigen must be prepared fresh immediately prior to use.
ELISA protocol:
1. Coat with AB78/DMSO in BBS. Incubate overnight at 4°C.
2. Wash plate 3X with 1X ELISA wash buffer.
3. Block (1% BSA & 0.05% Tween 20 in PBS) for 30 minutes at Room Temperature.
4. Wash plate 3X with 1X ELISA wash buffer.
5. Add rat serum. Incubate 1.5 hours at 37°C.
6. Wash plate 3X with 1X ELISA wash buffer.
7. Add goat anti-rat at a concentration of 2 gg/ml in ELISA diluent. Incubate 1 hr. at 37°C.
8. Wash plate 3X with 1X ELISA wash buffer.
9. Add rabbit anti-goat alkaline phosphatase at 2 gg/ml in ELISA diluent. Incubate 1 hr. at 37°C.
10. Wash 3X with 1X ELISA wash buffer.
11. Add Substrate. Incubate 30 minutes at room temperature.
12. Stop with 3N NaOH after 30 minutes.
Preparation of VIP2A(a) Antisera
A partially purified AB78 culture supernatant was separated by discontinuous SDS PAGE (Novex) following manufacturer’s instructions. Separated proteins were electrophoresed to nitrocellulose (S&S #21640) as described by Towbin etal., (1979). The nitrocellulose was stained with Ponceau S and the VIP2A(a) band identified. The VIP2A(a) band was excised and emulsified in DMSO immediately prior to injection. A rabbit was initially immunized with emulsified VIP2A(a) mixed approximately 1:1 with Freund's Complete adjuvant by intramuscular injection at four different sites. Subsequent immunizations occurred at four week intervals and were identical to the first, except for the use of Freund’ Incomplete adjuvant. The first serum harvested following immunization reacted with VIP2A(a) protein. Western blot analysis of AB78 culture supernatant using this antisera identifies predominately full length VIP2A(a) protein.
ד
EXAMPLE 13. ACTIVATION OF INSECTICIDAL ACTIVITY OF ΝΟΝ-ACTIVE BT STRAINS WITH AB78 VIP CLONES.
Adding pCIB6203 together with a 24 h culture (early to mid-log phase) supernatant from Bt strain GC91 produces 100% mortality in Diabrotica virgifera virgifera. Neither pCIB6203 nor GC91 is active on Diabrotica virgifera virgifera by itself. Data are shown below:
Test material Percent Diabrotica mortality ______
GC9116 pCIB6203 + GC91100
Control0
EXAMPLE 14. ISOLATION AND BIOLOGICAL ACTIVITY OF B. CEREUS AB81.
A second B. cereus strain, designated AB81, was isolated from grain bin dust samples by standard methodologies. A subculture of AB81 was grown and prepared for bioassay as described in Example 2. Biological activity was evaluated as described in Example 3. The results are as follows:
Insect species tested
Percent
Mortality
Ostrinia nubilalis0
Agrotis ipsilon0
Diabrotica virgifera virgifera55
EXAMPLE 15. ISOLATION AND BIOLOGICAL ACTIVITY OF
B. THURINGIENSIS AB6.
A B. thuringiensis strain, designated AB6, was isolated from grain bin dust samples by standard methods known in the art. A subculture of AB6 was grown and prepared for bioassay as described in Example 2. Half of the sample was autoclaved 15 minutes to test for the presence of β-exotoxin.
Biological activity was evaluated as described in Example 3. The results are as follows:
<td> Insect species tested</td><td> Percent Mortality</td>
<td> Ostrinia nubilalis</td><td> 0</td>
<td> Agrotis ipsilon Agrotis ipsilon (autoclaved sample) Diabrotica virgifera virgifera</td><td> 100 0 0</td>
The reduction of insecticidal acitivity of the culture supernatant to insignificant levels by autoclaving indicates that the active principle is not β-exotoxin.
Strain AB6 has been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA, and given Accession No. NRRL B-21060.
EXAMPLE 16. ISOLATION AND BIOLOGICAL CHARACTERIZATION OF
B. THURINGIENSIS AB88.
A Bt strain, designated AB88, was isolated from grain bin dust samples by standard methodologies. A subculture of AB88 was grown and prepared for bioassay as described ih Example 2. Half of the sample was autoclaved 15 minutes to test for the presence of β-exotoxin. Biological activity was evaluated against a number of insect species as described in Example 3. The results are as follows:
<td rowspan="2"> Insect species tested</td><td rowspan="2"> Order</td><td colspan="2"> Percent mortality of culture supernatant Non-</td>
<td> autoclaved</td><td> Autoclav ed</td>
<td> Agrotis ipsilon</td><td> Lepidoptera</td><td> 100</td><td> 5</td>
<td> Ostrinia nubilalis Spodoptera</td><td> Lepidoptera</td><td> 100</td><td> 0</td>
<td> frugiperda</td><td> Lepidoptera</td><td> 100</td><td> 4</td>
<td> Helicoverpa zea</td><td> Lepidoptera</td><td> 100</td><td> 12</td>
<td> Heliothis virescens Leptinotarsa</td><td> Lepidoptera</td><td> 100</td><td> 12</td>
<td> decemlineata Diabrotica</td><td> Coleoptera</td><td> 0</td><td> 0</td>
<td> virgifera virgifera</td><td> Coleoptera</td><td> 0</td><td> 5</td>
The reduction of insecticidal acitivity of the culture supernatant to insignificant levels by autoclaving indicates that the active principle is not β-exotoxin.
Delta-endotoxin crystals were purified from strain AB88 by standard methodologies. No activity from pure crystals was observed when bioassayed against Agrotis ipsilon.
EXAMPLE 17 PURIFICATION OF VIPS FROM STRAIN AB88:
Bacterial liquid culture was grown overnight [for 12h] at 30°C in TB media. Cells were centrifuged at 5000 x g for 20 minutes and the supernatant retained. Proteins present in the supernatant were precipitated with ammonium sulfate (70% saturation), centrifuged [at 5000 x g for 15 minutes] and the pellet retained. The pellet was resuspended in the original volume of 20 mM Tris pH 7.5 and dialyzed overnight against the same buffer at 4°C. AB88 dialysate was more turbid than comparable material from AB78. The dialysate was titrated to pH 4.5 using 20 mM sodium citrate (pH 2:5) and, after 30 min incubation at room temperature, the solution was centrifuged at 3000 x g for 10 min. The protein pellet was redissolved in 20 mM BisTris-Propane pH 9.0.
AB88 proteins have been separated by several different methods following clarification including isoelectric focusing (Rotofor, BioRad, Hercules, CA), precipitation at pH 4.5, ion-exchange chromotography, size exclusion chromatography and ultrafiltration.
Proteins were separated on a Poros HQ/N anion exchange column (PerSeptive Biosystems, Cambridge, MA) using a linear gradient from 0 to 500 mM NaCl in 20 mM Bis-Tris-Propane pH 9.0 at a flow rate of 4 ml/min. The insecticidal protein eluted at 250 mM NaCl.
European corn borer (ECB)-active protein remained in the pellet obtained by pH
4.5 precipitation of dialysate. When preparative IEF was done on the dialysate using pH 3-10 ampholytes, ECB insecticidal activity was found in all fractions with pH of 7 or greater. SDS-PAGE analysis of these fractions showed protein bands of MW ~60 kDa and ~80 kDa. The 60 kDa and 80 kDa bands were separated by anion exchange HPLC on a Poros-Q column (PerSeptive Biosystems, Cambridge, MA). N־terminal sequence was obtained from two fractions containing proteins of slightly differing MW, but both of approximately 60 kDa in size. The sequences obtained were similar to each other and to some δ-endotoxins.
anion exchange fraction 23 (smaller): xEPFVSAxxxQxxx (SEQIDNO:10) anion exchange fraction 28 (larger): xEYENVEPFVSAx (SEQ ID NO:11)
When the ECB-active pH 4.5 pellet was further separated by anion exchange on a Poros-Q column, activity was found only in fractions containing a major band of ~60 kDa.
Black cutworm-active protein also remained in the pellet when AB88 dialysate was brought down to pH 4.5. In preparative IEF using pH 3-10 ampholytes, activity was not found in the ECB-activelEF fractions; instead, it was highest in a fraction of pH 4.5-5.0. Its major components have molecular weights of ~35 and ~80 kDa.
The pH 4.5 pellet was separated by anion exchange HPLC to yield fractions containing only the 35 kDa material and fractions containing both 35 kDa and 80 kDa bands.
EXAMPLE 18. CHARACTERIZATION OF AB88 VIP.
Fractions containing the various lepidopteran active vegetative proteins were generated as described in Example 17. Fractions with insecticidal acitivity were separated in 8 to 16% SDS-polyacrylamide gels and transferred to PVDF membranes [LeGendre et al, (1989) in: A Practical Guide to Protein and Peptide Purification for Microsequencing, ed Matsudaria PT (Academic Press Inc, New Yorkl]. Biological analysis of fractions demonstrated that different VIPs were responsible for the different lepidopteran species activity.
The Agrotis ipsilon activity is due to an 80 kDa and/or a 35 kDa protein, either delivered singly or in combination. These proteins are not related to any δ-endotoxins from Bt as evidenced by the lack of sequence homology of known Bt δ-endotoxin sequences. The vip3A(a) insecticidal protein from strain AB88 is present mostly (at least 75% of the total) in supernatants of AB88 cultures.
Also, these proteins are not found in the AB88 δ-endotoxin crystal. N-terminal sequences of the major δ-endotoxin proteins were compared with the N-terminal sequences of the 80 kDa and 35 kDa VIP and revealed no sequence homology. The N-terminal sequence of the vip3A(a) insecticidal protein posses a number of positively charged residues (from Asn2 to Asn7) followed by a hydrophobic core region (from Thr8 to Ile34). Unlike most of the known secretion proteins, the vip3A(a) insecticidal protein from strain AB88 is not N-terminally processed during export.
A summary of the results follows:
<td> AgrotisWP N-terminal sequences</td><td> N-terminal sequence of major δ-endotoxin proteins</td>
<td></td><td> 130 kDa MDNNPNINE (SEQ ID NO:14)</td>
<td> 80 kDa MNKNNTKLPTRALP (SEQ ID NO:12)</td><td> 80 kDa MDNNPNINE (SEQ ID NO:15)</td>
<td> 35 kDa ALSENTGKDGGYIVP (SEQ ID NO:13)</td><td> 60 kDa MNVLNSGRTTI (SEQ ID NO:16)</td>
<td colspan="2"> The Ostrinia nubilalis activity is due to a 60 kDa VIP and the Spodoptera frugiperda activity is due to a VIP of unknown size. Bacillus thuringiensis strain AB88 has been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center^ 1815 North University Street, Peoria, Illinois 61604, USA and given the</td>
Accession No. N R R L B-21225.
EXAMPLE 18A. ISOLATION AND BIOLOGICAL ACTIVITY OF 8.
THURINGIENSIS AB424
A B. thuringiensis strain, designated AB424, was isolated from a moss covered pine cone sample by standard methods known in the art. A subculture of AB424 was grown and prepared for bioassay as described in Example 2.
Biological activity was evaluated as described in Example 3. The results are as follows:
<td> Insect species tested</td><td> Percent mortality</td>
<td> Ostrinia nubilalis</td><td> 100</td>
<td> Agrotis ipsilon</td><td> 100</td>
<td> Diabrotica virgifera</td><td> 0</td>
<td> virgifera</td><td></td>
Strain AB424 has been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA, and given Accession No. NRRL B-21439.
EXAMPLE 18B. CLONING OF THE VIP3A(a) and VIP3A(b) GENES WHICH ENCODE PROTEINS ACTIVE AGAINST BLACK CUTWORM.
Total DNA from isolates AB88 and AB424 was isolated [Ausubel etal (1988), in: Current Protocols in Molecular Biology (John Wiley & Sons, NY)] and digested with the restriction enzymes Xbal [library of 4.0 to 5.0 Kb size-fractionated Xbal fragments of B thuringiensis AB88 DNA] and EcoR\ [library of 4.5 to 6.0 Kb size-fractionated EcoRI fragments B thuringiensis AB424 DNA] respectively, ligated into pBluescript vector previously linearized with the same enzymes and dephosphorylated, and transformed into E. coli DH5a strain. Recombinant clones were blotted onto nitrocellulose filters which were subsequently probed with a <sup>3?</sup>P labeled 33-bases long oligonucleotide corresponding to the 11-N terminal amino acids of the 80 kDa protein active against Agrotis ipsilon (black cutworm). Hybridization was carried out at 42°C in 2 x SSC/0.1% SDS (1 x SSC = 0.15 m NaCI/0.015 M sodium citrate, pH 7.4) for 5 min and twice at 50°C in 1 x SSC/0.1 SDS for 10 min. Four out of 400 recombinant clones were positive. Insect bioassays of the positive recombinants exhibited toxicity to black cutworm larvae comparable to that of AB88 or AB424 supernantants.
Plasmid pCIB7104 contains a 4.5 Kb Xbal fragment of AB88 DNA. Subclones were constructed to define the coding region of the insecticidal protein.
E co//pCIB7105 was constructed by cloning the 3.5 Kb Xbal-Acclfragment of pCIB7104 into pBluescript.
Plasmid pCIB7106 contained a 5.0 Kb EcoRIfragment of AB424 DNA. This fragment was further digested with Hindi to render a 2.8 kb EcoRI-Hindl insert (pCIB7107), which still encoded a functional insecticidal protein.
The nucleotide sequence of pCIB7104, a positive recombinant clone from AB88, and of pCIB7107, a positive recombinant clone from AB424, was determined by the dideoxy termination method of Sanger etal., Proc. Natl. Acad. Sci. USA, 74:54635467 (1977), using PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kits and PRISM Sequenase® Terminator Double-Stranded DNA Sequencing Kit and analysed on an ABI373 automatic sequencer.
The clone pCIB7104 contains the VIP3A(a) gene whose coding region is disclosed in SEQ ID NO:28 and the encoded protein sequence is disclosed in SEQ ID NO:29. A synthetic version of the coding region designed to be highly expressed in maize is given in SEQ ID NO:30. Any number of synthetic genes can be designed based on the amino acid sequence given in SEQ ID NO:29.
The clone pCIB7107 contains the VIP3A(b) gene whose coding region is disclosed in SEQ ID NO:31 and the encoded protein is disclosed in SEQ ID NO:32. Both pCIB7104 and pCIB7107 have been deposited with the Agricultural Research Service Patent Culture Collection (NRRL) and given Accession Nos. NRRL B-21422 and B21423, respectively.
The VIP3A(a) gene contains an open reading frame (ORF) that extends form nucleotide 732 to 3105. This ORF encodes a peptide of 791 amino acids corresponding to a molecular mass of 88,500 daltons. A Shine-Dalgarno (SD) sequence is located 6 bases before the first methionine and its sequence identifies a strong SD for Eac///us.
The VIP3A(b) gene is 98% identical to VIP3A(a).
When blost of total DNA isolated from AB88 B thuringiensis cells were probed with a 33.base fragment that spans the N-terminal region of the VIP3A-insecticidal protein, single bands could be observed in different restriction digests. This result was confirmed by using larger probes spanning the coding region of the gene. A search of the Gen Bank data base revealed no homology to known proteins.
EXAMPLE 18C. EXPRESSION OF THE VIP3A INSECTICIDAL PROTEINS
The time course for expression of the VIP3A(a) insecticidal protein was analyzed by western blot. Samples from Bacillus thuringiensis Ab88 clutures were taken throughout ist growth curve and sporulation. The VIP3A(a) insecticidal protein can be detected in the supernatants of AB88 cultures during logarithmic phase, as early as 15 h after initiating the culture. It reached its maximum level during early stages of stationary phase and remained at high levels during and after sporulation. Similar results were obtained when supernatants of AB424 Bacillus cereus cultures were used. The levels of VIP3A(a) insecticidal protein reflected the expression of the VIP3A(a) gene as determined by Northern blot. The initiation of the sporulation was determined by direct microscopic observations and by analyzing the presence of δendotoxins in cell pellets. Cry-I type prtoeins could be detected late in the stationary phase , during and after sporulation.
EXAMPLE 18D. IDENTIFICATION OF NOVEL VIP3-LIKE GENES BY HYBRIDIZATION
To identify Bacillus containing genes related to the VIP3A(a) from isolate AB88, a collection of Bacillus isolates was screened by hybridization. Cultures of 463 Bacillus strains were grown in microtiter wells until sporulation. A 96-pin colony stampel was used to transfer the cultures to 150 mm plates containing L-agar. Inoculated plates were kept at 30°C for 10 hours, then at 4°C overnight. Colonies were blotted onto nylon filters and probed with a 1.2Kb Hzndlll VIP3A(a) derived fragment. Hybridization was performed overnight at 62°C using hybridization conditions of Maniatis et al. Molecular Cloning: A Laboratory Manual (1982). Filters were washed with 2xSSC/0.1% SDS at 62°C and exposed to X-ray film.
Of the 463 Bacillus strains screened, 60 contain VIP3-like genes that could detected by hybridization. Further characterization of some of them (AB6 and AB426) showed that their supernatants contain a BCW insecticidal protein similar to the Vip3 protein that are active against black cutworm.
EXAMPLE 18E. CHARACTERIZATION OF A B. thuringiensis SJRMH M2194 CONTAINING A CRYPTIC VIP3-LIKE GENE
A B. thuringiensis strain, designated M2194, was shown to contain VIP3-like gene(s) by colony hybridization as described in Example 18C. The M2194 VIP3 like gene is considered cryptic since no expression can be detected throughout the bacterial growth phases either by immunoblot analysis using polyclonal antibodies raised against the VIP3A(a) protein isolated from AB88 or by bioassay as described in Example 3.
Antiserum against purified VIP3A(a) insecticidal protein was produced in rabbits. Nictrocellulםseדbound protein (50 μ9) was dissolved in DMSO and emulsified with Freund's complete adjuvant (Difco). Two rabbits were given subcutaneous injections each month for three month. They were bled 10 days after the second and third injection and the serum was recovered from the blood sample [Harlow et al (1988) in : Antibodies: A Laboratory Manual (Cold Spring Harbor Lab Press, Plainview, NY)].
The M2194 VIP3-like gene was cloned into pKS by following the protocol described in Example 9, which created pCIB7108. E. co//containing pCIB7108 which comprises the M2194 VIP3 gene were active against black cutworm demonstrating that the gene encodes a functional protein with insecticidal activity. The plasmid pCIB7108 has been deposited with the Agricultural Research Service Patent Culture Collection (NRRL) and given Accession No. NRRL B-21438.
EXAMPLE 18F. INSECTICIDAL ACITIVITY OF VIP3A PROTEINS
The activity spectrum of VIP3A insecticidal proteins was qualitatively determined in insect bioassays in which recombinant E coli carrying the VIP‘A genes were fed to larvae. In these assays, cells carrying the VIP3A(a) and VIP3A(b) genes were insecticidal to Agrotis ipsilon, Spodoptera frugiperda, Spodoptera exigua, Heliothis virescens and Helicoverpa zea. Under the same expermimental conditions, bacterial extracts containing VIP3A proteins did not show any activity against Ostrinia nubilalis.
Effect of VIP*A insecticidal proteins on Agrotis ipsilon larvae
<td> Treatment______________________ TB medium</td><td> (%) Mortality_____ 5</td>
<td> AB88 Supernatant</td><td> too</td>
<td> Ab424; Supernatant</td><td> 100</td>
<td> Buffer</td><td> 7</td>
<td> . E coli pKS</td><td> 10</td>
<td> Ec0//pCIB7104 (AB88)</td><td> 100</td>
<td> E co//pCIB7105 (AB88)</td><td> 100</td>
<td> E co//pCIB7106 (AB424)</td><td> 100</td>
<td> E co//pCIB7107 (AB424)</td><td> 100</td>
<td> Effect of VIP3A insecticidal proteins</td><td> on lepidopteran insect larvae</td>
<td> Treatment Insect</td><td> (%) Mortality</td>
<td> E co//pKS BCW</td><td> 10</td>
<td> FAW</td><td> 5</td>
<td> BAW</td><td> 10</td>
<td> TBW</td><td> 8</td>
<td> CEW</td><td> 10</td>
<td> ECB</td><td> 5</td>
<td> Ecoli pCIB7105</td><td></td>
<td> E co//pCIB7107 BCW</td><td> 100</td>
<td> FAW</td><td> 100</td>
<td> BAW</td><td> 100</td>
<td> ; TBW</td><td> 100</td>
<td> CEW</td><td> 50</td>
<td> ECB</td><td> 10</td>
BCW = Black Cut Worm; FAW = Fall Army Worm; BAW = Best Army Worm; TBW = Tobacco Bud Worm; CEW = Corn Ear Worm; ECB = European Corn Borer
EXAMPLE 19. ISOLATION AND BIOLOGICAL ACTIVITY OF OTHER
BACILLUS SP.
Other Bacillus species have been isolated which produce proteins with insecticidal activity during vegetative growth. These strains were isolated from environmental samples by standard methodologies. Isolates were prepared for bioassay and assayed as described in Examples 2 and 3 respectively. Isolates which produced insecticidal proteins during vegetative growth with activity against Agrotis ipsilon in the bioassay are tabulated below. No correlation was observed between the presence of a δ-endotoxin crystal and vegetative insecticidal protein production.
<td colspan="3"> Presence of δ-</td>
<td> Bacillus isolate</td><td> endotoxin crystal</td><td> Percent mortality</td>
<td> AB6</td><td> -ו-</td><td> 100</td>
<td> AB53</td><td> -</td><td> 80</td>
<td> AB88</td><td> -ו-</td><td> 100</td>
<td> AB195</td><td> -</td><td> 60</td>
<td> AB211</td><td> -</td><td> 70</td>
<td> AB217</td><td> -</td><td> 83</td>
<td> AB272</td><td> -</td><td> 80</td>
<td> AB279</td><td> -</td><td> 70</td>
<td> AB289</td><td> +</td><td> 100</td>
<td> AB292</td><td> ו-</td><td> 80</td>
<td> AB294</td><td> -</td><td> 100</td>
<td> AB300</td><td> -</td><td> 80</td>
<td> AB359</td><td> -</td><td> 100</td>
Isolates AB289, AB294 and AB359 have been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria II 61604, USA and given the Accession Numbers NRRL B-21227, NRRL B-21229, and NRRL B-21226 respectively.
Bacillus isolates which produce insecticidal proteins during vegetative growth with activity against Diabrotica virgifera virgifera are tabulated below.
<td colspan="3"> Presence of δ-</td>
<td> ; Bacillus isolate</td><td> endotoxin crystal</td><td> Percent mortality</td>
<td> AB52</td><td> -</td><td> 50</td>
<td> AB59</td><td> -</td><td> 71</td>
<td> AB68</td><td> -ו-</td><td> 60</td>
<td> AB78</td><td> -</td><td> 100</td>
<td> AB 122</td><td> -</td><td> 57</td>
<td> AB218</td><td> - (</td><td> 64</td>
<td> AB256</td><td> -</td><td> 64</td>
Isolates AB59 and AB256 have been deposited in the,Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria Illinois 61604, USA, and given the Accession Numbers NRRL B-21228 and NRRL B-21230, respectively.
EXAMPLE 20. IDENTIFICATION OF NOVEL VIP1/VIP2 LIKE GENES BY HYBRIDIZATION
To identify strains containing genes related to those found in the
VIP1 A(a)/VIP2A(a) region of AB78, a collection of Bacillus strains was screened by hybridization. Independent cultures of 463 Bacillus strains were grown in wells of 96 well microtiter dishes (five plates total) until the cultures spbrulated. Of the strains tested, 288 were categorized as Bacillus thuringiensis, and 175 were categorized as other Bacillus species based on the presence or absence of δ-endotoxin crystals. For each microtiter dish, a 96-pin colony stamper was used to transfer approximately 10 μΙ of spore culture to two 150 mm plates containing L-agar. Inoculated plates were grown 4-8 hours at 30 °C, then chilled to 4 °C. Colonies were transferred to nylon filters, and the cells lysed by standard methods known in the art. The filters were hybridized to a DNA probe generated from DNA fragments containing both VIP1 A(a) and VIP2A(a) DNA sequences. Hybridization was performed overnight at 65 °C using the hybridization conditions of Church and Gilbert (Church, G.M., and W. Gilbert,
PNAS, 81:1991-1995 (1984)). Filters were washed with 2x SSC containing 0.1% SDS at 65 °C and exposed to X-Ray film.
Of the 463 Bacillus strains screened, 55 strains were identified that hybridized to the VIF1 ״ A(a)/VIP2A(a) probe. DNA was isolated from 22 of these strains, and analyzed using a Southern blot with VIP1 A(a)/VIP2A(a) DNA as probes. These strains were grouped into 8 classes based on their Southern blot pattern. Each class differed in Southern blot pattern from AB78. One class had a pattern identical to that of the VIP1 A(a)/VIP2A(a) homologs from Bacillus thuringiensis var tenebrionis (see below); Each of the 22 strains was tested for activity against western corn rootworm (WCRW). Three strains, AB433, AB434, and AB435 were found to be active on WCRW. Western blot analysis using VIP2A(a) antisera revealed that strains AB6, AB433', AB434, AB435, AB444, and AB445 produce a protein(s) of equivalent size to VIP2A(a).
Notable among the strains identified was Bacillus thuringiensis strain AB6, (NRRL B-21060) which produced a VIP active against black cutworm (Agrotis ipsilon) as described in Example 15. Western blot analysis with polyclonal antisera to VIP2A(a) and polyclonal antisera to VIP1 A(a) suggests that AB6 produces proteins similar to VIP2A(a) and VIP1 A(a). Thus, AB6 may contain VIPs similar to VIP1A(a) and VIP2A(a), but with a different spectrum of insecticidal activity.
EXAMPLE 21. CLONING OF A VIP1 A(a)/VIP2A(a) HOMOLOG FROM
BACILLUS THURINGIENSISVAR, TENEBRIONIS.
Several previously characterized Bacillus strains were tested for presence of DNA similar to VIP1 A(a)/VIP2A(a) by Southern blot analysis. DNA from Bacillus strains AB78, AB88, GC91, HD-1 and ATCC 10876 was analyzed for presence of VIP1 A(a)/VIP2A(a) like sequences. DNA from Bt strains GC91 and HD-1, and the Be strain ATCC 10876 did not hybridize to VIP2A(a)/VIP1A(a) DNA, indicating they lack DNA sequences similar to VIP1 A(a)/VIP2A(a) genes. Similarly, DNA from the insecticidal strain AB88 (Example 16) did not hybridize to VIP1 A(a)/VIP2A(a) DNA region, suggesting that the VIP activity produced by this strain does not result from VIP1 A(a)/VIP2A(a) homologs. In contrast, Bacillus thuringiensis var. tenebrionis (Btt) contained sequences that hybridized to the VIP1 A(a)/VIP2A(a) region. Further analysis confirmed that Btt contains VIP1 A(a)/VIP2A(a) like sequences.
To characterize the Btt homologs of VIP2A(a) and VIP1A(a), the genes encoding these proteins were cloned. Southern blot analysis identified a 9.5 kb Eco Rl restriction fragment likely to contain the coding regions for the homologs. Genomic DNA was digested with Eco Rl, and DNA fragments of approximately 9.5 kb in length were gel-purified. This DNA was ligated into pBluescript SK(+) digested with Eco Rl, and transformed into E. coli to generate a plasmid library. Approximately 10,000 colonies were screened by colony hybridization for the presence of VIP2A(a) homologous sequences. Twenty eight positive colonies were identified. All twenty eight clones are identical, and contain VIP1 A(a)/VIP2A(a) homologs. Clone pCIB7100 has been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria Illinois 61604, USA, and given the Accession Number B-21322. Several subclones were constructed from pCIB7100. A 3.8 kb Xba I fragment from pCIB7100 was cloned into pBluescript SK(+) to yield pCIB7101. A 1.8 kb Hind III fragment and a 1.4 kb Hind III fragment from pCIB7100 were cloned into pBluescript SK(+) to yield pCIB7102 and pCIB7103, respectively. Subclones pCIB7101, pCIB7102 and pCIB7i 03 have been deposited in the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria ’Illinois 61604, USA, and given the Accession Numbers B-21323, B-21324 and B-21325 respectively.
The;DNA sequence of the region of pCIB7100 containing the VIP2A(a)/VIP1 A(a) homologs was determined by the dideoxy chain termination method (Sanger etal., 1977, Proc. Natl. Acad. Sci. USA 74:5463-5467). Reactions were performed using PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kits and PRISM Sequenase® Terminator Double-Stranded DNA Sequencing Kits, and analyzed on an ABI model 373 automated sequencer. Custom oligonucleotides were used as primers to determine the DNA sequence in certain regions. The DNA sequence of this region is shown in SEQ ID NO:19.
The 4 kb region shown in SEQ ID NO:19 contains two open readings frames (ORFs), which encode proteins with a high degree of similarity to VIP1 A(a) and VIP2A(a) proteins from strain AB78. The amino acid sequence of the VIP2A(a)
־ homolog, designaled as VIP2A(b) using the standardized nomenclature, is found at SEQ ID NO:20 and the amino acid sequence of the VIPt A(a) homolog, designated as VIP1 A(b> using the standardized nomenclature, is disclosed at SEQ ID NO-21 The VIP2A(b) protein exhibits 91% amino acid identity to VIP2A(a) from AB78. An alignment of the amino acid sequences of the two VIPS proteins is provided in Table 19. The VIPlA(b) protein exhibits 77 % amino acid identity to VIP1 A(a) from AB78. An alignment of these two VIP1 proteins is provided in Table 20. The alignment shown in Table 20discloses the similarity between VIP1 A(b) and VIPt A(a) from AB78. This alignment reveals that the amino terminal regions of the two VIP1 proteins share higher amino acid identity in the amino terminal region than in the carboxy terminal region. In fact, the amino terminal two thirds (up to aa 618 of the VIP1 A(b) sequence shown in Table 20) of the two proteins exhibit 91% ״entity, <sub>while </sub>the carboxy-termmal third (from aa 619-833 of VIP1A(b)) exhibit only 35% identity
Western blot analysis indicated that Bacillus thuringiensis var. tenebrionis (Bit) produces both VIPt A(a) like and VIP2A(a) like proteins. However, these proteins do not appear to have activity against western corn rootworm. Bioassay for activity against western com rootworm was performed using either a 24 h culture supernatant from Btt or E. coliclone pCIB7100 (which contains the entire region of the VIP1 AfayVIP2A(a) homologs). No activity against western com rootworm was detected in either case.
Given the similarity between the VIP2 proteins from Btt and AB78, the ability of ™«ר<sup>B10</sup>״<sup> substitu,e</sup><sup>0</sup>׳<sup>, v,p2A(a)</sup> י״™׳ <sup>ab78 was ,es,ed</sup>.<sup>c</sup>* ־״».״״־ PCIB 206 (Wh,־h produces AB78 VIPt A(a) but not VIP2A(a) protein) were mixed with culture supernatant, and tested for activity against western corn rootworm While neither Btt culture supernatant nor cells containing pCIB6206 had activity on WCRW the mixture of Btt and pCIB6<sub>2</sub>06 gave high activity against WCRW. Furthermore ' additional b.oassay showed that the Btt clone pCIB7100, which contains the Btt ' VIP1A(b)/VIP2A(b) genes in E coli, also confers activity against WCRW when mixed ΓΓνί<sup>6</sup>״'<sup>ThUS</sup>’ <sup>1</sup>θ <sup>V</sup>'<sup>P2A(b)</sup> '™י“ <sup>Pr</sup>°<sup>dUCed by B״ iS</sup> '“** equivalent to the VIR2A(a) protein produced by AB78.
Thus, the ability to identify new strains with insecticidal activity by using VIP ONA as hybridization probes has been demonstrated. Furthermore, Musstrains that contain VIP1A(a)/VIP2A(a) like sequences, produce VIPt A(a)/v1P2A(a) like protein, yet demonstrate tox.city toward different insect pests. Similar <sub>methods can iden</sub>״<sub>f</sub> many more members of the VIP1/VIP2 family. <sub>Fufl</sub>״<sub>ermore</sub>. <sub>5״</sub>θ <sub>q(</sub> can. identify homologs of other varieties of VIPs (for example, the VIPs from AB88)
TABLE 19
Alignment of VfP<sub>2</sub> Amino Acid Sequences from BaciHus thunngiens.s ״ar. tenebnoms (VIP2A(b)) vs. AB78 (VIP2A(a)) ״־ ‘^MtKKjrwSKTIQVVIRTVLLSTVySITl.IMIVVIKADQLNIlISQSK 50 <sub>ID</sub> p״,.״
AB71 ־ <sub>M SEQ m N0:2</sub> ^^^tlLKIPDNAEDEKEDKGKAKEWGKEKGEEWRPPATEKGEMNHFLDN <sub>M</sub>0 ..............-1111 I. | , f |, ,, ^^^^KXTDKVEDEKWKEKAKHOtEKEKEHKLTATEKGKMNNELDN ' I I1111:111III.11H11HH
151 ™™־LTEG^^^ <sup>IH</sup>Ii::i:iiiiIiIiIIii<sub>HII</sub> '1.1111111111::1111111,,, '<sup>;</sup>'<sup>IiVIIi</sup>'<sup>V</sup>t'״eSGKGS<sup>,</sup>n׳PTKAGVILNHSEVBtn,1p<sub>MG</sub>y<sub>MVHVD</sub>p<sub>V</sub>g^<sub>v</sub>^ ^^'''^OVEG'rLKKSLDEKNDInAEAIISiOlKIyEDWAKNLTASQBEAIX) <sub>30() </sub>, <sup>:</sup><sup>:</sup>llllllll 11:111:11.11,,1,1 <sub>3M</sub>
350
...<sup>1111</sup><sup>1111111</sup>'״IIIIIIIIIIHIHIIIIIIIUIII <sup>1</sup>“<sup>(,</sup>'<sup>ΜΡ</sup>^<sup>ί</sup>’^ϊ0Ι5ΟΡΕΡ3<sub>Ι</sub>.ΚΟΓΕΕ0ιτ^βφ||<sub>)1ίΟ</sub>γ^τ<sub>3</sub>^$^^^^^<sub>ί</sub>,ρ '351
KIILRUJVPKGSTGAYLSMGGFSSEKEIIiOKDSKYaiDKiUEVIIKGV «0 ....<sup></sup> י........Hmm <sup>KIILRL</sup>°<sup>VPKGST</sup>®n3MGGFKEKEILWKDSKYHIDIOTEVlIKGV 450
451 KRYWDATLLTN 462 I I II I I I | | | | |
451 KRYWDATLLTN 462
TABLE 20
A״gnm״־<sub>t</sub> of v!P1 Amino Acid S^־»־״ <sub>from Baclllus </sub>fe/7edr/on/s (VIPiA(b)) vs.AB78(VIP1A(a)) <sup>5</sup>θ SEQ ID NO:21
SEQ ID NO :5 <sup>M</sup>'<sup>(</sup>'^״^״A^'<sup>/v</sup>TOlLLAPMELNGHVHAVNADSKINQIS־ITQ|iMQQKa4D '<sup>1</sup>ininii 1111.iium.num
Btt
Ab78 <sup>51</sup> n «״ <sup>11</sup> 11:111 י <sup>11</sup>י <sup>111111</sup>־ f 1 n iininiimi
»1־1
111 1 <sup>1 11111111111</sup>'<sup>111111</sup>1<sup>l:1</sup>1<sup>1</sup>1111111111 η n ״,
1־1
-LRNPEFNKKE
Hill mil <sup>ί></sup>^^<sup>Ε</sup>^50ΤΚΓΝΙΟ<sub>5</sub>ΚΤΓΚΕυ<0ΓΚ4.[)52<sub>Η</sub>2502<sub>ν</sub>2 ,<sup>,11,111</sup>11111Hn1nn1nn.ini ־90151 PIKIEYQSDTKFNIDSKTFKELKLFKIDSQNQPQQVQQDELRNPEFNKKE 200
198 SQEFLAKASKTNLFKQKMKRDIDEDTDTDGDSIPDLWEENGYTIQNKVAV 247
III HI 1:1 l-l I HI III 1:1 II HI III III III III III I III:: II
201 SQEFLAKPSKINLFTQKMKREIDEDTDTDGDSIPDLWEENGYTIQNRIAV 250
248 KWDDSLASKGYTKFVSNPLDSHTVGDPYTDYEKAARDLDLSNAKETFNPL. 297
III 11 III 11 HI I III II: IIIIII11IIIIIIIIIIIII11 HI IIII
251 KWDDSLASKGYTKFVSNPLESHTVGDPYTDYEKAARDLDLSNAKETFNPL 300
298 VAAFPSVNVSMEKVILSPNENLSNSVESHSSTNWSYTNTEGASIEAGGGP 347 mill I Illi I Illi II II Hill II Illi 111111111111:1 II II
301 VAAFPSVNVSMEKVILSPNENLSNSVESHSSTNWSYTNTEGASVEAGIGP 350
348 LGLSFGVSVTYQHSETVAQEWGTSTGNTSQFNTASAGYLNANVRYNNVGT 397
I: IIIIII. II HI III HI III III IIIIII IIIII III IIII III 11
351 KGISFGVSVNYQHSETVAQEWGTSTGNTSQFNTASAGYLNANVRYNNVGT 400
398 GAIYDVKPTTSFVLNNNTIATITAKSNSTALRISPGDSYPEIGENAIAIT 447 <sup>£</sup> II I III I I I 11 I I I I I: I I I I I I 11 11 I I I 1.1111:111. 1:1:1m
401 GAIYDVKPTTSFVLNNDTIATITAKSNSTALNISPGESYPKKGQNGIAIT 450
448 SMDDFNSHPITLNKQQVNQLINNKPIMLETDQTDGVYKIRDTHGNIVTGG 497
11111111111111 -11: -1:1111:1111:11111111:1111111111
4.51 SWDFNSHPITIJ^QVDIUINNKPMI^TNQTDGVYKIKDTHGNIVTGG 500
498 EWNGVTQQIKAKTASIIVDDGKQVAEKRVAAKDYGHPEDKTPPLTLKDTL 547 > 11 mm 11mm 1111. 111 r 1111111:: 111111.11111.1
501 EWNGVIQQIKAKTASIIVDDGERVAEKRVAAKDYENPEDKTPSLTLKDAL 550
548 KLSYPDEIKETNGLLYYDDKPIYESSVMTYLDENTAKEVKKQINDTTGKF 597 ' III I III II I .: I III I.: HI HI III III HI II III . I I: III III I
551 KLSYPDEIKEIEGLLYYKNKPIYESSVMTYLDENTAKEWKQLNDTTGKF 600 . . . ,598 W/NHLYDVKLTPKMNFTIKMASLYDGAENNHNSLGTWYLTYNVAGGNTG 647 I 11.1 I I I I I I I I I I 1. 11 I:. I I I .II. I. I I: I. I I I . I I I. I . .. 601 KDVSHLYDVKLTPKMNVTIKLSILYDNAESNDNSIGKWTNTNIVSGGNNG 650 '648 KRQYRSAHSCTWALSSEAKKKLNQNAlTYYLSMYMFTtoSTTEPTIEVAGE 697 1:11-1.:. 1::.1.:1.111.1 :11:1:111.:.1:.1.:.11
651 KKQYSSNNPDZ\NLTI1ITDAQEKLNKNRDYYISLYMKSEKNTQCEITIDGE 700
698 ^AITSKKVKEWQNYQRVDILVKNSEWMDKIYIRGNGTTNVYGDDVT 747 :11.I.I.:1.:11.1:11:.I .11:.:.1:.1:..:: 11:.
701 IYPITTKTVNVNKDNYKRLDIIAHNIKSNPISSLHIKTNDEITLFWDDIS 750
748 IPEVSAINPASLSDEEIQEIFKDSTIEYGNPSFVADAVTFK..... 788
I.: 1. 1.1. 1.1.11.: 1:. .ן.::.::...:.
751 ITDVASIKPENLTDSEIKQIYSRYGIKLEDGILIDKKGGIHYGEFINEAS 800
789 . NIKPLQNYVKEYEIYHK....SHRYEKKTVFDIMGVHYEYSIAREQ 830
II.IIII I|.|.: . |. .1..::. .:.:::. ..
801 FNIEPLQNYVTKYKVTYSSELGQNVSDTLESDKIYKDGTIKFDFTKYSKN 850
831 KKA 833
851 EQG 853
EXAMPLE 22. FUSION OF VIP PROTEINS TO MAKE A SINGLE POLYPEPTIDE
VIP proteins may occur in nature as single polypeptides, or as two or more interacting polypeptides. When an active VIP is comprised of two or more interacting protein chains, these protein chains can be produced as a single polypeptide chain from a gene resulting from the fusion of the two (or more) VIP coding regions. The genes encoding the two chains are fused by merging the coding regions of the genes to produce a single open reading frame encoding both' VIP polypeptides. The composite polypeptides can be fused to produce the smaller polypeptide as the NH<sub>2 </sub>terminus of the fusion protein, or they can be fused to produce the larger of the polypeptides as the NH<sub>2</sub> terminus of the fusion protein. A linker region can optionally be used between the two polypeptide domains. Such linkers are known in the art. This linker pan optionally be designed to contain protease cleavage sites such that once the single fused polypeptide is ingested by the target insect it is cleaved in the linker region to liberate the two polypeptide components of the active VIP molecule.
VIP1 A(a) and VIP2A(a) from B. cereus strain AB78 are fused to make a single polypeptide by fusing their coding regions. The resulting DNA comprises a sequence given in SEQ ID NO:22 with the encoded protein given in SEQ ID NO:23. In like manner, other fusion proteins may be produced.
The fusion of the genes encoding VIP1 A(a) and VIP2A(a) is accomplished using standard techniques of molecular biology. The nucleotides deleted between the VIP1A(a) and VIP2A(a) coding regions are deleted using known mutagenesis techniques or, alternatively, the coding regions are fused using PCR techniques.
The fused VIP polypeptides can be expressed in other organisms using a synthetic gene, or partially synthetic gene, optimized for expression in the alternative host. For instance, to express the fused VIP polypeptide from above in maize, one makes a synthetic gene using the maize preferred codons for each amino acid, see for example EP-A 0618976, herein incorporated by reference. Synthetic DNA sequences created according to these methods are disclosed in SEQ ID NO:17 (maize optimized version of the 100 kDa VIP1A(a) coding sequence), SEQ ID NO:18 (maize optimized version of the 80 kDa VIP1 A(a) coding sequence) and SEQ ID NO:24 (maize optimized version of the VIP2A(a) coding sequence).
Synthetic VIP1 and VIP2 genes optimized for expression in maize can be fused using PCR techniques, or the synthetic genes can be designed to be fused at a common restriction site. Alternatively, the synthetic fusion gene can be designed to encode a single polypeptide comprised of both VIP1 and VIP2 domains.
Addition of a peptide linker between the VIP1 and VIP2 domains of the fusion protein can be accomplished by PCR mutagenesis, use of a synthetic DNA linker encoding the linker peptide, or other methods known in the art.
The fused VIP polypeptides can be comprised of one or more binding domains. If more than one binding domain is used in the fusion, multiple target pests are controlled using such a fusion. The other binding domains can be obtained by using all or part of other VIPs; Bacillus thuringiensis endotoxins, or parts thereof; or other proteins capable of binding to the target pest or appropriate biding domains derived from such binding proteins.
One example of a fusion construction comprising a maize optimized DNA sequence encoding a single polypeptide chain fusion having VIP2A(a) at the Nterminal end and VIP1 A(a) at the C-terminal end is provided by pCIB5531. A DNA sequence encoding a linker with the peptide sequence PSTPPTPSPSTPPTPS (SEQ ID NO:47) has been inserted between the two coding regions. The sequence encoding this linker and relevant cloning sites is 5<sup>1</sup>- CGC GGG OCT TCT ACT CCC CCA ACT CCC TCT CCT AGC ACG CCT CCG ACA CCT AGC GAT ATC GGA TC C -3' (SEQ ID NO:48). Oligonucleotides were synthesized to represent both the upper and lower strands and cloned into a pUC vector following hybridization and phosphorylation using standard procedures. The stop codon in VIP2A(a) was removed using PCR and replaced by the Bglll restriction site with a Smal site. A translation fusion was made by ligating the Bam HI / Pstl fragment of the VIP2A(a) gene from pCIB5522 (see Example 24), a PCR fragment containing the Pstl-end fragment of the VIP2A(a) gene (identical to that used to construct pCIB5522), a synthetic linker having ends that would ligate with a blunt site at the 5’ end and with BamHI at the 3’ end and the modified synthetic VIP1 A(a) gene from pCIB5526 described below (See SEQ ID NO:35). The fusion was obtained by a four way ligation that resulted in a plasmid containing the VIP2A(a) gene without a translation stop codon, with a linker and the VIP1 A(a) coding region without the Bacillus secretion signal. The DNA sequence for this construction is disclosed in SEQ ID NO:49, which encodes the fusion protein disclosed in SEQ ID NQ:50. A single polypeptide fusion where VIP1 A(a) is at the N-terminal end and VIP2A(a) is at the C-terminal end can be made in a similar fashion. Furthermore, either one or both genes can be linked in a translation fusion with or without a linker at either the 5’ or the 3’ end to other molecules like toxin encoding genes or reporter genes.
EXAMPLE 23. TARGETING OF VIP2 TO PLANT ORGANELLES
Various mechanisms for targeting gene products are known to exist in plants and the sequences controlling the functioning of these mechanisms have been characterized in some detail. For example, the targeting of gene products to the chloroplast is controlled by a signal sequence found at the amino-terminal end of various proteins. This signal is cleaved during chloroplast import, yielding the mature protein (e.g. Comai etal. J. Biol. Chem. 263:15104-15109 (1988)). These signal sequences can be fused to heterologous gene products such as VIP2 to effect the import of those products into the chloroplast (van den Broeck etal. Nature 313:358363 (1985)). DNA encoding for appropriate signal sequences can be isolated from the 5’ end of the cDNAs encoding the RUBISCO protein, the CAB protein, the EPSP synthase enzyme, the GS2 protein and many other proteins which are known to be chloroplast localized.
Other gene products are localized to other organelles such as the mitochondrion and the peroxisome (e.g. Unger etal. Plant Molec. Biol. 13:411-418 (1989)). The cDNAs encoding these products can also be manipulated to effect the targeting of heterologous gene products such as VIP2 to these organelles. Examples of such sequences are the nuclear-encoded ATPases and specific aspartate amino transferase isoforms for mitochondria. Similarly, targeting to cellular protein bodies has been described by Rogers etal. (Proc. Natl. Acad. Sci. USA 82:6512-6516 (1985)).
By the fusion of the appropriate targeting sequences described above to coding seqbences of interest such as VIP2 it is possible to direct the transgene product to any organelle or cell compartment. For chloroplast targeting, for example, the chloroplast signal sequence from the RUBISCO gene, the CAB gene, the EPSP synthase gene, or the GS2 gene is fused in frame to the amino-terminal ATG of the transgene. The signal sequence selected should include the known cleavage site and the fusion constructed should take into account any amino acids after the cleavage site which are required for cleavage. In some cases this requirement may be fulfilled by the addition of a small number of amino acids between the cleavage site and the start codon ATG, or alternatively replacement of some amino acids within the coding sequence. Fusions constructed for chloroplast import can be tested for efficacy of chloroplast uptake by in vitro translation of in vitro transcribed constructions followed by in vitro chloroplast uptake using techniques described by (Bartlett etal. In: Edelmann et al. (Eds.) Methods in Chloroplast Molecular Biology, Elsevier, pp 10811091 (1982); Wasmann etal. Mol. Gen. Genet. 205:446-453 (1986)). These construction techniques are well known in the art and are equally applicable to mitochondria and peroxisomes.
The above described mechanisms for cellular targeting can be utilized not only in conjunction with their cognate promoters, but also in conjunction with heterologous promoters so as to effect a specific cell targeting goal under the transcriptional regulation of a promoter which has an expression pattern different to that of the promoter from which the targeting signal derives.
A DNA sequence encoding a secretion signal is present in the native Bacillus VIP2 gene. This signal is not present in the mature protein which has the N־terminal sequence of LKITDKVEDF (amino acid residues 57 to 66 of SEQ ID NO:2). It is possible to engineer VIP2 to be secreted out of the plant cell or to be targeted to subcellular organelles such as the endoplasmic reticulum, vacuole, mitochondria or plastids including chloroplasts. Hybrid proteins made by fusion of a secretion signal peptide to a marker gene have been successfully targeted into the secretion pathway. (Itirriaga G. etal., The Plant Cell. 1:381-390 (1989), Oenecke et al., The Plant Cell. 2:511990) 59־). Amino-terminal sequences have been identified that are responsible for targeting to the ER, the apoplast, and extracellular secretion from aleurone cells (Koehler & Ho, Plant Cell 2: 769-783 (1990)).
The presence of additional signals are required for the protein to be retained in the endoplasmic reticulum or the vacuole. The peptide sequence KDEL/HDEL at the carboxy-terminal of a protein is required for its retention in the endoplasmic reticulum (reviewed by Pelham, Annual Review Cell Biol., 5:1-23 (1989). The signals for retention of proteins in the vacuole have also been characterized. Vacuolar targeting signals may be present either at the amino-terminal portion, (Holwerda et al., The Plant Cell. 4:307-318 (1992), Nakamura etal., Plant Physiol., 101:1-5 (1993)), carboxy- terminal portion, or in the internal sequence of the targeted protein. (Tague etal., The Plant Cell, 4:307-318 (1992), Saalbach eta/. The Plant Cell. 3:695-708 (1991)). Additionally, amino-terminal sequences in conjunction with carboxy-terminal sequences are responsible for vacuolar targeting of gene products (Shinshi et al. Plant Molec. Biol. 14:357-368 (1990)). Similarly, proteins may be targeted to the mitochondria or plastids using specific carboxy terminal signal peptide fusions (Heijne et al., Eur. J, Biochem. 180:535-545 (1989), Archer and Keegstra, Plant Molecular Biology^ 23:1105-1115 (1993)).
־
In order to target VIP2, either tor secretion or to the various subcellufar <sub>organete</sub> atze optimized DNA sequence encoding a known signal peptide(s) may be ' designed to be at the 5’ or the 3־ end of tho ' <sup>y</sup> the cell a DNA <,. <sup>aS T</sup>° <sup>secrete VIP2</sup> ־ '״״' cell. DNA sequence encoding the eukaryotic secretion signal peptide
I^GWSWIFLFLLSGAAGVHCL (SEQ ID NO:25) from WO 96/00783 or any other described in the literature (hirriaga efaL JMantCehj ;381.390 ( 989), Denecke, ef aZ, ThePlantc1990) 2:51-59 .״־)) may be added to the 5' end of ״־her the complete VtP2 gene sequence or to the sequence truncated to encode t e mature protem or the gene truncated to nucleotide 286 cr encoding a protein to start a ammo acid residue 94 (methionine). To target VIP2to be retained in the ב“-<sup>a dna sequence ,he er s!9nai</sup> ־*׳>*EL. add,hon to the secretion signal, can be added to the 3’ end of the gene For vacuolar targeting a DNA sequence encoding the signal peptide 31^(^ 99^0 <sup>(</sup>$<sup>Ε</sup>θ‘D N°<sup>20</sup>^ ׳f<sup>w</sup>erda et a/., The_Plant_Cell, 4:3078 (1992)) can be des.g״ed to be adjacent to the secretion signal or a sequence encoding a carboxyl signat peptide as described by DombrowsH a,at. The Plant
1993) 87-596־:־) or a functional variation may be inserted at the 3^<sub>e </sub>gene^Similarly, VIP2 can be designed to be targeted to either the mitochondria or the P astids, including the chloroplasts, by inserting sequences in the VIP2 sequence escnbed that would encode the required targeting <sub>s1gnals</sub>. <sub>The </sub>־ignal present in ViP2 may be retained or removed Irom the Una. construe,™ ne example 01 a construction which incorporates a eukaryotic secretion signal ״sed to a coding sequence lor a VIP is provided by pCIB5528. Oli<sub>g</sub>״״־<sub>cl</sub>ectides corresponding to both the upper and lower strand Of sequences encoding the secretion signal peptide of SEQ ID NO:25 was synthesized and hp<־ th ggatccacc atg ggc tgg agc tgg atc ttc ctc X <sup>sequence 5</sup>'
GTG CAC TGC C^<sup>AC</sup>™ <sup>C</sup>“ θ<*
־. end of the secretion signal reseat J ends > sites BamHI and Pen τη ,. <sup>־Wends</sup> ״־־«Pending to restriction <sup>bamH</sup> and Pstl. The oligonucleotide was hybridized and nhne <sub>h </sub>ligated into PCIB5527 (construction described in Example 23A1 η η n coding sequence is disciosed in SEQ ID NO:42 which encodes the pZ “
-פ? in SEQ ID NO:43. This encoded protein comprises the eukaryotic secretion signal חו place of the Bacillus secretion signal.
One example of a construction which incorporates a vacuolar targetting signal fused to a coding sequence for a VIP is provided by pCIB5533. Oligonucleotides corresponding to both the upper and lower strand of sequences encoding the vacuolar targetting peptide of SEQ ID NO:3 was synthesized and has the sequence 5'-CCG CGG GCG TGC ACT GCC TCA GCA GCA GCA GCT TCG CCG ACA GCA ACC CCA TCC GCG TGA CCG ACC GCG CCG CCA GCA CCC TGC AG-3' (SEQ ID NO:44). When hybridized, the 5' end of the vacuolar targetting signal resembled “sticky-ends״ corresponding to restriction sites SacII and Pstl. The oligonucleotide was hybridized and phosphorylated and ligated into pCIB5528 (construction described above) which had been digested with SacII / Pstl using standard procedures. The resulting maize optimized coding sequence is disclosed in SEQ ID NO:45 which encodes the protein disclosed in SEQ ID NO:46. This encoded protein comprises the vacuolar targetting peptide in addition to the eukaryotic secretion signal.
The VIP1 gene can also be designed to be secreted or targeted to subcellular organelles by similar procedures.
EXAMPLE 23A. REMOVAL OF BACILLUS SECRETION SIGNAL FROM
VIP1 A(a) AND VIP2A(a)
VIP1 A(a) and VIP2A(a) are secreted during the growth of strain AB78. The nature of peptide sequences that act as secretion signals has been described in the literature (Simonen and Palva, Microbiological reviews, pg. 109-137 (1993)). Following the information in the above publication, the putative secretion signal was identified in both genes. In VIP1 A(a) this signal is composed of amino acids 1-33 {See SEQ ID NO:5). Processing of the secretion signal probably occurs after the serine at amino acid 33. The secretion signal in VIP2A(a) was identified as amino acids 1-49 {See SEQ ID NO:2). N-terminal peptide analysis of the secreted mature VIP2A(a) protein revealed the N-terminal sequence LKITDKVEDFKEDK. This sequence is found beginning at amino acid 57 in SEQ ID NO:2. The genes encoding these proteins have been modified by removal of the Bacillus secretion signals.
A maize optimized VIP1 A(a) coding region was constructed which had the sequences encoding the first 33 amino acids, i.e., the secretion signal, removed from its 5' end. This modification was obtained by PCR using an forward primer that contained the sequence 5'-GGA TCC ACC ATG AAG ACC AAC CAG ATC AGC-3' (SEQ ID NO:33), which hybridizes with the maize optimized gene (SEQ ID NO:26) at nucleotide position 100, and added a BamHI restriction site and a eukaryotic translation start site consensus including a start codon. The reverse primer that contained the sequence 5'־AAG CTT CAG CTC CTT G-3' (SEQ ID NO:34) hybridizes on the complementary strand at nucelotide position 507. A 527 bp amplification product was obtained containing the restriction sites BamHI at the 5* end and Hindlll site at the 3' end. The amplification product was cloned into a T- vector (described in Example 24, below) and sequenced to ensure the correct DNA sequence. The BamHI / Hindlll fragment was then obtained by restriction digest and used to replace the BamHI/Hindlll fragment of the maize optimized VIP1A(a) gene cloned in the rootpreferred promoter cassette. The construct obtained was designated pCIB5526. The maize optimized coding region for VIP1A(a) with the Bacillus secretion signal removed is disclosed as SEQ ID NO;35 and the encoded protein is disclosed as SEQ ID NO :36.
The gene encoding the processed form of VIP2A(a), i.e., a coding region with the secretion signal removed, was constructed by a procedure similar to that described for that used to construct the processed form of VIP1 A(a), above. The modification was obtained by PGR using the forward primer 5'-GGA TCC ACC ATG CTG CAG AAC CTG AAG ATC AC -3' (SEQ ID NO:37). This primer hybridizes at nucleotide position 150 of the maize optimized VIP2A(a) gene (SEQ ID NO:27). A silent mutation has been inserted at nucleotide position 15 of this primer to obtain a Pstl restriction site. The reverse primer has the sequence 5'־AAG CTT CCA CTC CTT CTC-3' (SEQ ID NO:38). A 259 bp product was obtained with Hindlll restriction site at the 3' end. The amplification product was cloned into a T- vector, sequenced and ligated to a BamHI /Hindi 11'digested root-preferred promoter cassette containing the maize optimized VIP2A(a). The construct obtained was designated pCIB5527. The maize optimized coding region for VIP2A(a) with the Bacillus secretion signal removed is disclosed as SEQ ID NO:39 and the encoded protein is disclosed as SEQ ID NO:40.
EXAMPLE 24 CONSTRUCTION AND CLONING OF THE VIP1 A(a) AND VIP2A(a) MAIZE OPTIMIZED GENES
Design: The maize optimized genes were designed by reverse translation of the native VIPlA(a) and VIP2A(a) protein sequences using codons that are used most often in maize (Murray etal., Nucleic Acid Research, 17:477-498 (1989)). To facilitate cloning, the DNA sequence was further modified to incorporate unique restriction sites at intervals of every 200-360 nucleotides. VIP1 A(a) was designed to be cloned in 11 such fragments and VIP2A(a) was cloned in 5 fragments. Following cloning of the individual fragments, adjacent fragments were joined using the restriction sites common to both fragments, to obtain the complete gene. To clone each fragment, oligonucleotides (50-85 nucleotides) were designed to represent both the upper and the lower strand of the DNA. The upper oligo of the first oligo pair was designed to have a 15 bp single stranded region at the 3’ end which was homologous to a similar single stranded region of the lower strand of the next oligo pair to direct the orientation and sequence of the various oligo pairs within a given fragment. The oligos are also designed such that when the all the oligos representing a fragment are hybridized, the ends have single stranded regions corresponding to the particular restriction site to be formed. The structure of each oligomer was examined for stable secondary structures such as hairpin loops using the OLIGO program from NBI Inc. Whenever neccesary, nucleotides were changed to decrease the stability of the secondary structure without changing the amino acid sequence of the protein. A plant ribosomal binding site consensus sequence, TAAACAATG (Joshi etal., Nucleic Acid Res., 15:6643-6653 (1987)) or eukaryotic ribosomal binding site concensus sequence CCACCATG (Kozak, Nucleic Acid Research, 12:857-872 (1984)) was inserted at the translational start codon of the gene.
I׳ -
Cloning: Oligos were synthesized by IDT Inc., and were supplied as lyophilized powders. They were resuspended at a concentration of 200 μΜ. To 30 μΙ of each oligo formamide was added a final concentration of 25-50% and the sample was boiled for two minutes before separation on a premade 10% polyacryamide / urea gel obtained from Novex. After electrophoresis, the oligo was detected by UV shadowing by placing the gel on a TLC plate containing a fluorescent indicator and exposing it to UV light. The region containing DNA of the correct size was excised and extracted from the polyacryamide by an overnight incubation of the minced gel fragment in a buffer containing 0.4 M LiCI, 0.1 mM EDTA. The DNA was separated from the gel residue by centrifugation through a Millipore UFMC filter. The extracted DNA was ethanol precipitated by the addition of 2 volumes of absolute alcohol. After centrifugation, the precipitate was resuspended in dH<sub>2</sub>0 at a concentration of 2.5 μΜ. Fragments were cloned either by hybridization of the oligos and ligation with the appropriate vector or by amplification of the hybridized fragment using a equimolar mixture of all the oligos for a particular fragment as a template and end-specific PCR primers.
Cloning by hybridization and ligation: Homologous double stranded oligo pairs were obtained by mixing 5 μΙ of the upper and of the lower oligo for each oligo pair with buffer containing 1X polynucleotide kinase (PNK) buffer (70 mM Tris-HCI (pH 7.6), 10 mM MgCI<sub>2</sub>,5 mM dithiothreitol (DTT)), 50 mM KCI, and 5 % formamide in a final volume of 50 μΙ. The oligos were boiled for 10 minutes and slow cooled to 37° C or room temperature. 10 μΙ was removed for analysis on a 4% agarose in a TAE buffer system (Metaphore®; FMC). Each hybridized oligo pair was kinased by the addition of ATP at a final concentration of 1 mM, BSA at a final concentration of 100 pg per ml and 200 units of polynucleotide kinase and 1 μΙ of ־!OX PNK buffer in a volume of 10 μΙ. Following hybridization and phosphorylation, the reaction was incubated at 37° C for 2 hours to overnight. 10 μΙ of each of the oligo pairs for a particular fragment, were mixed in a final volume of 50 μΙ. The oligo pairs were hybridized by heating at 80° C for 10 minutes and slow cooling to 37° C. 2 μΙ of oligos was mixed with about 100 ng of an appropriate vector and ligated using a buffer containing 50 mM Tris-HCI (pH 7.8), 10 mM MgCI<sub>2</sub>, 10 mM DTT, 1 mM ATP. The reaction was incubated at room temp, for 2 hours to overnight and transformed into DH5a strain of E.coli, plated on L- plates containing ampicillin at a concentration of 100 pg/ml using standard procedures. Positive clones were further characterized and confirmed by PCR miniscreen described in detail in EP-A 0618976 using the universal primers “Reverse and M13 “-20 “ as primers. Positive clones were identified by digestion of DNA with appropriate enzymes followed by sequencing. Recombinants that had the expected DNA sequence were then selected for further work.
PCR Amplification and cloning into T- vector:
PCR amplification was carried out by using a mixture of all the oligomers that represented the upper and the lower strand of a particular fragment (final concentration 5 mM each) as template, specific end primers for the particular fragment (final concentration 2 μΜ) 200 μΜ of each dATP, dTTP, dCTP and dGTP, 10 mM Tris-HCI (pH 8.3), 50 mM KCI, 1.5 mM MgCI<sub>2</sub>,0.01% gelatin and 5 units of Taq polymerase in a final reaction volume of 50 μΙ, The amplification reaction was carried out in a Perkin Elmer thermocycler 9600 by incubation at 95° C for 1 min (1 cycle), followed by 20 cycles of 95 °C for 45 sec., 50 °C for 45 sec., 72 °C for 30 sec. Finally the reaction was incubated for 5 min at 72°C before analyzing the product. 10 μΙ of the reaction was analyzed on a 2.5% Nusieve (FMC) agarose gel in a TAE buffer system. The correct size fragment was gel purified and used for cloning into a PCR cloning vector or T־vector. T-vector construction was as described by Marchuk et al., Nucleic Acid Research, 19:1154 (1991). pBIuescriptsk+ (Stratagene®, Ca.) was used as the parent vector. Transformation and identification of the correct clone was carried out as described above.
Fragments 1,3, 4, 5, 6, 8, and 9 of VIP1 A(a) and fragments 2 and 4 of VIP2A(a) were obtained by cloning of PCR amplification products; whereas, fragments 2, 7,10 and 11 of VIP1 A(a) and fragments 1,3, and 5 of VIP2A(a) were obtained by hybridization/ ligation.
Once fragments with the desired sequence were obtained, the complete gene was assembled by cloning together adjacent fragments. The complete gene was resequenced and tested for activity against WCRW before moving it into plant expression vectors containing the root preferred promoter (disclosed in U.S. patent application serial no. 08/017,209, herein incorporated by reference) and the rice actin promoter.
One such plant expression vector is pCIB5521. The maize optimized VIP1 A(a) coding region (SEQ ID NO:26) was cloned in a plant expression vector containing the root preferred promoter at the 5' of the gene with the PEP Carboxylase intron #9 followed by the 35S terminator at the 3' end. The plasmid also contains sequences for ampicillin resistance from the plasmid pUC19. Another plant expression vector is pCIB5522, which contains the maize optimized VIP2A(a) coding region (SEQ ID
NO:27) fused to the root preferred promoter at the 5' of the gene with the PEP
Carboxylase intron #9 followed by the 35S terminator at the 3' end.
EXAMPLE 25. NAD AFFINITY CHROMATOGRAPHY
A purification strategy was used based on the affinity of VIP2 for the substrate NAD. The supernatant from the pH 3.5 sodium citrate buffer treatment described in Example 4 was dialyzed in 20 mM TRIS pH 7.5 overnight. The neutralized supernatant was added to an equal volume of washed NAD agarose and incubated with gentle rocking at 4° C overnight. The resin and protein solution were added to a 10 ml disposable polypropylene column and the protein solution allowed to flow out. The column was washed with 5 column volumes of 20 mM TRIS pH 7.5 then washed with 2-5 column volumes of 20 mM TRIS pH 7.5,100 mM NaCl, followed by 2-5 column volumes of 20 mM TRIS 7.5. The VIP proteins were eluted in 20 mM TRIS pH
7.5 supplemented with 5 mM NAD. Approximately 3 column volumes of the effluent were collected and concentrated in a Centricon -10. Yield is typically about 7-15 gg of protein per ml of resin.
When the purified proteins were analyzed by SDS-PAGE followed by silver staining, two polypeptides were visible, one with Mr of approximately 80,000 and one with Mr of approximately 45,000. N-terminal sequencing revealed that the Mr 80,000 protein corresponded to a proteolytically processed form of VIP1 A(A) and the Mr 45,000 form corresponded to a proteolytically processed form of VIP2A(a). The copurification of V|P 1 A(a) with VIP2A(a) indicates that the two proteins probably form a complex and have protein-protein interacting regions. VIP1A(a) and VIP2A(a) proteins purified in this manner were biologically active against western com rootworm.
EXAMPLE 26. EXPRESSION OF MAIZE OPTIMIZED VIP1 A(a) AND VIP2A(a)
E. coli strains containing different plasmids comprising VIP genes were assayed for expression of VIPs. E. colistrains harboring the individual plasmids were grown overnight in L-broth and expressed protein was extracted from the culture as described in Example 3, above. Protein expression was assayed by Western Blot analysis using antibodies developed using standard methods known in the art, similar to those described in Example 12, above. Also, insecticidal activity of the expressed proteins were tested against Western corn rootworm, according to the method in
Example 3, above. The results of the E. coli expression assays are described below.
Expression of VIPs in E. coli
<td> Extract of E. coli Strain Harboring Indicated Plasmid</td><td> Assay No. 1 % Mo</td><td> Assay No. 2 !rtality</td><td> Protein Detected</td>
<td> Control</td><td> 0</td><td> 0</td><td> no</td>
<td> pCIB5521 (maize optimized VIP1A(a))</td><td> 47</td><td> 27</td><td> yes</td>
<td> pCIB5522 (maize optimized VIP2A(a))</td><td> 7</td><td> 7</td><td> yes</td>
<td> pCIB6024 (native VIP2A(a))</td><td> 13</td><td> 13</td><td> yes</td>
<td> PCIB6206 (native VIP1A(a))</td><td> 27</td><td> 40</td><td> yes</td>
<td> Extracts pCIB5521 + pC IB5522 combined</td><td> 87</td><td> 47</td><td></td>
<td> Extracts pCIB5521 + pCIB6024 combined</td><td> 93</td><td> 100</td><td></td>
<td> Extracts pCIB5522 + pCIB6206 combined</td><td> 100</td><td> 100</td><td></td>
<td> Extracts pCIB6024 + pCIB6206 combined</td><td> 100</td><td> 100</td><td></td>
The DNA from these plasmids was used to transiently express the VIPs in a maize protoplast expression system. Protoplasts were isolated from maize 2717 Line 6 suspension cultures by digestion of the cell walls using Cellulase RS and Macerase R10 in appropriate buffer. Protoplasts were recovered by sieving and centrifugation. Protoplasts were transformed by a standard direct gene transfer method using approximately 75 g plasmid DNA and PEG-40. Treated protoplasts were incubated overnight in the dark at room temperature. Analysis of VIP expression was accomplished חס protoplast explants by Western blot analysis and insecticidal activity against Western corn rootworm as described above for the expression in E. coli. The results of the maize protoplast expression assays are described below.
Expression of VIPs in Plant Protoplasts
<td> Extract Tested</td><td> Assay No. 1 % Mo</td><td> Assay No. 2 rtality</td><td> Protein Detected</td>
<td> No DNA control</td><td> 27</td><td> 10</td><td> no</td>
<td> pCIB5521 (p) (maize optimized VIP1A(a))</td><td> 20 (0)</td><td> 30</td><td> yes</td>
<td> pCIB5522 (p) (maize</td><td> 20 (0)</td><td> 20</td><td> yes</td>
<td> optmizied VIP2A(a)) Extracts pCI B5521 (p) +</td><td> 87(82)</td><td> 90</td><td></td>
<td> pCIB5522 (p) combined Extracts pCI B5521 (p) + pCIB5522 (e) combined</td><td> 100</td><td> -</td><td></td>
<td> Extracts pC IB5522 (p) + pCIB5521 (e) combined</td><td> 53 (36)</td><td> -</td><td></td>
<td> Extracts pCIB5521 (p) + pCIB6024 (e) combined</td><td> 100</td><td> -</td><td></td>
<td> Extracts pCIB5522 (p) + pCIB6206 (e) combined</td><td> 100</td><td> -</td><td></td>
<td> pCIB6024(e) (native</td><td> 0</td><td> -</td><td> yes</td>
<td> VIP2A(a)) pCIB6206(e) (native</td><td> 20</td><td> -</td><td> yes</td>
<td> VIP1A(a)) pCI B5521 + pCIB 5522</td><td> 100</td><td> 100</td><td> yes</td>
(plasmids delivered by cotransformation) (p) = extract of protoplast culture transformed with indicated plasmid (e) = extract of E. co//strain harboring indicated plasmid
The expression data obtained with both E. coli and maize protoplasts show that the maize optimized VIP1A(a) and VIP2A(a) genes make the same protein as the native VIP1A(a) and VIP2A(a) genes, respectively, and that the proteins encoded by the maize optimized genes are functionally equivalent to the proteins encoded by the native genes.
All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The following deposits have been made at Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA:
<td colspan="3"> Strain designation</td><td colspan="2"> Deposition Number Deposition Date</td>
<td><sup>5</sup>ג 5.׳2</td><td> 1. »</td><td> E. coli PL2</td><td> NRRL B-21221</td><td> March 09,1994</td>
<td></td><td> 2.</td><td> E. C0HPL2.</td><td> NRRL B-21221N</td><td> --------------— ' - * September 02,1994</td>
<td> 2/.9-55</td><td> 3. 1-</td><td> E co//pC IB6022</td><td> NRRL B 21222</td><td> March 09,1994</td>
<td> 11.3.35</td><td> , 4.</td><td> E. co//'pCIB6023</td><td> NRRL B-21223</td><td> ---------------:---------------j March 09, 1994</td>
<td></td><td> 5.</td><td> E. coli pCIB6023</td><td> NRRL B-21223N</td><td> . 1——׳——---—׳—“ September 02,1994</td>
<td></td><td> 6.</td><td> Bacillus thuringiensis</td><td></td><td></td>
<td></td><td></td><td> HD73-78VIP</td><td> NRRL B 21224</td><td> March 09,1994</td>
<td></td><td> 7.</td><td> Bacillus thuringiensis AB88</td><td> NRRLB-21225</td><td> March 09,1994</td>
<td></td><td><sup>8</sup>-</td><td> Bacillus thuringiensis AB359</td><td> NRRL B-21226</td><td> March 09,1994</td>
<td></td><td> 9.</td><td> Bacillus thuringiensis AB289</td><td> NRRL B-21227</td><td> March 09, 1994</td>
<td></td><td> 10.</td><td> Bacillus sp. AB59 .</td><td> NRRL B-21228</td><td> March 09,1994</td>
<td></td><td> 11.</td><td> . Bacillus sp. AB294</td><td> NRRL B-21229</td><td> March 09,1994</td>
<td></td><td> .12.</td><td> Bacillus sp. AB256</td><td> NRRL B-21230</td><td> March 09,1994</td>
<td></td><td> 13.</td><td> E. coli P5-4</td><td> NRRLB-21059</td><td> March 18,1993</td>
<td></td><td> 14</td><td> - E. coli P3-12</td><td> NRRL B-21061</td><td> March 18,1993</td>
<td></td><td> 15.</td><td> Bacillus cereus AB78</td><td> NRRLB-21058</td><td> March 18,1993</td>
<td></td><td> 16.</td><td> • Bacillus thuringiensis AB6</td><td> NRRL B-21060</td><td> March. 18,1993</td>
<td></td><td> 17.</td><td> E. co//pC IB6202</td><td> NRRLB-21321</td><td> September 02,1994</td>
<td></td><td> 18.</td><td> E. co//pCIB7100</td><td> NRRLB-21322</td><td> September 02,1994</td>
<td></td><td> 19.</td><td> E colipCIB7101</td><td> NRRL B-21323</td><td> September 02,1994</td>
<td></td><td> 20.</td><td> E co//pC IB7102</td><td> NRRL B-21324</td><td> September 02,1994</td>
<td></td><td> 21.</td><td> E co/ί pC IB7103</td><td> NRRL B-21325</td><td> September 02,1994</td>
<td></td><td> 22.</td><td> E co//pClB7104</td><td> NRRL 8:21422</td><td> March 24,1995</td>
<td> 505</td><td> 23.</td><td> E colipCIB7107</td><td> NRRL B-21423</td><td> March 24,1995</td>
<td></td><td> 24,</td><td> E. coli pCIB7108</td><td> NRRL B-21438</td><td> May 05, 1995</td>
<td> .3r</td><td> 25.</td><td> Bacillus thuringiensis AB424</td><td> NRRL B-21439</td><td> May. 05, 1995</td>
2/ 82 3 5 1 1 ־<sup>07,</sup>־
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
Passages in the description which are out of ambit of the appended claims do not constitute part of the claimed invention.
115382/ , SEQUENCE LISTING (1) GENERAL INFORMATION:
(A) NAME: CIBA-GEIGY AG .
(B) STREET: Klybeckstr. 14! ' ' (C) CITY: Basel (E) COUNTRY: Switzerland (F) POSTAL CODE (ZIP); 4002 (G) TELEPHONE: +41 61 69 11 n (H) TELEFAX: + 41 61 69g 79 76 (D TELEX: 962 991 <sup>(i״</sup> T ־^ ?״ ״<sub>ins Md Strains</sub> (iii) NUMBER OF SEQUENCES: 52 (iv) COMPUTER READABLE FORM.
(A) MEDIUM TYPE: Floppy disk <B) COMPUTER: IBM PC<sup>P</sup>co״pX<sub>le</sub> (C) OPERATING SYSTEM: PC-DOS/MS-DGS ' (D) SOFIWARE: Datentln ״ .
«crease #1.0, Version #1.30b (2) INFORMATION FOR SEQ ID NO: 1;
(i) SEQUENCE CHARACTERISTICS.' ' ' (A) . LENGTH: 6049 base pairs . (B) TYPE; nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY;.linear . (ii) MOLECULE TYPE: DNA. (genomic) (vi) ORIGINAL SOURCE:
(A) ORGANISM; Bacillus cereus (B) STRAIN: AB78 (C) INDIVIDUAL ISOLATE: NRRL B-21058 (ix) FEATURE:
(A) ΝΛΜΕ/ΚΕΥ: CDS (B) . LOCATION: 1082.24 67 (D) OTHER INFORMATION: /product״ ־־VIP2A(a)־ (ix) feature:
(A) ΝΑΜΕ/ΚΕΥ: misc feature (B) IOCATION: 24757.5126 (D) OTHER INFORMATION. /not־e. kd VIPiA(a) protein. <sub>This</sub><sup>9 Sequence for</sup> the 100
NO: 4 and translated sepam^.<sup>9 U</sup> 1 ־EQ ID <sup>11</sup>5382/3 (xi) SEQUENCE DESCRIPTION: SEQ ID NO;1:
ATCGATACAA TGTTGTTTTA CTTAGACCGG TAGTCTCTGT AATTTGTTTA ATGCTATATT 60 CTTTACTTTG ATACATTTTA ATAGCCATTT CAACCTTATC AGTATGTTTT TCTGGTCTT־C120
CTCCTTTTTT TCCACGAGCT CTAGCTGCGT TTAATCCTGT TTTGGTACGT TCGCTAATAA180
TATCTCTTTC TAATTCTGCA ATACTTGCCA TCATTCGAAA GAAGAATTTC CCCATAGCAT240
TAGAGGTATC AATGTTGTCA TGMTAGAAA TAAAATCTAC ACCTAGCTCT TTGAATTTTT300
CACTTAACTC AATTAGGTGT TTTGTAGAGC GAGAAATTCG ATCAAGTTTG TAAACAACTA360
TCTTATCGCC TTTACGTAAT ACTTTTAGCA ACTCTTCGAG TTGAGGGCGC TCTTTTTTTA420
TTCCTGTTAT TTTCTCCTGA TATAGCCTTT CTACACCATA TTGTTGCAAA GCATCTATTT. .480
GCATATCGAG ATTTTGTTCT TCTGTGCTGA CACGAGCATA ACCAAAAATC AAATTGGTTT c^ch’tcctat .ctaaatatat ctattaaaat agcaccaaaa accttattaa attaaaataa'
GGAACTTTGT TTTTGGATAT GGATTTTGGT ACTCAATATG GATGAGTTTT TAACGCTTTT660
GTTAAAAAAC AAACAAGTGC CATAAACGGT CGTTTTTGGG ATGACATAAT AAATAATCTG720
TTTGATTAAC CTAACCTTGT ATCOTACAG CCC^GTmA TTTGTACTTC AACTGACTGA780
ATATGAAAAC AACATGAAGG TTTCATAAAA ΊΤΓΑΤΑΤΑΤΤ TTCCATAACG GATGCTCTAT840
CTTTAGGTTA TAGTTAAATT ATAAGAAAAA AACAAACGGA GGGAGTGAAA AAAAGCATCT900
TCTCTATAAT TTTACAGGCT CTTTAATAAG AAGGGGGGAG ATTAGATAAT AAATATGAAT 960 ' ־ ATCTATCTAT AATTGTHGC TTGTACAATA ACTTATCTAA CTTTCATATA CAACAACAAA1020
ACAGACTAAA TCCAGATTGT ATATTCATTT TCAGTTGTTC CTTTATAAAA TAATTTCATA1080
A ATG .AAA AGA ATG GAG GGA AAG TTG ΊΤΓ ATG GTG TCA AAA AAA TTA
Met ,Lys Arg Met Glu Gly Lys Leu Phe Met Vai Ser Lys Lys Leu
15 .10 י־ :. <sup>5</sup> .
CAA
Gin
GTA GTT ACT AAA ACT GTA TTG. CTT AGT ACA GTT TTC .TCT ATA TCT Vai Val Thr Lys Thr Vai Leu Leu Ser Thr Vai Phe Ser He Ser <sup>25</sup>30
1126
1174
TTA TTA AAT AAT GAA GTG. ATA AAA GCT GAA CAA TTA AAT
Leu Leu Asn . Asn Glu Val He Lys Ala Glu Gin Leu. Asn <sup>35</sup> . 40
CAA AGT AAA TAT ACT AAC TTG CAA AAT CTA AAA ATC ACT
Gin. Ser Lys Tyr Thr Asn Leu Gin Asn Leu Lys He Thr . 55 <sub>60</sub>
GAG GAT TTT AAA GAA GAT AAG GAA AAA GCG AAA GAA TGG
ATA AAT TCT He Asn Ser 45
GAC AAG GTA Asp Lys Val
GGG AAA GAA
1222
1270
1318
<img file="IL115382A_D0001.tif" />
Glu Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu <sup>65</sup> 7075
AAA GAA AAA GAG TCG AAA CTA ACT GCT ACT GAA AAA GGA AAA ATGAAT
Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys MetAsn <sup>80</sup> . 85 go95
AAT TTT TTA GAT AAT AAA AAT GAT ATA AAG ACA AAT TAT AAA GAAATT
Asn Phe Leu .Asp. Asn Lys Asn Asp He Lys Thr Asn Tyr Lys Glulie <sup>100</sup> 105no
ACT TTT TCT ATG GCA GGC TCA TTT GAA GAT GAA ATA AAA GAT TTAAAA
Thr Phe Ser Met Ala Gly Ser Phe Glu Asp Glu He Lys Asp LeuLys
115 . .120 .
GAA ATT GAT AAG. ATG TTT GAT AAA ACC AAT CTA TCA AAT TCT ATTATC
Glu He Asp Lys Met Phe Asp Lys Thr Asn Leu Ser. Asn Ser lielie <sup>130</sup> 135. no
ACC TAT AAA AAT GTG GAA CCG ACA ACA ATT GGA TTT AAT AAA TCT TTA Thr Tyr Lys Asn Vai Glu Pro Thr Thr He Gly Phe Asn Lys Ser Leu 145 150 . 155 . . .
ACA GAA GGT AAT ACG ATT. AAT , TCT GAT GCA ATG .GCA CAG .TTT. AAA GAA Thr Glu Gly Asn Thr lie Asn Ser Asp Ala Met Ala Gin Phe Lys Glu <sup>L6U</sup> 165 170 . <sub>175</sub>
CAA TTT TTA GAT AGG GAT ATT AAG TTT GAT AGT TAT CTA GAT ACG CAT Gin Phe Leu Asp Arg Asp He Lys Phe Asp Ser Tyr Leu Asp Thr His
190 185 .־. 180
TTA ACT GCT CAA CAA GTT TCC AGT AAA GAA AGA GTT ATT TTG AAG GTT Leu Thr . Ala Gin Gin Vai Ser Ser Lys Glu Arg Vai lie Leu Lys Vai
205 200 י.'.. <sup>195</sup> '
ACG GTT CCG AGT GGG AAA GGT TCT ACT ACT CCA ACA AAA GCA GGT GTC . Thr. Vai Pro Ser Gly Lys Gly Ser. Thr Thr Pro Thr Lys Ala GlyVai' <sup>210</sup> '215,220
ATT TTA AAT AAT AGT GAA TAC AAA ATG CTC ATT GAT AAT GGG TATATG <sup>12e ASn ASn Ser Glu</sup> Ty<sup>r</sup>,.Lys Met Leu lie Asp Asn Gly ׳TyrMet <sup>22</sup>5 . 230235
GTC CAT GTA GAT AAG GTA TCA AAA CTG GTG AAA AAA GGG GTG GAG TCC
Vai Hrs Vai Asp Lys Vai Ser Lys Vai Vai Lys Lys Gly Vai Glu Cys
TTA CAA ATT GAA GGG ACT TTA AAA AAG AGT CTT GAC TTT AAA AAT GAT
Leu Gin He Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp
260' ., 265 ' . . 270
ATA AAT GCT GAA GCG CAT AGC TGG GGT ATG AAG AAT TAT GAA GAG TGG
He Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp <sup>275</sup> 280 285
V
1366
1414
1462
1510
1558
1606
1654
1702 .
1750
1798
1846
1894
1942
GCT
Ala
AAA GAT TTA ACC GAT Lys Asp Leu Thr Asp ' 290
AGG CAA
Arg
Gin
GAT TAT AAA
Asp Tyr Lys
GAA
Glu
TCG
Ser
ATC lie 310
AGT
Ser
GGA
Gly
AAT' GAA AAA Asn
Glu
Lys
TTA
Leu
GGC
Gly
GGG
Gly Lys
ATG
Met
AAG
AAA
Lys
CCG
CAA AGG
Gin Arg
AAT AAT
Asn Asn
CTA . GAT GCT
Leu
CCA
Pro. lie
ATA
Asp Ala
CCG
Pro
GAA
GAA
Glu
TAT
Tyr
CAA ATA
Gin He
AAT
Glu Asn
ATT lie 345
GCT
Ala
TTA
TTA
Leu
AGA
GAA TTT
Pro Glu
AAA
LysAsp Phe
GAT
TTT
GAA
Glu
TAT
Phe
GAA
GAT GGG TAT GCT Asp Gly Tyr Ala 300
AAT CAA GGC GGA Leu Arg Asn 315
Gin Gly Gly
1990
2038
AAA AAT
Lys
Asn
ATT
He
TCT GAT GCT
Ser Asp Ala
ACT
Thr Vai Tyr Arg Trp Cys • .350
GTG
TAT
AGA TGG TGT .2086
2134
GGT
Gly Tyr Gin lie
CAA ATT
AGT
Ser
GAT CCG TTA CCT TCT TTA Asp Pro
Leu Pro Ser Leu .365
2182
CAA TTT TTA Glu Gin
Phe ?Leu
AAT
Asn
ACA ATC
Thr lie
AAA
Lys
GAA GAC AAA GGA
Glu
Asp pys Gly
2230.
TAT ATG AGT ACA AGC. TTA Tyr Mef. Ser Thr Ser Leu 385.
TCG
Ser
AGT.GAA CGT CTT Ser
Glu
Arg Leu
GCA
Ala
GCT
Ala
TTT GGA
Phe Gly
TCT
Ser
2278
AGA AAA
Arg Lys 400
ATT ATA TTA CGA TTA He lie Leu Arg Leu
־. . .405
CAA
Gin
GTT
Vai
CCG AAA
Pro. Lys
GGA
Gly
AGT
Ser
ACG
Thr
GGT
Giy
GCG
Ala
2326
TAT
Tyr
TTA
AGT GCC ATT.GGT GGA
Leu. Ser Ala
He 420
Gly Gly
TTT GCA
Phe Ala
AGT Ser 425 .
GAA AAA Glu
GAG
Lys Glu
ATC
He
CTA CTT
Leu Leu
430 .
2374
GAT
Asp
AAA GAT AGT Lys Asp
Ser
AAA
Lys
TAT CAT
Tyr
His
AAA GTA
ATT GAT lie Asp Lys Vai Thr
440 '
ACA
GAG
Glu Vai
GTA
ATT ATT'.
He He
2422
AAA GGT GTT , Lys Gly Vai : . 450
AAG
Lys
CGA
Arg
TAT
Tyr
GTA
Vai
GTG
Vai
GAT GCA ACA TTA
Asp Ala Thr Leu
TTA ACA
Leu.Thr
AAT
Asn . 2467
TAAGGAGATG
AAAAATATGA
AGAAAAAGTT
AGCAAGTGTT GTAACGTGTA CGTTATTAGC 2527
TCCTATGTTT
TTGAATGGAA
ATGTGAATGC
TGITI'ACGCA
GACAGCAAAA CAAATCAAAT
2587
TTCTACAACA
CAGAAAAATC
AACAGAAAGA
GATGGACCGA
AAAGGATTAC TTGGGTATTA
2647
TTTCAAAGGA
AAAGATTTTA
GTAATCTTAC tatgtttgca
CCGACACGTG ATAGTACTCT
2707
TATTTATGAT
CAACAAACAG
CAAATAAACT
ATTAGATAAA
AAACAACAAG AATATCAGTC
2767
TATTCGTTGG
ATTGGTTTGA TTCAGAGTAA
AGAAACGGGA
GATTTCACAT TTAACTTATC
2827
TGAGGATGAA CAGGCAATTA TAGAAATCAA TGGGAAAATT ATTTCTAATA AAGGGAAAGA 2887 AAAGCAAGTT GTCCATTTAG AAAAAGGAAA ATTAGTTCCA ATCAAAATAG AGTATCAATC , '2947 AGATACAAAA TTTAATATTG ACAGTAAAAC ATITAAAGAA CTTAAATTAT TTAAAATAGA 3007 TAGTCAAAAC CAACCCCAGC AAGTCCAGCA AGATGAACTG AGAAATCCTG AATTTAACAA 3067 GAAAGAATCA CAGGAATTC־T TAGCGAAACC ATCGAAAATA AATCTTTTCA CTCAAAAAAT . 3127 GAAAAGGGAA ATTGATGAAG ACACGGATAC GGATGGGGAC TCTAHCCTG ACCTrrGGGA 3187 AGAAAATGGG TATACGATTC ACAATAGAAT CGCTGTAAAG TGGGACGATT CTCTAGCAAG 3247 TAAAGGGTAT ACGAAATTTG TTTCAAATCC ACTAGAAAGT CACACAGTTG GTGATCCTTA 3307 .35
TACAGATTAT GAAAAGGCAG CAAGAGATCT AGATTTGTCA AATGCAAAGG AAACGTTTAA 3367 CCCATTGGTA GCTGCTTTTC CAAGTGTGAA TGTTAGTATG GAAAAGGTGA TATTATCACC 3427 AAATGAAAAT TTATCCAATA GTGTAGAGTC TCATTCATCC ACGAATTGGT CTTATACAAA 3487 TACAGAAGGT GCTTCTGTTG AAGCGGGGAT TGGACCAAAA GGTATTTCGT .TCGGAGTTAG 35.47 CGTAAACTAT CAACACTCTG AAACAGTTGC ACAAGAATGG GGAACATCTA CAGGAAATAC 3607 TTCGCAATTC AATACGGCTT CAGCGGGATA TTTAAATGCA AATGTTCGAT ATAACAATGT 3667
AGGAACTGGT GCCATCTACG ATGTAAAACC TACAACAAGT TTTGTATTAA ATAACGATAC 3727 TATCGCAACT ATTACGGCGA AATCTAATTC TACAGCCTTA AATATATCTC CTGGAGAAAG 3,787 TTACCCGAAA ׳ AAAGGACAAA ATGGAATCGC AATAACATCA ATGGATGATT TTAATTCCCA 3847 TCCGATTACA ΤΤΑΑΑΤΑΆΑΑ AACAAGTAGA TAATCTGCTA AATAATAAAC CTATGATGTT 3907 GGA7ACA.AAC. CAMCAGATG GTGTTTATAA GATAAAAGAT ACACATGGAA ATATAGTAAC/ 3967 TGGCGGAGAA TGGAATGGTG TCATACAACA AATCAAGGCT AAAACAGCGT CTATTATTGT 4027 GGATGATGGG GAACGTGTAG. CAGAAAAACG TGTAGCGGCA AAAGATTATG AAAATCCAGA- . 4087 AGAT/kAAACA CCGTCTTTAA CTTTAAAAGA TGCCCTGAAG CTTTCATATC CAGAl’GAAAT 4147 AAAAGAAATA GAGGGATTAT TATATTATAA AAACAAACCG ATATACGAAT CGAGCGTTAT 4207 GACTTACTTA GATGAAAATA CAGCAAAAGA AGTGACCAAA CAATTAAATG ATACCACTGG 4267 GAAATTTAAA GATGTAACTC ATTTATATGA. TGTAAAACTG ACTCCAAAAA. tgaatgttac . 4327 AATCAAATTG TCTATACTTT ATGATAATGC TGAGTCTAAT GATAACTCAA TTGGTAAATG 4387 GACAAACACA AATATTGTTT CAGGTGGAAA TAACGGAAAA AAACAATATT CTTCTAATAA . 4447
TCCGGATGCT AATTTGACAT TAAATACAGA TGCTCAAGAA AAATTAAATA AAAATCGTGA
CTATTATATA AGTTTATATA TGAAGTCAGA AAAAAACACA CAATGTGAGA TTACTATAGA
TGGGGAGATT TATCCGATCA CTACAAAAAC AGTGAATGTG AATAAAGACA ATTACAAAAG
4507
4567
4627
ATTAGATATT ATAGCTCATA ATATAAAAAG TAATCCAATT TCTTCACITC ATATTAAAAC . . 4687
GAATGATGAA ATAACTTTAT. TTTGGGATGA .TATTTCTATA ACAGATGTAG CATCAATAAA 4747
ACCGGAAAAT TTAACAGATT CAGAAATTAA ACAGATTTAT AGTAGGTATG GTATTAAGTT 4807 AGAAGATGGA ATCCTTATTG ATAAAAAAGG TGGGATTCAT TATGGTGAAT TTATTAATGA V 4867 AGCTAGTTTT AATATTGAAC CATTGCAAAA TTATGTGACC AAATATGAAG TTACTTATAG 4927
2.1,355
IAGTGAGTTA GGACCAAACG tgagtgacac acttgaaagt GATAAAATTT ACAAGGATGG 4987 GACAATTAAA TTTGATTTTA CCAAATATAG TAAAAATGAA CAAGGATTAT TTTATGACAG 5047 TGGATTAAAT 'TGGGACTTTA AAATTAATGC TATTACTTAT GATGGTAAAG AGATGAATGT 5107 TTTTCATAGA ΤΑΤΑΑΤΑΆΑΤ AGTTATTATA TCTATGAAGC TGGTGCTAAA GATAGTGTAA 5167 AAGTTAATAT ACTGTAGGAT TGTAATAAAA GTAATGGAAT TGATATCGTA CTTTGGAGTG 5227 GGGGATACTT TGTAAATAGT TCTATCAGAA ACATTAGACT AAGAAAAGTT ACTACCCCCA 5287
CTTGAAZiATG AAGATTCAAC TGATTACAAA CAACCTGTTA AATATTATAA GGTTTTAACA 5347 ΑΑΑΙΑΤΐΑΑΑ CTCTTTATGT TAATACTGTA ATATAAAGAG TTTAATTGTA TTCAAATGAA 5407 GCTTTCCCAC AAAATTAGAC TGATTATCTA ATGAAATAAT CAG7?CT7\ATT TTGTAGAACA 5467 GGTCTGGTAT TATTGTACGT GGTCACTAAA AGATATCTAA TATTATTGGG CAAGGCGTTC 5527 CATGATTGAA TCCTCGAATG TCTTGCCCTT TTCATTTATT TAAGAAGGAT TGTGGAGAAA 5587 TTATGGTTTA .GATAATGAAG AAAGACTTCA CTTCTAATTT TTGATGTTAA ATAAATCAAA 5647 ATTTGGCGAT TCACATTGTT TAATCCACTG ATAAAACATA CTGGAGTGTT CTTAAAAAAT 5707 CAGCTI'TTTT CTTTATAAAA TTTTGCTTAG CGTACGAAAT TCGTGTTTTG TTGGTGGGAC 5767 CCCATGCCCA TCAACTTAAG AGTAAATTAG TAATGAACTT TCGTTCATCT GGATTAAAAT 5827 AACCTCAAAT TAGGACATGT TTTTAAAAAT AAGCAGACCA AATAAGCCTA GAATAGGTAT 5887 ΟΆΊΤΓΤΤΑΑΑ AATTATGCTG CTlTCTTTTG TTTTCCAAAT CCATTATACT CATAAGCAAC 5947 ACCCATAATG TCAAAGACTG TTTTTGTCTC ATATCGATAA GCTTGATATC GAATTCCTGC 6007 ־
AGCCCGGGGG ATCCACTAGT TCTAGAGCGG CCGCCACCGC GG
6049 (2) INFORMATION FOR SEQ ID NO:2:
(i) SEQUENCE CHARACTERISTICS: ' (A) LENGTH: 462 amino acids (B) ,TYPE: amino acid (D) TOPOLOGY: linear' (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:
Met Lys Arg Met Glu Gly Lys.Leu Phe Met Vai Ser Lys Lys Leu Gin
.. 15 ־... . 10 ' ' <sup>5</sup> :־. יי <sup>1</sup>
Vai Val Thr Lys Thr Vai Leu Leu Ser Thr Vai Phe Ser lie Ser Leu
. 30 . . 25 ' י <sup>20</sup> .
Leu Asn Asn Glu Val lie Lys Ala Glu Gin Leu Asn He Asn Ser Gin 35 . 40' . 45.
Ser Lys Tyr Thr Asn Leu Gin Asn Leu Lys He Thr Asp Lys Val Glu . <sup>50</sup> 55 'GO ) Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys
.30 י. : 75 . ..־.־. <sup>7065</sup>
Glu Lys Glu Trp . Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn 85 . . 90 . . 95 .
Phe Leu Asp Asn Lys Asn Asp He Lys Thr Asn Tyr Lys Glu lie Thr <sup>1</sup>.θθ . 105. . . no
Phe Ser Met Ala Gly Ser Phe Glu Asp Glu lie Lys Asp Leu Lys Glu <sup>115 120</sup>. . 125
He Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser lie He Thr <sup>130</sup> . . 135 . . 140 <sub>;</sub> ..
Tyr Lys Asn Val Glu Pro Thr Thr lie Gly Phe Asn Lys Ser Leu Thr . <sup>145</sup>. . . ' - 150 . . . 155.!60
Glu Gly Asn Thr He Asn Ser Asp Ala Met Ala Gin Phe Lys GluGin <sup>165</sup> ' . ' <sup>170</sup> .175
Phe . Leu Asp Arg Asp lie Lys Phe Asp Ser Tyr Leu Asp Thr HisLeu
180 1851.90
Thr Ala Gin Gin Val Ser Ser Lys Glu Arg Val He Leu Lys ValThr <sup>195</sup> . 200 . .205
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val He . 21° 215 . '220
Leu Asn Asn Ser Glu Tyr Lys Met Leu lie Asp Asn Gly Tyr Met Val <sup>225</sup> 230 . 235240
v.
/3
His Val Asp Lys Val Ser
Lys Val Val Lys Lys
Gly
Val Glu
Cys Leu
Gin lie. Glu Gly Thr Leu
Lys Lys
Ser Leu. Asp
Phe
Lys. Asn
Asp He
Asn Ala
Glu Ala His.Ser 275 .
Trp Gly ' 280
Met
Lys Asn
Tyr
Glu Glu Trp Ala
Lys Asp
Leu Thr Asp
Ser Gin . .295
Arg
Glu
Ala
Leu Asp Gly Tyr Ala Arg
Gin Asp Tyr Lys Glu lie Asn
Asn
Tyr
Leu
Arg.Asn Gin Gly Gly Ser
320 .'.־ <sup>315</sup>
Gly Asn Glu Lys
Leu
Asp Ala
Gin lie Lys
Asn lie Ser Asp Ala Leu
Gly Lys Lys Pro lie Pro
Glu Asn He Thr 345 '
Val
Tyr Arg Trp Cys Gly 350
Met Pro Glu?Phe .'.. 355
Gly Tyr
Gin
He
Ser Asp Pro
Leu.Pro Ser Leu Lys
Asp Phe
Glu Glu
Gin
Phe
Leu
Asn
Thr
He Lys
Glu
Asp Lys Gly Tyr.
Met Ser
Thr Ser'Leu
Ser Ser
Glu
Arg
Leu Ala,
Ala
Phe
Gly
Ser Arg
Lys. He lie Leu
Arg
Leu Gin Val Pro Lys.Gly SerThr
Gly
Ala
Leu Ser
Ala He
Gly Gly Phe
Ala Ser Glu
Lys Glu lie Leu ' 43.0
Leu
Asp .
Lys Asp
Ser Lys
Tyr His lie
Asp Lys Val 440
Thr Glu Val lie 1!<sub>e </sub>445'
Lys
Gly Val
Lys Arg
Tyr.Val
Val
Asp Ala Thr
Leu Leu Thr Asn.
(2) INFORMATION
FOR. SEQ
ID NO:3
SEQUENCE CHARACTERISTICS:
(A) LENGTH: 20 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOIXOGY: linear (ii)
MOLECULE TYPE: peptide (ix)
FEATURE:
(A) NAME/KEY: Peptide (B) LOCATION: 1.20 (D) OTHER INFORMATION- /πλΙλ- .<ו1^4ה ,targetting ukmahon. ./note-Signal peptide for vacuolar
1T5382/3 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:
Ser Ser Ser Ser Phe Ala Asp Ser Asn Pro He Arg Val Thr Aj
Asp Arg ’
Ala Ala Ser Thr (2) INFORMATION FOR SEQ ID NO:4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2655 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single • . (0) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO . (vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus . (B) STRAIN: AB78 (C) INDIVIDUAL ISOLATE (ix) FEATURE:
. (A) NAME/KEY: CDS (B) LOCATION: 1.2652 (D) OTHER INFORMATION:
cereus
NRRL B-21058 .
/note־ Thk°i <sup>W(JRMA</sup>TION: /product100 ־ kDa protein VIPlA(a) /note- This sequence is identical to the portion of SEO ID ncTi between and including nucleotide 2475 to 5126 ״ ° (xi) SEQUENCE DESCRIPTION; SEQ ID NO:4:
• ATG AAA AAT ATG AAG AAA
Met Lys Asn Met Lys Lys
L. 465
AAG
Lys
TTA GCA AGT GTT Leu Ala Ser 470
Val
GTA
Val
ACG
Thr
TGT ACG TTA
Cys Thr Leu :
TTA GCT.CCT Leu
Ala
480
Pro
ATG TTT TTG
Met Phe Leu
AAT
Asn
GGA AAT GTG Gly Asn
Val
AAT
Asn
GCT
Ala
GTT
Val
TAC GCA GAC Tyr Ala. Asp
AGC
Ser
AAA
Lys
ACA
Thr
AAT.CAA ATT
Asn Gin He
500'
TCT ACA
Ser Thr
ACA
Thr
CAG
Gin
AAA
Lys
AAT
Asn
CAA
Gin
CAG AAA GAG
Gin Lys Glu
ATG GAC CGA ΆΆΑ GGA TTA CTT Met Asp Arg ׳ Lys Gly Leu Leu 515
AGT AAT CTT ACT ATG TTT GCA Ser Asn
GAT CAA
Asp Gin
GGG TAT TAT TTC Gly Tyr
Tyr Phe
AAA GGA AAA GAT Lys
Gly Lys
Asp
TTT
Phe
CCG
Leu Thr Met Phe Ala Pro 530
CAA ACA GCA AAT AAA CTA Gin Thr Ala Asn Lys
. ־ 545
CAG TCT ATT CGT. TGG ATT GGT —-<sup>1</sup> Ser Ηθ Arg Trp lie Gly <sup>550</sup> 565
Gin
TTC
Phe
GGG
Gly
GAA
Glu
AAA
Lys
ATA lie
ACA TTT AAC TTA TCT Thr Phe Asn Leu
AAA ATT ATT Lys lie He
TCT
Ser
595
AAA
Lys
ITT
Leu
ACA
Thr
CGT GAT
Arg Asp
TTA GAT AAA
Leu Asp Lys
TTG ATT CAG
Leu
GAG
Ser Glu Asp
AAT AAA
Asn Lys
GAT
He Gin
GAA CAG
Glu Gin
GGG AAA GAA
Gly Lys Glu
AGT
Ser
AAA
Lys
ACT
Thr
CTT.
Leu
ATT lie Tyr
TAT240
AGT
Ser
CAA CAA GAA TAT Gin 555
Gin Glu Tyr
AAA GAA
Lys Glu
ACG GGA GAT
Thr Gly Asp
336
GCA. ATT ATA GAA ATC AAT Ala 585 lie lie
Glu lie Asn
AAG
Lys
CAA
Gin
GTT
Vai
GTC
Vai
CAT TTA .
His Leu
GGA AAA
Gly Lys
TTA GTT CCA
Leu. Vai Pro
AAT ATT GAC
Phe Asn lie Asp 625
AGT
Ser
AAA
Lys
ATC
He
ACA
Thr
AAA ATA
Lys lie
TTT AAA
Phe, Lys
GAG TAT
Glu Tyr
CAA TCA
Gin
Ser
GAT ACA Asp Thr .
480
GAA
Glu
CTT AAA
Leu Lys
TTA
Leu
TTT
Phe
AAA
Lys
GAT Asp. .640
AGT CAA
Ser Gin
AAC CAA
Asn Gin
CCC
Pro
CAG
Gin Gin Vai
CAA GTC
CAG
Gin
CAA GAT
Gin
Asp
GAA
Glu
CTG
Leu
AGA.
Arg '
AAT CCT
Asn Pro 655
GAA TTT
Glu Phe
AAC AAG. AAA Asn.Lys Lys 660
GAA
Glu
TCA.CAG
Ser Gin
TTG
GAA
Glu Phe
665 .
TTA
Leu
GCG
Ala
AAA CCA
Lys Pro
670
TCG AAA;ATA AAT
Ser Lys lie Asn
CTT
Leu
TTC
Phe
ACT
Thr Gin
CAA
AAA ATG
Lys Met
680 ־
AAA AGG Lys
Arg Glu
GAA ATT GAT GAA
He Asp Glu 685
GAC
Asp
ACG GAT ACG Thr
Asp Thr
GAT. GGG Asp Gly
GAC
Asp
TCT ATI.
Ser He
695 ,
CCT
Pro
GAC
Asp Leu
CTT
TGG
Trp
GAA GAA AAT Glu Glu Asn 700
GGG
Gly Tyr
TAT
ACG
Thr
ATT
He
CAA
Gin
AAT AGA
Arg lie Ala 710
ATC GCT
Asn
GTA AAG TGG
Vai Lys Trp Asp Asp . 715
GAC
GAT
TCT CTA
SerLeu
GCA
Ala
AGT
Ser
AAA
Lys. Gly Tyr
GGG
TAT
ACG
Thr
AAA
Lys
TTT GTT
Phe Vai
TCA AAT CCA CTA
Ser Asn Pro Leu
GAA
Glu
AGT CAC
Ser His
<img file="IL115382A_D0002.tif" />
, 118 ־
CCT TAT. ACA GAT TAT GAA
Pro Tyr Thr Asp Tyr Glu
ACA GTT
Thr Vai
GGT GAT
Gly Asp
AAG
Lys
GCA GCA AGA GAT CTA Ala Ala
Arg Asp Leu
GAT TTG
Asp Leu
TCA AAT
Ser Asn
GCA AAG GAA. ACG TTT Ala Lys Glu Thr Phe 755
AAC
Asn 760
CCA
Pro Leu Vai
TTG GTA
GCT GCT TTT
Ala Ala Phe • 765 . .
CCA AGT
Pro Ser
GTG AAT
Vai Asn
GIT AGT ATG' GAA AAG Vai Ser Met
Glu Lys
GTG
Vai
ATA TTA TCA CCA AAT GAA lie Leu Ser Pro Asn Glu 780
AAT TTA
Asn Leu . '785
TCC AAT
Ser.Asn
AGT
Ser
GTA
Vai
GAG
Glu
TCT CAT TCA Ser His Ser 790 .
TCC
Ser
ACG AAT
Thr Asn
TGG TCT TAT
Trp Ser Tyr
1008
ACA
Thr
AAT ACA.GAA Asn Thr Glu 800 .
GGT.
Gly Ala
GCT
TCT.
Ser Vai
GTT
GAA
Glu
GCG
Ala Gly
GGG
ATT GGA
CCA AAA GGT lie Gly Pro Lys Gly. 810
1056
TCG TTC
ATT lie Ser Phe 815
GGA'GTT AGC Gly Vai
Ser
GTA AAC
Vai Asn Tyr
TAT
CAA CAC
Gin His
TCT GAA
Ser Glu
ACA GTT GCA
Thr Vai Ala 830 <sup>;</sup>
1104
TGG
Trp Gly Thr
835,
GGA ACA
TCT ACA
Ser
Thr
GGA AAT ACT TCG CAA Gly Asn Thr Ser Gin 840
TTC
Phe
AAT. ACG
Asn Thr
GCT
Ala
1152
TCA GCG
Ser Ala
GGA TAT TTA AAT Gly Tyr Leu Asn Ala 850 .
GCA
AAT GTT CGA TAT AAC Asn Vai Arg Tyr Asn 855.
AAT GTA GGA ACT .
Asn Vai Gly Thr . . 860
1200
GGT GCC ATC
Gly Ala He
TAC GAT
Tyr Asp
GTA
Vai
AAA CCT ACA ACA AGT TTT Lys Pro Thr Thr Ser Phe 870
GTA TTA AAT AAC Vai Leu Asn Asn
<sup>ז</sup> 875
1248
GAT ACT' ATC
Asp Thr He
880
GCA ACT
Ala
Thr
ATT lie
885
ACG GCG AAA Thr Ala Lys
TCT
Ser
AAT TCT
Asn Ser
ACA GCC TTA AAT Thr Ala. Leu Asn
1296
ATA TCT: CCT GGA GAA AGT TAC lie
Ser Pro
Gly Glu Ser Tyr 900 .
CCG
Pro
AAA
Lys Lys
AAA
GGA CAA
Gly Gin
AAT
Asn
GGA ATC
Gly He
GCA
Ala
910.
1344
ATA lie
ACA-TCA
Thr Ser
ATG
Met
GAT GAT TTT Asp Asp 915 .
Phe
AAT
Asn
TCC
Ser
CAT CCG ATT
His Pro lie
ACA
Thr
TTA AAT
Leu Asn
AAA
Lys
1392
AAA CAA GTA
Lys Gin Vai
GAT
Asp 930
AAT
Asn
CTG
Leu
CTA AAT
Leu
Asn
AAT
Asn Lys
AAA
CCT ATG
Pro Met
ATG TTG
Met Leu
GAA
Glu
ACA
Thr
1440
AAC CAA ACA
Asn Gin Thr
GAT GGT
Asp Gly
GTT
Vai
TAT
Tyr
AAG
Lys
ATA AAA
He Lys
GAT ACA
Asp Thr.His Gly
CAT GGA
AAT
Asn
ATA
He
1488
־
950 .
GTA ACT GGC'GGA GAA TGG AAT Vai Thr Gly Gly Glu Trp Asn ?60. <sub>%5</sub>
ACA GCG
Thr Ala 975
TCT ATT ATT GTG GAT Ser
GTAGCG
Ala. Ala
GCA
Vai
ACT
Thr
TTA
Leu
He
AAA
Lys
GGT GTC ATA CAA CAA Gly Vai lie Gin Gin 970
GAT GGG. GAA CGT GTA He Vai Asp Asp Gly Glu Arg Vai <sup>980</sup> . .985
GAT TAT
Asp Tyr
GAA
Glu
ATC AAG lie Lys
GCA GAA
Ala Glu
AAT CCA GAA GAT AAA ACA CCG Asn Pro Glu Asp Lys Thr Pro 1000
GCT AAA
Ala Lys
AAA.CGT Lys
Arg 990
TCT
Ser 1005
TTA .
Leu
1536
1584
1632
AAA
Lys Asp Ala 1010
GAT
GCC
CTG
Leu Lys
AAG
CTT
Leu
TCA TAT CCA GAT GAA ATA Ser Tyr Pro Asp’ Glu lie 1015
AAA
Lys 1020
GAA
Glu
1680 gga tta tta tat
ATA GAG ( J______ lie Glu 'Gly Leu Leu Tyr 1025
GTT ATG ACT TAC TTA GAT Vai Met Thr Tyr Leu Asp 1040
TTA AAT GAT ACC ACT Leu.Asn 1055
Asp Thr Thr
TAT
Tyr
AAA AAC AAA CCG ATA TAC GAA .TCG ־;״ ' > Lys
Lys Asn 1030
GAA .
Glu . 1045
AAT
Ash Thr
ACA
GCA
Ala
GTA AAA ;Vai Lys
TAT GAT
Tyr Asp
ACA
Thr
AAT
Ash
Pro lie Tyr Glu Ser .1035
AGC
Ser
1728
GGGAAA
Gly Lys
1060
TTT AAA GAT. Phe
Lys Asp
GTA .
Vai . 1065
AAA
Lys
<td> GAA GTG</td><td> ACC AAA CAA</td>
<td> Glu Vai</td><td> Thr Lys Gin</td>
<td> 1050</td><td> . </td>
<td> AGT CAT</td><td> TTA TAT GAT</td>
<td> Ser His</td><td> Leu Tyr Asp</td>
1070
1776
1824
CTG ACT CCA
Leu Thr Pro׳Lys Met 1075
AAA ATG
AAT
Asn
GTT ACA .
Vai' Thr
1080
ATC lie
AAA
Lys
TTG TCT Leu
Ser.
ATA CTT He Leu 1085
1872
AAT GCT GAG TCT AAT GAT AAC TCA'ATT Asn Asp Asn Ser He . 1095
Asn Ala Glu
1090
AAT, ATT GTT Asn He Vai . 1105
AAT CCG GAT Asn Pro 1120 .
TTA
Leu 1135
AAA
Lys
ACT
Asp
Ser
GGT AAA
Gly Lys
TGG ACA AAC .
TrpThr Asn
..־ .1100
1920
TCA
Ser
GCT
Ala
AAT.AAA Asn
AAC
Asn
Lys
AAT
Asn
ACA
Thr
CAA
Gin
GGT
Gly Gly Asn Asn Gly Lys '.. . 1110 .
GGA AAT AAC GGA AAA
AAT TTG ACA TTA AAT
Asn Leu Thr . 1125.
Leu
Asn
AAA CAA TAT TCT Lys Gin Tyr Ser 1115. .
TCT.
Ser
1968
CGT
Arg Asp Tyr Tyr lie 1140
GAC TAT TAT
TGT GAG ATT Cys Glu lie
1155
ACT
Thr
ATA
ATA He
ACA AAA. ACA GTG AAT GTG
AAT
ACA
Thr Asp Ala Gin Glu Lys 1130
GAT GCT CAA. GAA
AGT
Ser .Leu Tyr Met Lys Ser
1145 .־
TTA TAT ATG
GAT GGG GAG
Asp Gly Glu 1160
AAA GAC AAT TAC
AAA .
2016
AAG TCA
GAA
Glu
1150'
2064
ATT TAT CCG lie Tyr Pro 1165 .
ATC He
2112
AAA AGA TTA GAT׳
2160
2208
Thr Thr
Lys Thr Vai
1170
Asn
Vai Asn Lys Asp Asn
1175
Tyr Lys Arg Leu Asp
י 1180 . ATT ATA
- He lie
GCT CAT Ala His 1185.
AAT
Asn
ATA
He.
AAA
AGT AAT CCA ATT‘ Lys Ser Asn Pro He '1190
TCT TCA ___ ___
Ser Ser Leu His . 1195
CTT CAT
ATT
He
AAA
Lys
ACG AAT
Thr Ash
1200
GAT Asp ’ 1215
CAG
Gin
GAT
GAA ATA Asp Glu
GTA GCA Vai Ala Ser
TCA ATA
He
ATT TAT. AGT lie Tyr
Ser
He
ACT TTA TIT Thr Leu,Phe 1205
TGG GAT
Trp Asp Asp lie Ser He 1210
AAA
Lys Pro Glu Asn Leu 1220
CCG GAA AAT
AGG
Arg Tyr Gly 1235
TAT GGT
TTA
GAT ATT TCT ATA
ACA
Thr
ACA GAT TCA GAA ATT AAA. Thr Asp Ser Glu.lie Lys 1225
ATT AAG TTA
Lys Leu : .;. 1240
He
1230 . .2256 .2304 .’
GAT
Asp Lys Lys Gly Gly 1250 '
GAA GAT GGA ATC CTT ATT Glu Asp Gly He Leu lie ' 1245
2352
AAA AAA
TTT AAT
Phe Asn
TAT AGT
Tyr
GGT
GGG ATT CAT, TAT C״ . Us His Tyr Gly Glu '1255.
GGT. GAA TTT. ATT AAT i Phe lie Ash
GAA Glu 1260
GCT AGT
Ala Ser:
2400
ATT GAA CCA lie Glu Pro 1265
TTG CAA
Leu Gin Asn Tyr Vai
׳ . 1270
AAT
TAT GTG
ACC AAA TAT Thr Lys.Tyr 1275
GAA GTT.ACT Glu Vai Thr
2448
Ser
1280
AAA Lys 1295
AGT GAG TTA Ser Glu Leu
ATT TAC AAG GAT He Tyr Lys Asp
GGA
Gly
CCA AAC GTG AGT Pro Asn Vai Ser 1285
GGG
Gly 1300
ACA ATT AAA
Thr He
Lys
GAC
Asp
ACA CTT GAA AGT GAT Thr Leu Glu ,Ser Asp 1290 . .
TTT GAT
Phe Asp.Phe Thr .1305.
TTT. ACC
AAA TAT AGT Lys Tyr
2496
2544
AAA AAT GAA CAA GGA TTA TTT TAT -- .—1 Glh Gly Leu Phe Tyr 1315
Lys Asn Glu
GAC
Asp
AGT GGA TTA AAT
Ser
1310
TGG GAC TH Ser Gly Leu Asn Tip Asp Phe <sup>1320</sup> ' . 1325
TTT
2592
AAA AIT AAT C~~ ך.' Lys lie Asn Ala He Thr '1330.
GCT ATT. ACT
TAT
GAT
GGT. AAA GAG ATG AAT GTT TTT CAT Tyr Asp Gly^Lys Glu Met Asn Vai Phe His
1340
2640
AGA TAT AAT AAA. TAG Arg Tyr Asn Lys 1345 .
(2) INFORMATION FOR SEQ ID NO:5‘: .
(i) SEQUENCE CHARACTERISTICS־ ' <A) LENGTH: 884 amino acids (B) TYPE:amino acid (D) TOPOLOGY: linear
2655
<img file="IL115382A_D0003.tif" />
(ii) MOLECULE TYPE: protein (xi) SEQUENCE
Met
-. 1
Lys Asn Met
Lys
DESCRIPTION: SEQ. ID NO:5:
Lys Lys Leu Ala Ser.Vai v<sub>a</sub>! '10
Leu
Ala Pro Met
Thr Cys Thr Leu
Phe
Leu
Asn
Gly Asn Vai Asn Ala
Vai
Ser Lys Thr Asn . . 35
Tyr Ala Asp
Gin He
Ser
Ihr.Thr Gin Lys
Asn
Gin
Gin Lys Glu
Met Asp Arg Lys
Gly Leu Leu
Gly Tyr Tyr Phe
Lys
Gly Lys
Asp Phe
Ser
Asn Leu Thr
Met Phe Ala Pro
Thr Arg Asp
Ser
Thr Leu
Asp
Gin Gin Thr
He Tyr
Gin Ser . lie
Phe Thr Phe . H5
Gly Lys
He
Glu Lys
Ala Asn Lys
Arg Trp He 100
Asn Leu Ser
He Ser Asn
Gly Lys Leu
Vai
Leu
Leu Asp Lys.Lys . 90
Gin Gin Glu
..95
Gly
Glu
Leu
Asp
He Gin Ser Lys 105 .
Glu Gin Ala He
Lys Gly Lys Glu Lys Gin
-— . . 140
Glu
He
Vai
Thr Gly Asp 110 .
Glu He, Asn
Vai. His Leu
Lys Phe Asn lie. Asp . •165
Ser
Pro . He Lys He Glu : . . ' i55
Lys Thr Phe Lys Glu
170 .י.
Tyr Gin
Leu Lys
Ser Asp Thr ..
160 .
Leu
He Asp Ser Gin Asn
. 180 ־ .
Phe Lys
Asn
Pro Glu
Ser
Lys He 210.
Gin
Pro Gin Gin
Phe Asn Lys Lys Glu Ser Gin
Vai
Gin.Gin Asp.Glu '190
Glu Phe Leu Ala
Leu Arg.
Lys Pro
Asp 225
Asn Leu Phe Thr Gin Lys Met 215. ;.
Thr Asp Thr. Asp cly Asp Ser <sub>Ile Pr0</sub>
Gly. Tyr Thr He Gin. Asn Arg He Ala
Lys Arg Glu,lie-Asp Glu
Asp 235
Vai
Ala Ser Lys Gly Tyr Thr Lys ׳Phe Vai <sup>260</sup> . 265
Leu Trp Glu Glii Asn
Lys Trp Asp Asp Ser Leu
255
Ser
Asn Pro Leu Glu Ser His 270 .
/3
Thr varay ״p p<sub>ro</sub> Tyr <sub>Thr</sub> AspTyr <sub>Glu lys</sub> ,.
<sup>280</sup>285
Asp Leu Ser Asn Ma Lys Glu Thr <sub>Phe</sub> a״־ <sub>Pto Valph(־</sub> '300
Pro Ser Val val Ser. Met Glu Lys Val He i^u Ser Pro Asn Glu .' <sup>310</sup> .. . 315 . . .
A״־ Leu Ser As״ Ser Val Glu Ser Bis Ser Ser <sub>T</sub>hx ״־״ <sub>Tro </sub><sup>325</sup> . ' 330 ' 33<sub>5</sub><sup>y</sup> י‘ Clu Ala Gly He <sub>Giy</sub> ״, <sub>Lys </sub><sup>345</sup> .. 350 .
11־ Ser Phe Gly val Ser Val Asn Tyr <sub>fli5</sub> . , . <sup>360</sup> . .:. '365 ..
Gl״ Glu Trp <sub>G</sub>ly Thr Ser Tip: Gly Asn Thr Ser Gl״ <sub>Phe</sub> ,,.
<sup>375</sup> . ' 380 ..י.
<sub>e1y Ihr</sub> . 395
Gly Ala Tie Tyr Asp Val Lys Pro Thr Thr Ser Phe Val leu As״ Ash <sup>410</sup>415
Asp Thr He Ma Thr He Thr Ala Lys Ser A״־ Ser Thr Ma Leu As״ ' <sup>425</sup> ..130
He Ser Pro Gly Glu Ser 1y<sub>r</sub> Pro Lys Lys Gly Gl״ Asn Gly He Ala .<sup>44</sup>5 . . ...־
Tie Thr Ser Met Asp Asp Phe As״ Ser Bls Pro He Thr Leu A״־ Lys <sup>J33</sup> .460 . ..<sup>3</sup> .;׳ .
Lg Gin Val Asp Asn Uu Leu Asn As״ Lys Pro M־<sub>t</sub> «־<sub>t</sub> Leu Glu Thr . . /U Λ7׳ς <sup>4/5</sup> : 480
A״־ Gin Thr Asp Gly Va! Tyr Lys ώ Lys Asp Thr Bls Gly Asn lie . . <sup>490</sup> . '.495 . .י .
val Thr Gly Gly Glu Trp-As״ Gly Val He Gin Gl״ He Lys Ma Lyf
Thr Ala Ser He He Val Asp Asp Gly Glu Ar, val Ala Glu Lys Mo .:. . <sup>520</sup> ' 525.
val Ala Ma Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu , s4n
Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu He Lys Gl״ '<sup>55</sup>° «δ <sub>560</sub>
He Glu Gly Leu leu Tyr Tyr'Lys Asn Lys Pro He Tyr Glu Ser Ser
Val
Met Thr
Leu
Val
Ztf.35
Tyr Leu Asp Glu Asn
Asn Asp Thr Thr Gly Lys Phe
Lys Leu Thr Pro Lys Met Asn <sup>610</sup> . . 615
Tyr Asp Asn Ala Glu Ser Asn Asp <sup>625</sup> 630
Thr Asn
Asn Asn
Leu Asn
Lys
Thr lie
Lys
Asp
Tie
Pro
Lys
Asn Thr
Thr
Lys lie
Ala
Thr
Val
Gin lie . 770
Asn
Ala
Tyr
Thr Ala Lys
Lys
Val
Asn
Val Ser Gly Gly Asn Asn
645 :
Asp Ala Asn Leu Thr,Leu
660 : . 665
Asn Arg Asp Tyr Tyr Tie 68C
Gin
Thr
His
Asp
Ser
Asp
Thr
Ser
Val
He lie
Gly Lys
Asn
Ser
Cys
Glu lie
Thr lie
Val
Asn
Glu lie
Asn
Val lie
Lys
He Thr
Lys Pro
Glu Val Thr Lys Gin
Ser His
Lys Leu
Leu . Tyr Asp
Ser.Il<sub>e</sub> Le<sub>u</sub>
Gly Lys Trp Thr Asn
Lys Gin ׳tyr Ser Ser
Thr Asp Ala Gin Glu . 670
Leu Tyr Met Lys Ser 685
Asp Gly Glu He Tyr Pro
Asn Lys Asp
Ser Asn
Leu Phe
Glu Asn
760. .
Ser Arg tyr Gly lie Lys . 775 . '
Lys
Glu lie <sup>sp</sup> Asn Tyr Lys Arg Leu Asp
Pro
He Ser Ser Leu
Trp Asp Asp.Tie
Ser
Leu
Leu
A־P Lys Lys Gly Gly He <sub>B</sub>i<sub>s</sub> Tyr Gly Glu . 790
Phe Asn lie Glu
Pro
Leu Gin Asn
Tyr Val
His lie lie
Thr
Thr Asp Ser .765.
Glu lie
Lys
Glu
Phe
Thr
Asp Gly lie
Leu
He
He Asn Glu
Lys Tyr Glu
Ala
Ser
Tyr Ser. Ser Glu
Leu
Gly
Pro
Asn
Val Ser
Asp
Lys lie
Tyr Lys
Asp. Gly
Thr lie
Lys' Phe
Val
Thr
Thr Leu Glu Ser
Asp Phe
Asp
Thr Lys Tyr Ser
Lys Asn . 850
Glu Gin
Gly Leu
Tyr Asp Ser
Gly Leu
Asn Trp Asp Phe
V
A
Lys He Asn Ala lie Thr Tyr Asp Gly Lys Glu. Met Asn Vai Phe His <sup>875</sup> ' 880'
Arg Tyr Asn Lys (2) INFORMATION FOR SEQ ID NO:6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2004 base pairs (B) TYPE: nucleic acid .(C) STRANDEDNESS: single (D) TOPOLOGY:, linear ' , (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE:.
(A) ORGANISM: Bacillus cereus (B) STRAIN: AB78 (C) INDIVIDUAL ISOLATE: NRRL B-21058 (ix) /note־ feature:
(A) ΝΑΜΕ/ΚΕΥ: CDS (B) LOCATION: 1.2001 (D) OTHER INFORMATION: /product80 ־ kDa protein VIPlA(a)' <sup>Th</sup>i<sup>s</sup>. <sup>se</sup>^<sup>ence 1</sup>s identical to that found in SEO id ncTi een and including nucleotide positions 3126 and 5126 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:
ATG
Met
CCT
Pro
AAA.AGG GAA ATT GAT Lys Arg Glu He Asp ; . . 890.
GAA GAC ACG GAT ACG GAT GGG GAC TCT ATT Glu Asp Thr Asp Thr Asp Gly Asp Ser lie <sup>895</sup> . .900
GTA
Vai
GAC CTT TGG GAA GAA AAT GGG TAT ACG ATT'CAA Asp Leu Trp Glu Glu Asn Gly Tyr Thr lie Gin <sup>905</sup> .910 .
AAT AGA ATC GCT Asn Arg He Ma 915
AAG TGG GAC GAT TCT CTA GCA Lys Trp Asp Asp Ser Leu Ala \ '920
AGT AAA GGG TAT ACG AAA TTT Ser Lys Gly Tyr Thr Lys Phe 925 95<sub>o</sub>
GTT
Vai
TCA AAT
Ser Asn
CCA CTA GAA AGT CAC ACA GTT GGT GAT CCT Pro Leu Glu Ser His Thr Vai Gly Asp Pro yd5 . 940
TAT ACA GAT TAT . Tyr Thr Asp Tyr 945
GAA AAG GCA GCA AGA GAT Glu Lys'Ala Ala Arg Asp 950
CTA GAT TTG TCA AAT GCA AAG GAA ACG TTT Leu Asp Leu Ser Asn Ala Lys Glu Thr Phe <sup>955</sup> 960
GTA GCT
Vai Ala
GCT TTT CCA
Ala
y.i.W
AAC CCA TTG Asn Pro Leu 965 .
GTG ATA.TTA
Vai lie
TCA TCC
Ser Ser
Phe Pro
AGT
Ser
GTG AAT
Vai Asn
GTT AGT ATG
Vai Ser Met
GAA AAG
Glu Lys
980 .
. 288.
Leu
TCA CCA
Pro Asn
Ser
ACG
Thr Asn
1000 '
AAT
AAT
GAA AAT
Glu Asn
TTA
Leu
TCC AAT
Ser Asn
AGT
Ser
GTA GAG
Vai Glu Ser His 995.
TCT CAT.
TGG TCT
Trp Ser
TAT ACA
Tyr Thr
AAT ACA
Asn Thr 1005
GAA
Glu
GGT GCT TCT GTT Gly Ala Ser Vai 1010
GAA
Glu
GCG׳GGG ATT GGA CCA AAA ΑΣ3.: Gly
CAA CAC lie
1015
Gly Pro
Lys
GGT
Gly
ATT He 1020
TCG
Ser
TTC Phe. Gly
GGA
GCT AGC GTA AAC
Vai Ser Vai Asn Tyr 1025
TAT , 432 .
TCT GAA ACA Gin His. Ser Glu 1030
ACT TCG CAA Thr.Ser Gin .1045
CGA TAT
Arg Tyr
AAC
Asn
Thr
GTT GCA
Vai Ala
1035
CAA GAA
Gin Glu
TGG GGA
Trp Gly
ACA TCT ACA Thr Ser Thr 1040 <sub>:</sub>
GGA AAT
Gly Asn
ACA AGT
TTC
Phe
AAT
Asn
ACG GCT TCA GCG Thr Ala Ser Ala 1050
AAT
Asn Vai
1065.
GTA
GGA 'ACT GGT GCC Gly Thr. Gly Ala
TTT GTA Thr Ser Phe
Vai
1080
TTA
Leu
AAT AAC
Asn Asn
GGA TAT
Gly Tyr
1055
TTA AAT GCA Leu Ash Ala
AAT
Asn
GTT
Vai 1060 ,528
ATC TAC GAT GTA AAA CCT He Tyr Asp . Vai Lys Pro 1070
ACA
Thr 1075 . 576.
GAT ACT' ATC Asp Thr He .1085 .
GCA ACT ACT ACG GCG AAA Ala Thr lie Thr Ala Lys 1090
624
TCT AAT TCT Ser Asn Ser 1095
ACA GCC
Thr
Ala
TTA
Leu
AAT
Asn
ATA TCT CCT _______ n״״<sup>Ser Pro Gly Glu Ser</sup> ?yr Pro tys 1105
GGA GAA AGT
TAC CCG AAA
672.
' AAA GGA
Lys Gly Gin Asn 1110
CAA AAT
GGA-ATC
Gly He
GCA ATA ACA TCA ATG GAT GAT TTT Ala lie Thr Ser Mot Asp Asp Phe 11-0. וו on
1120
AAT
Asn
TCC
Ser . 720; '
CAT CCG ATT ACA His Pro He Thr 1125
TTA
Leu
AAT.
Asn 1130
AAA
Lys
AAA CAA GTA GAT AAT Lys Gin Vai Asp Asn . 1135'
CTG
Leu
CTA
Leu
AAA CCT. ATG ATG Lys Pro. Met
AATAAT
Asn 1140
Asn
Met
TTG Leu. 1 1145
GAA
Glu
ACA Thr. Asn
AAC
CAA
Gin
ACA GAT GGT Thr Asp Gly 1150
GTT
Vai
TAT AAG
Tyr Lys
1155
ATA lie
AAA GAT
Lys
Asp
ACA
Thr
CAT His 1160
GGA. AAT
Gly Asn
ATA GTA
He Vai
ACT Thr 1165 .
GGC GGA
Gly Gly
GAA
Glu
TGG
Trp
AAT GGT GTC Asn Gly Vai 1170
ATA
He
CAA
Gin
CAA
Gin
ATC AAG' GCT lie Lys Ala
AAA ACA GCG TCT ACT.ATT GTG GAT GAT GGG Ly־ Thr Ala Ser n<sub>־ Ile v־a tep</sub><sup>1175</sup> . . 1180 1185
GAA CGT GTA
Glu Arg Vai
1190
GCA
Ala
GAA .’AAA CGT GTA GCG Glu,Lys Arg Vai 1195
Ala
GCA AAA GAT TAT GAA' AAT
Asn
Ala
Lys Asp Tyr
1200
Glu
CCA
Pro
GAA GAT AAA Glu Asp Lys 1205
ACA
Thr
CCG TCT TTA ACT
Pro
TTA
AAA
TAT
Tyr
CCA
Pro
GAT
AAA
Lys
CCG
Pro
ATA
He
GCA AAA GAA Ala Lys
Ser Leu Thr 1210
GAA ATA .
Glu lie :
1225
TAC
Tyr 1240 '
GAA
Glu
GTG ACC
Vai Thr
1255
Glu
GAT GTA :
Asp Vai
1270
AGT CAT
Ser His
TTA
Leu
AAA
Lys
TCG
Ser
ACA ATC AAA, TTG Thr lie Lys 1285
Leu
TCA
Ser
ATT. GGT lie Gly
AAA .GGA
Gly
GAT GCC CTG Leu Lys Asp Ala ’ 1215
GAA ATA GAG GGA TTA. TTA Glu He Glu Gly Leu Leu , 1230
AGC.GTT
Vai Met Thr 1245 .
Ser
CAA
ATG ACT
Leu
AAG
Lys
CTT
Leu
TCA Ser 1220
1008
AAA
Lys Gin
TTA AAT
Leu Asn 1260
TAT GAT GTA Tyr Asp Vai . . 1275
TCT ATA CTT lie Leu 1290
Ser
TGG .
Lys .Trp '
1305
ACA AAC
Thr Asn
AAA
Lys
GAT
Asp
TAT
Tyr Tyr Lys Asn 1235
TAT AAA AAC , 1056
TAC TTA GAT GAA AAT ACA Tyr Leu
Asp Glu Asn Thr
1250
1104
ACC
Thr
ACT
Thr
GGG AAA TTT AAA Gly Lys Phe Lys 1265 .'
CTG
Leu Thr Pro Lys Met 1280
TAT
Tyr Asp Asn
GAT ״AAT
ACT
CCA AAA ATG
GCT GAG TCT AAT
Ala Glu 1295
Ser Asn
1152
AAT
Asn
GTT
Vai
1200
ACA
Thr
AAT ATT
Asn lie Vai . 1310
GTT
TCA
Ser
AAA AAA CAA TAT TCT. TCT AAT Lys
Lys Gin Tyr
1320 '
Ser.Ser Asn
AAT ,CCG GAT
Asn Pro 1325 ;
GCT
Asp .'Ala
AAT
Asn Thr
ACA
GAT
Asp
1335:
GCT CAA
Ala Gin
GAA
Glu
AAA TTA
Lys leu Asn Lys 1340 ’
AAT AAA
AAT iCGT
AGT
Ser
TTA-TAT ATG AAG
Lys Ser
Leu Tyr Met 1350
TCA GAA.AAA AAC Glu Lys 1355
Asn
ACA
Thr
GAT
Asp Asn
1300
AAC .
1248
GGT GGA
Gly Gly Asn Asn 1315
AAT AAC
1296 .
AAT
Asn
GAC
TTG ACA TTA Leu Thr . Leu 1330
1344
TAT TAT ATA 1392
Asn Arg Asp Tyr Tyr Lie : 1345
CAA
Gin Cys Glu .1360 .TGT GAG
ACT ATA .
ATT lie Thr. lie . 1440
GAT
Asp Gly Glu 1365
GGG GAG
ATT
He
TAT
Tyr
CCG
Pro 1370'
ATC ACT lie Thr Thr
ACA
AAA
Lys
ACA GTG
Thr Vai
1375
AAT
Asn
GTG
Vai
AAT AAA
Asn. Lys
1380 .
1488
GAC AAT TAC
Asp Asn Tyr
AAA AGA
Lys
Arg 1385
TTA GAT ATT
Leu Asp lie
ATA
He
GCT י Ala . 1390
CAT
His
AAT
Asn
ATA AAA
He Lys
AGT AAT
Ser Asn
1395
1536
CCA ATI־ TCT TCA CTT CAT ATT AAA
ACG
AAT GAT
GAA ATA ACT
TTA TTT
1584
Pro lie Ser Ser Leu . 1400
TGG GAT GAT ATT TCT Tip. Asp Asp lie Ser .1415
His He Lys Thr Asn Asp Glu He Thr Leu Phe <sup>1405</sup> 1410
ATA ACA GAT GTA GCA TCA ATA AAA CCG GAA AAT . lie Thr Asp . Vai Ala Ser lie Lys Pro Glu Asn 1420 1425
TTA ACA GAT TCA GAA ATT Leu Thr Asp Ser Glu lie . 1430 .
AAA CAG ATT TAT AGT AGG TAT GGT ATT AAG Lys^Gin He Tyr Ser Arg Tyr Gly He Lys
י 440! .<sup>1</sup>435
1680
TTA GAA GAT GGA ATC Leu Glu Asp Gly He 1445
CTT ATT GAT AAA AAA GGT GGG ATT CAT TAT GGT Leu He Asp Lys Lys Gly Gly lie His Tyr Gly <sup>1450</sup> 55^1 .:.־ . .<sub>I4</sub>|0.
L728
GAA TTT ATT AAT GAA GCT AGT TTT AAT ATT GAA CCA Glu Phe He Asn Glu Ala Ser Phe Asn He G!u Pro !465 . 1470
TTG CCA AAT TAT Leu Pro Asn Tyr 1475
1776
GTG ACC AAA TAT GAA Vai Thr Lys Tyr Glu 1480
GTT ACT TAT AGT AGT GAG TTA GGA CCA AAC Vai Thr Tyr Ser Ser Glu leu Gly Pro Asn
1485 . 1<sub>490</sub>
GTG
Vai
1824
AGT GAC
Ser Asp
ACA. CTT
Thr Leu 1495 .
GAA AGT GAT,AAA ATT TAC AAG GAT GGG ACA ATT AAA Glu Ser Asp Lys lie Tyr Lys Asp Gly Thr lie' Lys <sup>1500</sup> !505
1872
TTT GAT TTT
Phe Asp Phe
1.510
CC AAA TAT AGT AAA AAT GAA CAA GGA TTA TTT TAT GAC Thr Lys Tyr Ser Lys Asn Glu Gin Gly Leu Phe Tyr Asp <sup>15</sup>I<sup>2 * * 5</sup> . 1520
1920
AGT GGA TTA AAT TGG GAC TTT AAA ATT AAT GCT ATT ACT
Ser Giy Leu Asn Trp Asp Phe Lys He Asn Ala lie Thr
.־־ 1535 ' 1530 <sup>1525</sup>
AAA GAG ATG AAT GTT TTT CAT AGA TAT AAT AAA TAG
Lys Glu Met Asn Vai Phe His Arg Tyr Asn Lvs .1545. .. . ' !550
TAT GAT GGT.
Tyr Asp Gly
1540
1968
2004 (2) INFORMATION FOR SEQ ID NO:7:
(i) SEQUENCE CHARACTERISTICS.־ <sup>?</sup> ׳ .־ (A) LENGTH: 667 amino'acids ' ..
(B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ. ID NO:7:
Met Lys Arg Glu He Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser He . 15 10־ . <sup>5</sup> .Pro Asp Leu Trp Glu Glu Asn Giy Tyr Thr He Gin Asn Arg He Ala !28 11 5 3 8 2 /3 <sup>20</sup> 25 .30 , Val Lys Trp Asp Asp Ser feu Ala Ser Lys Gly Tyr Thr Lys Phe Val 35 4045 . Ser Asn Pro Leu Glu Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr
60 ' . 55 . 'י
Glu Lys Ala Ala Arg Asp Leu Asp. feu Ser Asn Ala Lys Glu Thr Phe
<sup>80</sup> .־- ...־. <sup>75</sup> .<sup>7</sup>° י:. .־־
Asn Pro Leu Val Ala Ala Phe Pro Ser Val Asn Val Ser Met Glu ' 85 ', 90 . 95.
Val He feu Ser Pro Asn Glu Asn feu Ser Asn Ser Val Glu Ser His <sup>100 105</sup> 110
Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val Glu
.125 .־. . 120 . <sup>115</sup>
Aia Gly He Gly Pro Lys Gly He Ser Phe Gly Val Ser Val Asn Tyr
' . '40! ;..־ 135 . . <sup>130</sup>'
Gin His Ser Glu Thr Val Ala Gin Glu Trp Gly Thr Ser Thr Gly Asn <sup>150</sup> . <sup>155</sup> .:. 160
Thr Ser Gin Phe Asn Thr Ala Ser Ala Gly Tyr Leu Asn Ala As״ Val <sup>165</sup> . ,170 .!75
Arg Tyr Asn Asn Val Gly Thr Gly Ala lie Tyr Asp Val Lys Pro Thr <sup>180</sup> 185 \ ' ..' !90
Thr. Ser Phe Val feu Asn Asn Asp Thr He Ala Thr He Thr Ala Lys <sup>195</sup> .'. 200 '205 ־ .־ .Ser Asn Ser Thr Ala feu Asn He Ser Pro Gly Glu Ser ׳Tyr Pro Lys <sup>2</sup>.* 220 . ׳ . 215. ־
Lys Gly Gin As״ Gly He Ala lie Thr Ser Met Asp Asp Phe Asn Ser . .:' '. <sup>230</sup> ' . 235 ,240
His Pro He Thr feu As״ Lys Lys. Gin Val Asp Ash feu Leu Asn Asn . <sup>245</sup> . ' <sub>;</sub> '. . 250255 י
Lys Pro Met Met feu Glu Thr . As״ Gin Thr Asp Gly Val Tyr Lys lie ' 260 . . '265270
Lys Asp Thr His Gly Asn lie Val Thr Gly Gly Glu. Trp Asn Gly Val . <sup>275</sup> . .<sup>28</sup>Ο . 285.
He Gin Gi״ He Lys Ala Lys Thr Ala Ser lie lie Val Asp Asp Gly 295300
Glu Arg Val Ala Glu Lys Arg Val Ala Ala Lys Asp Tyr Glu Asn Pro
חלל . 315 <sup>310</sup> ׳'
V
1 5 3 8 2
Glu Asp Lys Thr Pro Sex Leu Thr to, Lys' Asp M<sub>a</sub> !״־ <sub>Lys fe</sub>״ <sup>325</sup> ;330 <sub>33S</sub>
Tyr Pro Asp Glu lie Lys Glu He Glu'Gly !yr Lys Asn <sup>345 350</sup>
Lys Pro lie Tyr Glu Ser Ser Val M־t Thr lyr Leu Asp Glu Asn Thr
360 .365
Ala Lys Glu Vai Thr Lys Gin leu Asn Asp Thr !hr Gly Lys Phe Lys
380. <sup>375</sup> ' , ׳
Asp Val Ser Bls leu Tyr Asp Vai Lys leu Thr Pro Lys «et Asn Vai <sup>yU 395</sup> . ., 400 י
Thr He Lys leu Ser He Leu Tyr Asp As״ Ala Glu Ser Asn Asp Asn <sup>: 410</sup> ..י ,.415 .־;
Ser lie Gly Lys Trp Thr Ash Thr As״ lie Val Ser Gly Gly As״ Asn <sup>U</sup> . <sup>425</sup> 430
Gly Lys Lys Gin Tyr Ser Ser Asn Asn Pro Asp Ala Asn Leu Thr Leu
440 י
As״ Thr Asp Ala Gin Glu Lys Leu Asn Lys Asn Arg Asp Tyr Tyr He '460
Ser Leu Tyr Ket Lys Ser Glu Lys Asn Thr Gin Cys Glu lie Thr11־ ; . , <sup>4 75</sup> ,«0
Asp Gly Glu lie Tyr Pro He Thr Thr Lys Thr Val Asn Val As״Lys <sup>485</sup> 490 ,495
Asp A״־ Tyr Lys Arg to, Asp He lie Ala Bls Asn He Lys Sex Asn ' ' <sup>505</sup> .510 .י .
<td> Pro</td><td> He</td><td> Sex 515</td><td> Ser</td><td> Leu His</td><td> lie</td><td> . Lys 520</td><td> Thr Asn</td><td> Asp</td><td> Glu He . Thr ' 525</td><td> Leu Phe</td>
<td> Ttp</td><td> Asp 530</td><td> Asp</td><td> . He</td><td> Ser lie</td><td> Thr 535</td><td> Asp</td><td> Val Ala</td><td> Ser</td><td> He Lys Pro 540</td><td> Glu.Asn</td>
<td> . Leu 545</td><td> Thr</td><td> Asp</td><td> Ser</td><td> Glu .lie' 550'</td><td> Lys</td><td> Gin</td><td> He. Tyr</td><td> Ser .555</td><td> Arg Tyr Gly</td><td> He Lys 560</td>
<td> Leu</td><td> Glu</td><td> Asp</td><td> Gly</td><td> He Leu 565</td><td> He</td><td> Asp</td><td> Lys Lys 570</td><td> Gly</td><td> Gly.lie His</td><td> Tyr.Gly 575</td>
<td> Glu</td><td> Phe</td><td> lie</td><td> Asn 580</td><td> Glu Ala</td><td> Ser</td><td> Phe</td><td> Asn' He 585</td><td> Glu</td><td> Pro Leu Pro 590</td><td> Asn Tyr</td>
<td> Val</td><td> Thr</td><td> Lys 595</td><td> Tyr</td><td> GluVal</td><td> Thr</td><td> Tyr 600</td><td> Ser Ser</td><td> Glu</td><td> Leu Gly Pro 605 .</td><td> Asn Val</td>
1 5 3 8 27 3
S־<sup>r</sup> Asp Thr ten <sub>G</sub>lu Sex Asp Lys lie Tyr Lys Asp Gly The He Lys
.. 620 <sup>615</sup> ־ .
Phe Asp Phe The Lys Tyr Ser Lys Asn Glu Gin Gly Leu Phe Tyr Asp ' <sup>630</sup> . 63554$
Ser Gly Leu. Asn Trp Asp Phe Lys He As״ Ale He Thr Tyr Asp a״ <sup>655</sup> . ''«655.«צ
Lys Glu Met Asn Vai Phe His Arg Tyr Asn Lvs <sup>660</sup> 565' (2) INFORMATION FOR SEQ ID NO:8:
(i) SEQUENCE CHARACTERISTICS.
(A) LENGTH: 16 amino, acids (B) TYPE; amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide . (iii) HYPOTHETICAL: NO (v) FRAGMENT TYPE: N-tenuinal.
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus cereus (B) STRAIN: AB78 (C) : INDIVIDUAL ISOLATE: NRRL B-21058 (ix) FEATURE:
(A). NAME/KEY: Peptide . (B) LOCATION: 1.16 (D) OTHER INFORMATION: /note־־ protein purified from strain,AB78
N terminal sequence of (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:
Lys Arg Glu He Asp Glu Asp Thr Asp Thr Asx Gly Asp Ser lie Pro
15 .י.<sup>10</sup> ' . <sup>5</sup> . ' , : ';/ (2) INFORMATION FOR SEQ ID NO:9: '.
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOIOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO
V
<td></td><td> A .-131-. (i.v) ANTI-SENSE: NO . . (ix) FEATURE: (A) NAME/KEY: misc feature (B) LOCATION: 1.21 Bacillus thuringiensis <sup>y</sup> (xi) SEQUENCE DESCRIPTION: SEQ ID׳NO:9; . GAAATTGATC AAGATACNGA T 21 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 14 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide. .(iii) HYPOTHETICAL: NO <sup>!</sup> (v) . FRAGMENT TYPE: N-terminal •' .- .</td>
<td></td><td> (vi) ORIGINAL SOURCE: ' . . ' (A) ORGANISM: Bacillus thuringiensis (B) STRAIN: AB88 (ix) FEATURE:. . (A) NAME/KEY: Peptide . (B) LOCATION: 1.14 ' (D) OTHER INFORMATION: /note= N-terminal amino acid !SiIpH״ <sup>Pr</sup>°<sup>te1n kn0wn as</sup> anion exchange fraction 23 . . (xi) SEQUENCE DESCRIPTION: SEQ׳ ID NO:10: Xaa Glu Pro Phe Val Ser Ala Xaa Xaa Xaa Gin Xaa Xaa Xaa . <sup>5</sup> ' 10 (2) INFORMATION FOR SEQ. ID NO:11: (i) SEQUENCE CHT^RACTERISTICS: (A) LENGTH:' 13 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOWGY: N-terminal</td>
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:
Xaa Glu Tyr Glu.Asn Vai Glu Pro Phe Vai Ser Ala Xaa ' <sup>1</sup> . <sup>5</sup> . 10 (2) INFORMATION FOR SEQ ID NO:12:.
(i) SEQUENCE CHARACTERISTICS: ־.'.<
(A) LENGTH: 14 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: N-terminal (vi) ORIGINAL SOURCE;
(A). ORGANISM: Bacillus' thurigiensis (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:
Met Asn Lys Asn Asn Thr. Lys Leu Pro Thr Arg Ala Leu Pro <sup>1 5</sup> . 10 (2) INFORMATION FOR SEQ ID NO:13: , (i) SEQUENCE׳CHARACTERISTICS:
• (A) LENGTH: 15 amino acids .
(B) TYPE: amino acid . (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (v) FRAGMENT TYPE; N-terminal (vi) ORIGINAL SOURCE;
(A) . ORGANISM: Bacillus thuringiensis (B) STRAIN: AB88 (ix) FEATURE;.
(A) . NAME/KEY: Peptide (B) LOCATION: 1.15 (D) OTHER INFORMATION: /note״ ־N-teminal amino acid sequence of 35 kDa VIP active against Agrotis ipsilon״ (xi) SEQUENCE,DESCRIPTION: SEQ ID NO-13:
Ma t״־ <sub>Ser</sub> Glu A״־ Tbx <sub>Gly Ly־ Gly Gly</sub> θ . / <sup>5</sup> ' <sup>1</sup>°. /./15 (2) INFORMATION FOR SEQ ID NO: 14 .
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 9 amino acids (B) TYPE: amino acid .
(C) STRANDEDNESS: single (D) TOPOIOGY: N-terminal.- . (vi) ORIGINAL SOURCE: /' .(A) ORGANISM: Bacillus thuringiensis .' (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14
Met Asp Asn Asn Pro Asn He Asn Glu <sup>1</sup> 5.
(2) INFORMATION FOR SEQ ID NO:15:
(i) SEQUENCE.CHARACTERISTICS:
(A) LENGTH: 9 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY; linear ./ (iij MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (v) FRAGMENT TYPE: N-terminal (ix) FEATURE:
(A) NAME/KEY: Peptide (B) LOCATION: 1.9 (D) OTHER INFORMATION. -, kDa delta-endotoxin ‘ / terminal sequence of 80 (xi) SEQUENCE DESCRIPTION; SEQ ID NO:15:
Met Asp Asn Asn Pro Asn He Asn Glu <sup>1</sup>: . ' <sup>5</sup> (2) INFORMATION FOR SEQ ID NO: 16:.
(i), SEQUENCE CHARACTERISTICS:
(A) LENGTH; 11 amino acids /
(B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY:: linear .
(ii) MOLECULE TYPE: peptide.
(iii) HYPOTHETICAL: NO (v) FRAGMENT TYPE: N-terminal (vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis (ix) FEATURE:
(A) NAME/KEY: Peptide (B) LOCATION: 1.11 (D) OTHER INFORMATION: /note= N-terminal sequence from 60 kDa delta-endotoxin (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:
Met Asn Vai Leu Asn Ser Gly Arg Thr Thr He <sup>1</sup> 510;
(2) INFORMATION FOR SEQ ID NO:17: .
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2655 base pairs (B) TYPE: nucleic acid' (C) . STRANDEDNESS: single (D) TOPOLOGY: linear ־ .
(ii) MOLECULE TYPE: DNA (genomic) (iii). HYPOTHETICAL:' NO .
(iv) ANTI-SENSE: NO \ (ix) FEATURE:
(A) NAME/KEY: misc_feature <sup>!</sup> (B) LOCATION: 1.2652 (D) OTHER INFORMATION: /note= Maize optimized DNA sequence for 100 kd VIPlA(a) protein from AB78 (xi)' SEQUENCE DESCRIPTION: SEQ ID NO:17:
ATGAAGAACA TGAAGAAGAA GCTGGCCAGC GTGGTGACCT GCACCCTGCT GGCCCCCATG TTCCTGAACG GCAACGTGAA CGCCGTGTAC GCCGACAGCA AGACCAACCA GATCAGCACC ACCCAGAAGA ACCAGCAGAA GGAGATGGAC CGCAAGGGCC TGCTGGGCTA CTACTTCAAG
GGCAAGGACT TCAGCAACCT GACCATGTTC GCCCCCACGC GTGACAGCAC CCTGATCTAC 240
GACCAGCAGA GCGCCAACAA GCTGCTGGAC AAGAAGCAGC AGGAGTACCA GAGCATCCGC 300
TGGATCGGCC TGATCCAGAG CAAGGAGACC GGCGACTTCA CCTTCAACCT GAGCGAGGAC. 360
GAGCAGGCCA TCATCGAGAT CAACGGCAAG ATCATCAGCA ACAAGGGCAA GGAGAAGCAG 420
GTGGTGCACC TGGAGAAGGG CAAGCTGGTG CCCATCAAGA TCGAGTACCA GAGCGACACC480
AAGTTCAACA TCGACAGCAA GACCTTCAAG GAGCTGAAGC TTTTCAAGAT CGACAGCCAG540
AACCAGCCCC AGCAGGTGCA GCAGGACGAG CTGCGCAACC CCGAGTTCAA CAAGAAGGAG600
AGCCAGGAGT TCCTGGCCAA GCCCAGCAAG ATCAACCTGT TCACCCAGCA GATGAAGCGC660
GAGATCGACG AGGACACCGA CACCGACGGC GACAGCATCC CCGACCTGTG GGAGGAGAAC720.
GGCTACACCA TCCAGAACCG CATCGCCGTG AAGTGGGACG ACAGCCTGGC TAGCAAGGGC780
TACACCAAGT TCGTGAGCAA CCCCCTGGAG AGCCACACCG TGGGCGACCC CTACACCGAC840
TACGAGAAGG CCGCCCGCGA CCTGGACCTG AGCAACGCCA AGGAGACCTT CAACCCCCTG900
GTGGCCGCCT TCCCCAGCGT GAACGTGAGC ATGGAGAAGG TGATCCTGAG CCCCAACGAG 960
AACCTGAGCA ACAGCGTGGA GAGCCACTCG AGCACCAACT GGAGCTACAC CAACACCGAG1020
GGCGCCAGCG TGGAGGCCGG CATCGGTCCC AAGGGCATCA GCTTCGGCGT GAGCGTGAAC1080
TACCAGCACA GCGAGACCGT GGCCCAGGAG TGGGGCACCA GCACCGGCAA CACCAGCCAG1140
TTCAACACCG CCAGCGCCGG CTACCTGAAC GCCAACGTGC GCTACAACAA CGTGGGCACC1200
GGCGCCATCT ACGACGTGAA GCCCACCACC AGCTTCGTGC TGAACAACGA CACCATCGCC1260
ACCATCACCG CCAAGTCGAA TTCCACCGCC CTGAACATCA GCCCCGGCGA GAGCTACCCC1320
AAGAAGGGCC AGAACGGCAT CGCCATCACC AGCATGGACG ACTTCAACAG CCACCCCATC1380
ACCCTGAACA AGAAGCAGGT GGACAACCTG CTGAACAACA AGCCCATGAT GCTGGAGACC1440
AACCAGACCG ACGGCGTCTA CAAGATCAAG GACACCCACG GCAACATCGT GACCGGCGGC1500
GAGTGGAACG GCGTGATCCA GCAGATCAAG GCCAAGACCG CCAGCATCAT CGTCGACGAC1560
GGCGAGCGCG TGGCCGAGAA GCGCGTGGCC GCCAAGGACT ACGAGAACCC CGAGGACAAG . 1620 ACCCCCAGCC TGACCCTGAA GGACGCCCTG AAGCTGAGCT ACCCCGACGA GATCAAGGAG1680־
ATCGAGGGCC TGCTGTACTA CAAGAACAAG CCCATCTACG AGAGCAGCGT GATGACCTAT1740
CTAGACGAGA ACACGGCCAA GGAGGTGACC AAGCAGCTGA ACGACACCAC CGGCAAGTTC1800
AAGGACGTGA GCCACCTGTA CGACGTGAAG CTGACCCCCA AGATGAACGT GACCATCAAG I860 '
115.Π 2 / 3
CTGAGCATCC TGTACGACAA CGCCGAGAGC AACGACAACA GCATCGGCAA GTGGACCAAC 1920
ACCAACATCG TGAGCGGCGG CAACAACGGC aagaagcagt acagcagcaa caaccccgac1980
GCCAACCTGA CCCTGAACAC CGACGCCCAG GAGAAGCTGA ACAAGAACCG CGACTACTAC <sup>!</sup>2040
ATCAGCCTGT ACATGAAGAG CGAGAAGAAC ACCCAGTGCG AGATCACCAT. CGACGGCGAG2100
ATATACCCCA TCACCACCAA GACCGTGAAC GTGAACAAGG ACAACTACAA GCGCCTGGAC2160
ATCATCGCCC ACAACATCAA GAGCAACCCC ATCAGCAGCC TGCACATCAA GACCAACGAC2220
GAGATCACCC TGTTCTGGGA CGACATATCG ATTACCGACG TCGCCAGCAT CAAGCCCGAG2280
AACCTGACCG ACAGCGAGAT CAAGCAGATA TACAGTCGCT ACGGCATCAA GCTGGAGGAC.2340
GGCATCCTGA TCGACAAGAA GGGCGGCATC CACTACGGCG AGTTCATCAA CGAGGCCAGC2400
TTCAACATCG AGCCCCTGCA GAACTACGTG ACCAAGTACG AGGTGACCTA CAGCAGCGAG2460
CTGGGCCCCA ACGTGAGCGA CACCCTGGAG AGCGACAAGA TTTACAAGGA CGGCACCATC2520
AAGTTCGACT TCACCAAGTA CAGCAAGAAC GAGCAGGGCC TGTTCTACGA CAGCGGCCTG2580
AACTGGGACT TCAAGATCAA CGCCATCACC TACGACGGCA AGGAGATGAA CGTGTTCCAC2640.
CGCTACAACA AGTAG . . '2655 (2) INFORMATION FOR SEQ ID NO:18:
.(i) SEQUENCE CHARACTERISTICS:' (A) LENGTH: 2004 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single.
(D) TOPOLOGY: linear (it) MOLECULE TYPE: DNA (genomic) . (iii). HYPOTHETICAL: NO (iv) . ANTI-SENSE :' NO (ix) FEATURE: .
(A) NAME/KEY: misc_feature (B) LOCATION: 1.2004 (D) OTHER INFORMATION: /note= Maize optimized DNA sequence for VIPlA(a) 80 kd<sup>:</sup> protein from AB78 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:
ATGAAGCGCG AGATCGACGA GGACACCGAC ACCGACGGCG ACAGCATCCC CGACCTGTGG . -137 GAGGAGAACG GCTACACCAT CCAGAACCGC ATCGCCGTGA AGTGGGACGA CAGCCTGGCT 120
AGCAAGGGCT ACACCAAGTT. CGTGAGCAAC CCCCTGGAGA GCCACACCGT GGGCGACCCC 180 . TACACCGACT ACGAGAAGGC CGCCCGCGAC CTGGACCTGA GCAACGCCAA GGAGACCTTC 240
I AACCCCCTGG TGGCCGCCTT CCCCAGCGTG AACGTGAGCA TGGAGAAGGT. GATCCTGAGC 300
I CCCAACGAGA ACCTGAGCAA CAGCGTGGAG AGCCACTCGA GCACCAACTG GAGCTACACC 360
I AACACCGAGG GCGCCAGCGT GGAGGCCGGC ATCGGTCCCA AGGGCATCAG CTTCGGCGTG420
AGCGTGAACT ACCAGCACAG CGAGACCGTG GCCCAGGAGT GGGGCACCAG CACCGGCAAC480
ACCAGCCAGT TCAACACCGC CAGCGCCGGC TACCTGAACG CCAACGTGCG CTACAACAAC540
GTGGGCACCG GCGCCATCTA CGACGTGAAG CCCACCACCA GCTTCGTGCT GAACAACGAC600
ACCATCGCCA CCATCACCGC CAAGTCGAAT TCCACCGCCC TGAACATCAG CCCCGGCGAG660
AGCTACCCCA AGAAGGGCCA GAACGGCATC ,GCCATCACCA GCATGGACGA CTTCAACAGC720 . I CACCCCATCA CCCl'GAACAA GAAGCAGGTG GACAACCTGC TGAACAACAA GCCCATGATG780 נ־וגץ CTGGAGACCA accagaccga cggcgtctac aagatcaagg acacccacgg caacatcgtg840
ACCGGCGGCG AGTGGAACGG CGTGATCCAG CAGATCAAGG CCAAGACCGC CAGCATCATC 900
I GTCGACGACG GCGAGCGCGT GGCCGAGAAG CGCGTGGCCG CCAAGGACTA CGAGAACCCC960
I GAGGACAAGA CCCCCAGCCT GAQCCTGAAG GACGCCCTGA AGCTGAGCTA CCCCGACGAG1020
ATCAAGGAGA TCGAGGGCCT GCTGTACTAC AAGAACAAGC CCATCTACGA GAGCAGCGTG1080
ATGACCTATC TAGACGAGAA CACCGCCAAG GAGGTGACCA. AGCAGCTGAA CGACACCACC1140
I GGCAAGTTCA AGGACGTGAG CCACCTGTAC GACGTGAAGC TGACCCCCAA GATGAACGTG1200
I ACCATCAAGC TGAGCATCCT GTACGACAAC GCCGAGAGCA ACGACAACAG CATCGGCAAG1260
I TGGACCAACA CCAACATCGT GAGCGGCGGC AACAACGGCA AGAAGCAGTA CAGCAGCAAC1320
I AACCCCGACG CCAACCTGAC CCTGAACACC GACGCCCAGG AGAAGCTGAA CAAGAACCGC1380
I GACTACTACA TCAGCCTGTA CATGAAGAGC GAGAAGAACA CCCAGTGCGA GATCACCATC1440
GACGGCGAGA TATACCCCAT CACCACCAAG ACCGTGAACG TGAACAAGGA CAACTACAAG1500
CGCCTGGACA TCATCGCCCA CAACATCAAG AGCAACCCCA TCAGCAGCCT GCACATCAAG1560
ACCAACGACG AGATCACCCT GTTCTGGGAC GACATATCGA TTACCGACGT CGCCAGCATC 1620
AAGCCCGAGA ACCTGACCGA CAGCGAGATC AAGCAGATAT ACAGTCGCTA CGGCATCAAG1680
I CTGGAGGACG GCATCCTGAT CGACAAGAAG GGCGGCATCC ACTACGGCGA GTTCATCAAC1740
3 / 2 ρ ד יי 11
GAGGCCAGCT TCAACATCGA GCCCCTGCAG AACTACGTGA CCAAGTACGA GGTGACCTAC 1800
21. «5
AGCAGCGAGC .TGGGOCCCAA CGTGAGCGAC
GGCACCATCA AGTTCGACTT CACCAAGTAC
AGCGGCCTGA ACTGGGACTT CAAGATCAAC
ACCCTGGAGA GCGACAAGAT TTACAAGGAC
AGCAAGAACG AGCAGGGCCT GTTCTACGAC
GCCATCACCT ACGACGGCAA GGAGATGAAC .I860
1920
1980
GTGTTCCACC GCTACAACAA GTAG (2) INFORMATION FOR SEQ ID NO :19:
,2004
5.6.95 (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 4074 base pairs.
(B) TYPE: nucleic acid (C) :STRANDEDNESS: single (D) TOPOLOGY: linear .
(ii) MOLECULE TYPE: DNA' (genomic) (ix) FEATURE:. . ;
(A) NAME/KEY: CDS (B) LOCATION. 1. .1386 (D) OTHER INFORMATION: /product- VTP2A(b) from Btt (ix) FEATURE:
(A) NAME/KEY: CDS (B) LOCATION: 1394.3895 (D) OTHER INFORMATION: /product־ VIPlA(b) from Btt .
(ix) FEATURE: ' ־' (A) NAME/KEY: misc_feature (B) LOCATION: 1.4074 (D) OTHER INFORMATION: /note= Cloned DNA sequence from Btt which contains the genes for both VIPlA(t)) and VIP2A(b)<sup>״</sup> (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19;
ATG CAA AGA ATG GAG GGA AAG TTG TTT GTG GTG TCA AAA ACA TTA CAA
Met Gin Arg Met Glu Gly Lys Leu Phe Vai Vai Ser Lys Thr Leu - Gin . . . / <sup>670</sup> ' '.'. 675' 680
GTA GTT ACT AGA ACT GTA TTG CTT AGT ACA GTT TAC TCT ATA ACT TTA
Vai Vai Thr Arg Thr Vai Leu Leu Ser Thr Vai Tyr Ser He Thr Leu
685 690 ’695
TTA AAT AAT GTA GTG ATA AAA GCT GAC CAA TTA AAT ATA AAT TCTCAA
Leu Ash Asn Vai Vai He Lys Ala Asp Gin Leu Asn lie Asn SerGin <sup>700</sup> . 705 710 .715
AGT AAA TAT ACT AAC TTG CAA AAT CTA. AAA ATC CCT GAT' AAT GCA GAG
Ser Lys Tyr Thr Asn Leu Gin Asn Leu Lys He Pro Asp Asn Ala Glu
<img file="IL115382A_D0004.tif" />
־ 139720
5.6,15
<td> GAT TTT AAA</td><td> GAA GAT</td><td> AAG GGG</td><td colspan="3"> AAA GCG AAA GAA TGG GGG AAA GAG AAA</td>
<td> Asp Phe Lys</td><td rowspan="2"> Glu Asp 735</td><td> Lys Gly</td><td rowspan="2"> Lys Ala .740</td><td> Lys Glu Trp Gly Lys Glu</td><td rowspan="2"> Lys</td>
<td></td><td></td><td> . 745</td>
<td> GGG GAA GAG</td><td> TGG AGG</td><td> CCT CCT</td><td> GCT ACT</td><td> GAG AAA GGA GAA’ ATG AAT</td><td> AAT</td>
<td> Gly Glu Glu 750</td><td> Trp Arg</td><td> Pro Pro</td><td> Ala Thr 755 <sub>:</sub></td><td> Glu Lys Gly Glu Met Asn 760</td><td> Asn</td>
<td> TTT TTA GAT</td><td> AAT AAA</td><td> AAT GAT</td><td> ATA AAG</td><td> ACC AAT TAT AAA GAA ATT</td><td> ACT</td>
<td> Phe Leu Asp 765</td><td> Asn Lys</td><td> Asn Asp 770</td><td> lie Lys</td><td> Thr Asn Tyr Lys Glu lie 775</td><td> Thr</td>
<td> TTT TCT ATG</td><td> GCA GGT</td><td colspan="2"> TCA TGT GAA GAT</td><td> GAA ATA AAA GAT TTA GAA</td><td> GM</td>
<td> Phe Ser Met 780</td><td> Ala Gly</td><td> Ser Cys 785</td><td> Glu Asp</td><td> Glu He Lys Asp Leu Glu 790.</td><td> Glu 795</td>
<td> ATT GAT AAG</td><td> ATC TTT</td><td> GAT AAA</td><td> GCC AAT</td><td> CTC TCG AGT TCT ATT ATC</td><td> ACC</td>
<td> He Asp Lys</td><td> He Phe 800</td><td> Asp Lys</td><td> Ala Asn</td><td> Leu Ser Ser Ser lie He 805 810</td><td> Thr</td>
<td> TAT/AAA AAT</td><td> GTG GAA</td><td> CCA GCA</td><td> ACA ATT</td><td colspan="2"> GGA TTT AAT AAA TCT TTA ACA</td>
<td> Tyr Lys Asn</td><td> Vai Glu' 815</td><td> Pro Ala</td><td> Thr lie 820</td><td> Gly Phe Asn Lys Ser Leu 825</td><td> Thr</td>
<td> GAA GGT AAT</td><td> ACG ATT</td><td> AAT TCT</td><td> GAT GCA</td><td> ATG GCA CAG TTT AAA GAA</td><td> CM</td>
<td> Glu Gly Asn 830</td><td> Thr He</td><td> Asn Ser</td><td> Asp Ala 835</td><td> Met Ala Gin Phe Lys Glu 840</td><td> Gin</td>
<td> TTT TTA GGT</td><td> AAG GAT</td><td> ATG AAG</td><td> TTT GAT</td><td> AGT TAT CTA GAT ACT CAT</td><td> TTA</td>
<td> Phe Leu Gly 845</td><td> Lys . Asp</td><td> Met Lys 850</td><td> Phe Asp</td><td> Ser Tyr Leu Asp Thr His 855</td><td> Leu</td>
<td> ACT GCT CM</td><td> CAA GTT</td><td> TCC AGT</td><td> AAA AAA</td><td> AGA GTT ATT TTG AAG GTT</td><td> ACG</td>
<td> Thr Ala Gin 860 '</td><td> Gin Vai</td><td> Ser Ser 865</td><td> Lys Lys</td><td> Arg Vai He Leu Lys. Vai 870</td><td> Thr 875</td>
<td> GTT CCG AGT</td><td> GGG AAA</td><td> GGT TCT</td><td> ACT ACT</td><td> CCA ACA AAA GCA GGT GTC</td><td> ATT</td>
<td> Vai Pro Ser</td><td> Gly Lys 880</td><td> Gly Ser</td><td> Thr Thr.</td><td> Pro Thr Lys Ala Gly Vai 885 : 890</td><td> He</td>
<td> TTA AAC AAT</td><td> AAT GAA</td><td> TAC AAA</td><td> ATG CTC</td><td> ATT GAT AAT' GGG TAT GTG</td><td> CTC</td>
<td> Leu Asn Asn</td><td> Asn Glu 895</td><td> Tyr Lys</td><td> Met Leu 900</td><td> He Asp׳ Asn Gly Tyr Vai 905</td><td> Leu</td>
<td> CAT GTA GAT</td><td> AAG GTA</td><td> TCA AAA</td><td> GTA GTA</td><td> AAA AAA GGG ATG GAG TGC</td><td> TTA</td>
<td> His Vai Asp . 910</td><td> Lys Vai</td><td> Ser Lys</td><td> Vai Vai 915</td><td> Lys Lys Gly Met Glu Cys 920</td><td> Leu</td>
<td> CAA GTT GAA</td><td> GGG ACT</td><td> TTA AAA</td><td> AAG AGT</td><td> CTC GAC TTT AAA AAT GAT</td><td> ATA</td>
<td> Gin Vai Glu 925'</td><td> Gly Thr</td><td> Leu Lys '930</td><td> Lys Ser</td><td colspan="2"> Leu Asp Phe Lys Asn Asp He 935</td>
<td> AAT GCT GM</td><td> GCG CAT</td><td> AGC TGG</td><td> GGG ATG</td><td> AAA ATT TAT GAA GAC TGG</td><td> GCT</td>
76־5
<td rowspan="2"> Asn Ala 940</td><td colspan="3"> Glu Ala His Ser Trp Gly Met Lys He Tyr Glu Asp Trp Ala</td>
<td> 945</td><td> 950'</td><td> 955</td>
<td> AAA AAT</td><td> TTA ACC,GCT TCG CAA</td><td> AGG GAA GCT TTA GAT</td><td> GGG TAT GCT AGG 912</td>
<td> Lys Asn</td><td> Leu Thr Ala Ser Gin</td><td> Arg Glu Ala Leu Asp</td><td> Gly Tyr Ala Arg</td>
<td> J</td><td> . 960</td><td> 965</td><td> 970</td>
<td> . CAA GAT</td><td> TAT. AAA GAA ATC AAT</td><td> AAT TAT TTG CGC AAT</td><td> CAA GGC GGG AGT 960</td>
<td> Gin Asp</td><td> Tyr Lys Glu He Asn</td><td> Asn Tyr Leu Arg Asn</td><td> Gin Gly Gly Ser</td>
<td></td><td> 975</td><td> 980</td><td> 985</td>
<td> GGA AAT</td><td> GAA AAG CTG GAT.GCC</td><td> CAA TTA AAA AAT ATT</td><td> TCT GAT GCT TTA 1008</td>
<td> Gly Asn</td><td> Glu Lys Leu Asp Ala</td><td> Gin Leu Lys Asn He</td><td> Ser Asp Ala Leu</td>
<td></td><td> 990</td><td> 995</td><td> 1000 . .</td>
<td> GGG AAG</td><td> AAA CCC ATA CCA GAA</td><td> AAT ATT ACC GTG' TAT</td><td> AGA TGG TGT GGC 1056</td>
<td> Gly Lys</td><td> Lys Pro lie Pro ,Glu</td><td colspan="2"> Asn He Thr Val Tyr Arg Trp Cys Gly</td>
<td colspan="4"> 1005 1010 1015</td>
<td> ATG CCG</td><td> GAA TTT GGT TAT CAA</td><td> ATT AGT GAT CCG TTA</td><td> CCT TCT TTA AAA 1104</td>
<td> Met Pro</td><td> Glu Phe Gly Tyr Gin</td><td> lie Ser Asp Pro Leu</td><td> Pro Ser Leu Lys</td>
<td> 1020</td><td> 1025</td><td> 1030</td><td> . 1035</td>
<td> GAT TTT</td><td> GAA GAA CAA TTT TTA</td><td> AAT ACA ATT AAA GAA</td><td> GAC AAA GGG TAT 1152</td>
<td> Asp Phe</td><td> Glu Glu Gin Phe Leu</td><td> Asn Thr He Lys Glu</td><td> Asp Lys Gly Tyr</td>
<td></td><td> 1040</td><td> 1045</td><td> 1050</td>
<td> ATG AGT</td><td> ACA AGC TTA TCG AGT</td><td> GAA CGT CTT GCA GCT</td><td> TTT GGA TCT AGA 1200</td>
<td> Met Ser</td><td> Thr Ser Leu Ser Ser</td><td> Glu Arg Leu Ala Ala</td><td> Phe Gly Ser Arg</td>
<td></td><td> 1055</td><td> 1060</td><td> 1065</td>
<td> AAA ATT</td><td> ATA TTA CGC. TTA CAA</td><td> GTT CCG AAA GGA AGT</td><td> ACG GGG GCG TAT 1248</td>
<td> Lys. lie</td><td> lie Leu Arg Leu Gin</td><td> Val Pro Lys Gly Ser</td><td> Thr Gly Ala Tyr</td>
<td></td><td> 1070</td><td> 1075</td><td> 1080</td>
<td> TTA AGT</td><td> GCC ATT GGT GGA TTT</td><td> GCA AGT GAA AAA GAG</td><td> ATC CTA CTT GAT 1296</td>
<td> Leu Ser</td><td> Ala He Gly Gly Phe</td><td> Ala Ser Glu Lys Glu</td><td> He Leu Leu Asp</td>
<td colspan="4"> 1085 1090 . 1095</td>
<td> AAA GAT</td><td> AGT AAA TAT.CAT ATT</td><td> GAT AAA GCA ACA GAG</td><td> GTA ATC ATT AAA 1344</td>
<td> Lys Asp</td><td> Ser Lys Tyr His lie</td><td> Asp Lys Ala Thr Glu</td><td> Val He lie Lys</td>
<td> : 1100 .</td><td> 1105</td><td> ' 1110 .</td><td> 1115 .</td>
<td> GGT GTT</td><td> AAG CGA TAT GTA GTG</td><td> GAT GCA ACA TTA TTA</td><td> ACA AAT 1386</td>
<td> Gly Val</td><td> Lys Arg Tyr Val Val</td><td> Asp Ala Thr Leu Leu</td><td> Thr Asn .</td>
<td></td><td> 1120</td><td> .1125</td><td></td>
<td> TAAGGAG</td><td> ATG AAA AAT ATG AAG</td><td> AAA AAG TTA GCA AGT.</td><td> GTT GTA ACC TGT 1435</td>
<td></td><td> Met Lys Asn Met Lys</td><td> Lys Lys Leu Ala Ser</td><td> Val Val Thr Cys</td>
<td></td><td> 1 5</td><td> 10</td><td></td>
<td> ATG TTA</td><td> TTA GCT CCT ATG TTT</td><td> TTG AAT GGA AAT GTG</td><td> AAT GCT GTT AAC 1483</td>
<td> Met Leu</td><td> Leu Ala Pro Met Phe</td><td> Leu Asn Gly Asn Val</td><td> Asn Ala Val Asn</td>
<td> 15</td><td> 20,</td><td> 25</td><td> 30</td>
Λ
GCG GAT AGT AAA ATA AAT CAG ATT TCT ACA ACG CAG GAA AAC CAA CAG
Ala Asp Ser Lys He Asn Gin He Ser Thr Thr Gin Glu Asn Gin Gin . 40 45
AAA GAG ATG GAC CGA AAG GGA TTA TTG GGA TAT TAT TTC AAA GGA AAA
Lys Glu Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys GlyLys
5560
GAT TTT AAT AAT CTT ACT ATG TTT GCA CCG ACA CGT GAT AAT ACCCTT
Asp Phe Asn Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Asn ThrLeu . 7075
ATG TAT GAC CAA CAA ACA GCG AAT GCA TTA TTA GAT AAA AAA CAACAA
Met Tyr Asp Gin Gin Thr Ala Asn Ala Leu Leu Asp Lys Lys GinGin
8590
GAA TAT CAG TCC ATT CGT TGG ATT GGT TTG ATT CAG CGT AAA GAAACG
Glu Tyr Gin Ser He Arg Trp lie Gly Leu lie Gin Arg Lys GluThr
100 105110
GGC GAT TTC ACA TTT AAC TTA TCA AAG GAT GAA CAG GCA ATT ATAGAA
Gly Asp Phe Thr Phe Asn Leu Ser Lys Asp Glu Gin Ala He HeGlu
115 120125
ATC GAT GGG AAA ATC ATT TCT AAT AAA GGG AAA GAA AAG CAA GTTGTC lie Asp Gly Lys He lie Ser Asn Lys Gly Lys Glu Lys Gin VaiVai
130 135140 '
CAT TTA GAA AAA GAA AAA TTA GTT CCA ATC AAA ATA GAG TAT CAATCA
His Leu Glu Lys Glu Lys Leu Vai Pro He Lys lie Glu Tyr GinSer
145 150155
GAT ACG AAA TTT AAT ATT.GAT AGT AAA ACA TTT AAA GAA CTT AAATTA
Asp Thr Lys Phe Asn He Asp Ser Lys Thr Phe Lys Glu Leu LysLeu
160 165170
TTT AAA ATA GAT AGT CAA AAC CAA TCT CAA CAA GTT CAA CTG AGAAAC
Phe Lys He Asp Ser Gin Asn Gin Ser Gin Gin Vai Gin Leu ArgAsn
175 180 185.190
CCT GAA TTT AAC AAA AAA GAA TCA CAG GAA TTT TTA GCA AAA GCATCA
Pro Glu Phe Asn Lys Lys Glu Ser Gin Glu Phe Leu Ala Lys AlaSer ' 195 . 200.205
AAA ACA AAC CTT TTT AAG CAA AAA ATG AAA AGA GAT ATT GAT GAAGAT
Lys Thr. Asn Leu Phe Lys Gin Lys Met Lys. Arg Asp He Asp GluAsp ’ 210 '215220 '
ACG GAT ACA GAT GGA GAC TCC ATT CCT GAT CTT TGG GAA GAA AAT.GGG
Thr Asp Thr Asp Gly Asp Ser lie Pro Asp Leu Trp Glu Glu AsnGly
225 230235.
TAC ACG ATT CAA AAT AAA GTT GCT GTC AAA TGG GAT GAT TCG CTAGCA
Tyr Thr lie Gin Asn Lys Vai Ala Vai Lys Trp Asp Asp Ser LeuAla
v. 240 245250
1531
1579
1627
1675
1723
1771
1819
1867
1915
1963
2011
2059
2107
2155
<td rowspan="3"></td><td rowspan="3"> AGT AAG Ser Lys ־ , 255</td><td colspan="3"> GGA TAT ACA AAA TTT GTT TCG AAT CCA TTA GAC AGC CAC ACA</td><td rowspan="3"> 2203</td>
<td> Gly Tyr Thr Lys</td><td rowspan="2"> Phe Vai Ser Asn</td><td> Pro Leu Asp Ser His Thr .</td>
<td> 260</td><td> 265 270</td>
<td></td><td> GTT GGC Vai Gly</td><td> GAT CCC TAT ACT Asp Pro Tyr Thr 275</td><td> GAT TAT GAA AAG Asp Tyr Glu Lys 280</td><td> GCC GCA AGG GAT TTA GAT Ala Ala Arg Asp Leu Asp 285</td><td> 2251</td>
<td></td><td> TTA TCA Leu Ser (I</td><td> AAT GCA AAG GAA Asn Ala Lys Glu 290</td><td> ACG TTC AAC CCA Thr Phe Asn Pro 295</td><td> TTG GTA GCT GCT TTT CCA Leu Vai Ala Ala Phe Pro 300</td><td> 2299</td>
<td></td><td> .' AGT GTG Ser Vai</td><td> AAT GTT AGT ATG Asn Vai Ser Met 305</td><td> GAA AAG GTG ATA Glu Lys Vai He 310</td><td> TTA TCA CCA AAT GAA AAT Leu Ser Pro Asn Glu Asn 315</td><td> . 2347</td>
<td></td><td> TTA TCC Leu Ser 320</td><td> AAT AGT GTA GAG Asn Ser Vai Glu</td><td> TCT CAT TCA TCC Ser His Ser Ser 325</td><td> ACG AAT TGG'TCT TAT ACG Thr Asn Trp Ser Tyr Thr 330</td><td> 2395</td>
<td></td><td> AAT ACA Asn Thr 335</td><td> GAA GGA GCT TCC Glu Gly Ala Ser 340</td><td> ATT GAA GCT GGT He Glu Ala Gly</td><td> GGC GGT CCA TTA GGC CTT Gly Gly Pro Leu Gly Leu 345 350</td><td> 2443</td>
<td> 5.6.¾</td><td> TCT TTT Ser Phe</td><td> GGC GTG AGT GTT Gly Vai Ser Vai 355</td><td> ACT TAT CAA CAC Thr Tyr Gin His 360</td><td> TCT GAA ACA GTT GCA CAA Ser Glu Thr Vai Ala Gin 365</td><td> 2491</td>
<td></td><td> GAA TGG Glu Trp</td><td> GGA ACA TCT ACA Gly Thr Ser Thr 370</td><td> GGA AAT ACT TCA Gly Asn Thr Ser . 375</td><td> CAA TTC AAT ACG GCT TCA Gin Phe Asn Thr Ala Ser . 380</td><td> 2539</td>
<td></td><td> GCG GGA Ala Gly</td><td> TAT TTA AAT GCA Tyr Leu Asn Ala 385 .</td><td> AAT GTT CGG TAT Asn Vai Arg Tyr 390</td><td> AAC AAT GTA GGG ACT GGT ' Asn Asn Vai Gly Thr Gly 395</td><td> 2587</td>
<td></td><td> GCC ATC Ala He <sup>400</sup></td><td> TAT GAT GTA AAA Tyr Asp Vai Lys</td><td> CCT ACA ACA AGT Pro Thr Thr Ser 405</td><td> TTT GTA TTA AAT AAC AAT Phe Vai Leu Asn Asn Asn 410</td><td> '.. 2635</td>
<td></td><td> ACC ATC . Thr He 415</td><td> GCA ACG ATT ACA Ala Thr lie Thr 420</td><td> GCA AAA TCA AAT Ala Lys Ser Ash</td><td> TCA ACA GCT TTA CGT ATA Ser Thr Ala Leu Arg lie 425 430</td><td> 2683</td>
<td></td><td> TCT CCG Ser Pro.</td><td> GGG GAT AGT TAT Gly Asp Ser. Tyr 435</td><td> CCA GAA ATA GGA Pro Glu He Gly ' 440</td><td> GAA AAC GCT ATT GCG ATT Glu Asn Ala He Ala lie 445</td><td> 2731.</td>
<td></td><td> ACA TCT Thr Ser</td><td> ATG GAT GAT TTT Met Asp Asp Phe 450</td><td> AAT TCT CAT CCA Asn Ser His Pro 455</td><td> ATT ACA TTA AAT AAA.CAA lie Thr Leu Asn Lys Gin 460</td><td> 2779</td>
<td> <</td><td> CAG GTA Gin Vai</td><td> AAT CAA TTG ATA Asn Gin Leu lie</td><td> AAT AAT AAG CCA Asn Asn Lys Pro</td><td> ATT ATG CTA. GAG ACA GAC lie.Met Leu Glu Thr Asp</td><td> 2827</td>
51.¢
<td></td><td>-</td><td> 115382/2</td>
<td> CAA</td><td> 465 470 ACA GAT GGT GTT TAT AAA ATA AGA.GAT ACA</td><td> :<sup>475</sup> CAT GGA AAT ATT GTA 2875</td>
<td> Gin</td><td> Thr Asp Gly Val Tyr Lys He Arg Asp Thr</td><td> His Gly Asn lie Val</td>
<td> ACT</td><td> 480 485 GGT GGA GAA TGG AAT GGT GTA ACA CAA CAA</td><td> 490 . ATT AAA GCA AAA ACA 2923</td>
<td> Thr</td><td> Gly Gly Glu Trp Asn Gly Val Thr Gin Gin</td><td> lie Lys Ala Lys Thr</td>
<td> 495 GCG</td><td> 500 505 TCT ATT ATT GTG GAT GAC GGG.AAA CAG GTA</td><td> 510 GCA GAA AAA CGT GTG 2971</td>
<td> Ala</td><td> Ser He He Val Asp Asp Gly Lys Gin Val</td><td> Ala Glu Lys Arg Val</td>
<td> GCG</td><td> 515 520 GCA AAA GAT TAT GGT CAT CCA GAA GAT AAA</td><td> 525 ACA CCA CCT TTA ACT 3019</td>
<td> Ala</td><td> Ala Lys Asp Tyr Gly His Pro Glu Asp Lys</td><td> Thr Pro Pro Leu Thr</td>
<td> TTA</td><td> 530 535 AAA GAT ACC CTG AAG CTT. TCA TAC CCA GAT</td><td> 540 . ' GAA .ATA. AAA GAA ACT 3067</td>
<td> Leu</td><td> Lys Asp Thr Leu Lys Leu Ser Tyr Pro Asp</td><td> Glu Tie Lys Glu Thr</td>
<td> AAT</td><td> 545 550 GGA TTG TTG TAC TAT GAT GAC AAA CCA ATC</td><td> 555 TAT GAA TCG AGT GTC 3115</td>
<td> Asn</td><td colspan="2"> Gly Leu Leu Tyr Tyr Asp Asp Lys Pro lie Tyr Glu Ser Ser Val</td>
<td> ATG</td><td> 560 . 565 ACT TAT CTG GAT GAA AAT ACG GCA AAA GAA</td><td> 570 GTC AAA AAA CAA ATA 3163</td>
<td> Met</td><td> Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu</td><td> Val Lys Lys Gin He</td>
<td> 575 AAT</td><td> 580 585 GAT ACA ACC GGA AAA TTT AAG GAT GTA AAT</td><td> 590. CAC TTA TAT GAT GTA 3211</td>
<td> Asn</td><td> Asp Thr Thr Gly Lys Phe Lys Asp Val Asn</td><td> His Leu Tyr Asp Val</td>
<td> AAA</td><td> 595 600 CTG ACT CCA AAA ATG AAT TTT ACG ATT AAA</td><td> 605 ATG GCT TCC TTG TAT 3259</td>
<td> Lys</td><td> Leu Thr Pro Lys Met Asn Phe Thr lie Lys</td><td> Met Ala Ser Leu Tyr </td>
<td> GAT</td><td> '610 ., 615 GGG GCT GAA AAT AAT CAT AAC TCT TTA GGA</td><td> 620 . ACC TGG TAT TTA ACA 3307</td>
<td> Asp</td><td> Gly Ala Glu Asn Asn His Asn Ser Leu Gly</td><td> Thr Trp Tyr Leu Thr</td>
<td> TAT</td><td> ' 625 630 AAT GTT GCT GGT GGA AAT ACT GGG AAG AGA</td><td> 635 CAA TAT CGT TCA GCT . 3355</td>
<td> Tyr</td><td> Asn Val Ala Gly Gly Asn Thr Gly Lys Arg</td><td> Gin Tyr Arg Ser Ala</td>
<td> CAT</td><td> 640 645 TCT TGT GCA CAT GTA GCT CTA TCT TCA GAA</td><td><sup>650</sup> GCG AAA. AAG AAA CTA /. 3403 '</td>
<td> His</td><td> Ser Cys Ala His Val Ala. Leu Ser Ser Glu</td><td> Ala Lys Lys Lys Leu</td>
<td> 655 AAT</td><td> 660 665 CAA AAT GCG AAT TAC TAT CTT AGC ATG TAT</td><td> 670 ATG AAG GCT GAT TCT 3451</td>
<td> Asn</td><td> Gin Asn Ala Asn Tyr Tyr Leu Ser Met Tyr</td><td> Met Lys Ala Asp Ser</td>
<td> ACT</td><td> 675 680 ACG GAA CCT ACA ATA GAA GTA GCT GGG GAA</td><td> 685 AAA TCT GCA ATA ACA 3499</td>
Thr Thr Glu Pro Thr He Glu Vai Ala Gly Glu Lys Ser Ala He Thr 690 . 695 . 700,
AGT AAA AAA GTA AAA TTA AAT AAT CAA AAT TAT CAA AGA GTT GATATT
Ser Lys Lys Vai Lys Leu Asn Asn Gin Asn Tyr Gin Arg Vai Asplie
705 710715
TTA GTG AAA AAT TCT GAA AGA AAT CCA ATG GAT AAA ATA TAT ATAAGA
Leu Vai Lys Asn Ser Glu Arg Asn Pro Met Asp Lys He Tyr HeArg
720 725730
GGA AAT .GGC ACG ACA AAT GTT TAT GGG GAT GAT GTT ACT ATC CCAGAG
Gly Asn Gly Thr Thr Asn Vai Tyr Gly Asp Asp Vai Thr He ProGlu
735 740 / 745 .750
GTA TCA GCT ATA AAT CCG GCT AGT CTA TCA GAT GAA' GAA ATT CAAGAA
Vai Ser Ala He Asn Pro Ala Ser Leu Ser Asp Glu Glu He GinGlu
755 760 -765
ATA TTT AAA GAC TCA . ACT ATT GAA TAT GGA AAT CCT AGT TTC GTTGCT
He Phe Lys Asp Ser Thr He Glu Tyr Gly Asn Pro Ser Phe VaiAla
770 775780
GAT GCC GTA ACA TTT AAA AAT ATA AAA CCT TTA CAA AAT TAT GTA׳ AAG
Asp Ala Val Thr Phe Lys Asn He Lys Pro Leu Gin Asn Tyr Vai Lys '785 790795
GAA TAT GAA ATA TAT CAT AAA TCT CAT CGA TAT GAA AAG AAA ACG GTC
Glu Tyr Glu He Tyr His Lys Ser His Arg Tyr Glu Lys Lys Thr Val
800 805810
TTT GAT ATC ATG GGT GTT CAT TAT GAG. TAT AGT ATA GCT AGG GAA CAA
Phe Asp lie Met Gly Val His Tyr Glu Tyr Ser lie Ala Arg Glu Gin
815 820 825830
AAG AAA GCC GCA TAATTTTAAA AATAAAACTC GTTAGAGTTT ATTTAGCATG
Lys Lys Ala Ala
GTATTTTTAA GAATAATCAA TATGTTGAAC CGTTTGTAGC TGTTTTGGAA GGGAATTTCA . TTTTATTTGG TCTCTTAAGT TGATGGGCAT GGGATATGTT CAGCATCCAA GCGTTTNGGG
GGTTANAAAA TCCAATTTT (2) INFORMATION FOR SEQ ID NO:20:.
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH:.462 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear, (ii) MOLECULE TYPE: protein
. ׳,3547
3595
3643
3691
3739
3787
3835
3883
3935
3995
4055
4074
’.= 1 1 5 3 82 /2 (xi) SEQUENCE DESCRIPTION; SEQ ID NO:20:
Met Gin Arg Met Glu Gly Lys Leu Phe Vai Vai Ser Lys Thr Leu Gin
י. 15 . 10 ' 51 ..
Vai 'Vai Thr Arg Thr Vai Leu Lei! Ser Thr Vai Tyr Ser He Thr Leu 20 2530
Leu Asn Asn Vai Vai lie Lys Ala Asp Gin Leu Asn lie Ash Ser Gin . 35 4045
Ser Lys Tyr Thr Asn Leu Gin Asn Leu . Lys He Pro Asp Asn Ala Glu 50 ' 5560
Asp Phe Lys Glu Asp Lys Gly Lys Ala Lys Glu Trp Gly Lys Glu Lys 65 . 70 . 7580
Gly Glu Glu Trp . Arg Pro Pro Ala Thr Glu Lys Gly Glu Met Asn Asn .85 9095
Phe Leu Asp Asn Lys Asn Asp He Lys Thr Asn Tyr Lys Glu He Thr 100 105110
Phe Ser Met Ala Gly Ser Cys Glu Asp Glu lie Lys Asp Leu Glu Glu 115 120125
He Asp Lys He Phe Asp Lys Ala Asn Leu Ser Ser Ser He He Thr 130 135 .140
Tyr Lys Asn Vai Glu Pro Ala Thr lie Gly Phe. Asn Lys Ser LeuThr
145 150 155160
Glu Gly Asn Thr He Asn Ser Asp . Ala Met Ala Gin Phe Lys GluGin
165 170. 175
Phe Leu Gly Lys Asp Met Lys Phe Asp Ser Tyr Leu Asp Thr His Leu 180 . 185.190
Thr Ala Gin Gin Vai Ser Ser. Lys Lys Arg Vai lie Leu Lys Vai Thr .195 200205
Vai Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Vai He 210 215 220
Leu Asn Asn Asn Glu Tyr Lys Met Leu He Asp Asn Gly Tyr Vai Leu 225 230 235240
His. Vai Asp Lys Vai Ser Lys Vai Vai Lys Lys Gly Met Glu CysLeu
245 250255
Gin Vai Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asplie ' 260 265 .270
Asn Ala Glu Ala His Ser Trp Gly Met Lys lie Tyr Glu Asp TrpAla
275 280. 285 '« 1153
Lys Asn Leu Thr Ala Ser Gin Arg Glu Ala Leu Asp Gly Tyr Ala Arg
290 295 300
<td> Gin'Asp</td><td> Tyr Lys Glu He Asn Asn Tyr Leu Arg Asn</td><td> Gin Gly Gly Ser</td>
<td> 305</td><td> 310 . . ' 315</td><td> 320</td>
<td> Gly Asn</td><td> Glu Lys Leu Asp Ala Gin Leu Lys Asn He 325 330</td><td> Ser Asp Ala Leu 335</td>
<td> Gly Lys</td><td> Lys Pro He Pro Glu Asn He Thr Vai Tyr 340. , 345</td><td> Arg Trp Cys Gly <sup>350</sup></td>
<td> Met Pro</td><td> Glu Phe Gly Tyr Gin He Ser Asp Pro Leu 355 360 .</td><td> Pro Ser Leu Lys 365 .</td>
<td> Asp Phe 370</td><td> Glu Glu Gin Phe Leu Asn Thr He Lys Glu 375 380</td><td> Asp Lys Gly Tyr</td>
<td> Met Ser 385</td><td> Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala 390 395</td><td> Phe Gly Ser Arg 400</td>
<td> Lys He</td><td> He Leu Arg Leu Gin Vai Pro Lys Gly Ser 405 410</td><td> Thr Gly Ala Tyr 415</td>
<td> Leu Ser</td><td> Ala He Gly Gly Phe Ala Ser Glu Lys Glu 420 425</td><td> He Leu Leu Asp 430</td>
<td> Lys Asp</td><td> Ser Lys Tyr His He Asp Lys Ala Thr Glu 435 440</td><td> Vai He lie Lys 445</td>
<td> Gly Vai • 450</td><td> Lys Arg Tyr Vai.Vai Asp Ala Thr Leu.Leu 455 460</td><td> Thr Asn</td>
(2) INFORMATION FOR SEQ ID NO:21:
,(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 834 amino acids (B) .TYPE: amino acid . (D) TOPOLOGY: linear.
(ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:
Met Lys Asn Met Lys Lys Lys Leu Ala Ser Vai Vai Thr Cys Met Leu
5 1015
Leu Ala Pro Met Phe Leu Asn Gly Asn Vai Asn Ala Vai. Asn AlaAsp
2530
Ser Lys He Asn Gin lie Ser Thr Thr Gin Glu Asn Gin Gin Lys Glu 35 4045
Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe
55 . . 60
Asn' Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Asn Thr Leu Met Tyr 65, 70 7580
Asp Gin . Gin Thr Ala Asn Ala Leu Leu Asp Lys Lys Gin Gin Glu Tyr 85 9095
Gin Ser lie Arg Trp He Gly Leu lie Gin Arg Lvs Glu Thr Glv Asp 100 105 110
Phe Thr Phe Asn Leu Ser Lys Asp Glu Gin Ala He He Glu He Asp 115 120.125
Gly Lys He lie Ser Asn Lys Gly Lys Glu Lys Gin Vai Vai His Leu 130 135140
Glu Lys Glu Lys Leu Vai Pro He Lys He Glu Tyr Gin Ser AspThr
145 150 . 155160
Lys Phe Asn lie Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu PheLys
165 170175
He Asp Ser Gin Asn Gin Ser Gin Gin Vai Gin Leu Arg Asn Pro Glu 180 185190
Phe Asn Lys Lys Glu Ser Gin Glu Phe Leu Ala Lys Ala Ser Lys Thr 195 200205
Asn Leu Phe Lys Gin Lys Met Lys Arg Asp lie Asp Glu Asp Thr Asp 210 215220,
Thr Asp Gly Asp Ser He Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr <sup>225</sup> 230 . 235240 lie Gin Asn Lys Vai Ala Vai Lys Trp Asp Asp. Ser Leu Ala Ser Lys 245 250 .255
Gly Tyr Thr Lys Phe Vai Ser׳ Asn Pro Leu Asp Ser His Thr . Vai Gly 260 265: 270
Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp LeuSer
275. . 280285
Asn .Ala Lys Glu Thr Phe Asn Pro Leu Vai Ala Ala Phe Pro SerVai
290 . 295300
Asn Vai Ser Met Glu Lys Vai lie Leu Ser Pro Asn Glu Asn LeuSer
305 310 315320
Asn Ser Vai Glu Ser His Ser Ser Thr Asn Trp Ser Tyr<sup>:</sup>Thr AsnThr
335 330 .י .325
Glu Gly Ala Ser He Glu Ala Gly Gly Gly Pro Leu Gly Leu Ser Phe
148- 1 1 5 3 8 2
A . 340 345350
Gly Vai Ser Vai Thr.Tyr Gin His Ser Glu Thr Vai Ala Gin Glu Trp '355 360365 ' Gly Thr Ser Thr Gly,Asn Thr Ser Gin Phe Asn Thr Ala Ser Ala Gly 370 . 375380.
Tyr Leu Asn Ala Asn Vai Arg Tyr Asn Asn Vai Gly Thr Gly AlaHe
385 390 395400
Tyr Asp Vai Lys Pro Thr Thr Ser Phe Vai Leu Asn Asn Asn ThrHe
י 415 . 410405
Ala Thr He Thr Ala Lys Ser Asn Ser Thr Ala Leu Arg lie Ser Pro 420 425 .430
Gly Asp Ser Tyr Pro Glu He Gly Glu Asn Ala lie Ala He Thr Ser 435 440 445
Met Asp Asp Phe Asn Ser His Pro. He Thr Leu Asn Lys Gin Gin Vai 450 455460'
Asn Gin Leu He Asn Asn Lys Pro He Met Leu Glu Thr Asp GinThr
465 470 475480
Asp Gly Vai Tyr Lys lie Arg Asp Thr His Gly Asn He Vai ThrGly
485 490495
Gly Glu Trp Asn Gly Vai Thr Gin Gin lie Lys Ala Lys Thr Ala Ser 500 505510
He lie Vai Asp Asp Gly Lys Gin Vai Ala Glu Lys Arg Vai Ala Ala
525׳ 520515
Lys Asp Tyr Gly His Pro Glu Asp Lys Thr Pro Pro Leu Thr Leu Lys 530 535;540
Asp Thr Leu Lys Leu Ser Tyr Pro Asp Glu He Lys Glu Thr Asn Gly 545 550 , 555560
Leu Leu Tyr Tyr Asp Asp Lys Pro He Tyr Glu Ser Ser Vai Met Thr
575׳ . 570 -565
Tyr Leu Asp Glu Asn Thr Ala Lys Glu Vai Lys Lys Gin lie Asn Asp 580 585590
Thr Thr Gly Lys Phe Lys Asp Vai Asn His Leu Tyr Asp Vai Lys Leu 595 600605
Thr Pro Lys Met Asn Phe Thr He Lys Met Ala Ser Leu Tyr Asp Gly 610 615'620
Ala Glu Asn Asn His Asn Ser Leu Gly Thr Trp Tyr Leu Thr Tyr Asn <sup>625</sup> . 630 635640
<td rowspan="2"> Val Ala</td><td rowspan="2"> Gly Gly Asn 645</td><td colspan="2"> Thr Gly Lys Arg Gin Tyr Arg Ser Ala His Ser</td>
<td> 650</td><td> 655 </td>
<td> Cys Ala</td><td> His Val Ala</td><td> Leu Ser Ser Glu Ala Lys Lys</td><td> Lys Leu Asn Gin</td>
<td></td><td> ' 660</td><td> 665</td><td> 670 .</td>
<td> Asn Ala</td><td> Asn Tyr Tyr</td><td> Leu Ser Met Tyr Met Lys Ala</td><td> Asp Ser Thr Thr</td>
<td></td><td> 675</td><td> 680</td><td> 685</td>
<td> Glu Pro</td><td> Thr.lie Glu</td><td> Val Ala Gly Glu Lys Ser Ala</td><td> lie Thr Ser Lys</td>
<td> 690</td><td></td><td> 695 700</td><td></td>
<td> Lys Val</td><td> Lys Leu Asn</td><td> Asn Gin Asn Tyr Gin Arg Val</td><td> Asp He Leu Val</td>
<td> 705</td><td></td><td> 710 715</td><td> 720</td>
<td> Lys Asn</td><td> Ser Glu Arg</td><td> Asn Pro Met Asp Lys He Tyr</td><td> lie Arg Gly Asn</td>
<td></td><td> 725</td><td> 730</td><td> 735</td>
<td> Gly Thr Thr Asn</td><td colspan="2"> Val Tyr Gly Asp Asp Val Thr lie Pro Glu Val Ser</td>
<td> 740</td><td> 745</td><td> 750</td>
<td> Ala He Asn Pro ' 755</td><td> Ala Ser Leu Ser Asp GluGlu 760</td><td> He Gin Glu lie Phe 765</td>
<td> Lys Asp Ser Thr 770</td><td> He Glu Tyr Gly Asn Pro Ser 775</td><td> Phe Val Ala Asp Ala 780</td>
<td> Val Thr Phe Lys 785</td><td> Asn He Lys Pro Leu Gin Asn 790 795</td><td> Tyr Val Lys Glu Tyr 800</td>
<td> Glu lie Tyr His</td><td> Lys Ser His Arg Tyr Glu Lys 805 . 810</td><td> Lys Thr Val Phe Asp '815</td>
<td> He Met Gly Val 820</td><td> His Tyr Glu Tyr Ser He Ala 825</td><td> Arg Glu Gin Lys Lys 830</td>
Ala Ala (2) INFORMATION FOR SEQ ID.NO:22: .
(i) SEQUENCE CHARACTERISTICS:.
(A) LENGTH:.4041 base pairs (B) TYPE: nucleic acid (C> STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE:
(A) NAME/KEY: CDS (B) LOCATION: 1.4038 (D) OTHER INFORMATION: /product“ VIPlA(a)/VIP2A(a) fusion
A product 115382/2 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:
ATG AAA AGA ATG GAG GGA AAG TTG TTT ATG GTG TCA AAA AAA TTA CAA48
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys LeuGin
835 840 845 .850
GTA GTT ACT AAA ACT GTA TTG CTT AGT ACA GTT TTC TCT ATA TCT TTA96
Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser He SerLeu
855 . 860 .865
TTA AAT AAT GAA GTG ATA AAA GCT GAA CAA TTA AAT ATA AAT TCT CAA144
Leu Asn Asn Glu Val He Lys Ala' Glu Gin Leu Asn He Asn SerGin
870 875880
AGT AAA TAT ACT AAC TTG CAA AAT CTA AAA ATC ACT GAC AAG GTA GAG192
Ser Lys Tyr Thr Asn Leu Gin Asn Leu Lys He Thr Asp Lys ValGlu
885 '890895
GAT TTT AAA GAA GAT AAG GAA AAA GCG AAA GAA TGG GGG AAA GAA AAA 240
Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys GluLys
900 905910
GAA AAA GAG TGG AAA CTA ACT GCT ACT GAA AAA GGA AAA ATG AAT AAT288
Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn
915 920 925930
TTT TTA GAT AAT AAA AAT GAT ATA AAG ACA AAT TAT AAA GAA ATT ACT336
Phe Leu Asp Asn Lys Asn Asp lie Lys Thr Asn Tyr Lys Glu lie Thr
935 . 940945,
TTT TCT ATG GCA GGC TCA TTT GAA GAT GAA ATA AAA GAT TTA AAA GAA384
Phe Ser Met Ala Gly Ser Phe Glu Asp Glu lie . Lys Asp Leu Lys Glu
950 955 .960 .
ATT' GAT AAG ATG TTT GAT AAA ACC AAT CTA TCA AAT TCT ATT. ATC ACC432 lie Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser lie. lie Thr
965 '970 975'
TAT AAA AAT GTG GAA CCG ACA ACAATT GGA TTT AAT AAA TCT TTA ACA ' 480 .
Tyr Lys Asn Val Glu Pro Thr Thr He Gly Phe Asn Lys Ser LeuThr
980 . 985.990
GAA GGT AAT ACG ATT AAT TCT GAT GCA ATG GCA CAG TTT AAA GAA CAA528
Glu Gly Asn Thr He Asn Ser Asp Ala Met Ala Gin Phe Lys GluGin
995 1000 10051010
TTT TTA GAT AGG. GAT ATT AAG TTT GAT AGT TAT CTA GAT ACG CAT TTA576
Phe Leu Asp Arg Asp He Lys Phe Asp Ser Tyr Leu Asp Thr HisLeu
1015 10201025
ACT GCT CAA CAA GTT TCC AGT AAA GAA AGA GTT ATT TTG AAG GTT ACG. 624
Thr Ala Gin Gin Val Ser Ser Lys Glu Arg Val He Leu Lys Val Thr
2/ 82 3 5 1 1 ־<sup>151</sup>
1030 10351040
GTT CCG AGT . GGG AAA GGT TCT ACT ACT CCA ACA AAA GCA GGT GTC ATT672
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly ValHe.
1045 10501055
TTA AAT AAT AGT GAA TAC AAA ATG CTC ATT GAT AAT GGG TAT ATG GTC720
Leu Asn Asn Ser Glu Tyr Lys Met Leu He Asp Asn Gly Tyr MetVal
1060 . 10651070
CAT GTA GAT AAG GTA TCA AAA'GTG GTG AAA AAA GGG GTG GAG TGC TTA768
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val.Glu CysLeu:
1075 1080 10851090
CAA ATT GAA GGG ACT TTA AAA. AAG AGT CTT GAC TTT AAA AAT GAT ATA816
Gin lie Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn AspTie
1095 '11001105
AAT GCT GAA GCG CAT AGC TGG GGT ATG AAG AAT TAT GAA GAG TGG GCT' 864
Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala 1110 11151120
AAA GAT TTA ACC GAT TCG CAA AGG GAA GCT TTA GAT GGG TAT GCT AGG912
Lys Asp Leu Thr Asp Ser Gin Arg Glu Ala Leu Asp Gly Tyr AlaArg
1125 11301135
CAA GAT TAT AAA GAA ATC AAT AAT TAT TTA AGA AAT CAA GGC GGA AGT960.
Gin Asp Tyr Lys Glu He Asn Asn Tyr Leu Arg Asn Gin Gly GlySer
1140 1145H50
GGA AAT GAA AAA CTA GAT GCT CAA ATA AAA AAT ATT TCT GAT GCT TTA1008 .Gly Asn Glu Lys Leu Asp Ala Gin He Lys Asn He Ser Asp Ala Leu .
1155 1160 1165 .1170'
GGG. AAG AAA CCA ATA CCG GAA AAT ATT ACT GTG TAT AGA . TGG TGT GGC1056.
Gly Lys Lys Pro He Pro Glu Asn lie Thr Val Tyr Arg Trp Cys Gly
1175 11801185
ATG CCG GAA TTT GGT TAT CAA ATT AGT GAT CCG TTA CCT TCT TTA AAA1104
Met Pro Glu Phe Gly Tyr Gin He Ser Asp Pro Leu Pro Ser Leu Lys .
, 1190 ' ' 1195 .1200
GAT TTT GAA GAA CAA TTT TTA AAT ACA ATC AAA GAA GAC AAA GGA TAT '1152
Asp Phe Glu Glu Gin Phe Leu Asn Thr He Lys Glu Asp Lys Gly Tyr'
.. 1205 12101215
ATG AGT ACA AGC TTA TCG AGT GAA CGT CTT GCA GCT TTT GGA TCT AGA .1200
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly SerArg . . 1220 1225.1230
AAA ATT ATA TTA CGA TTA CAA GTT CCG AAA GGA AGT ACG GGT GCG TAT
Lys He He Leu Arg Leu Gin Val Pro Lys Gly Ser Thr Gly MaTyr
1235 1240' 1245!250
TTA AGT GCC ATT GGT GGA TTT GCA AGT GAA AAA GAG ATC CTA CTT GAT1296 '<sup>52</sup> 11 5 3 82 /2
Leu Ser Ala lie Gly Gly Phe Ala Ser Glu Lys Glu 11־ Leu Leu Asp <sup>1255</sup> 1260 1265
<td> AAA GAT ACT AAA TAT CAT ATT GAT AAA GTA ACA GAG GTA ATT ATT AAA Lys Asp Ser Lys !yr His Ile Asp Lys Vai Thr Glu Vai 2 2 <sup>1270</sup> 1275 1280</td><td> 1344</td>
<td> CTT MG CGA TAT GTA CTG GAT GCA ACA TTA TTA ACA AAT ATG AAA Gly Vai Lys Arg Tyr Vai Vai Asp Ala Thr Leu Leu Thr Asn Met Lys I<sup>285</sup> 1290 !295</td><td> 1392</td>
<td> AAT ATG AAG AAA AAG TTA GCA ACT GTT GTA ACG TCT ACG TTA TTA GCT ״״״<sup>YS LYS 1Y־ Uu Ma Se1 Val Val</sup>'<sup>Thr</sup> ™ ™ 2 .<sup>L</sup>'׳<sup>uu</sup> 1305 131Q</td><td> 1440</td>
<td> CCT ATG TTT TTG AAT GGA AAT GTG AAT GCT GTT TAC GCA GAC AGC AAA Pro Met Phe Leu Asn Gly As״ val Asn Ala Vai ,yr 2 2p £ <sup>1320</sup> 1325 1330</td><td> 1488</td>
<td> Thr ?Γ Γ<sup>Τ ACA ACA</sup> CAA CAG AAA.GAG ATG GAC r Asn Gin He Ser Thr Thr Gin Lys Asn Gin Gin Lys Glu Met Asp 1335 .1340 <sub>1345</sub></td><td> 1536</td>
<td> CGA AAA GGA TTA CTT GGG TAT TAT TTC AAA GGA AAA GAT TTT ACT AAT Arg Lys Gly I־u Leu Gly Tyr lyr Phe Lys Gly Lys Asp 2 2 2 <sup>1350</sup> 1355 !360</td><td> 1584</td>
<td> CTT ACT ATG TTT GCA CCG ACA CGT GAT AGT ACT CTT ATT TAT GAT CAA Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu 2 ™ ™ 1365 1370 !375</td><td> 1632</td>
<td> ™ <sup>MT</sup> ™ CIA ™ GAT AAA AAA CAA CAA GAS TAT CAG TCT Uft<sup>1¥</sup> י ״<sup>S UU LyS L</sup>>׳<sup>S G1</sup><sup>G1</sup><sup>G</sup>l״ ΤΥ״ “ S <sup>1380</sup> 1385 1390</td><td> 1680</td>
<td> ATT CGT TGG ATT GCT TTG ATT CAG AGT AAA GAA ACG GGA GAT TTC ACA lie Arg Trp !1־ Gly I־u He Gin Ser Lys Glu Thr Gly Asp 2 S <sup>1400</sup> 1405 1.410</td><td> 1728</td>
<td> TTT AAC TTA TCT GAG GAT GAA CAG GCA ATT ATA GAA ATC AAT GGG AAA Phe A״־ Uu Ser Glu Sap Glu Gin Ala Π־11 ־ <sub>Glu Ile</sub> As״ <sup>1415</sup> 1420 1425</td><td> 1776</td>
<td> ATT ATT TCT AAT AAA GGG AAA GAA AAG CAA GTT GTC CAT TTA GAA AAA 11־ He Ser Asn Lys Gly Lys Glu Lys Gl״ Val Val His ™ ™ “ <sup>143</sup>Ο 1435 <sub>i440</sub></td><td> 1824</td>
<td> GGA AAA; TTA GTT CCA ATC AAA ATA GAG TAT CAA TCA GAT ACA AAA TTT Gly Lys Leu Val Pro lie Lys lie Glu Tyr Gin Ser Asp Thr Lys Phe <sup>כ</sup> I<sup>450</sup> 1455</td><td> 1872</td>
<td> AAT ATT GAC ACT AAA ACA TTT AAA GAA CTT AAA TTA TTT AAA ATA GAT lie Asp Ser Lys Thr Phe Lys Glu leu Lys Leu Phe Lys lie Asp 1465 !470</td><td> 1920</td>
AGT CAA AAC CAA Ser Gin Asn Gin 1475
GAA TTT
Glu Phe
ATA AAT
He Asn
CCC CAG CAA GTC CAG CAA GAT GAA CTG AGA AAT CCT
Pro Gin Gin Vai Gin Gin Asp Glu Leu Ara Asn Pro <sup>14</sup>8O 1485 <sub>1490</sub>
AAC AAG AAA GAA TCA CAG GAA TTC TTA GCG AAA CCA TCG AAA Asn Lys Lys Glu Ser Gin Glu Phe Leu Ala Lys Pro Ser Lys <sup>1495</sup> 1500 15Q5
CTT TTC ACT CAA AAA ATG AAA AGG GAA ATT GAT GAA GAC ACG Leu Phe Thr Gin Lys Met Lys Arg Glu lie Asp Glu Asp Thr <sup>1510</sup> 1515 !520
GAT ACG GAT GGG GAC TCT ATT CCT GAC CTT Asp Thr Asp Gly Asp Ser lie Pro Asp Leu 1525 1530
TGG. GAA GAA AAT GGG TAT Trp Glu Glu Asn Gly Tyr 1535
ACG ATT CAA AAT AGA ATC GCT GTA AAG TGG GAC GAT TCT CTA GCA AGT <sup>Thr 11e Ma Val Lys Tr</sup>P <sup>As</sup>P w Ser Leu Ala Ser <sup>1540</sup> ' 15451550
AAA GGG TAT ACG AAA TTT CTT TCA AAT CCA CTA GAA AGT CAC ACACTT
Lys Gly Tyr Thr Lys Phe Vai Ser Asn Pro leu Glu Ser His ThrVai <sup>1555</sup> 1560 1565
GGT GAT CCT TAT ACA GAT TAT GAA AAG GCA GCA AGA GAT CTA GATTTG ly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu AspLeu
1575 15801585
GCT TTT CCA AGT
Ala Phe Pro Ser
1600
AAT GAA AAT TTA
Asn Glu Asn Leu 1615
TCT TAT ACA AAT . Ser Tyr Thr Asn l^U 1625 1630
ACA GAA GCT GCT TCT CTT GAA GCG GGG ATT GGA CCA AAA GCT ATT TCG
Thr Glu Gly Ala Ser Vai Glu Ala 1635 1640
TTC GGA; GTT AGC CTA AAC TAT CAA
Phe Gly Vai Ser Vai Asn Tyr Gin
1655
TCA AAT GCA AAG GAA ACG TTT AAC CCA TTG GTA GCT Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Vai Al a 1590 1595
GTG AAT GTT AGT ATG GAA AAG CTG ATA TTA TCA CCA
Vai Asn Vai Ser Met Glu Lys Vai He Leu Ser Pro
1605 1610 - .
TCC AAT ACT GTA GAG TCT CAT TCA TCC ACG AAT TGG
Ser Asn Ser Vai Glu Ser His Ser Ser Thr Asn Trp
Gly lie Gly Pro Lys Gly lie Ser 1645 1650
CAC TCT GAA ACA GTT GCA CAA GAA His Ser Glu Thr Vai Ala Gin Glu 1660 1665
1968
2016
2064
2112
2160
2208
2256
2304
2352
2400
2448
2496
TGG GGA.ACA TCT ACA GGA Trp Gly.Thr Ser Thr Gly • 1670
GGA TAT TTA AAT GCA AAT
Gly Tyr ,Leu Asn Ala Asn 1685 .
AAT ACT TCG CAA TTC Asn Thr Ser Gin Phe 1675
GTT CGA TAT AAC AAT Vai Arg Tyr Asn Asn 1690
AAT ACG GCT TCA GCG Asn Thr Ala Ser Ala 1680
CTA GGA ACT GCT GCC Vai Gly Thr Gly Ala 1695
2544
2592 .54 115382/2
ATC TAC GAT GTA AAA He
Tyr Asp Vai 1700
Lys
CCT
Pro
ACA ACA
Thr Thr
1705
AGT
Ser
TTT GTA
Phe
Vai
TTA AAT
Leu Asn 1710
AAC GAT
Asn Asp
ACT
Thr
2640
ATC י He .
1715
GCA
Ala
ACT ATT
Thr lie
ACG
Thr
GCG
Ala Lys
1720
AAA
TCT
Ser
AAT
Asn
TCT
Ser
ACA > Thr . 1725
GCC
Ala
TTA
Leu
AAT ATA
Asn lie
TCT
Ser 1730 . 2688
CCT GGA
Pro
TCA
Ser
GTA
Gly
ATG
Met
GAT
Vai Asp
TCT
Ser
GCA
Ala
GAA AGT
Glu Ser
TAC Tyr : 1735
CCG
Pro
AAA
Lys
Lys Gly Gin Asn
1740
AAT GGA
Gly He
ATC
GCA
Ala
ATA
He 1745
ACA
Thr
2736
GAT GAT TTT. AAT Asp Asp Phe Asn 1750
AAT י
Asn : 1765
CTG CTA AAT
Leu Leu
Asn
TCC
Ser
CAT
His
CCG ATT
Pro lie 1755
ACA
Thr
TTA AAT
Leu
Asn
AAA .
Lys 1760
AAA CAA
Lys Gin
2784
AAT
Asn
AAA Lys 1770
CCT
Pro
ATG
Met
ATG TTG
Met Leu
GAA .
Glu <sup>1 </sup>1775
ACA
Thr
AAC CAA
Asn Gin
2832
Gly 1
1795
ACA
Thr
<td colspan="3"> GAT GGT GTT TAT AAG ATA AAA GAT ACA</td>
<td> Asp Gly Vai Tyr 1780</td><td> Lys</td><td> He Lys Asp Thr 1785</td>
<td> GGA GAA TGG AAT</td><td> GGT</td><td> GTC ATA CAA CAA</td>
<td> Gly Glu Trp Asn 1</td><td> Gly 180C</td><td> Vai lie Gin Gin 1</td>
CAT GGA .
His Gly .
1790
ATC . He : 1805
AAG
Lys
AAT
Asn
ATA
He
GTA
Vai
ACT
Thr
2880
GCT
Ala
AAA
Lys
ACA
Thr
GCG
Ala 1810
2928
ATT
He
ATT GTG lie Vai
GAT 1 Asp . 1815
GAT GGG
Asp Gly
GAA
Glu
CGT
Arg
GTA GCA GAA Vai Ala Glu 1820
AAA
Lys
CGT
Arg
GTA Vai . 1825
GCG
Ala
2976
AAA
Lys
GAT TAT
Asp Tyr
1830
GAA AAT
Glu
Asn
CCA
Pro
GAA
Glu
GAT .
Asp 1835
AAA ACA CCG Lys Thr Pro
TCT
Ser
TTA Leu 1840 .
ACT TTA
Thr Leu
3024
AAA
Lys Asp Ala Leu
1845
GAT.GCC CTG
AAG
Lys
CTT
Leu
TCA TAT
Ser Tyr
1850
CCA GAT GAA ATA Pro
Asp Glu
AAA
He Lys
1855
GAA
Glu
ATA He
GAG
Glu
3072
GGA TTA
Gly Leu
1860
TTA
Leu
TAT
Tyr
TAT
Tyr. Lys
AAA
AAC AAA
Asn Lys 1865
CCG
Pro
ATA
He
TAC
Tyr
GAA TCG
Glu Ser
1870
AGC
Ser
GTT
Vai
ATG
Met
3120
ACT TAC
Thr Tyr
1875
TTA
Leu
GAT
Asp
GAA
Glu
AAT
Asn 1880
ACA GCA
Thr Ala
AAA
Lys
GAA
Glu
GTG .
Vai <sup>1 </sup>1885
ACC
Thr
AAA
Lys
CAA TTA AAT
Gin Leu Asn ' 1890
3168
GAT
Asp
ACC
Thr Thr Gly
ACT GGG
AAA
Lys : 1895
TTT
Phe
AAA
Lys
GAT GTA
Asp Vai
AGT Ser 1900
CAT
His
TTA
Leu
TAT
GAT GTA AAA Tyr Asp Vai Lys 1905
3216
CTG
Leu
ACT CCA AAA
Thr Pro Lys
ATG AAT
Met Asn
GTT
Vai
ACA ATC
Thr lie
AAA TTG
Lys Leu
TCT
Ser
ATA CTT TAT GAT He Leu Tyr Asp
3264
V
A
1910 . 1915
1920
AAT GAT AAC
Asn Asn Asn
3312
AAT
Asn
GCT
Ala
GAG
Glu 1925
TCT
Ser
TCA ATT Ser. lie 1930
GGT
Gly
AAA
Lys
TGG
Trp
ACA AAC
Thr Asn
1935
ACA AAT
Thr Asn , ATT lie
GTT
Vai 1940
TCA
Ser
GGT
Gly Gly
GGA
AAT
Asn
AAC ׳ Asn י 1945
GGA AAA
Gly Lys
AAA
Lys
CAA Gin.Tyr 1950
TAT
TCT TCT
Ser Ser
AAT
Asn
AAT
Asn
3360
CCG
Pro
GAT GCT
Asp Ala 1955 .
AAT
Asn
TTG. ACA Leu
Thr
1960
TTA
Leu
AAT
Asn
ACA
Thr
GAT
Asp Ala Gin
1965
GCT CAA
GAA AAA
Glu
Lys
TTA
Leu Asn
1970
AAT
3408
<td> AAA AAT CGT GAC TAT TAT Lys Asn Arg Asp Tyr Tyr 1975 '</td>
<td> ACA CAA TGT GAG ATT ACT</td>
<td> Thr Gin Cys Glu lie Thr</td>
<td> 1990</td>
<td> AAA ACA GTG AAT GTG AAT</td>
<td> Lys Thr Vai Asn Vai Asn</td>
<td> 2005</td>
<td> GCT CAT AAT ATA AAA AGT</td>
<td> Ala His Asn lie Lys Ser</td>
<td> 2020</td>
<td> AAT GAT GAA ATA ACT TTA</td>
<td> Asn Asp Glu lie. Thr Leu</td>
<td><sup>2035</sup> . 2040</td>
<td> GCA TCA ATA AAA. CCG GAA .</td>
<td> Ala Ser He Lys Pro Glu ,</td>
2055
AAA
Lys
ATA lie
TTT
Phe
ATA
He
AGT
Ser
TTA
Leu
TAT
Tyr 1980
ATG AAG
Met
Lys
TCA
Ser
GAA
Glu
AAA AAC
Lys Asn
1985
3456
TAT
Tyr
AGT
Ser
AGG
Arg
TAT .GGT
Tyr Gly
2070
ATT
He
AAA
Lys
GGT GGG .
Gly Gly
2085
ATT
He
CAT
His
TAT
Tyr
ATT
GAA CCA TTG lie Glu Pro 2100
Leu
CAA
Gin
AAT
Asn
AGT GAG
Ser Glu
2115
TTA
Leu
GGA
Gly
CCA
Pro
TAC AAG
GAT
GGG
ACA
GAT GGG ׳
Asp Gly 1
1995
GAC AAT
Asp Asn
2010
AAT
Asn : 2025
AAT
Asn
AAG
Lys
GGT
Gly
GAG
Glu
TAC
Tyr
ATT
He
TAT
Tyr
AAA
Lys Arg
AGA
CCA
Pro
ATT
He
TCT
Ser
TGG
Trp Asp
TTA
Leu
TTA
Leu
GAT
GAT
Asp
ACA
Thr
CCG ATC .
Pro He
2000
TTA GAT
Leu Asp
2015
TCA CTT
Ser Leu
2030
ATT TCT lie Ser 2045
GAT <sup>1 </sup>Asp . 2060
GAA 1
Glu j 2075
GAA TTT
Glu Phe
2090
TAT 1yr ' 2105
AAC
Asn 2120
GTG
Vai
ATT AAA
ACT
Thr
ATT lie
GTG
Vai
AGT
Ser
TTT
ACC
Thr
CAT
His
ATT lie
AAA
Lys
ATA
He
ACA
Thr
TCA
Ser
GAA
Glu
ATT
He
AAA
Lys
GAT GGA
Asp Gly
ATT AAT lie
Asn
AAA
Lys Tyr
TAT
GAC
Asp Thr Leu
ACA CTT
ACA
Thr
ATA
He
ACG
Thr
GAT GTA
Asp Vai
2050
CAG ATT Gin He . 2065
3504
3552
3600
3648
3696
ATC lie
CTT
Leu
ATT
He .
2080
GAT AAA
Asp Lys
3744
GAA GCT
Glu
Ala .
2095
GAA
Glu 2110 .
GAA
Glu 2125
GAT TTT ACC AAA
AGT
Ser
TTT AAT
Phe
Asn
3792
GTT ACT
Vai
Thr
TAT
Tyr
AGT
Ser
3840
AGT
Ser
GAT
Asp Lys
AAA
ATT
He 2130
TAT
AGT AAA
AAT
3936
3888
I
Λ
Tyr Lys Asp Gly Thr He 2.135 gaa caa gga tta ttt tat
Glu Gin Gly Leu Phe Tyr 2150
AAT GOT ATT ACT TAT GAT
Asn Ala He Thr Tyr Asp 2165
AAT AAA TAG
Asn Lys
2180
Lys Phe Asp Phe Thr Lys 2140
GAC AGT GGA TTA AAT TGG
Asp Ser Gly Leu Asn Trp 2155
GGT AAA GAG ATG AAT GTT
Gly Lys Glu Met Asn Vai 2170
Tyr Ser Lys Asn . 2145
GAC TTT AAA ATT 3984
Asp Phe Lys lie
2160
TTT CAT AGA TAT 4032
Phe His Arg Tyr 2175
4041 (2) INFORMATION FOR SEQ ID NO:23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1346 amino acids (B) TYPE: amino acid (D) TOPOIOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:
Met Lys. Arg Met Glu Gly Lys Leu Phe Met Vai Ser Lys Lys Leu Gin <sup>5 1</sup>θ15 val Val>Thr Lys Thr Vai Leu Leu Ser Thr Vai Phe Ser He Ser leu 25 . 30'
Leu Asn Asn Glu Val lie Lys Ala Glu Gin Leu Asn He Asn Ser Gin
Ser Lys Tyr Thr Asn leu Gin Asn Leu Lys lie Thr Asp Lys Val Glu <sup>U 55</sup>60 'י
Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu. Trp Gly Lys Glu Lys <sup>70</sup> . <sup>75</sup>10
Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys' Gly Lys Met As״ As״ <sup>85</sup> 90
Phe leu Asp As״ Lys As״ Asp lie Lys Thr Asn Tyr Lys Glu HeThr
Phe Ser Met Ala. Gly Ser Phe Glu Asp Glu' lie Lys Asp Leu LysGlu
He A?P Lys Met. Phe Asp Lys Thr Asn leu Ser Asn Ser lie HeThr <sup>135</sup>140 j Tyr Lys Asn Val Glu Pro Thr Thr He Gly Phe Asn Lys Ser Leu Thr
5 3 8 2 /2
5.6.35 <sup>145 150</sup> . 155'
16U
Glu Gly Asn Thr He Asn Ser Asp Ala Met Ala Gin Phe Lys Glu Gin ' . <sup>165</sup> ..<sup>17</sup> . ־O ,'175
Phe Leu Asp Arg Asp lie Lys Phe Asp Ser Tyr leu Asp Thr His Leu <sup>180</sup> 185
Thr Aia Gin Gin Vai Ser Ser Lys Glu Arg Vai lie Leu Lys Vai Thr . <sup>ϋ</sup> 200 205..
<sup>Val</sup> ’9in <sup>Ser Gly Lys Gly Ser Thr ThrFro</sup> Thr Lys Ala Gly Vai He . . <sup>215</sup>220
Leu Asn Asn Ser Glu Tyr Lys Met Leu He Asp Asn Gly Tyr Met Vai <sup>5</sup> ' . <sup>230</sup> 235240.
His Vai Asp Lys Vai Ser Lys Vai Vai Lys Lys Gly Vai ׳Glu Cys Leu <sup>245</sup> . J 250 . .255
Gin . He Glu Gly Thr leu Lys Lys Ser leu Asp Phe Lys Asn Asp lie <sup>260</sup> 265 .270
Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala <sup>275</sup> 280.285
Lys Asp Leu Thr Asp Ser Gin Arg Glu Ala leu Asp Gly Tyr Ala Arg . 295300
Gin Asp Tyr Lys Glu He Asn Asn Tyr Leu Arg Asn Gin Gly Gly Ser ' <sup>310</sup> 315320
Gly Asn Glu Lys Leu Asp Ala Gin He Lys Asn lie Ser Asp Ala Leu <sup>325</sup> 330
Gly Lys Lys Pro lie Pro Glu Asn lie Thr Vai. Tyr Arg Trp Cys Gly <sup>340</sup> , . 345 ,. 350
Met Pro Glu Phe' Gly Tyr Gin He Ger Asp Pro' Leu Pro Ser Leu Lys <sup>3</sup>55 . 360 .365.
Asp ^e Glu Glu Gin Phe Leu Asn Thr He Lys Glu Asp, Lys Gly Tyr 375330
S<sub>er</sub> Thr Ser leu Ser Ser Glu Arg leu Ala Ala Phe Gly Ser Arg <sup>390</sup> 395400
Lys He lie leu Arg Leu Gin Vai Pro Lys Gly Ser Thr Gly Ala TVr <sup>405</sup> 410 leu Ser Ala lie Gly Gly Phe Ala Ser Glu Lys Glu He Leu Leu Asp <sup>420</sup> . 425.430
Lys Asp Ser Lys Tyr His lie Asp Lys Vai Thr Glu Vai lie He Lvs <sup>435</sup> 440 445 .
158- 115382/2
Gly Val Lys Arg Tyr Vai Vai Asp Ala Thr <sub>Uu</sub> !*״ <sup>455</sup>. . 460
<td> Asn Met Lys</td><td> Lys Lys</td>
<td> 465</td><td></td>
<td> Pro Met Phe</td><td> Leu Asn</td>
<td></td><td> 485</td>
<td> Thr Asn Gin</td><td> He Ser</td>
Leu Ala Ser Val Val Thr Cys Thr Leu Leu Ala <sup>470 473</sup>480
Gly Asn Val Asn Ala Val Tyr Ala Asp Ser Lys <sup>490</sup>495
Thr Thr Gin Lys Asn Gin Gin Lys Glu Met Asp 505510
Arg Lys Gly
Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Ser Ash <sup>520</sup>525
5.6.35
Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu He Tyr Asp Gin <sup>535</sup> .540
Gin Thr Ala Asn Lys Leu Leu Asp Lys Lys Gin Gin Glu Tyr Gin Ser 55° . 555560
He Arg Trp He Gly Leu He Gin Ser Lys Glu Thr Gly Asp Phe Thr <sup>565 3</sup>?Ο
PheAs״ Leu Ser Glu Asp Glu Gin Ala He He Glu lie Asn Gly Lys <sup>580</sup> . 585
<td> lie</td><td> He</td><td> Ser 595</td><td> Asn</td><td> Lys</td><td> ; Gly</td><td> Lys</td><td> ! Glu 600</td><td> Lys Gin</td><td> Val</td><td> Val</td><td> His 605</td><td> Leu</td><td> Glu</td><td><sup>1 L</sup>Y<sup>S</sup></td>
<td> Gly</td><td> Lys 610</td><td> Leu</td><td> Val</td><td> Pro</td><td> lie</td><td> Lys 615</td><td> ' He</td><td> Glu Tyr</td><td> Gin</td><td> Ser 620</td><td> ASp</td><td> Thr</td><td> Lys</td><td> Phe</td>
<td> Asn 625</td><td> He</td><td> Asp</td><td> Ser</td><td> Lys</td><td> Thr 630</td><td> Phe</td><td> Lys</td><td> Glu Leu</td><td> Lys 635</td><td> Leu</td><td> Phe</td><td> Lys</td><td> He</td><td> Asp 640</td>
<td> Ser</td><td> Gin</td><td> Asn</td><td> Gin</td><td> Pro 645</td><td> Gin</td><td> Gin</td><td> Val</td><td> Gin Gin 650</td><td> Asp</td><td> Glu</td><td> Leu</td><td> Arg</td><td> Asn 655</td><td> Pro.</td>
<td> Glu</td><td> Phe</td><td> Asn</td><td> Lys 660</td><td> Lys</td><td> Glu</td><td> Ser</td><td> Gin</td><td> Glu Phe 665</td><td> Leu</td><td> Ala</td><td> Lys</td><td> Pro 670</td><td> Ser</td><td> Lys</td>
<td> lie</td><td> Asn</td><td> Leu 675</td><td> Phe</td><td> Thr</td><td> Gin</td><td> Lys</td><td> Met 680.</td><td> Lys Arg</td><td> Glu</td><td> lie</td><td> Asp 685</td><td> Glu</td><td> Asp</td><td> Thr</td>
<td> Asp</td><td> Thr 690</td><td> Asp</td><td> Gly</td><td> Asp</td><td> Ser</td><td> He 695</td><td> Pro</td><td> Asp Leu</td><td> Trp</td><td> Glu 700</td><td> Glu</td><td> Asn</td><td> Gly</td><td> Tyr</td>
<td> Thr 705</td><td> He</td><td> Gin .</td><td> Asn</td><td> Arg</td><td> lie 710</td><td> Ala</td><td> Val</td><td> Lys Trp</td><td> Asp 715</td><td> Asp</td><td> Ser</td><td> Leu</td><td> Ala</td><td> Ser 720</td>
<td> Lys 1</td><td> Gly <sup>1</sup></td><td> Tyr ’</td><td> Thr</td><td> Lys 725</td><td> Phe '</td><td> Val</td><td> Ser .</td><td> Asn Pro ' 730</td><td> Leu 1</td><td> Glu ;</td><td> Ser ;</td><td> His ׳</td><td> Thr 735</td><td> Val</td>
Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu . 750 ־ > 745 .״ . 740 .
Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro Ser <sup>755</sup> 760/65
Val Asn Val Ser Met Glu Lys Val lie Leu Ser Pro Asn Glu Asn 770 775780
Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr Thr Asn <sup>785</sup> ' <sup>79</sup>°. 7 <sup>795</sup>800
Thr Glu Gly Ala Ser Val Glu Ala Gly He Gly Pro Lys Gly He Ser
805 810815
Phe Gly Val Ser Val Asn Tyr Gin His Ser Glu Thr Val Ala Gin Glu 820 825830 ;
Trp Gly Thr Ser Thr Gly Asn Thr Ser Gin Phe Asn Thr Ala Ser Ala 835 840845
Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr Gly Ala <sup>850</sup>. 855860 lie Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn AspThr <sup>865 870</sup> 875 .880
He Ala Thr He Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn HeSer
885 890895
Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gin Asn Gly He Ala He Thr <sup>900</sup> . 905910
Ser Met Asp Asp Phe Asn Ser His Pro He Thr Leu Asn Lys Lys Gin <sup>915</sup> 920 . . 925 .
Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr Asn Gin 930 935 ' . 940
Thr Asp Gly Val Tyr Lys He Lys Asp Thr His Gly Asn lie Val Thr <sup>945 950</sup> 955 ' 960
Gly Gly Glu Trp Asn Gly Val He Gin Gin lie Lys Ala Lys Thr Ala <sup>965</sup> 970 975
<td colspan="2"> Ser lie lie Val Asp Asp Gly Glu Arg Val Ala Glu</td><td rowspan="2"> Lys Arg.Val Ala 990</td>
<td> 980</td><td> 985</td>
<td> Ala Lys Asp Tyr Glu Asn Pro 995</td><td> Glu Asp.Lys Thr Pro 1000</td><td> Ser Leu Thr Leu 1005</td>
<td> Lys Asp Ala Leu Lys Leu Ser 1010 . !015</td><td> Tyr Pro Asp Glu lie 1020 ׳</td><td> Lys Glu lie Glu 1</td>
<td> Gly Leu Leu Tyr Tyr Lys Asn</td><td> Lys Pro lie Tyr Glu</td><td> Ser Ser Val Met</td>
- 1 15382/2
Λ .
<sub>)104</sub> 1035 . /י. <sup>10301025</sup> .Thr Tyr Leu Asp Glu Asn Thr Ala Lys. Glu Val Thr Lys. Gin Leu Asn <sup>1045</sup> . 10501055
Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp Val Lvs <sup>1060</sup> . .10651070
Leu Thr Pro^Lys Met Asn Val Thr He Lys Leu Ser He Leu Tyr Asp <sup>1075</sup> lOSQ : 1085
X<sup>G1U Ser 11e Gly Lys Tr</sup>P <sup>Thr</sup> As״ Thr As״ <sup>1090 1095</sup>1100 <sup>Val Ser Gly Gly Asn</sup> Asn Gly Lys Lys Gin Tyr Ser Ser Asn Asn <sup>1110</sup> . 1115112(
Pro Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gin Glu. Lys Leu Asn <sup>1125</sup> ' . 1130 . .1135
Lys Asn Arg Asp Tyr Tyr He Ser Leu Tyr Met Lys Ser Glu Lys Asn 1110 11451150
Thr Gin Cys Glu He Thr He Asp Gly Glu lie Tyr Pro He Thr Thr <sup>1155</sup> 1160 1165 '
Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp lie He <sup>ii/U</sup> 11751180
Ala His Asn He Lys Ser Asn Pro He Ser Ser Leu His He Lys Thr
;־טוו 11901185
11<sup>95</sup>1200
Asn Asp Glu He Thr Leu Phe Trp Asp Asp lie Ser lie Thr Asp Val <sup>1205</sup> 121°1215
Ala Ser He Lys Pro Glu Asn Leu Thr Asp Ser Glu He Lys Gin lie <sup>1220</sup> . . 1225'
Tyr Ser Arg Tyr' Gly He Lys Leu Glu Asp Gly He Leu lie Asp Lys •. 1235 . 1240 1245.
<sup>Lys G</sup>J<sup>y Gly Ue His</sup> GlyGlu Phe lie Asn Glu Ala Ser Phe Asn <sup>1250</sup> 1255!260 lie Glu Pro Leu Gin Asn Tyr Val 12651270
Ser Glu Leu Gly Pro Asn Val Ser ' . .1285 .
Thr Lys Tyr Glu Val Thr Tyr Ser.
<sup>127</sup>51280
Asp Thr,Leu Glu Ser Asp Lys lie
1290!295
Tyr Lys Asp Gly Thr He Lys Phe Asp Phe Thr Lys 1300 . . 1305
Tyr Ser Lys Asn
1310
Glu
Gin Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe Lys lie ' 1315 1320 1325
Asn Ala He Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His Arg Tyr
1330 1335' 1340'
Asn Lys 1345 (2) INFORMATION FOR SEQ ID NO:24:
<sup>1</sup> (ij SEQUENCE CHARACTERISTICS׳:
(A) LENGTH: 1399 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS; single (D) TOPOLOGY: linear . .
(ii) MOLECULE TYPE; DNA (genomic) (ix) FEATURE:
(A) ΝΆΜΕ/ΚΕΥ: misc feature (B) LOCATION: 1.1386 (D) OTHER INFORMATION: /note= Maize optimized DNA sequence for VIP2A(a) protein from AB78 (xi) SEQUENCE.DESCRIPTION: SEQ ID NO:24:
ATGAAGCGCA TGGAGGGCAA GCTGTTCATG GTGAGCAAGA AGCTCCAGGT GGTGACCAAG60
ACCGTGCTGC TGAGCACCGT GTTCAGCATC AGCCTGCTGA ACAACGAGGT GATCAAGGCC 120
GAGCAGCTGA ACATCAACAG CCAGAGCAAG TACACCAACC TCCAGAACCT GAAGATCACC180
GACAAGGTGG AGGACTTCAA GGAGGACAAG GAGAAGGCCA AGGAGTGGGG CAAGGAGAAG240
GAGAAGGAGT GGAAGCTTAC CGCCACCGAG AAGGGCAAGA TGAACAACTT CCTGGACAAC300
AAGAACGACA TCAAGACCAA CTACAAGGAG ATCACCTTCA GCATGGCCGG CAGCTTCGAG360
GACGAGATCA AGGACCTGAA GGAGATCGAC AAGATGTTCG ACAAGACCAA CCTGAGCAAC420
AGCATCATCA CCTACAAGAA CGTGGAGCCC ACCACCATCG GCTTCAACAA GAGCCTGACC480
GAGGGCAACA CCATCAACAG CGACGCCATG GCCCAGTTCA AGGAGCAGTT CCTGGACCGC540
GACATCAAGT TCGACAGCTA CCTGGACACC CACCTGACCG CCCAGCAGGT GAGCAGCAAG600
GAGCGCGTGA TCCTGAAGGT GACCGTCCCC AGCGGCAAGG GCAGCACCAC CCCCACCAAG660 ׳ GCCGGCGTGA TCCTGAACAA CAGCGAGTAC AAGATGCTGA TCGACAACGG CTACATGGTG '720
CACGTGGACA AGGTGAGCAA GGTGGTGAAG AAGGGCGTGG AGTGCCTCCA GATCGAGGGC780
ACCCTGAAGA AGAGTCTAGA CTTCAAGAAC GACATCAACG CCGAGGCCCA CAGCTGGGGC 840
<img file="IL115382A_D0005.tif" />
ATGAAGAACT ACGAGGAGTG GGCCAAGGAC CTGACCGACA GCCAGCGCGA GGCCCTGGAC .900
GGCTACGCCC GCCAGGACTA CAAGGAGATC AACAACTACC TGCGCAACCA GGGCGGCAGC960
GGCAACGAGA AGCTGGACGC CCAGATCAAG AACATCAGCG ACGCCCTGGG CAAGAAGCCC1020
ATCCCCGAGA ACATCACCGT GTACCGCTGG TGCGGCATGC CCGAGTTCGG CTACCAGATC . 1080
AGCGACCCCC TGCCCAGCCT GAAGGACTTC GAGGAGCAGT TCCTGAACAC CATCAAGGAG1140
GACAAGGGCT ACATGAGCAC CAGCCTGAGC AGCGAGCGCC TGGCCGCCTT CGGCAGCCGC1200
AAGATCATCC TGCGCCTGCA GGTGCCCAAG GGCAGCACCG GCGCCTACCT GAGCGCCATC1260
GGCGGCTTCG CCAGCGAGAA GGAGATCCTG CTGGACAAGG ACAGCAAGTA CCACATCGAC 1320 AAGGTGACCG AGGTGATCAT CAAGGGCGTG AAGCGCTACG TGGTGGACGC. CACCCTGCTG 1380 ACCAACTAGA TCTGAGCTC (2) INFORMATION FOR SEQ ID NO:25:
. (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 19 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear .
(ii) MOLECULE TYPE: peptide (ix) FEATURE: ...
(A) NAME/KEY: Peptide (B) LOCATION: 1.,19 (D) OTHER INFORMATION: /note= Secretion signal peptide to secrete VIP2 out of a cell (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:
Gly Trp' Ser Tip lie Phe Leu Phe Leu Leu Ser Gly Ala Ala Gly Val.
<sup>1 5</sup> 10 . 15
His Cys Leu (2) INFORMATION FOR SEQ ID NO:26:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2655 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid
V (A) DESCRIPTION: /desc = Synthetic.DNA' (iii) HYPOTHETICAL: NO
56.35 (ix) FEATURE:
(A) NAME/KEY: misc_feature (B) LOCATION: 1.2655 (D) OTHER INFORMATION: /note= maize optimized DNA sequence encoding VIPlA(a) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:
ATGAAGAACA TGAAGAAGAA GCTGGCCAGC GTGGTGACCT GCACGCTGCT GGCCCCCATG60
TTCCTGAACG GCAACGTGAA CGCCGTGTAC GCCGACAGCA AGACCAACCA GATCAGCACC120
ACCCAGAAGA ACCAGCAGAA GGAGATGGAC CGCAAGGGCC TGCTGGGCTA CTACTTCAAG180
GGCAAGGACT TCAGCAACCT GACCATGTTC GCCCCCACGC GTGACAGCAC CCTGATCTAC240
GACCAGCAGA CCGCCAACAA GCTGCTGGAC AAGAAGCAGC AGGAGTACCA GAGCATCCGC300
TGGATCGGCC TGATCCAGAG CAAGGAGACC GGCGACTTCA CCTTCAACCT GAGCGAGGAC360
GAGCAGGCCA TCATCGAGAT CAACGGCAAG ATCATCAGCA ACAAGGGCAA GGAGAAGCAG420
GTGGTGCACC TGGAGAAGGG CAAGCTGGTG CCCATCAAGA TCGAGTACCA GAGCGACACC480
AAGTTCAACA TCGACAGCAA GACCTTCAAG GAGCTGAAGC TTTTCAAGAT CGACAGCCAG540
AACCAGCCCC AGCAGGTGCA GCAGGACGAG CTGCGCAACC CCGAGTTCAA CAAGAAGGAG600
AGCCAGGAGT TCCTGGCCAA GCCCAGCAAG ATCAACCTGT TCACCCAGCA GATGAAGCGC660
GAGATCGACG AGGACACCGA CACCGACGGC GACAGCATCC CCGACCTGTG GGAGGAGAAC720
GGCTACACCA TCCAGAACCG CATCGCCGTG AAGTGGGACG ACAGCCTGGC TAGCAAGGGC780
TACACCAAGT TCGTGAGCAA CCCCCTGGAG AGCCACACCG TGGGCGACCC CTACACCGAC.840
TACGAGAAGG CCGCCCGCGA CCTGGACCTG AGCAACGCCA AGGAGACCTT CAACCCCCTG900
GTGGCCGCCT TCCCCAGCGT GAACGTGAGC ATGGAGAAGG TGATCCTGAG CCCCAACGAG960
AACCTGAGCA ACAGCGTGGA GAGCCACTCG AGCACCAACT GGAGCTACAC CAACACCGAG1020
GGCGCCAGCG TGGAGGCCGG CATCGGTCCC AAGGGCATCA GCTTCGGCGT GAGCGTGAAC . 1080
TACCAGCACA GCGAGACCGT GGCCCAGGAG TGGGGCACCA GCACCGGCAA CACCAGCCAG1140
TTCAACACCG CCAGCGCCGG CTACCTGAAC GCCAACGTGC GCTACAACftA CGTGGGCACC1200
GGCGCCATCT ACGACGTGAA GCCCACCACC AGCTTCGTGC TGAACAACGA CACCATCGCC1260
׳1
ACCATCACCG CCAAGTCGAA TTCCACCGCC CTGAACATCA GCCCCGGCGA GAGCTACCCC AAGAAGGGCC AGAACGGCAT CGCCATCACC AGCATGGACG ACTTCAACAG CCACCCCATC ACCCTGAACA AGAAGCAGGT GGACAACCTG CTGAACAACA AGCCCATGAT.GCTGGAGACC AACCAGACCG ACGGCGTCTA CAAGATCAAG GACACCCACG GCAACATCGT GACGGGCGGC GAGTGGAACG GCGTGATCCA GCAGATCAAG GCCAAGACCG.CCAGCATCAT CGTCGACGAC GGCGAGCGCG TGGCCGAGAA GCGCGTGGCC GCCAAGGACT ACGAGAACCC CGAGGACAAG ACCCCCAGCC TGACCCTGAA GGACGCCCTG AAGCTGAGCT ACCCCGACGA GATCAAGGAG ATCGAGGGCT TGCTGTACTA CAAGAACAAG CCCATCTACG AGAGCAGCGT GATGACCTAT CTAGACGAGA ACACCGCCAA GGAGGTGACC AAGCAGCTGA ACGACACCAC CGGCAAGTTC AAGGACGTGA GCCACCTGTA CGACGTGAAG CTGACCCCCA AGATGAACGT GACCATCAAG CTGAGCATCC TGTACGACAA CGCCGAGAGC AACGACAACA GCATCGGCAA GTGGACCAAC ACCAACATCG TGAGCGGCGG CAACAACGGC AAGAAGCAGT ACAGCAGCAA CAACCCCGAC GCCAACCTGA CCCTGAACAC CGACGCCCAG GAGAAGCTGA ACAAGAACCG CGACTACTAC ATCAGCCTGT ACATGAAGAG CGAGAAGAAC ACCCAGTGCG AGATCACCAT CGACGGCGAG ATATACCCCA TCACCACCAA GACCGTGAAC GTGAACAAGG ACAACTACAA GCGCCTGGAC ATCATCGCCC ACAACATCAA GAGCAACCCC ATCAGCAGCC TGCACATCAA GACCAACGAC GAGATCACCC TGTTCTGGGA CGACATATCG ATTACCGACG TCGCCAGCAT CAAGCCCGAG AACCTGACCG ACAGCGAGAT CAAGCAGATA TACAGTCGCT ACGGCATCAA GCTGGAGGAC GGCATCCTGA TCGACAAGAA AGGCGGCATC CACTACGGCG AGTTCATCAA CGAGGCCAGC TTCAACATCG AGCCCCTGCA GAACTACGTG ACCAAGTACG AGGTGACCTA CAGCAGCGAG CTGGGCCCCA ACGTGAGCGA CACCCTGGAG AGCGACAAGA TTTACAAGGA CGGCACCATC AAGTTCGACT TCACCAAGTA CAGCAAGAAC GAGCAGGGCC TGTTCTACGA CAGCGGCCTG AACTGGGACT TCAAGATCAA CGCCATCACC TACGACGGCA AGGAGATGAA CGTGTTCCAC CGCTACAACA AGTAG (2) INFORMATION FOR SEQ ID NO:27:
(i) SEQUENCE CHARACTERISTICS: .
(A) LENGTH: 1389 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single .
1320 .1380
1440
1500
1560
1620
1680
1740
1800 . 1860
1920
1980
2040
2100
2160
2220
2280
2340
2400
2460
2520
2580
2640
2655
5,635
2/ 82 3 5 1 1 ז<sup>55,</sup> (D) TOPOLOGY; linear . (ii) MOLECULE TYPE; other, nucleic acid (A) DESCRIPTION: /desc - Synthetic DNA (iii) HYPOTHETICAL: NO ' (ix) FEATURE:
(A) NAME/KEY: misc_feature (B) LOCATION: 1.1389 (D) OTHER INFORMATION: /note= maize optimized DNA sequence encoding VIP2A(a) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:
ATGAAGCGCA TGGAGGGCAA GCTGTTCATG GTGAGCAAGA AGCTCCAGGT GGTGACCAAG60
ACCGTGCTGC. TGAGCACCGT GTTCAGCATC AGCCTGCTGA ACAACGAGGT GATCAAGGCC120
GAGCAGCTGA ACATCAACAG CCAGAGCAAG TACACCAACC TCCAGAACCT GAAGATCACC180
GACAAGGTGG AGGACTTCAA GGAGGACAAG GAGAAGGCCA AGGAGTGGGG CAAGGAGAAG240
GAGAAGGAGT GGAAGCTTAC CGCCACCGAG AAGGGCAAGA TGAACAACTT CCTGGACAAC300
AAGAACGACA TCAAGACCAA CTACAAGGAG ATCACCTTCA GCATAGCCGG CAGCTTCGAG360
GACGAGATCA AGGACCTGAA GGAGATCGAC AAGATGTTCG ACAAGACCAA CCTGAGCAAC420
AGCATCATCA CCTACAAGAA CGTGGAGCCC AC.CACCATCG GCTTCAACAA GAGCCTGACC480
GAGGGCAACA CCATCAACAG CGACGCCATG GCCCAGTTCA AGGAGCAGTT CCTGGACCGC540
GACATCAAGT TCGACAGCTA CCTGGACACC CACCTGACCG CCCAGCAGGT GAGCAGCAAG600
GAGCGCGTGA TCCTGAAGGT GACCGTCCCC AGCGGCAAGG GCAGCACCAC CCCCACCAAG660
GCCGGCGTGA TCCTGAACAA CAGCGAGTAC AAGATGCTGA TCGACAACGG CTACATGGTG 720 CACGTGGACA AGGTGAGCAA GGTGGTGAAG AAGGGCGTGG AGTGCCTCCA GATCGAGGGC780 .ACCCTGAAGA AGAGTCTAGA CTTCAAGAAC GACATCAACG CCGAGGCCCA CAGCTGGGGC '840
ATGAAGAACT ACGAGGAGTG GGCCAAGGAC CTGACCGACA GCCAGCGCGA GGCCCTGGAC900
GGCTACGCCC GCCAGGACTA CAAGGAGATC AACAACTACC TGCGCAACCA GGGCGGCAGC960
GGCAACGAGA AGCTGGACGC CCAGATCAAG AACATCAGCG ACGCCCTGGG CAAGAAGCCC1020
ATCCCCGAGA ACATCACCGT GTACCGCTGG TGCGGCATGC CCGAGTTCGG CTACCAGATC1080
AGCGACCCCC TGCCCAGCCT GAAGGACTTC GAGGAGCAGT TCCTGAACAC CATCAAGGAG1140 •166.
GACAAGGGCT ACATGAGCAC CAGCCTGAGC AGCGAGCGCC TGQOOGOCTT CGGCAGCOSC 1200
AAGATCATCC TGCGCCTGCA GGTGCCCAAfi GGCAGCACTG GTGCCTACCT GAGCGCCATC 1260
GGCGGCTTCG CCAGCGAGAA GGAGATCCTG CTGGATAAGG ACAGCAAGTA CCACATCGAC . 1320
AAGGTGACOG AG0IGATCAT CAAGGGOGTG AAGCGCTACG TGGTGGACGC CACCCTGCTG 1380
ACCAACTAG ' 1389 (2) INFORMATION FOR SEQ 3 NO:28:
(i) sequence characteristics:
(A) LENGTH: 2378 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single.
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (ixj FEATURE:
(A) NAME/KEY: CDS (B) LOCATION: 3.2375 (D) OTHER INFOPMATION: /note״ Native DNA sequence encoding VIP3A(a) protein from AB88 as contained in pCIB7104” (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28;
AGATGAAC ATG AAC AAG AAT AAT ACT AAA TTA AGO ACA AGA GCC TTA CCA50
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala leu Pro . 510
AGT TTT ATP GAT TAT ITT AAT GGC ATT TAT GGA TTT GCC ACT GGT ATCi 98
Ser Phe lie Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly lie
20 25 .30
AAA GAC ATT ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT CTA '146
Lys Asp He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly AspLeu
40 45.
ACC CTA GAC GA ATT TTA AAG AAT CAG CAG TTA CIA AAT GAT ATP TCT194
Thr Leu Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp HeSer . 50 5560
GGT AAA TTG GAT GGG GTG AAT GGA AGC TEA AAT GAT CTT ATC GCA CAG242
Gly Lys Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin
7075
GGA AAC TTA AAT ACA GAA TTA TCT AAG GAA ATA TTA AAA ATT GCA AAT290
Gly Asn Leu Asn Thr Glu Leu Ser Lys Glu lie Leu lys He Ala Asn j 80 85 <sup>;</sup> 90 •167.
5.6.55
GM CM MT CM GTT TTA MT GAT GTT AAT AAC AM CTC GAT GCG ATA.
Glu Gin Asn Gin Vai Leu Asn Asp Vai Asn Asn Lys Leu Asp Ala He
100 105no
AAT ACG ATG CTT CGG GTA TAT CIA CCT AAA ATT ACC TCT ATG TIG AGT
Asn Thr Met Leu Arg Vai Tyr Leu Pro Lys lie Thr Ser .Met Leu Ser
115 . 120125
GAT GTA ATG AAA CM AAT TAT GCG CTA AGT CTG CM ATA GM TAC TTA
Asp Vai Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tvr Leu
130 135 . <sup>:</sup>140 .
AGT AAA CM TTG CM GAG ATT TCT GAT AAGTTG GAT ATT ATT AAT GTA
Ser . Lys Gin Leu Gin Glu lie Ser Asp Lys Leu Asp He He Asn Vai <sup>1</sup>45 .150155
AAT GTA CTT ATT AAC TCT ACA CTT ACT GAA ATT ACA CCT GCG TAT CAA
Asn Vai Leu Tie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin
160 155170
AfiG ATT AAA TAT GTG AAC GAA AAA ΤΊΤ GAG GAA TTA ACT ITT GCT ACA
Arg He Lys Tyr Vai Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr
I<sup>75</sup> 190 . 18519Q
GAA ACT AGT TCA AM GTA AM AAG GAT GGC TCT CCT GCA GAT ATTCTT
Glu Thr Ser Ser Lys Vai Lys Lys Asp Gly Ser Pro Ala Asp HeLeu
195 200205
GAT GAG TTA ACT GAG TTA ACT GM CTA GOG AAA AGT GTA ACA AAAAAT
Asp Glu Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Vai Thr LysAsn
210 215220
GMCTPGGATGOTTTTGAATTTTACCTTAATACATTCCACGATGTAATG
Asp Vai A3p Gly phe Glu Phe Tyr Leu Asn Thr Phe His Asp Vai Met <sup>22</sup>5 230235
GTA (XA AAT MT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GM
Vai Gly Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu 240 245250
TTA ATT ACT AAA GAA AAT GTG AAA ACA AGT GGC AGP GAG GPC GGA AAT Leu He Thr Lys Glu Asn Vai Lys Thr Ser Gly Ser Glu Vai Gly Asn <sup>255</sup> 250. 265270
GTT TAT AAC TTC TTA ATT GTA TTA ACA GCT CTG CAA GOO CAA GCT TTT Vai Tyr Asn Pha leu Tie Vai leu Thr Ala Leu Gin Ala Gin Ala Phe 275 280285
CTT ACT TTA ACA ACA TGC CGA AAA TTA TTA GGC TTA GCA GAT ATT GAT
Leu Thr, Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp 290 295300
33$
TAT ACT TCP ATT ATG MT GM CAT .TTA AAT AAG GAA AAA GAG GAA ITT Tyr Thr'.Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe
V *168305 310
AGA GTA AAC ATC CTC CCT ACA CTT TCT AAT ACT . TTT TCT AAT CCT AAT Arg Val Asn He feu Pro Hir feu Ser Asn Thr Phe Ser A8n Pro Asn 320 325 .330 • TAT GCA AAA GTT AAA GGA AGT GAT GAA GAT GCA AAG <sub>ATG</sub> ATT GTGGAA
Tyr Ala Ly3 Val Lys Gly Ser Asp Glu Asp Ala Lys Met He ValGlu
335. . 340 . 345350
GCT AAA CCA GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GATTCA
Ala Lys Pro Gly His Ala Leu He Gly Phe Glu Ils Ser Asn AspSer
355 360 .365
ATT ACA GTA TTA AAA GTA TAT GAG GCT AAG CTA AAA CAA AAT TAT CAA lie Thr Val feu Lys Val Tyr Glu Ala Lys Leu Lya Gin Asn Tyr Gin
370 375380
GTC GAT AAG ®T TCC TTA TCG GAA GTT ATT TAT GGT GAT ATG GAT AAA
Val Asp Lys Asp Ser feu Ser Glu Val lie Tyr Gly Asp Met Asp Lvs
385 390395
TTA TTG TGC CCA GAT CM TCT GAA CAA ATC TAT TAT ACA AAT AACATA
Leu Leu Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn AsnPe
400 405410
GTA TTT CCA AAT GAA TAT GTA ATT ACT ΆΑΑ AIT GAT TTC ACT AAAAAA
Val Phe Pro Asn Glu Tyr Val He The Lys He Asp Phe Thr LysLys <sup>415</sup> 420 425430
ATG AAA ACT TTA AGA TAT ®G GTA AGA GCG AAT TTT TAT GAT TCT TCT Met Lys Thr feu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser 435 440445
ACA GGA GAA AIT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG Thr Gly Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser. Ser Glu Ala
450 455. 460
GAG TAT AGA ACG TTA AGT GCT AAT &T ®T GGG GTG TAT ATG CCG TTA Glu Tyr Arg Thr feu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu <sup>455</sup> 470.475
GGT GTC ATC AGT GAA ACA ITT . TTG ACT CCG AIT AAT GGG TTT GGC CTC Gly Val He Ser Glu Thr Phe Leu Thr Pro He Aan Gly Phe Gly Leu
480 485.490
CAA GCT GAT GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCATAT
Gin Ala Asp Glu Asn Ser Arg Leu He Thr leu Thr Cys Lya SerTyr <sup>495</sup> 500 505 .510
TTA AGA GAA CTA CTG CTA GCA ACA GAC ΊΤΑ AGC AAT AAA GAA ACTAAA
Leu Arg Glu feu Leu leu Ala Thr Asp Leu Ser Aan Lya Glu ThrLys
515 520525
TTG ATC GTC CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGS
1010
1058
1106
1154
1202
1250
1298
1346
1394
1442
1490
1538
1586
1634
Leu lie Vai Pro Pro Ser Gly Phe He Ser A3n He Vai Glu A3n Gly 530 535/ 540
TCC ATA GAA GAG GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT1682
Ser lie Glu Glu Asp Asn Leu Glu Pro Tip Lys Ala Asn Asn LysAsn
545 550 555,.
GCG TAT GTA GAT. CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT1730
Ala Tyr Vai Asp His Thr׳ Gly Gly Vai Asn Gly Thr Lys Ala LeuTyr
560 565570
GTT CAT AAG GAC GGA GGA ATT TCA CAA KT ATT GGA GAT AAG TTA AAA1778
Vai His Lys Asp Gly Gly He Ser Gin Phe lie Gly Asp Lys Leu Lys
׳. 590 585 '580575
CCG AAA ACT GAG TAT GTA ATC CAA TAT ACT GTT AAA. GGA AAA CCT TCT. .1826
Pro Lys Thr Glu Tyr Vai lie Gin Tyr Thr Vai Lys Gly Lys Pro Ser
595 600605
ATT.CAT TTA AAA GAT GAA AAT ACT &Ά TAT ATT CAT TAT GAA GAT ACA1874.
He His Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu AspThr
610 615620
AAT AAT AAT TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA 1922
Asn Asn Asn Leu Glu Asp Tyr Gin Thr He Asn Lys Arg Phe ThrThr . 625 . 630635
GGA ACT GAT TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA1970
Gly Thr Asp Leu Lys Gly Vai Tyr Leu He Leu Lys $er Gin AsnGly
640 645650
GAT GAA GCT TGG GGA GAT AAC TTT ATT AIT TTG GAA ATT AGT OCT TCT2018
Asp Glu Ala Trp Gly Asp Asn Phe He lie Leu Glu He Ser ProSer
655 660 665670
GAA AAG TTA TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT2066
Glu Lys Leu Leu Ser Pro Glu Leu He Asn Hu: Asn Asn Trp ThrSer ’ 675 680685
ADG GGA TCA ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA2114
Thr Gly Ser Thr Asn He Ser Gly Asn Thr leu Thr Leu Tyr GinGly
690 695700
GGA CGA GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT2152
Gly Arg Gly He leu Lys Gin Asn Leu Gin Leu Asp Ser Phe SerThr
705 710715
TAT AGA GTG TAT TTT TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT ΑΘ2210
Tyr Arg Vai Tyr phe Ser Vai Ser Gly Asp Ala Asn Vai Arg lieArg
720 725730
MT ICT AGG GAA GTG TTA TTT ©A AAA AG^ TAT ATG AGC GGT GCT AAA2258
Asn Ser Arg Glu Vai Leu Phe Glu Lya Arg Tyr Met Ser Gly AlaLys
735 74 0 745•750
־170־
GAT GTT TCT GAA ATG CTC ACT. ACA AAA ITT GAG AAA GAT AAC TTT TAT 2306
Asp Val Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr
755 760 765 . ΑΊΑ GAG CCT TCT CAA GGG AAT AAT CTA TAI GGT GGT CCT ACT GIA CAT2354
He Glu Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He ValHis
770 775.780
TTT TAC GAT GTC TCT ATT AAG TAA2378
Phe Tyr Asp Val Ser He Lys
785.(2) INFORMATION FOR SEQ ID N0:29:
5-6-95 (i) SEQUENCE CHARACTERISTICS:
(A) IH4GT3. 789 amino acids (B) TYPE: amino acid .
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein .
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 1015 lie Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 2530
He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr leu 35 4045
Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp lie Ser Gly Lys 50 5560
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin Gly Asn 65 70 7580
Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys Ila Ala Asn Glu Gin 85 9095
Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr 100 105110
Met Leu Arg Val Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115. 120125
Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys
130 135140
Gin Leu Gin Glu lie Ser Asp Lys Leu Asp He lie Asn Val AsnVal
145 150 155160
Leu lie Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He
V
170 175
Lys Tyr Vai Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185190
Ser Ser Lys Vai Lys lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 .205 . Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Vai Thr Lys Asn Asp. Vai 210 215 . 220.
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Vai Met VaiGly
225 230 235240
Asa Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leulie
245 250255
Thr Lys Glu Asn Vai Lys Thr Ser Gly Ser Glu Vai Gly Asn Vai Tyr 260 265270
Asn Phe Leu He Vai Leu Thr Ala Leu Gin Ala Gin Ala Phe leu Thr 275 280285
Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp Tyr Thr 290 295300
Ser He Met Asn Glu Bis Leu Asn Lys Glu Lys Glu Glu Phe Arg Vai
305 310 315320
Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
325 330335
Lys Vai Lys Gly Ser Asp Glu Asp Ala Lys Met He Vai Glu Ala lys .340 345'.350
Pro Gly His Ala Leu He Gly Phe Glu He Ser Asn Asp Ser He Thr 355 360365
Vai Leu lys Vai Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Vai Asp 370 375380
Lys Asp Ser Leu Ser Glu Vai He Tyr Gly Asp Met Asp Lya LeuLeu
385 390 395400
Cys Pro Asp Gin Ser Glu Gin lie Tyr Tyr Thr Asn Asn He VaiPhe
405 410415
Pro Asn Glu Tyr Vai He Thr Lys lie Asp Phe Thr Lys Lys Met Lys 420 425430 .
Thr Leu Arg Tyr Glu Vai Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440445
Glu He Asp Leu Asn Lys Lys Lys Vai Glu Ser Ser Glu Ala Glu Tyr 450 455460 •72
Arg Thr Leu Ser Ala Asn Asp Asp Gly Vai Tyr Met Pro Leu GlyVai
465 470 475480
He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu GinAla . 485' . 490 ..'495.
Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 ' 510 . .
Glu Leu Leu Leu Ala Thr Asp Leu Ser ׳ Asn Lys Glu Thr Lys Leu He 515 ' 520 525 ׳
Vai Pro Pro Ser Gly Phe He Ser Asn He Vai Glu Asn Gly Ser lie 530 535540
Glu Glu Asp Asn Leu Glu Pro Tip Lys Ala Asn Asn Lys Asn Ala Tyr
545 550 555560
Vai Asp His Thr Gly Gly Vai Aan Gly Thr Ly3 Ala Leu Tyr Vai His
565 ' 570575
Lys Asp Gly Gly lie Ser Gin Phe He Gly Asp Lys Leu Ly3 Pro Lys 580 585590
Thr Glu Tyr Vai He Gin Tyr Thr Vai Lys Gly Lys Pro Ser lie His ' . 595 600605
Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615620
Asn Leu Glu Asp Tyr Gin Thr lie Asn Lya Arg Phe Thr Thr GlyThr
625 630 635640
Asp Leu Lys Gly Vai Tyr Leu He Leu Lys Sex Gin Asn Gly AspGlu
645 . 650¢55
Ala Trp Gly Asp Asn. Phe lie He Leu Glu He Ser Pro Ser Glu Lys 660 665670
Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Tip Thr Ser Thr Gly 675 680685
Ser Thr Asn lie Sex Gly A3n Thr Leu Thr Lieu Tyr Gin Gly Gly Arg 690 695 700.
Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr TyrArg
705 710 . 715720
Vai Tyr Phe Ser Vai Ser Gly Asp Ala Asn Vai Arg He Arg AsnSer
725 730735
Arg Glu Vai Leu Phe Glu Lys Arg Tyr Mat Ser Gly Ala Lys Asp Vai 740 . 745750
<img file="IL115382A_D0006.tif" />
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu
755 . 760 765
Leu Ser Gin Gly Asn Asn leu Tyr Gly Gly Pro He Val H13 Phe Tyr
770 775 780
Asp Vai Ser He Lys
785 .
(2) INFORMATION FOR SEQ ID NO:30i (i) SEQUENCE CHARACTERISTICS :
(A) LENGTH: 2403 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY; linear (11} MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc - <sup>,</sup>'Synthetic DNA״ (Hi) HYPOTHETICAL.: NO (ix) FEATURE!
(A) NAME/KEY: mi3c_feature (B) LOCATION: 11.2389 (D) OTHER INFORMATION: /note- maize optimized DNA sequence encoding VIP3A(a) (2d) SEQUENCE DESCRIPTION: SEQ ID NO:30:
GGATCCACCA ATGAACATGA ACAAGAACAA CACCAAGCTG AGCACCCGCG CCCTGCCGAG CTTCATCGAC TACTTCAACG GCATCTACGG CTTCGCCACC GGCATCAAGG ACATCATGAA CATGATCTTC AAGACCGACA CCGGCGGCGA CCTGACCCTG GACGAGATCC TGAAGaACCA GCAGCTGCTG AACGACATCA GCGGCAAGCT GGACGGCGTG AACGGCAGCC TGAACGACCT GA'ICGCCGAG GGCAACCTGA ACACCGAGCT GAGOAAGGAG ATCCTTAAGA TCGCCAACGA GCAGAACCAG GTGCTGAACG ACGTGAACAA CAAGCTGGAC GCCATCAACA CCATGCTGCG CGTGTACCTG CCGAAGATCA CCAGCATGCT GAGCGACCTG ATGAAGCAGA ACTACGCCCT GAGCCTGCAG ATCGAGTACC TGAGCAAGCA GCTGCAGSAfi ATCAGCGACA AGCTGGACAT CATCAACGTG AACGTCCTGA TCAACAGCAC CCTGACCGAG ATCACCCCGG CCTACCAGCG CATCAAGTAC GTGAACGAGA AGTTCGAAGA GCTGACCTTC GCCACCGAGA OCAGCAGCAA GGTGAAGAAG GACGGCAGCC CGGCOGACAT CCTGGACGAG CTGACCGAGC TGACCGAlSCT GGCCAAGAGC GTGACCAAGA ACGACGTGGA CGGCTTCGAq TTCTACCTGA ACACCTTCCA
2-50 ϊ, י י. . : י י . CGACGTGATG GTGGGCAACA ACCTGTTCGG CCECAGCGCC CTGAAGACCG CCA3CGAGCT 780
GAICACCAAG GAGAACGTGA AGACCAGCGG CAGCGAGGTG GGCAACGTOT ACAACTTCCT840
GATCGTGCTG ACCGCCCTGC AGGOCCAGGC CITCCTGACC CTGAOCACCT GTCGCAAGCT900
GCTGGGCCTG GCCGACATCG ACTACACCAG CAKAIGAAC GAGCACTTGA ACAAGGAGAA960
י'.'.'. י ' ' . '
GGAGGAGTTC CGCGTGAACA TCCTGCCGAC CCTGAGCAAC ACOTCAGCA ACCCGAACTA1020
CGCCAAGGTG AAGGGCAGCG ACGAGGACGC CAAGATGATC GTGGAGGCTA ASCCGGGCCA1080
CGCGTTGATC GGCTTCGAGA TCAGCAACGA CAGCATCAOC GTGCTGAAGG TGTACGAGGC1140
CAAGCTGAAG CAGAACTACC AGGTGGACAA GGACAGCITG AGCGAGGTGA TCTACGGCGA1200
CATGGACAAG CTGCTGTGTC CGGACCAGAG CGAfiCAAATC TACTACACCA ACAACATCGT1260
GTTCCCGAAC GAGTACGTGA TCACCAAGAT CGACTKXXl AAGAAfflT®1320
CTACGAGGTG ACCGCCAACT TCTACGACAG CAGCACCGGC GAGATCGACC TGAACAAGAA ' 1380 GAAGGTGGAG AGCAGCGAGG CCGAGTACCG CACCCTGAGC GCGAACGACG ACGGCGTCTA 1440 CATGCCACTG GGCG1GATCA GCGAGACCTT CCTGACCCCG ATCAACGGCT TTCGCCTGCA:1500
GGCCGACGAG AACAGCCGCC TGATCACCCT GACCTGTAAG AGCTACCTGC GCGAGCTGCT 1560 GCTAGCCAOC GACCTGAGGA ACAAGGAGAC CAAGCTGMC GKXX2&CGA GCGGCTTCAT ,1620
CAGCAACATC GTGGAGAACG GCAGCATC® GGAfiGACAAC CTGGABCCGT GGAAGGOCAA1680
CAACAAGAAC GCCTACGTGG ACCACAGCGG CGGCGTGAAC GGCACCAAGG CCCTGIACGT1740
I ' ' .' ;'
GGAiaAGGAC GGCGGCATCA CXXAGTTCAT CGGCSACAAG CTGAAGCCEA AGACCGAGTA1800
CGTGATpCAG TACACCGTGA AGGGCAAGCC ATCGOTCAC CTGAAGS10G AGAACACCGG1860
CTACATCCAC TAOGAGGACA CCAACAACAA CCWW3GAC TACCAGACCA TCAACAAGCG1920
CITCAOCAOC ggcaccgacc tgaagggcct GTACCTGATC ctgaagagcc AGAAOGQCGA . 1980
CGAGGC0TGG GGCGACAACT. TCATCATCCT GGAGAKAGC (XGAGCGAGA AGCTGCTGAG2040
CCCOGAGCTG atcaacacca ACAACTGGAC CAGCACCGGC agcaccaaca TCAGCGGCAA2100
CACCCTGACC CTGTACCAGG GCGGCCGCGG CMCCTGAAG CAGAACCTGC AGCTGGACAG2160
CTTCAG0ACC TACCGCGTGT ACTTCAGCCT GAGCGGCGAC GCCAACGTGC GCATCCGCAA2220
CAGCCGOGAG GTGCTGTTCG AGAAGAGGTA.CATGAGCGGC GCCAAGGACS TGAGCGAGAT 2280 GTTCACCACC AAGTTCGASk AGGfiCAACTT CIACATCGAG CTGAGCCAGG GCAACAACCT 2340 gtacggcggc CCGATCGlGC acttctacga cgtgagcatc aagttaacgt agagctcaga . 2400
TCT 2403 (2) INFCRMATICN FOR SEQ ID N0:31:
(i) SEQuEKE CHARACTERISTICS:
(A) LENGTH; 2612 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO .
י (ix) FEATURE:
(A) NAME/KEY: CDS (B) LOCATION: 118.2484 (D) OTHER INFORMATION: /note- Native DNA sequence encoding VU?3A(b) fran ΆΒ424 (xi) SEQUENCE DESCRIPTION: SEQ ID N0:31:
ATTGAAATTG ATAAAAAGTI ATGAGTGTTT AATAATCAGT AATTACCAAT AAAGAATTAA60
GAATACAAGT 5TACAAGAAA TAAGTGTTAC AAAAAATAGC TGAAAAGGAA GATGAAC117
ATG AAC AAG AAT AAT ACT AAA TTA AGO ACA AGA GCC TTA CCA AGT TTT165
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 790 . 795 800805
ATT GAT . TAT ITC AAT GGC ATT TAT GGA TIT (£C ACT GGT ATC AAA GAC213
He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He LysAsp
010 815820
ATT ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT OTA ACC CTA261
He Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu ThrLeu
825 830835
GAC GAA ATT TTA AAG AAT CAG CAG CTA CTA AAT GAT ATT TCT GGT AAA309
Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp lie Ser GlyLys
840 845850
TTG: GAT OGG GTG AAT GGA AGC TTA AAT CTT ATC GCA CAG GGA AAC357
Leu Asp Gly Val Asn GLy Ser leu. Asn Asp leu He Ala Gin GlyAsn
855 8608 55 ttaaatacagaattatctaaggaaatattaaaaattgcaaaigaacaa 405
Leu Asn Thr Glu Leu Ser Ly3 Glu He leu Ly3 He Ala Asn GluGin
870 875 880885
AAT. CAA GTT TTA AAT GAT GTT AAT AAC AAA CTC GAT GCG ATA AAT ACG453
1153
<img file="IL115382A_D0007.tif" />
Λ
56.$
Asn Gin Val Leu Asn Asp Val Asn Asn Lys
890 895
ATG CTT CGG GTA TAT CTA CCT.AAA ATT ACC Met Leu Arg Val Tyr Leu Pro Lys He Thr 905 910
Leu Asp Ala He Asn
Thr
TCT ATG TTG AGT GAT GTA Ser Met Leu Ser Asp Val 915.
ATG AAA CAA AAT TAT GCG CTA AGT CTG CAA ATA GAA TAC TTA AGT AAA
Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu SerLvs
920 925 , 93Q
CAA TTG CAA GAG ATT TCT. GAT AAG TTG GAT ATT ATT AAT GTA AATGTA
Gin Leu Gin Glu lie Ser Asp. Lys Leu Asp lie He Asn Val AsnVal <sup>935</sup> 940 .945
CTT ATT AAC TCT ACA׳ CTT ACT GAA ATT ACA CCT GCG TAT CAA AGGATI’
Leu, He Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin Aralie
965 960 955׳950
AAA TAT GTG AAC GAA AAA TTT GAG GAA TTA ACT TTT GCT ACA GAAACT
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr GluThr <sup>970</sup> 975.980
AGT TCA AAA GTA AAA AAG GAT GGC TCT CCT GCA GAT ATT CGT GATGAG
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Arg AspGlu
985 990995
TTA ACT GAG TTA ACT GAA CTA GCG AAA AGT GTA ACA AAA AAT GATGTG
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn AspVal ' <sup>1000</sup> .10051010
GAT GGT TTT GAA TTT TAC CTT AAT ACA TTC.CAC GAT .GTA ATG GTA GGA
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
1015 1020 1025'
AAT AAT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GAA TTA׳ATT
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leulie <sup>1</sup>030 1035 1040 .104;
ACT AAA GAA AAT GTG AAA ACA AGT GGC AGT GAG GTC GGA AAT GTT TAT
Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr <sup>1050</sup> 1055 1060
AAC TTC CTA ATT GTA TTA ACA GCT CTG CAA GCA AAA GCT ΤΓΤ CTT ACT
Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr
1065 1070 <sup>L</sup> 1075
TTA ACA CCA TGC CGA AAA TTA TTA GGC TTA GCA GAT. ATT GAT TAT ACT
Leu Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr
1080 1085 1090
TCT ATT ATG AAT GAA. CAT TTA AAT AAG GAA AAA GAG GAA TTT AGA GTA
Ser lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Ara Val
1095 . 1100 Π05
1029
1077
-'<sup>7</sup>7 1 1 5 3 8 2 7 2
AAC ATC CTC CCT ACA CTT TCT AAT ACT TTT TCT AAT CCT AAT TAT GCA 1125
Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Al 9
1110 .1115 1120 1125
AAA GTT AAA GGA AGT GAT GAA GAT GCA AAG ATG ATT GTG GAA GCT AAA1173
Lys Vai Lys Gly Ser Asp Glu Asp Ala Lys Met lie Vai Glu AlaLys
1130. 1135 . 1140
CCA GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GAT TCA ATT ACA!221
Pro Gly His Ala Leu lie Gly Phe Glu He Ser Asn Asp Ser HeThr
1145' ... . 1150 .'1155
GTA TTA.AAA GTA TAT. GAG GCT AAG CTA AAA CAA AAT TAT CAA GTC GAT1269
Vai Leu Lys Vai Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin VaiAsp.
1160 11651170
AAG GAT . TCC TTA TCG GAA GTT ATT TAT GGC GAT ATG GAT AAA TTA TTG1317
Lys Asp Ser Leu Ser Glu Vai He Tyr Gly Asp Met Asp Lys LeuLeu
1175 11801185
TGC CCA GAT CAA TCT GGA CAA ATC TAT' TAT ACA AAT AAC ATA GTA TTT1365
Cys Pro Asp Gin Ser Gly Gin He Tyr Tyr Thr Asn Asn lie VaiPhe
1190 ’ 1195 1200 1205 '
CCA AAT GAA TAT GTA ATT ACT AAA ATT GAT TTC ACT AAA AAA ATG AAA1413
Pro Asn Glu Tyr Vai He Thr Lys' He Asp Phe Thr Lys Lys MetLys
1210 12151220
ACT TTA AGA TAT GAG GTA ACA GCG AAT TTT TAT GAT TCT TCT ACA GGA1461
Thr Leu Arg Tyr Glu Vai Thr Ala Asn Phe Tyr Asp Ser Ser ThrGly
1225 . 1230 1235 '
GAA ATT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG GAG TAT1509
Glu He Asp Leu Asn Lys Lys Lys Vai Glu Ser Ser Glu Ala GluTyr
1240 12451250
AGA ACG TTA AGT GCT AAT GAT GAT GGG GTG TAT ATG CCG TTA GGT GTC1557
Arg Thr Leu Ser Ala Asn Asp Asp Gly Vai Tyr Met Pro Leu GlyVai
1255 12601265
ATC AGT GAA ACA TTT TTG: ACT CCG ATT AAT GGG TTT GGC CTC CAA GCT ' 1605
He Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu Gin Ala 1270 1275 . 12801285
GAT GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCA TAT TTA AGA1653
Asp Glu. Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr LeuArg
1290 1295.1300
GAA CTA CTG CTA GCA ACA GAC TTA AGC AAT AAA GAA ACT AAA TTG ATC 1701 .׳
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys LeuHe . 1305 1310 1315
GTC CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGG TCC ATA1749
Vai Pro Pro Ser Gly Phe He Ser Asn He Vai Glu Asn Gly Ser He
1 5 3 8 2 /2
GAA GAG. GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT GCG׳ TAT 1797
Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr
1335 1340 1345
GTA GAT CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT GTT CAT1845
Vai Asp His Thr Gly Gly Vai Asn Gly Thr Lys Ala Leu Tyr VaiHis
1350 1355 13601365
AAG GAC GGA GGA ATT TCA CAA TTT ATT GGA GAT AAG TTA AAA CCG AAA1893
Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys ProLys • . 1370 . 1375 . 1380 .
ACT GAG TAT GTA ATC CAA TAT ACT GTT AAA GGA AAA CCT TCT ATT CAT1941
Thr Glu Tyr Vai He Gin Tyr Thr Vai Lys Gly Lys Pro Ser lieHis
1385 1390 . . 1395TTA AAA GAT GAA AAT ACT GGA TAT ATT CAT TAT GAA GAT ACA AAT AAT1989
Leu Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr AsnAsn
' ' י 1410 . 1405 1400
AAT TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA GGA ACT2037
Asn Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr GlyThr
1415 14201425
5.6.55
GAT TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA GAT GAA2085
Asp Leu Lys Gly Vai Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu
1430 ; 1435 14401445
GCT TGG GGA GAT AAC TTT ATT ATT TTG GAA ATT AGT CCT TCT GAA AAG2133
Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys
1450 . 1455 .1460
TTA TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT ACG GGA2181
Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn׳ Trp Thr Ser Thr Gly
1465 14701475' . TCA ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA GGA CGA 2229
Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg ' 1480 . 1485 . 1490
GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT TAT AGA2277
Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr TyrArg
1495 ' 1500. ' 1505 . GTG TAT TTC TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT AGA AAT TCT2325
Vai Tyr Phe Ser Vai Ser Gly Asp Ala Asn Vai Arg lie Arg AsnSer
1510 ' 1515 1520.1525
AGG GAA GTG TTA TTT GAA AAA AGA TAT ATG AGC GGT GCT AAA GAT GTT2373
Arg Glu Vai Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys AspVai
1530. ' 15351540
TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT AAC TTC TAT ATA GAG2421
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr lie Glu
5382/2 1 1
׳ 1555 15501545
CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT ATT GTA CAT TTT TAC2469
Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro lie Val His Phe Tyr <sup>;</sup> 1560 '. 15651570'
GAT GTC TCT ATT AAG TAAGATCGGG ATCTAATATT AACAGTTTTT׳ AGAAGCTAAT 2524 Asp Val Ser Ile Lys
- 1575‘
TCTTGTATAA TGTCCTTGAT TATGGAAAAA CACAATTTTG. TTTGCTAAGA TGTATATATA . .2584
GCTCACTCAT TAAAAGGCAA TCAAGCTT2612 (2) INFORMATION FOR SEQ ID NO:32:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 789 amino acids' (B) TYPE: amino acid ; .
. . (D) TOPOLOGY: linear' .
(ii) MOLECULE TYPE: protein ;(xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe <sup>1</sup> ί <sup>5</sup> 1 1015 lie Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly lie Lys Asp
25:30 lie Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40'45
Asp Glu lie Leu Lys Asn Gin Gin Leu Leu Asn Asp He Ser Gly Lys 50 5560
Leu Asp: Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 ' . 70 . 75 .80
Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys lie Ala Asn Glu Gin
. י' 95 . , . 90 ' 35׳
Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr . 100 <sup>:</sup> 105 .no
Met Leg Arg Val Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val ;115 120125 '
Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu Ser Lys 130 135 ; 140
Gin Leu Gin Glu lie Ser Asp Lys Leu Asp He He Asn Val Asn Val
.160 155 150 ׳145
115382/z
5.6.35
<td> Leu He Asn Ser Thr Leu Thr Glu He</td><td colspan="2"> Thr Pro Ala Tyr Gin Arg lie</td>
<td> מ 165</td><td> 170 '</td><td> 175</td>
<td> Lys Tyr Val Asn Glu Lys Phe Glu Glu 180 ' 185</td><td colspan="2"> Leu Thr.Phe Ala Thr Glu Thr 190</td>
<td> Ser Ser Lys Val Lys Lys Asp Gly Ser 195 200</td><td colspan="2"> Pro Ala Asp lie Arg Asp Glu 205</td>
<td> Leu Thr Glu Leu Thr Glu Leu Ala. Lys . -.210 ' 215 -</td><td colspan="2"> Ser Val Thr Lys Asn Asp Val <sup>220</sup></td>
<td> Asp Gly Phe Glu Phe Tyr Leu Asn Thr</td><td colspan="2"> Phe His Asp Val Met Val Glv</td>
<td> 225 230</td><td> 235</td><td> 240</td>
<td> Asn Asn Leu Phe Gly Arg. Ser Ala Leu 245</td><td colspan="2"> Lys Thr Ala Ser Glu Leu He 250 255</td>
<td> Thr Lys. Glu Ash Val Lys Thr Ser Gly 260 265</td><td colspan="2"> Ser Glu Val Gly Asn Val Tyr 270</td>
<td> Asn Phe Leu He Val Leu Thr Ala Leu 275 280</td><td colspan="2"> Gin Ala Lys Ala PheLeu Thr 285</td>
<td> Leu Thr Pro Cys Arg Lys Leu Leu Gly 290 295</td><td colspan="2"> Leu Ala Asp lie Asp Tyr Thr 300</td>
<td> Ser He Met Asn Glu His Leu</td><td> Asn Lys Glu Lys Glu Glu Phe Arg Val</td>
<td> 305 310</td><td> 315 320</td>
<td> Asn He Leu Pro Thr Leu Ser 325</td><td> Asn Thr Phe Ser.Asn Pro Asn Tyr Ala 330 335</td>
<td> Lys Val Lys Gly Ser Asp Glu ׳340</td><td> Asp Ala Lys Met He Val Glu Ala Lys 345 350 .</td>
<td> Pro' Gly His Ala Leu .He Gly 355 .</td><td> Phe Glu lie Ser Asn Asp Ser lie Thr 300 365</td>
<td> Val Leu Lys Val Tyr Glu Ala 370 . 375</td><td> Lys Leu Lys Gin Asn Tyr Gin Val Asp 380</td>
<td> Lys Asp Ser Leu Ser Glu Val 385 390</td><td> He Tyr Gly Asp Met Asp Lys Leu Leu 395 400</td>
<td> Cys Pro Asp Gin Ser Gly Gin 405 .</td><td> He Tyr Tyr Thr Asn Asn He Val' Phe 410 415</td>
<td> Pro Asn Glu Tyr Val He Thr 420</td><td> Lys He Asp Phe Thr Lys Lys Met Lys 425 '430</td>
<td> Thr Leu Arg Tyr Glu Val Thr 435</td><td> Ala Asn Phe Tyr Asp Ser Ser Thr Gly 440 445</td>
Glu He Asp Leu Asn Lys Lys Lys Vai Glu Ser Ser Glu Ala Glu Tyr
460 . ' 455 . '׳450
Arg Thr Leu Ser Ala Asn Asp Asp Gly Vai Tyr Met Pro.Leu Gly Vai 465 470 475 480
He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 . 490495
Asp Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr Leu Ara .510 > <sub>:</sub> י 505 ־ .־ ' 500 . .
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520. 525
Vai Pro Pro Ser Gly Phe He Ser Asn lie Vai Glu Asn Gly Ser lie 530, 535540
Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn AlaTyr
545 . 550 555560
Val Asp His Thr Gly Gly Vai Asn Gly Thr Lys Ala Leu Tyr VaiHis
565 570575.
Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585590
Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 .605
Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn • 610 615620
Asn Leu Glu Asp Tyr Gin Thr He Asn Lys Arg Phe Thr Thr Gly Thr <sup>625</sup> 630 635 . 640
Asp Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn' Gly Asp Glu 645 650 .655
Ala Trp Gly Asp Asn Phe He He Leu Glu lie Ser Pro Ser Glu Lys-
670׳ 665660
Leu Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser ThrGly
675' 680 .685
Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly GlyAra
690 695 .700
Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr TyrArg
705 710 715720
Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser
725 . 730 ' 735
Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val
740 745 . .'.. 750
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr lie Glu '.755 760 ' 765
Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr <sup>770</sup> 775 . 780
Asp Val Ser lie Lys .785 (2) INFORMATION FOR SEQ ID NO:33:
(i) SEQUENCE CHARACTERISTICS:' . .(A) LENGTH: 30 base׳pairs (B) TYPE: nucleic acid .
(C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = forward primer used to make PCIB5526 (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:
GGATCCACCA TGAAGACCAA CCAGATCAGC (2) INFORMATION FOR SEQ ID NO:34:
(i) SEQUENCE. CHARACTERISTICS:.
(A) LENGTH; 15 base pairs :
(B) TYPE: nucleic acid <sup>,</sup>'.(Ο) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A)' DESCRIPTION: /desc = reverse primer used to make pCIB5526 (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:
AAGCTTCAGC TCCTT (2) INFORMATION FOR SEQ ID NO:35:
1 5 3 8 2 / 2 ' (i) SEQUENCE CHARACTERISTICS:
(A) .LENGTH; 2576 base pairs ' (B) TYPE: nucleic acid
:.(C) STRANDEDNESS: single ; (D) TOPOLOGY: linear ' (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = Synthetic DNA (iii) HYPOTHETICAL: NO (ix) FEATURE:' ' (A) NAME/KEY: CDS . ' (B) LOCATION: 9.2564 .
(D) OTHER INFORMATION: /note־ Maize optimized sequence encoding VIPlA(a) with the Bacillus secretion signal removed as contained in pCIB5526 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:
5-6.¢
GATCCACC ATG AAG ACC AAC CAG ATC AGC ACC ACC CAG AAG AAC CAG CAG Met Lys Thr Asn Gin He Ser Thr Thr Gin Lys Asn Gin Gin 825 830 835
<td colspan="2"> AAG GAG</td><td colspan="4"> ATG GAC CGC AAG</td><td colspan="2"> GGC CTG</td><td colspan="8"> CTG GGC TAC TAC TTC AAG GGC AAG</td><td rowspan="3"> 98</td>
<td rowspan="2"> Lys</td><td rowspan="2"> Glu</td><td rowspan="2"> Met</td><td colspan="2" rowspan="2"> Asp Arg 840</td><td rowspan="2"> Lys</td><td rowspan="2"> Gly</td><td rowspan="2"> leu</td><td rowspan="2"> Leu</td><td colspan="7"> Gly Tyr Tyr Phe Lys Gly Lys</td>
<td> 845</td><td colspan="6"> 850</td>
<td> GAC</td><td> TTC</td><td> AGC</td><td> AAC</td><td> CTG</td><td> ACC</td><td> ATG</td><td> TTC</td><td> GCC</td><td> CCC</td><td> ACG</td><td> CGT</td><td colspan="2"> GAC AGC</td><td> ACC</td><td> CTG</td><td> 146</td>
<td> Asp</td><td> Phe</td><td colspan="2"> Ser.Asn</td><td> Leu</td><td> Thr</td><td> Met</td><td> Phe</td><td> Ala</td><td> Pro</td><td> Thr</td><td colspan="3"> Arg Asp Sep</td><td> Thr</td><td> Leu</td><td></td>
<td></td><td></td><td></td><td> 855</td><td></td><td></td><td></td><td></td><td> 860</td><td></td><td></td><td></td><td></td><td> 865</td><td></td><td></td><td></td>
<td> ATC</td><td> TAC</td><td> GAC</td><td> CAG</td><td> CAG</td><td> ACC</td><td> GCC</td><td> AAC</td><td> AAG</td><td colspan="2"> CTG CTG</td><td colspan="3"> GAC AAG AAG</td><td> CAG</td><td> CAG</td><td> 194</td>
<td> He</td><td colspan="2"> Tyr Asp</td><td> Gin</td><td> Gin</td><td> Thr</td><td> Ala</td><td> Asn</td><td> Lys</td><td> Leu</td><td> Leu</td><td> Asp</td><td colspan="2"> Lys Lys</td><td> Gin</td><td> Gin</td><td></td>
<td></td><td></td><td> 870</td><td></td><td></td><td></td><td></td><td> 875</td><td></td><td></td><td></td><td></td><td> 880</td><td></td><td></td><td></td><td></td>
<td> GAG</td><td> TAC</td><td> CAG</td><td colspan="3"> AGC ATC CGC</td><td> TGG</td><td> ATC</td><td> GGC</td><td> CTG</td><td> ATC</td><td> CAG</td><td> AGC</td><td colspan="2"> AAG .GAG</td><td> ACC</td><td> 242</td>
<td colspan="2"> Glu Tyr</td><td> Gin</td><td> Ser</td><td colspan="3"> He Arg Trp</td><td> He</td><td> Gly</td><td> Leu</td><td> He</td><td> Gin</td><td> Ser</td><td> Lys</td><td> Glu</td><td> Thr</td><td></td>
<td></td><td> 885</td><td></td><td></td><td></td><td></td><td> 890</td><td></td><td></td><td></td><td></td><td> 895</td><td></td><td></td><td></td><td></td><td></td>
<td> GGC</td><td> GAC</td><td> TTC</td><td> ACC</td><td> TTC</td><td> AAC</td><td> CTG</td><td> AGC</td><td> GAG</td><td> GAC</td><td> GAG</td><td> CAG</td><td> GCC</td><td> ATC</td><td> ATC</td><td> GAG</td><td> 290</td>
<td colspan="2"> Gly Asp</td><td> Phe</td><td> Thr</td><td> Phe</td><td> Asn</td><td> Leu</td><td> Ser</td><td colspan="2"> Glu Asp</td><td> Glu</td><td> Gin</td><td> Ala</td><td> He</td><td> lie</td><td> Glu</td><td></td>
<td> 900</td><td></td><td></td><td></td><td></td><td> 905</td><td></td><td></td><td></td><td></td><td> 910</td><td></td><td></td><td></td><td></td><td> 915</td><td></td>
<td> ATC</td><td> AAC</td><td> GGC</td><td> AAG</td><td> ATC</td><td> ATC</td><td> AGC</td><td> AAC.</td><td> AAG</td><td colspan="2"> GGC.AAG</td><td> GAG</td><td> AAG</td><td> CAG</td><td> GTG</td><td> GTG</td><td> 338</td>
<td> He</td><td> Asn</td><td> Gly</td><td> Lys</td><td> He</td><td> He</td><td> Ser</td><td> Asn</td><td> Lys</td><td colspan="2"> Gly Lys</td><td> Glu</td><td> Lys</td><td> Gin</td><td> Val</td><td> Val</td><td></td>
<td></td><td></td><td></td><td></td><td> 920</td><td></td><td></td><td></td><td></td><td> 925</td><td></td><td></td><td></td><td></td><td> 930</td><td></td><td></td>
<td> CAC</td><td> CTG</td><td> GAG</td><td> AAG</td><td> GGC</td><td> AAG</td><td> CTG</td><td> GTG</td><td> CCC</td><td colspan="2"> ATC. AAG</td><td> ATC</td><td> GAG</td><td> TAC</td><td> CAG</td><td> AGC</td><td> 386</td>
<td> His</td><td> Leu</td><td> Glu</td><td colspan="3"> Lys Gly Lys</td><td> Leu</td><td> Val</td><td> Pro</td><td colspan="2"> lie Lys</td><td> He</td><td> Glu</td><td> Tyr</td><td> Gin</td><td> Ser</td><td></td>
<td></td><td></td><td></td><td> 935</td><td></td><td></td><td></td><td></td><td> 940</td><td></td><td></td><td></td><td></td><td> 945</td><td></td><td></td><td></td>
<td> GAC</td><td> ACC</td><td> AAG</td><td colspan="3"> TTC AAC ATC</td><td> GAC</td><td> AGC</td><td> AAG</td><td> ACC</td><td> TTC</td><td colspan="3"> AAG GAG CTG</td><td> AAG</td><td> CTT</td><td> 434</td>
V
184 Asp Thr Lys Phe Asn lie Asp Ser Lys Thr Phe. Lys Glu Leu Lys Leu
950 ..;. 955 . ' . 960
TTC AAG ATC GAC AGC CAG AAC CAG CCC CAG CAG GTG CAG .CAG GAC GAG 482
Phe Lys lie Asp Ser Gin Asn Gin Pro Gin Gin Val Gin Gin Asp Glu 965 ' 970975
CTG CGC AAC CCC GAG TTC AAC AAG AAG GAG AGC CAG GAG TTC CTG GCC 530 Leu Arg Asn Pro Glu Phe Asn Lys Lys Glu Ser Gin Glu Phe Leu Ala 980 . 985 . , 990 .995
AAG CCC AGC AAG ATC AAC CTG TTC ACC. CAG CAG ATG AAG CGC GAG ATC : 578
Lys Pro Ser/Lys lie Asn Leu Phe Thr Gin Gin Met Lys Arg Glu lie
1010׳ 10051000
GAC GAG GAC ACC GAC ACC GAC GGC GAC AGC ATC CCC GAC CTG. TGG GAG '626 Asp Glu Asp Thr Asp Thr Asp. Gly. Asp Ser He'Pro Asp Leu Trp . Glu
1015 1020 .1025
GAG AAC GGC TAC ACC ATC CAG AAC CGC ATC GCC GTG AAG׳ TGG GAC GAC ‘674
Glu Asn Gly Tyr Thr He Gin Asn Arg He Ala Val Lys Trp Asp Asp 1030 10351040
AGC CTG GCT AGC AAG GGC TAC ACC AAG TTC GTG AGC AAC CCC CTG GAG 722 Ser Leu Ala Ser Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu
1045 10501055
AGC CAC ACC GTG GGC GAC CCC TAC ACC GAC TAC GAG AAG GCC GCC CGC 770 Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg 1060 1065 <sub>t</sub> 10701075
GAC CTG GAC CTG AGC AAC GCC AAG GAG ACC TTC .AAC CCC CTG GTG GCC 818
Asp Leu Asp Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala 1080 10851090
GCC TTC CCC AGC GTG AAC GTG AGC ATG GAG AAG. GTG ATC CTG AGC CCC 866
Ala Phe Pro Ser Val Asn Val Ser Met Glu Lys Val lie Leu Ser Pro 1095 1100 .1105
AAC GAG AAC CTG AGC AAC AGC GTG GAG AGC CAC TCG AGC ACC AAC TGG 914
Asn Glu .Asn Leu Ser Asn Ser Val Glu Ser His Ser. Ser Thr Asn Trp 1110 11151120
AGC TAC ACC AAC ACC GAG GGC GCC AGC GTG GAG GCC GGC ATC GGT CCC 962 Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val Glu Ala Gly lie Gly Pro .
1125 11301135
AAG GGC ATC AGC TTC GGC GTG AGC GTG AAC TAC CAG CAC AGC GAG ACC 1010 Lys Gly He Ser Phe Gly Val Ser Val Asn Tyr Gin His Ser Glu Thr 1140 1145 1150 1155
GTG GCC CAG GAG TGG GGC ACC AGC ACC GGC AAC ACC AGC CAG TTC AAC 1058 Val Ala Gin Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gin Phe Asn
1170 . ׳11651160
-1.85-' ACC GCC AGC GCC GGC TAC CTG AAC GCC AAC GTG CGC TAC AAC AAC GTG 1106
Thr Ala Ser Ala Gly Tyr Leu Asn Ala fen;Val Arg Tyr Asn Asn Val
־ 1185 . . 1180 <sup>1175</sup>
GGC ACC GGC GCC ATC TAC GAC GTG AAG CCC ACC ACC AGC TTC GTG CTG1154
Gly Thr Gly Ala He Tyr Asp Val Lys Pro Thr Thr Ser Phe ValLeu
1190 .: .1195 . ..1200
AAC AAC GAC ACC ATC GCC ACC ATC ACC GCC. AAG TCG AAT TCC ACC GCC1202
Asn Asn Asp Thr lie Ala Thr lie Thr Ala Lys Ser Asn Ser ThrAla
1205 . 1210 . . ; 1215
CTG AAC ATC AGC CCC GGC GAG AGC TAC CCC AAG AAG GGC CAG AAC GGC1250
Leu Asn He Ser . Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gin Asn Gly
1220 . 1225 1230 . 1235
ATC GCC ATC ACC AGC ATG GAC GAC TTC AAC AGC CAC CCC ATC ACC CTG . 1298
He Ala lie Thr Ser Met Asp Asp.Phe Asn Ser His Pro .lie Thr Leu
1240 . 1245 : . . . . 1250
AAC AAG AAG CAG GTG GAC AAC CTG CTG AAC AAC AAG CCC ATG ATG CTG1346
Asn Lys Lys Gin Val Asp Asn Leu Leu Asn Asn Lys Pro Met MetLeu
1255 12601265
GAG ACC AAC CAG ACC GAC GGC GTC TAC AAG ATC AAG GAC ACC CAC GGC1394
Glu Thr Asn Gin Thr Asp Gly Val Tyr Lys He Lys Asp Thr HisGly
1210 1215!280
AAC ATC GTG ACG GGC GGC GAG TGG AAC GGC GTG ATC CAG CAG ATC AAG1442
Asn He. Val Thr Gly Gly Glu Trp Asn Gly Val lie Gin Gin HeLys
1285 12901295
GCC AAG ACC GCC AGC ATC ATC GTC GAC GAC GGC GAG CGC GTG GCC GAG1490
Ala Lys .Thr Ala Ser He He Val Asp Asp Gly Glu Arg Val AlaGlu
1300 . 1305 1310 . 1315 .
AAG CGC GTG GCC GCC AAG GAC TAC GAG AAC CCC GAG GAC AAG ACC CCC1538
Lys Arg Val Ala Ala Lys . Asp Tyr Glu Asn Pro Glu Asp Lys ThrPro .
1320. .:. 13251330
AGC CTG ACC CTG AAG GAC GCC CTG AAG CTG AGC TAC CCC GAC GAG ATC1586
Ser Leu Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu lie
1335 13401345 .AAG GAG ATC GAG GGC TTG CTG TAC TAC AAG AAC. AAG CCC ATC TAC GAG1634
Lys Glu lie Glu Gly Leu Leu Tyr Tyr Lys fen Lys Pro lie Tyr Glu ' . 1350 1355 1360 .
AGC AGC GTG ATG ACC TAT CTA GAC GAG AAC ACC GCC AAG GAG GTG ACC1682
Ser Ser Val Met Thr Tyr Leu Asp Glu fen. Thr Ala Lys Glu Val Thr
1365 ' 13701375
AAG CAG: CTG AAC GAC ACC ACC GGC AAG TTC AAG GAC GTG AGC CAC CTG1730
Lys Gin Leu Asn Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu
5.6.55
TAC GAC.GTG
Tyr Asp Val ' ATC CTG TAC He Led
ACC AAC
Thr
AGC
Ser
Tyr
Asn
AAG
Lys
CTG ACC
Leu Thr 1400
GAC.
Asp Asn Ala
1415
ACC AAC
Thr Asn 1430
AGC AAC
Ser Asn 1445
GAG . Glu .'1460 .
AGC
Ser
CCC
Pro
Leu
CAC
His
AAC GCC
AAG
Lys
CTG
Leu
GAG
Glu
ATC lie
AAG
Lys
ACC
Thr
GAC ATC
Asp
CCC AAG ATG AAC GTG ACC ATC AAG CTG AGC Pro Lys Met
Asn Val Thr He Lys Leu Ser <sup>1405</sup> 1410
1778
GAG AGC
Glu
Ser
AAC 1 Asn . 1420
GAC AAC AGC ATC GGC AAG TGG Asp Asn Ser lie Gly Lys Trp <sup>1</sup> 1425
1826
ATC.GTG. AGC He
Val Ser
Gly. Gly Asn
1435
AAC GGC AAG AAG Asn Gly Lys Lys 1440
CAG
Gin
TAC
Tyr
1874
AAC
Asn
AAC
Asn
AAC
Asn
CCC
Pro
GAC GCC AAC
Asp Ala Asn 1450 '
CTG ACC
Leu Thr Leu
CTG
AAC ACC GAC
Asn Thr Asp 1455
GCC
Ala
CAG
Gin
1922
AAG
Lys Asn Arg Asp . 1465
AAC CGC GAC
TAC TAC ATC .
Tyr Tyr lie .
1470
AGC
Ser
CTG TAC
Leu Tyr
ATG
Met.
AAG
Lys 1475
1970
ACC CAG
Thr Gin 1480
ACC . Thr : 1495 lie
1510
ATC lie
ATC
He’ Lys Thr 1525
AAG ACC
TGC
Cys
GAG
Glu lie Thr He 1485
ATC ACC ATC
GAC GGC
Asp Gly
GAG
Glu
ATA ' lie <sup>1 </sup>1490
TAC
Tyr
2018
AAG
Lys
GCC
Ala
AAC
Asn
ACC
Thr
GTG
Val
AAC
Asn
GTG AAC
Val Asn 1500
GAC AAC
AAG
Lys Asp Asn
TAC
Tyr Lys
1505
AAG
CGC
Arg
2066
CAC-AAC His
GAC
Asp
Asn
ATC . lie 1515
AAG
Lys
AGC
Ser
AAC CCC
Asn
Pro
ATC He 1520
AGC
Ser
AGC
Ser
CTG
Leu
2114
GAG .
Glu 1530
ATC
He
ACC
Thr
CTG
Leu
TIC
Phe
GAC GAC
TGG
Trp Asp Asp 1535
ATA
He
TCG
Ser
2162
ATT . He <sup>1 </sup>1540
ACC GAC GTC
Thr Asp Val
GCC
Ala
AGC Ser 1545 . .
ATC lie
AAG
Lys
CCC
Pro Glu
GAG
AAC י
Asn 1550
CTG ACC
Leu Thr
GAC
Asp
AGC.GAG Ser
2210
Glu
1555
ATC AAG CAG He Lys Gin
ATA lie
TAC
Tyr 1560
AGTCGC
Ser Arg
TAC GGC
Tyr Gly
ATC . He : 1565
AAG
Lys
CTG.GAG Leu
Glu
GAC. GGC .
Asp Gly
1570
ATC lie
2258
CTG
ATC.GAC He !:Asp
AAG
Lys Lys Gly Gly 1575
AAA GGC GGC
ATC
He
CAC
His 1580
TAC GGC
Tyr Gly
GAG
Glu
TTC
Phe
ATC AAC lie Asn 1585
GAG
Glu
2306
GCC
Ala
AGC TTC AAC Ser
Phe Asn 1590
ATC GAG He
Glu
CCC
Pro
CTG 1
Leu ׳ 1595
CAG AAC
Gin
TAC
Tyr
GTG
Val Thr
1600
ACC
AAG
Lys
TAC
Tyr
GAG
Glu
GTG
Val
ACC
Thr
TAC AGC
Tyr Ser
AGC
Ser
GAG
Glu
CTG
Leu
GGC CCC
Gly Pro
AAC GTG
Asn Val
AGC GAC ACC
Ser Asp Thr
CTG
Leu
GAG
Glu
2402
2354
Asn
Λ
1605 1610
AGC GAC AAG ATT TAC AAG GAC GGC ACC ATC AAG TTC
Ser Asp Lys He Tyr Lys Asp Gly Thr He Lys Phe
1620 1625 1630
TAC AGC AAG AAC GAG CAG GGC CTG TTC TAC GAC AGC
Tyr Ser Lys Asn Glu Gin Gly Leu Phe Tyr Asp Ser
1θ<sup>4</sup>θ 1645
GAC TTC
Asp Phe
GGC CTG
Gly Leu
ACC AAG
Thr Lys 1635
AAC TGG
Asn Trp 1650
2450
2498
GAC TTC
Asp Phe
AAG ATC AAC GCC ATC ACC TAC GAC GGC AAG GAG ATG AAC GTG Lys lie Asn Ala He Thr Tyr Asp Gly Lys Glu Met Asn Vai <sup>1655</sup> 1660 !665
2546
TTC CAC CGC TAC AAC AAG TAGATCTGAG CT Phe His Arg Tyr Asn Lys
1670
2576
5.6.35 (2) INFORMATION FOR SEQ ID NO:36:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 852 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:
<td> Met I</td><td> Lys</td><td> Thr</td><td> Asn</td><td> Gin 5</td><td> lie</td><td> Ser</td><td> Thr</td><td> Thr</td><td> Gin 10</td><td> Lys</td><td> Asn</td><td> Gin</td><td> Gin</td><td> Lys 15</td><td> Glu</td>
<td> Met</td><td> Asp</td><td> Arg</td><td> Lys 20</td><td> Gly</td><td> Leu</td><td> Leu</td><td> Gly</td><td> Tyr 25</td><td> Tyr</td><td> Phe</td><td> Lys</td><td> Gly</td><td> Lys 30</td><td> Asp</td><td> Phe</td>
<td> Ser</td><td> Asn</td><td> Leu '35</td><td> Thr</td><td> Met</td><td> Phe</td><td> Ala</td><td> Pro 40</td><td> Thr</td><td> Arg</td><td> Asp</td><td> Ser</td><td> Thr 45</td><td> Leu</td><td> lie</td><td> Tyr</td>
<td> Asp</td><td> Gin 50</td><td> Gin</td><td> Thr</td><td> Ala</td><td> Asn</td><td> Lys 55</td><td> Leu</td><td> Leu</td><td> Asp</td><td> Lys</td><td> Lys 60</td><td> Gin</td><td> Gin</td><td> Glu</td><td> Tyr</td>
<td> Gin 65</td><td> Ser</td><td> He</td><td> Arg</td><td> Trp</td><td> lie 70</td><td> Gly</td><td> Leu</td><td> He</td><td> Gin</td><td> Ser 75</td><td> Lys</td><td> Glu</td><td> Thr</td><td> Gly</td><td> Asp 80</td>
<td> Phe</td><td> Thr</td><td> Phe</td><td> Asn</td><td> Leu 85</td><td> Ser</td><td> Glu</td><td> Asp</td><td> Glu</td><td> Gin 90</td><td> Ala</td><td> He</td><td> He</td><td> Glu.</td><td> He 95</td><td> Asn</td>
<td> Gly</td><td> Lys</td><td> He</td><td> He 100</td><td> Ser</td><td> Asn</td><td> Lys</td><td> Gly</td><td> Lys 105</td><td> Glu</td><td> Lys</td><td> Gin</td><td> Vai</td><td> Vai 110</td><td> His</td><td> Leu</td>
<td> Glu</td><td> Lys</td><td> Gly 115</td><td> Lys</td><td> Leu</td><td> Vai</td><td> Pro</td><td> He 120</td><td> Lys</td><td> He</td><td> Glu</td><td> Tyr</td><td> Gin 125</td><td> Ser</td><td> Asp</td><td> Thr</td>
<td> Lys</td><td> ?he</td><td> Asn</td><td> He</td><td> Asp</td><td> Ser</td><td> Lys</td><td> Thr</td><td> Phe</td><td> Lys</td><td> Glu</td><td> Leu</td><td> Lys</td><td> Leu</td><td> Phe</td><td> Lys</td>
V
188 130
56$
He Asp 145
Asn Pro
Ser Lys
Asp Thr
Gly Tyr
Ala
Thr
He
Ser
Val
Ser
Gin
Asn
Gin
Pro
Gin
Gin
Val
Gin
Gin
Asp
Glu
Leu
Arg
Glu
Phe
Asn
Lys
Lys
Glu
Ser
Gin
Glu
Phe
Leu
Ala
Lys
Pro
He
Asn
Leu
Phe
Thr
Gin
Gin
Met
Lys Arg Glu
He
Asp
Glu
Asp ' 195
Thr
Thr He
Gly Asp
Asp Gly Asp
Gin
Pro
Ser
He
Pro
Asp
Leu Trp
Glu
Glu
Asn
Asn Arg
Thr
Tyr
Lys
Thr lie
Ala
Val
Lys
Trp
Asp Asp
Ser
Leu
Phe
Val
Ser
Asn
Pro
Leu
Glu
Ser
His
Asp Tyr
Glu
Lys
Ala
Ala
Arg
Asp
Leu
Asp
Pro
Asn
He
Gin
Ser
Gly lie
Asp
Thr
<td colspan="6"><sup>1</sup> Leu Ser Asn ?da Lys Glu</td><td rowspan="2"> Thr</td><td colspan="4" rowspan="2"> Phe Asn Pro Leu 265</td><td colspan="3" rowspan="2"> Val Ala Ala 270</td><td rowspan="2"> Phe</td>
<td colspan="2"></td><td colspan="4"> 260</td>
<td> Ser</td><td> Val 275</td><td> Asn</td><td> Val</td><td> Ser</td><td> Met</td><td> Glu 280</td><td> Lys</td><td> Val</td><td> He</td><td> Leu</td><td> Ser 285</td><td> Pro</td><td> Asn</td><td> Glu</td>
<td> Leu 290</td><td> Ser</td><td> Asn</td><td> Ser</td><td> Val</td><td> Glu 295</td><td> Ser</td><td> His</td><td> Ser</td><td> Ser</td><td> Thr 300</td><td> Asn</td><td> Trp</td><td> Ser</td><td> Tyr</td>
<td> Asn</td><td> Thr</td><td> Glu</td><td> Gly</td><td> Ala 310</td><td> Ser</td><td> Val</td><td> Glu</td><td> Ala</td><td> Gly 315</td><td> He</td><td> Gly</td><td> Pro</td><td> Lys</td><td> Gly 320</td>
<td> Ser</td><td> Phe</td><td> Gly</td><td> Val 325</td><td> Ser</td><td> Val</td><td> Asn</td><td> Tyr</td><td> Gin 330</td><td> His'</td><td> Ser</td><td> Glu</td><td> Thr</td><td> Val 335</td><td> Ala</td>
<td> Glu</td><td> T^p</td><td> Gly .340</td><td> Thr</td><td> Ser</td><td> Thr</td><td> Gly</td><td> Asn 345</td><td> Thr</td><td colspan="2"> Ser Gin</td><td> Phe</td><td> Asn 350</td><td> Thr</td><td> Ma</td>
<td> Ala</td><td> Gly 355</td><td> Tyr</td><td> Leu</td><td> Asn</td><td> Ala</td><td> Asn 360</td><td> Val</td><td colspan="3"> Arg Tyr Asn</td><td> Asn 365</td><td> Val</td><td> Gly</td><td> Thr</td>
<td> Ala 370</td><td> lie</td><td colspan="2"> Tyr Asp</td><td> Val</td><td> Lys 375</td><td> Pro</td><td> Thr</td><td> Thr</td><td> Ser</td><td> Phe 380</td><td> Val</td><td> Leu</td><td> Asn</td><td> Asn</td>
<td> Thr</td><td> He</td><td> Ala</td><td> Thr</td><td> He 390</td><td> Thr</td><td> Ala</td><td> Lys</td><td> Ser</td><td> Asn 395</td><td> Ser</td><td> Thr</td><td> Ala</td><td> Leu</td><td> Asn 400</td>
<td> Ser</td><td> Pro</td><td> Gly</td><td> Glu 405</td><td> Ser</td><td> Tyr</td><td> Pro</td><td> Lys</td><td> Lys 410</td><td colspan="2"> Gly Gin</td><td> Asn</td><td> Gly</td><td colspan="2"> lie Ala 415</td>
Thr
Ser
Met
Asp Asp
Phe
Asn
Ser
His
Pro He
Thr
Leu
Asn Lys
<td> Lys</td><td> Gin</td><td colspan="2"> Vai Asp Asn Leu 435</td><td> Leu</td><td> Asn 440</td><td> Asn</td><td colspan="2"> Lys Pro</td><td> Met</td><td> Met 445</td><td colspan="2"> Leu Glu</td><td> Thr</td>
<td> Asn</td><td> Gin 450</td><td colspan="2"> Thr Asp Gly Vai</td><td colspan="2"> Tyr Lys 455</td><td> He</td><td colspan="2"> Lys Asp</td><td> Thr 460</td><td> His</td><td colspan="2"> Gly Asn</td><td> lie</td>
<td> Vai 465</td><td> Thr</td><td> Gly Gly Glu</td><td> Trp 470</td><td colspan="2"> Asn Gly</td><td> Vai</td><td> He</td><td> Gin 475</td><td> Gin</td><td> He</td><td> Lys</td><td> Ala</td><td> Lys 480</td>
<td colspan="2"> Thr Ala</td><td> Ser He He .485</td><td> Vai</td><td colspan="4"> Asp Asp Gly Glu 490</td><td colspan="2"> Arg Vai</td><td> Ala</td><td> Glu</td><td colspan="2"> Lys Arg 495</td>
<td> Vai</td><td> Ala</td><td> Ala Lys Asp 500</td><td> Tyr</td><td> Glu</td><td> Asn</td><td> Pro .505</td><td> Glu</td><td colspan="2"> Asp Lys</td><td> Thr</td><td> Pro 510</td><td> Ser</td><td> Leu</td>
<td> Thr</td><td> Leu</td><td> Lys Asp Ala 515</td><td> Leu</td><td> Lys</td><td> Leu .520</td><td> Ser</td><td> Tyr</td><td> Pro</td><td> Asp</td><td> Glu 525</td><td> lie</td><td> Lys</td><td> Glu</td>
<td> He</td><td> Glu 530</td><td> Gly Leu Leu</td><td> Tyr</td><td> Tyr 535</td><td> Lys</td><td> Asn</td><td> Lys</td><td> Pro</td><td> lie. 540</td><td> Tyr</td><td> Glu</td><td> Ser</td><td> Ser</td>
<td> Vai <sup>545</sup></td><td> Met</td><td> Thr</td><td> Tyr</td><td> Leu</td><td> Asp 550</td><td> Glu</td><td> Asn</td><td> Thr</td><td> Ala</td><td> Lys 555</td><td> Glu</td><td> Vai</td><td> Thr</td><td> Lys</td><td> Gin 560</td>
<td> Leu</td><td> Asn</td><td> Asp</td><td> Thr</td><td> Thr 565</td><td> Gly</td><td> Lys</td><td> Phe</td><td> Lys</td><td> Asp 570</td><td> Vai</td><td> Ser</td><td> His</td><td> Leu</td><td> Tyr 575</td><td> Asp</td>
<td> Vai</td><td> Lys</td><td> Leu</td><td> Thr 580</td><td> Pro</td><td> Lys</td><td> Met</td><td> Asn</td><td> Vai 585</td><td> Thr</td><td> He</td><td> Lys</td><td> Leu</td><td> Ser 590</td><td> He</td><td> Leu</td>
<td colspan="2"> Tyr Asp</td><td> Asn 595</td><td> Ala</td><td> Glu</td><td> Ser</td><td> Ash</td><td> Asp 600</td><td> Asn</td><td> Ser</td><td> He</td><td> Gly</td><td> Lys 605</td><td> Trp</td><td> Thr</td><td> Asn</td>
<td> Thr</td><td> Asn 610</td><td> He</td><td> Vai</td><td colspan="2"> Ser Gly</td><td> Gly 615</td><td> Asn</td><td> Asn</td><td colspan="2"> Gly Lys</td><td> Lys 620</td><td> Gin</td><td> Tyr</td><td> Ser</td><td> Ser</td>
<td> Asn 625</td><td> Asn</td><td> Pro</td><td> Asp</td><td> Ala</td><td> Asn 630</td><td> Leu</td><td> Thr</td><td> Leu.</td><td> Asn</td><td> Thr 635</td><td> Asp</td><td> Ala</td><td> Gin</td><td> Glu</td><td> Lys 640.</td>
<td> Leu</td><td> Asn</td><td> Lys</td><td> Asn</td><td colspan="3"> Arg Asp Tyr 645</td><td> Tyr</td><td> He</td><td> Ser 650</td><td> Leu</td><td colspan="3"> Tyr Met Lys</td><td> Ser 655</td><td> Glu</td>
<td> Lys</td><td> Asn</td><td> Thr</td><td> Gin 660</td><td> Cys</td><td> Glu</td><td> He</td><td> Thr</td><td> He 665</td><td> Asp</td><td colspan="5"> Gly Glu lie Tyr Pro 670</td><td> He</td>
<td> Thr</td><td> Thr</td><td colspan="2"> Lys Thr 675</td><td> Vai</td><td> Asn</td><td> Vai</td><td> Asn 680</td><td> Lys</td><td> Asp</td><td colspan="3"> Asn Tyr Lys 685</td><td> Arg</td><td> Leu</td><td> Asp</td>
<td> He</td><td> He 690</td><td> Ala</td><td> His</td><td> Asn</td><td> He</td><td> Lys 695</td><td> Ser</td><td> Asn</td><td> Pro</td><td> He</td><td> Ser 700</td><td> Ser</td><td> Leu</td><td> His</td><td> He</td>
Lys Thr Asn Asp Glu He Thr Leu Phe Trp Asp Asp He Ser lie Thr
חלד 715 <sup>710 705</sup>
Asp Vai Ala Ser He Lys Pro Glu Asn Leu Thr Asp Ser Glu lie Lys <sup>725</sup> 730 735
Gin lie Tyr Ser Arg Tyr Gly He Lys Leu Glu Asp Gly lie Leu lie <sup>740</sup> 745 . .
Asp Lys Lys Gly Gly He His Tyr Gly Glu Phe lie Asn Glu Ala Ser
755 760. 765
Phe Asn lie Glu Pro Leu Gin Asn Tyr Vai Thr Lys Tyr Glu Vai Thr <sup>770</sup> . 775780
Tyr Ser Ser Glu Leu Gly Pro Asn Vai Ser Asp Thr Leu Glu Ser Asr>
<sup>785 790</sup> 795 .
Lys He Tyr Lys Asp Gly Thr lie Lys Phe Asp Phe Thr Lys Tyr Ser
810815
Lys Asn Glu Gin Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe <sup>820</sup> 825830
Lys He Asn Ala lie Thr Tyr Asp Gly Lys Glu Met Asn Vai Phe His <sup>8</sup>35 840845
Arg Tyr Asn Lys (2) INFORMATION FOR SEQ ID NO:37:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs (B) type: nucleic acid ' (C) STRANDEDNESS: single <D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid
DESCRIPTION: /desc = forward primer used to make pCloObz. / . (iii) HYPOTHETICAL: NO (Xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:
GGATCCACCA TGCTGCAGAA CCTGAAGATC AC (2) INFORMATION FOR SEQ ID NO:38:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear
1 538272 (ii) MOLECULE TYPE: other nucleic acid <sub>ηΓΤ</sub>ηςς97״<sup>Α> DESCRIPTI0N:</sup> /desc.= reverse primer used to make PvJJjOuZ / (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:
AAGCTTCCAC TCCTTCTC (2) INFORMATION FOR SEQ ID NO:39:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1241 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = Synthetic DNA (iii) HYPOTHETICAL: NO (ix) FEATURE:
(A) NAME/KEY: CDS (B) LOCATION; 9.1238 (D) OTHER INFORMATION: '/note״ ־Maize optimized sequence encoding VIP2A(a) with the Bacillus secretion removed as contained in pCIB5527
DNA signal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:
GATCCACC ATG CTG CAG AAC CTG AAG ATC ACC GAC AAG GTG GAG GAC TTC Met Leu Gin Asn Leu Lys lie Thr Asp Lys Vai Glu Asp Phe <sup>855</sup> 860 . . 865
AAG GAG GAC AAG GAG AAG GCC Lys Glu Asp Lys Glu Lys Ala 870
GAG TGG AAG CTT ACC GCC ACC Glu Trp Lys Leu Thr Ala Thr 885
AAG GAG TGG GGC AAG GAG AAG' GAG AAG .
Lys Glu Trp Gly Lys Glu Lys Glu Lvs 875 880
GAG AAG GGC AAG ATG AAC AAC TTC CTG Glu Lys׳ Gly Lys Met Asn Asn Phe Leu <sup>890</sup> 895
GAC AAC AAG AAC GAC ATC Asp Asn Lys Asn Asp He 900
AAG ACC AAC TAC AAG GAG ATC ACC TTC AGC Lys Thr Asn Tyr Lys Glu He Thr Phe Ser 905 910 .
ATA GCC GGC AGC TTC GAG
GAC GAG ATC AAG GAC CTG AAG GAG ATC GAC
־192
S.5.’j5
<td> He 915</td><td> Ala</td><td> . Gly</td><td><sup>r</sup> Sei</td><td> : Phe</td><td> Glu 920</td><td> Asp</td><td> Glu</td><td> lie</td><td> Lys</td><td> Asp 925</td><td> Leu</td><td> Lys</td><td> Glu</td><td> . He</td><td> Asp 930</td>
<td> AAG</td><td> ATG</td><td> TTC</td><td> GAC</td><td> : AAG</td><td> .ACC</td><td> AAC</td><td> CTG</td><td> AGC</td><td> AAC</td><td> AGC</td><td> ATC</td><td> ATC</td><td> ACC</td><td> TAC</td><td> AAG</td>
<td> Lys</td><td> Met</td><td> Phe</td><td> Asp</td><td> 1 .Lys .935</td><td> Thr</td><td> Asn</td><td> Leu</td><td> Ser</td><td> Asn 940</td><td> Ser</td><td> He</td><td> He</td><td> Thr</td><td> Tyr 945</td><td> Lys</td>
<td> AAC</td><td> GTG</td><td> GAG</td><td> CCC</td><td> ACC</td><td> ACC</td><td> ATC</td><td> GGC</td><td> TTC</td><td> AAC</td><td> AAG</td><td> AGC</td><td> CTG</td><td> ACC</td><td> GAG</td><td> GGC</td>
<td> Asn</td><td> Val</td><td> Glu</td><td> Pro 950</td><td> Thr</td><td> Thr</td><td> He</td><td> Gly</td><td> Phe 955</td><td> Asn</td><td> Lys</td><td> Ser</td><td> Leu</td><td> Thr 960</td><td> Glu</td><td> Gly</td>
<td> AAC</td><td> ACC</td><td> ATC</td><td> AAC</td><td> AGC</td><td> GAC</td><td> GCC</td><td> ATG</td><td> GCC</td><td> CAG</td><td> TTC</td><td> AAG</td><td> GAG</td><td> CAG</td><td> TTC</td><td> CTG</td>
<td> Asn</td><td> Thr</td><td> lie 965</td><td> Asn</td><td> Ser</td><td> Asp</td><td> Ala</td><td> Met׳ 970</td><td> Ala</td><td> Gin</td><td> Phe</td><td> Lys</td><td> Glu 975</td><td> Gin</td><td> Phe</td><td> Leu</td>
<td> GAC</td><td> CGC</td><td> GAC</td><td> ATC</td><td> AAG'</td><td> TTC</td><td> GAC</td><td> AGC</td><td> TAC</td><td> CTG</td><td> GAC</td><td> ACC</td><td> CAC</td><td> CTG</td><td> ACC</td><td> GCC</td>
<td> Asp</td><td> Arg 980</td><td> Asp</td><td> He</td><td> Lys</td><td> Phe</td><td> Asp 985</td><td> Ser</td><td> Tyr</td><td> Leu</td><td> Asp</td><td> Thr 990</td><td> His</td><td> Leu</td><td> Thr</td><td> Ala</td>
<td> CAG</td><td> CAG</td><td> GTG</td><td> AGC</td><td> AGC</td><td> AAG</td><td> GAG</td><td> CGC</td><td> GTG</td><td> ATC</td><td> CTG</td><td> AAG</td><td> GTG</td><td> ACC</td><td> GTC</td><td> CCC</td>
<td> Gin 995</td><td> Gin</td><td> Val</td><td> Ser</td><td> Ser</td><td> Lys 1000</td><td> Glu</td><td> Arg</td><td> Val</td><td> He</td><td> Leu 1005</td><td> Lys</td><td> Val</td><td> Thr</td><td> Val</td><td> Pro 1010</td>
<td> AGC</td><td> GGC</td><td> AAG</td><td> GGC</td><td> AGC</td><td> ACC</td><td> ACC</td><td> CCC</td><td> ACC</td><td> AAG</td><td> GCC</td><td> GGC</td><td> GTG</td><td> ATC</td><td> CTG</td><td> AAC</td>
<td> Ser</td><td> Gly</td><td> Lys</td><td> Gly</td><td> Ser</td><td> Thr</td><td> Thr</td><td> Pro</td><td> Thr</td><td> Lys</td><td> Ala</td><td rowspan="2"> Gly</td><td> Val</td><td> lie</td><td> Leu</td><td> Asn</td>
<td></td><td></td><td></td><td></td><td> 1015</td><td></td><td></td><td></td><td></td><td> 1020</td><td></td><td></td><td></td><td> 1025</td><td></td>
38.6 .434
<td colspan="2"> AAC AGC GAG TAC AAG ATG Asn Ser Glu Tyr Lys Met</td>
<td></td><td> 1°<sup>30</sup></td>
<td> GAC</td><td> AAG GTG AGC AAG GTG</td>
<td> Asp</td><td> Lys Val Ser Lys Val 1045</td>
<td> GAG</td><td> GGC ACC CTG AAG AAG</td>
<td> Glu</td><td> Gly Thr Leu Lys Lys</td>
1060
CTG
Leu
ATC GAC AAC He Asp Asn 1035
AAG AAG GGC
GGC
Gly Tyr
TAC
ATG GTG
Met Val
1040
CAC
His
GTG
Val
GTG
Val Lys Lys Gly 1050
GTG
Val'
GAG
Glu
TGC CTC
Cys Leu
1055
CAG
Gin
ATC
He
GAG GCC
Glu Ala 1075 .
CAC.
His
AGC
Ser
CTG ACC
Leu Thr
GAC
Asp
AGC
Ser
TAC
Tyr
AAG
Lys Glu
GAG
GAG
Glu
AGT CTA GAC TTC AAG Ser Leu Asp Phe Lys 1065
TGG
Trp Gly I
1080
GGC
ATG AAG
Met
AAC
Lys.Asn
CAG CGC
Gin Arg 1095
ATC AAC lie Asn 1110
AAC
Asn
GAG
Glu
GCC
Ala
CTG
TAC
Tyr
CTG
Leu
AAG CTG
Lys Leu .
1125
GAC GCC
Asp Ala
CAG ATC
Gin He
AAC 1 Asn . 1070
GAC ATC
Asp He
AAC
Asn
GCC Ala
674.
TAC GAG י
Tyr Glu 1
1085
GAG TGG GCC
Glu
GAC GGC TAC Leu Asp Gly Tyr 1100
CGC AAC
Arg Asn
1115
CAG
Gin
Trp Ala
AAG
Lys
GAC .
Asp 1090''
GCC
Ala
CGC
Arg
CAG
Gin 1105
GAC
Asp
GGC
Gly Gly
GGC
AGC Ser 1120
GGC AAC . Gly Asn
AAG Lys Asn He 1130
AAC ATC
AGC
Ser
GAC GCC Asp Ala \ 1135
CTG GGC AAG
Leu Gly Lys
V
5.6-55
<td colspan="3" rowspan="2"> AAG CCC ATC Lys Pro He 1.140</td><td colspan="12"> CCC GAG AAC ATC ACC GTG TAC CGC TGG TGC GGC ATG CCC</td>
<td> Pro</td><td> Glu</td><td> Asn</td><td colspan="3"> He Thr . Vai 1145</td><td> Tyr</td><td colspan="3"> Arg Trp Cys 1150</td><td colspan="2"> Gly Met Pro</td>
<td> GAG</td><td> TTC</td><td> GGC</td><td> TAC</td><td colspan="2"> CAG ATC</td><td> AGC</td><td colspan="2"> GAC CCC</td><td> CTG</td><td colspan="3"> CCC AGC CTG</td><td> AAG GAC</td><td> TTC</td>
<td colspan="2"> Glu Phe 1155</td><td> Gly</td><td> Tyr</td><td> Gin</td><td colspan="2"> He Ser 1160</td><td colspan="2"> Asp Pro</td><td> Leu</td><td colspan="2"> Pro Ser 1165</td><td> Leu</td><td> Lys Asp</td><td> Phe 1170</td>
<td colspan="2"> GAG GAG</td><td> CAG</td><td> TTC</td><td> CTG</td><td> AAC</td><td> ACC</td><td colspan="2"> ATC AAG</td><td> GAG</td><td colspan="2"> GAC AAG</td><td> GGC</td><td> TAC ATG</td><td> AGC</td>
<td> Glu</td><td> Glu</td><td> Gin</td><td> Phe</td><td> Leu</td><td> Asn</td><td> Thr</td><td colspan="2"> lie Lys</td><td> Glu</td><td colspan="2"> Asp Lys</td><td rowspan="2"> Gly</td><td> Tyr Met</td><td> Ser.</td>
<td></td><td></td><td> -.</td><td></td><td colspan="2"> 1175 '</td><td></td><td></td><td></td><td colspan="2"> H80</td><td></td><td colspan="2"> 1185 .'</td>
<td rowspan="2"> ACC Thr</td><td> AGC</td><td> CTG</td><td> AGC</td><td colspan="2"> AGC GAG</td><td> CGC</td><td colspan="2"> CTG GCC</td><td> GCC</td><td> TTC</td><td> GGC</td><td> AGC</td><td> CGC AAG</td><td> ATC</td>
<td> Ser</td><td> Leu</td><td> Ser</td><td> Ser</td><td> Glu.</td><td> Arg</td><td> Leu</td><td> Ala</td><td> Ala</td><td> Phe</td><td> Gly</td><td> Ser</td><td> Arg Lys</td><td> lie</td>
<td></td><td></td><td></td><td colspan="2"> 1190</td><td></td><td></td><td></td><td colspan="2"> 1195</td><td></td><td></td><td></td><td> 1200 -</td><td></td>
<td> ATC</td><td> CTG</td><td> CGC</td><td> CTG</td><td> CAG</td><td> GTG</td><td> CCC</td><td> AAG</td><td> GGC</td><td> AGC</td><td> ACT</td><td> GGT</td><td> GCC</td><td> TAC CTG</td><td> AGC׳</td>
<td> He</td><td> Leu</td><td> Arg 1205</td><td> Leu</td><td> Gin</td><td> Vai</td><td> Pro</td><td colspan="2"> Lys Gly 1210</td><td colspan="2"> Ser Thr</td><td> Gly</td><td colspan="2"> Ala Tyr Leu 1215</td><td> Ser</td>
<td> GCC</td><td> ATC</td><td> GGC</td><td> GGC</td><td> TTC</td><td> GCC</td><td> AGC</td><td> GAG</td><td> AAG</td><td> GAG</td><td> ATC</td><td> CTG</td><td> CTG</td><td> GAT AAG</td><td> GAC</td>
<td> Ala</td><td> lie 122C</td><td colspan="2"> Gly Gly 1</td><td> Phe</td><td> Ala</td><td colspan="2"> Ser Glu 1225-</td><td> Lys</td><td> Glu</td><td> lie</td><td> Leu 123C</td><td> Leu 1</td><td colspan="2"> Asp Lys Asp</td>
<td> AGC</td><td> AAG</td><td> TAC</td><td> CAC</td><td> ATC</td><td> GAC</td><td> AAG</td><td> GTG</td><td> ACC</td><td> GAG</td><td> GTG</td><td> ATC</td><td> ATC</td><td> AAG GGC</td><td> GTG</td>
<td> Ser 1235</td><td> Lys</td><td> Tyr</td><td> His</td><td> He</td><td> Asp 1240</td><td> Lys</td><td> Vai</td><td> Thr</td><td> Glu</td><td> Vai 1245</td><td> He</td><td> lie</td><td colspan="2"> Lys Gly Vai 1250</td>
<td> AAG</td><td> CGC</td><td> TAC</td><td> GTG</td><td> GTG</td><td> GAC</td><td> GCC</td><td> ACC</td><td> CTG</td><td> CTG</td><td colspan="2"> ACC AAC</td><td rowspan="2"> TAG</td><td></td><td></td>
<td> Lys</td><td> Arg</td><td> Tyr</td><td> Vai</td><td> Vai</td><td> Asp</td><td> Ala</td><td> Thr</td><td> Leu</td><td> Leu</td><td colspan="2"> Thr Asn</td><td></td><td></td>
<td></td><td></td><td></td><td></td><td> 1255</td><td></td><td></td><td></td><td></td><td> 1260</td><td></td><td></td><td></td><td></td><td></td>
1010
1058
י 1106
1154
1202 ' 1241 (2) INFORMATION FOR SEQ ID NO:40:
. (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 410 amino acids .
(B) TYPE: aminoacid (D) TOPOLOGY: linear (ii) MOLECULE TYPE:' protein (xi) SEQUENCE DESCRIPTION:. SEQ ID NO:40:'
Met Leu Gin Asn Leu Lys He Thr Asp Lys Vai Glu Asp Phe Lys Glu <sup>1 5</sup> 10. .
Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys GluTrp . <sup>20</sup> - . 25 30.
Lys Leu' Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu AspAsn <sup>35</sup> 4045
Lys Asn Asp lie Lys Thr Asn Tyr Lys Glu He Thr Phe Ser He Ala <sup>50</sup> 55go
Gly Ser Phe Glu Asp Glu He Lys Asp Leu Lys Glu lie Asp Lys Met . . <sup>70 75</sup>SO
Phe Asp Lys Thr Asn. Leu Ser Asn Ser lie He Thr Tyr Lys AsnVal <sup>85</sup> 9095
Glu Pro Thr Thr He Gly Phe Asn Lys Ser Leu Thr Glu Gly Asn Thr <sup>100</sup> 105 ,no
He Asn Ser Asp Ala Met Ala Gin Phe Lys Glu Gin Phe Leu Asp Arg . <sup>115</sup> 125. 120 . . י <sup>715</sup>Pile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu Thr Ala Gin Gin 130 13514c
Val Ser Ser Lys Glu Arg Val He Leu Lys Val Thr Val Pro Ser Gly <sup>145 150</sup> 155 -165.
Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val He Leu Asn Asn Ser 155 170^75
Glu Tyr Lys Met Leu He Asp Asn Gly Tyr Met Val His Val Asp Lys
180 185 . 190
Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu Gin lie Glu Gly <sup>195</sup> 200205
Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp lie Asn Ala Glu Ala <sup>210</sup> 215. 220
<td> His 225</td><td> Ser</td><td> Trp</td><td> Gly</td><td> Met</td><td> Lys 230</td><td> Asn</td><td> Tyr</td><td> Glu</td><td> Glu Trp Ala Lys 235.</td><td> fep</td><td> Leu</td><td> Thr 240</td>
<td> Asp</td><td> Ser</td><td> Gin</td><td> Arg</td><td> Glu 245</td><td> Ala</td><td> Leu</td><td> fep</td><td> Gly</td><td> Tyr Ala Arg. Gin 250</td><td> fep</td><td> Tyr 255</td><td> Lys</td>
<td> Glu</td><td> lie</td><td> fen</td><td> fen 260</td><td> Tyr</td><td> Leu</td><td> Arg</td><td> fen</td><td> Gin 265</td><td> Gly Gly Ser Gly</td><td> fen 270</td><td> Glu</td><td> Lys</td>
<td> Leu</td><td> Asp</td><td> Ala 275</td><td> Gin</td><td> He</td><td> Lys</td><td> fen</td><td> lie 280</td><td> Ser</td><td> Asp Ala Leu Gly 285</td><td> Lys</td><td> Lys</td><td> Pro</td>
<td> lie</td><td> Pro 290</td><td> Glu</td><td> Asn</td><td> lie</td><td> Thr</td><td> Val 295</td><td> Tyr</td><td> Arg</td><td> Trp Cys Gly Met 300</td><td> Pro</td><td> Glu</td><td> Phe</td>
<td> Gly 305</td><td> Tyr</td><td> Gin.</td><td> He</td><td> Ser</td><td> Asp 310</td><td> Pro</td><td> Leu</td><td> Pro</td><td> Ser Leu Lys fep 315</td><td> Phe</td><td> Glu</td><td> Glu 320</td>
Gin Phe leu Asn Thr lie Lys Glu Asp . Lys Gly Tyr Met Ser Thr Ser <sup>325</sup> 330335
Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys He He Leu <sup>340</sup> 345350
2/ 2 8 3 5 11 ־<sup>95</sup>י־
Arg Leu Gin Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser Ala He <sup>355</sup> 360 .365
Gly Gly Phe Ala Ser Glu Lys Glu He Leu Leu Asp Lys Asp Ser Lvs <sup>370</sup> . 375 '380
Tyr His lie Asp Lys Val Thr Glu Val He lie Lys Gly Val Lys Ara <sup>385</sup> 390 395 400
Tyr Val Val Asp Ala Thr Leu Leu Thr Asn <sup>4</sup>°5410 (2) INFORMATION.FOR SEQ ID NO:41:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 72 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (Ά) DESCRIPTION: /desc = oligonucleotide encoding eukaryotic secretion signal used to construct pCIB5527 (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:
GGATCCACCA TGGGCTGGAG CTGGATCTTC CTGTTCCTGC TGAGCGGCGC CGCGGGCGTG CACTGCCTGC AG (2) INFORMATION FOR SEQ ID NO:42:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1241 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single . (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = Synthetic DNA (iii) HYPOTHETICAL: NO (ix) FEATURE:
(A)' NAME/KEY: CDS ־ '(B) LOCATION: 9.1238 (D) OTHER INFORMATION: /note= Maize optimized DNA sequence encoding VIP2A(a) with the Bacillus secretion signal removed and the eukaryotic secretion signal inserted as contained in pCIB5528 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:
GATCCACC ATG CTG CAG AAC CTG׳ AAG ATC ACC GAC AAG GTG GAG GAC TTC Met Leu Gin Asn feu Lys He Thr Asp Lys Val Glu Asp Phe 415 420
AAG GAG GAC AAG GAG AAG GCC AAG GAG TGG GGC AAG GAG AAG GAG AAG iys θΐυ Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys <sup>425</sup> '., <sup>430</sup> 435440 . GAG TGG AAG CTT ACC GCC ACC GAG AAG GGC AAG ATG AAC AAC TTC CTG Glu Trp Lys feu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu <sup>445</sup> 450455
GAC AAC AAG AAC GAC ATC AAG ACC AAC TAC AAG GAG ATC ACC TTC AGC Asp Asn Lys Asn Asp lie Lys Thr Asn Tyr Lys Glu He Thr Phe Ser
460 465.4
ATA GCC GGC AGC TTC GAG GAC GAG ATC AAG GAC CTG AAG GAG ATC GAC He Ala Gly Ser Phe Glu Asp Glu lie Lys Asp feu Lys Glu He Asp <sup>475</sup> . 480485
AAG ATG TTC GAC AAG ACC AAC CTG AGC AAC AGC ATC ATC ACC TAC AAG Lys Met Phe Asp Lys Thr Asn feu Ser Asn Ser lie He Thr Tyr Lys <sup>490</sup> 495500'
AAC GTG GAG CCC ACC ACC ATC GGC TTC AAC AAG AGC CTG ACC GAG GGC Asn Val Glu Pro Thr Thr lie Gly Phe Asn Lys Ser Leu Thr Glu Gly
520 <sub>:</sub> . 515 510 .י
AAC ACC ATC AAC AGC GAC GCC ATG GCC CAG TTC AAG GAG CAG TTC CTG Asn Thr lie Asn Ser Asp Ala Met Ala Gin Phe Lys Glu Gin Phe Leu
j. . ' <sup>525</sup> : ' . 530535
GAC GGC GAC ATC AAG TTC GAC AGC TAC CTG GAC ACC CAC CTG ACC GCC Asp Arg Asp lie Lys Phe Asp Ser Tyr Leu Asp Thr His feu Thr Ala ; <sup>540</sup> ' . 545550
CAG . CAG GTG AGC AGC AAG GAG CGC GTG ATC CTG AAG GTG ACC GTC CCC Gin Gin Val Ser Ser Lys Glu Arg Val lie feu Lys Val Thr Val Pro <sup>555</sup> ; 560565 :
AGC GGC AAG GGC AGC ACC ACC CCC ACC' AAG GCC GGC GTG ATC CTG AAC Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val He feu Asn
580 575 ־. י . י <sup>570</sup>
׳338
AAC AGC Asn Ser <sup>585</sup> ' i
GAC AAG* Asp Lys<sup>1</sup>)
GAG TAC AAG ATG CTG ATC GAC AAC GGC TAC ATG' GTG CAC GTG
Glu Tyr Lys Met feu lie Asp Asn Gly Tyr Met Val HisVal <sup>590</sup> , 595600
GTG AGC AAG GTG GTG MG AAG GGC GTG GAG TGC CTC CAGATG
Val Ser Lys Val Val Lys Lys Gly Val Glu Cys feu Ginlie
<img file="IL115382A_D0008.tif" />
1010
1058
1106
1154
1202
11538 ־<sup>197</sup>־
615 . ׳610 ׳
GAG GGC ACC CTG AAG AAG AGT CTA GAC TTC AAG AAC GAC ATC AAC GCC Glu Gly. Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp lie.Asn Ala <sup>620</sup> . 625630
GAG GCC CAC AGC TGG GGC ATG AAG AAC TAC GAG GAG TGG GCC AAGGAC
Glu Ala His Ser Trp Gly Met, Lys Asn Tyr Glu Glu Trp Ala LysAsp <sup>635</sup> . ' 640645
CTG ACC GAC AGC CAG CGC GAG GCC CTG GAC GGC TAC GCC CGC CAGGAC
Leu Thr Asp Ser Gin Arg Glu Ala Leu Asp Gly Tyr Ala Arg GinAsp . <sup>650</sup> 655 660 ' . '.
TAC AAG GAG ATC AAC AAC TAC . CTG CGC AAC CAG GGC GGC AGC GGC AAC Tyr Lys Glu He Asn Asn Tyr Leu Arg Asn Gin Gly Gly Ser Gly Asn
680> ׳675 <sup>670</sup> ' <sup>665</sup>
<td> GAG</td><td> AAG</td><td> CTG</td><td> GAC</td><td> GCC</td><td> CAG ATC</td><td> : AAG</td><td> : AAC</td><td> ATC</td><td> AGC</td><td> : GAC</td><td> GCC</td><td> ' CTG</td><td> GGC AAG</td>
<td> Glu</td><td> Lys</td><td> Leu</td><td> Asp</td><td> Ala 685</td><td> Gin lie</td><td> Lys</td><td> Asn</td><td> He 690</td><td> Ser</td><td> Asp</td><td> Ma</td><td> Leu</td><td> Gly Lys 695</td>
<td> AAG</td><td> . CCC</td><td> ATC</td><td> CCC</td><td> GAG</td><td> AAC ATC</td><td> ACC</td><td> GTG</td><td> TAC</td><td> CGC</td><td> TGG</td><td> TGC</td><td> GGC</td><td> ATG CCC</td>
<td> Lys</td><td> Pro</td><td> He</td><td> Pro</td><td> Glu</td><td> Asn He</td><td> Thr</td><td> Val</td><td> Tyr</td><td> Arg</td><td> Trp</td><td> Cys</td><td> Gly</td><td> Met Pro</td>
<td></td><td></td><td></td><td> 700</td><td></td><td></td><td></td><td> 705</td><td></td><td></td><td></td><td></td><td> 710</td><td></td>
<td> GAG</td><td> TTC</td><td> GGC</td><td> TAC</td><td> CAG</td><td> ATC AGC</td><td> GAC</td><td> CCC</td><td> CTG</td><td> CCC</td><td> AGC</td><td> CTG</td><td> AAG</td><td> GAC TTC</td>
<td> Glu</td><td> Phe</td><td> Gly 715</td><td> Tyr</td><td> Gin</td><td> lie Ser</td><td> Asp 720</td><td> Pro</td><td> Leu</td><td> Pro</td><td> Ser</td><td> Leu 725</td><td> Lys</td><td> Asp Phe</td>
<td> GAG</td><td> GAG</td><td> CAG</td><td> TTC</td><td> CTG</td><td> AAC ACC</td><td> ATC</td><td> AAG</td><td> GAG</td><td> GAC</td><td> AAG</td><td> GGC</td><td> TAC</td><td> ATG AGC</td>
<td> Glu</td><td> Glu 730</td><td> Gin</td><td> Phe</td><td> Leu</td><td> Asn Thr 735</td><td> lie</td><td> 'Lys</td><td> Glu</td><td> Asp</td><td> Lys 740</td><td> Gly</td><td> Tyr</td><td> Met Ser</td>
<td> ACC</td><td> AGC</td><td> CTG</td><td> AGC</td><td> AGC.</td><td> GAG CGC</td><td> CTG</td><td> GCC</td><td> GCC</td><td> TTC</td><td> GGC</td><td> AGC</td><td> CGC</td><td> AAG ATC</td>
<td> Thr 745</td><td> Ser</td><td> Leu</td><td> Ser</td><td> Ser</td><td> Glu Mg 750.</td><td> Leu</td><td> Ala</td><td> Ala</td><td> Phe 755</td><td> Gly</td><td> Ser</td><td> Arg</td><td> Lys lie 760</td>
<td> ATC</td><td> CTG</td><td> CGC</td><td> CTG</td><td> CAG</td><td> GTG CCC</td><td> AAG</td><td> GGC׳</td><td> AGC.</td><td> ACT</td><td> GGT</td><td> GCC</td><td> TAC</td><td> CTG AGC</td>
<td> He</td><td> Leu</td><td> Arg</td><td> Leu</td><td> Gin</td><td> Val Pro</td><td> Lys</td><td> Gly</td><td> Ser</td><td> Thr</td><td> Gly</td><td> Ma</td><td> Tyr</td><td> Leu Ser</td>
<td></td><td></td><td></td><td></td><td> 765</td><td></td><td></td><td></td><td> 770</td><td></td><td></td><td></td><td></td><td> 775</td>
<td> GCC.</td><td> ATC</td><td> GGC</td><td> GGC</td><td> TTC</td><td> GCC AGC</td><td> GAG</td><td> AAG</td><td> GAG</td><td> ATC</td><td> CTG</td><td> CTG</td><td> GAT .</td><td> AAG GAC</td>
<td> Ala</td><td> He</td><td> Gly</td><td> Gly 780</td><td> Phe</td><td> Ala Ser</td><td> Glu</td><td> Lys 785</td><td> Glu</td><td> lie'</td><td> Leu</td><td> Leu</td><td> Asp 790</td><td> Lys Asp</td>
<td> AGC.</td><td> AAG</td><td> TAC</td><td> CAC</td><td> ATC</td><td> GAC AAG</td><td> GTG</td><td> ACC</td><td> GAG</td><td> GTG</td><td> ATC</td><td> ATC</td><td> AAG (</td><td> GGC GTG</td>
<td> Ser</td><td> Lys .</td><td> Tyr 795.</td><td> His</td><td> He</td><td> Asp Lys.</td><td> Val 800</td><td> Thr</td><td> Glu</td><td> Val</td><td> He</td><td> He 805</td><td> Lys (</td><td> Ely Val</td>
<td> AAG י</td><td> CGC '</td><td> TAC</td><td> GTG</td><td> GTG</td><td> GAC GCC</td><td> ACC</td><td> CTG</td><td> CTG .</td><td> ACC</td><td> AAC</td><td rowspan="2"> TAG</td><td></td><td></td>
<td> Lys .</td><td> Arg <sup>1</sup></td><td> Tyr</td><td> Val '</td><td> Val .</td><td> Asp Ala</td><td> Thr</td><td> Leu</td><td> Leu</td><td> Thr</td><td> Asn</td><td></td><td></td>
<td colspan="2"> 810</td><td></td><td></td><td></td><td> 815</td><td></td><td></td><td></td><td></td><td> 820</td><td></td><td></td><td></td>
1241 ־ ISO . 115382/2 (2) INFORMATION FOR SEQ. ID NO:43:
י .' (i) SEQUENCE CHARACTERISTICS: .
(A) LENGTH: 410 amino acids (B) TYPE:־amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:
Met Leu Gin Asn Leu Lys He Thr Asp Lys Val Glu Asp Phe Lys Glu . .<sup>1</sup><sup>5</sup> ... . ' 10 . 15
Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys Glu Trp 20 25 30.
Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu Asp Asn .35 4045
Lys Asn Asp He Lys Thr Asn. Tyr Lys Glu He Thr Phe Ser lie Ala <sup>50</sup> '55go
Gly Ser Phe Glu Asp Glu lie Lys Asp Leu Lys Glu He Asp Lys Met <sup>65</sup> . ™ 75 ./ «ο
<td colspan="4"> Phe Asp Lys Thr Asn</td><td rowspan="2"> Leu</td><td colspan="7" rowspan="2"> Ser Asn Ser He He Thr Tyr 90</td><td colspan="3" rowspan="2"> Lys Asn Val 95</td>
<td colspan="2"></td><td colspan="2"> 85</td>
<td> Glu</td><td> Pro Thr</td><td> Thr 100</td><td> He</td><td> Gly</td><td> Phe</td><td> Asn</td><td> Lys 105</td><td> Ser</td><td> Leu</td><td> Thr</td><td> Glu</td><td> Gly 110</td><td> Asn</td><td> Thr</td>
<td> He</td><td colspan="2"> Asn Ser.Asp 115</td><td> Ala</td><td> Met</td><td> Ala</td><td colspan="2"> Gin Phe 120 .</td><td> Lys</td><td> Glu</td><td> Gin</td><td> Phe 125</td><td> Leu</td><td colspan="2"> Asp Arg</td>
<td> Asp</td><td colspan="2"> He Lys Phe 130</td><td> Asp</td><td> Ser</td><td> Tyr 135</td><td> Leu</td><td colspan="2"> Asp Thr</td><td> His</td><td> Leu 140</td><td> Thr</td><td> Ala</td><td> Gin</td><td> Gin</td>
<td> Val 145</td><td> Ser Ser</td><td> Lys</td><td> Glu</td><td> Arg 150</td><td> Val</td><td> He</td><td colspan="2"> Leu Lys</td><td colspan="3"> Val Thr Val 155</td><td> Pro</td><td> Ser</td><td> Gly 160.</td>
<td> Lys</td><td> Gly Ser</td><td> Thr</td><td> Thr 165</td><td> Pro</td><td> Thr</td><td> Lys</td><td> Ala</td><td> Gly 170.</td><td> Val</td><td> lie.</td><td> Leu.</td><td> Asn</td><td> Asn 175</td><td> Ser</td>
<td> Glu</td><td> Tyr Lys</td><td> Met 180</td><td> Leu</td><td> He</td><td> Asp</td><td> Asn</td><td colspan="3"> Gly Tyr Met 185</td><td> Val</td><td> His</td><td> Val 190</td><td> Asp</td><td> Lys</td>
<td> Val</td><td> Ser Lys 195</td><td> Val</td><td> Val</td><td> Lys</td><td> Lys</td><td> Gly 200</td><td> Val</td><td> Glu</td><td> Cys</td><td> Leu</td><td> Gin 205</td><td> lie</td><td> Glu</td><td> Gly</td>
<td> Thr</td><td> Leu Lys 210,</td><td> Lys</td><td> Ser</td><td> Leu</td><td> Asp 215</td><td> Phe</td><td> Lys</td><td> Asn</td><td> Asp</td><td> He 220</td><td colspan="2"> Asn Ala</td><td> Glu</td><td> Ala</td>
<td> His 225</td><td colspan="2"> Ser Trp Gly</td><td> Met</td><td> Lys 230</td><td> Asn</td><td> Tyr</td><td> Glu</td><td> Glu</td><td> Trp 235</td><td> Ala</td><td colspan="2"> Lys Asp</td><td> Leu</td><td> Thr 240</td>
/2
Asp Ser Gin Arg Glu Ala Leu Asp . Gly Tyr Ala Arg Gin Asp Tyr Lys . 245 250 . '255
Glu׳ lie Asn Asn Tyr Leu Arg Asn Gin Gly Gly Ser Gly Asn Glu Lys 260 265270
Leu Asp Ala Gin lie Lys Asn lie Ser Asp Ala Leu Gly Lys Lys Pro 275 280285 lie Pro Glu Asn He Thr Val Tyr Arg Trp Cys Gly Met Pro Glu Phe
.׳ 300 295 290 .
Gly Tyr Gin lie Ser Asp Pro . Leu Pro Ser Leu Lys Asp Phe Glu Glu
305 310 . '315320
Gin Phe Leu Asn . Thr He Lys Glu Asp Lys Gly Tyr Met Ser Thr Ser
325 330335
Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys lie He Leu 340 345350
Arg Leu Gin Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser Ala He 355 360365
Gly Gly Phe Ala Ser Glu Lys Glu He Leu Leu Asp Lys Asp Ser Lvs 370 375380
Tyr His He Asp Lys Val Thr Glu Val He lie Lys Gly Val Lys Arg
385 390 395400
Tyr Val Val Asp Ala Thr Leu Leu Thr Asn ׳ 405 410 (2) INFORMATION FOR SEQ ID NO:44:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 86 basepairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear . (ii) MOLECULE TYPE: other.nucleic acid (A). DESCRIPTION: /desc = oligonucleotide encoding vacuolar targetting peptide used to construct pCIB5533 (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:
CCGCGGGCGT GCACTGCCTC AGCAGCAGCA GCTTCGCCGA CAGCAACCCC ATCCGCGTGA 60
I
1 5 3 8 2 /
CCGACCGCGC CGCCAGCACC CTGCAG 86 (2) INFORMATION.FOR SEQ ID NO:45:
,(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1358 base pairs (B) TYPE: nucleic acid ' . (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = Synthetic DNA (iti) HYPOTHETICAL: NO.
(ix) FEATURE: .
(A) NAME/KEY: CDS .
(B) LOCATION: 9.1355 (D) OTHER INFORMATION: /note־ Maize optimized VIP2A(a) with the Bacillus secretion signal removed and the vacuolar targetting signal inserted as contained in pCIB5533 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:
GATCCACC ATG GGC TGG AGC TGG ATC TTC CTG TTC CTG CTG AGC GGC GCC50
Met Gly Trp Ser Trp He Phe Leu Phe Leu Leu Ser Gly Ala
415420
GCG GGC GTG CAC TGC CTC AGC AGC AGC AGC TTC GCC GAC AGC AAC CCC. 98
Ala Gly Val His Cys Leu Ser Ser Ser Ser Phe Ala Asp Ser Asn Pro 425 '430 . 435440
ATC CGC GTG ACC GAC CGC GCC GCC AGC ACC CTG CAG AAC CTG AAG ATC146
He Arg Val Thr Asp Arg Ala Ala Ser Thr Leu GlnAsn Leu LysHe
445 450 . 455
ACC GAC AAG GTG GAG GAC TTC AAG GAG GAC AAG GAG AAG GCC AAG GAG.194
Thr Asp Lys Val Glu Asp Phe Lys Glu Asp Lys Glu Lys Ala. LysGlu
470 465 '. ־ 460
TGG. GGC AAG GAG AAG GAG AAG GAG TGG AAG CTT ACC GCC ACC GAG AAG242
Trp Gly Lys Glu Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr GluLys <sup>:</sup> •475 480485
GGC AAG ATG AAC AAC TTC CTG GAC AAC AAG AAC GAC ATC AAG ACC AAC290
Gly Lys Met Asn Asn Phe Leu Asp Asn Lys Asn Asp He Lys ThrAsn
490 495'500
TAC AAG GAG ATC ACC TTC AGC ATA GCC GGC AGC TTC GAG GAC GAG ATC338
Tyr Lys Glu He Thr Phe Ser lie Ala Gly Ser Phe Glu Asp GluHe
505 510 515520
AAG GAC CTG AAG GAG ATC GAC AAG ATG TTC GAC AAG ACC AAC CTG AGC386
Lys Asp
Leu Lys
Glu lie Asp Lys Met Phe Asp Lys Thr Asn Leu Ser
525. 530535
AAC AGC ATC ATC ACC. TAC AAG AAC GTG GAG CCC ACC ACC ATC GGC TTC Asn Ser He lie Thr Tyr Lys Asn Val Glu Pro Thr Thr He Gly Phe <sup>540</sup> 545550
AAC AAG AGC CTG ACC GAG GGC AAC ACC ATC AAC AGC GAC GCC ATGGCC
Asn Lys Ser Leu Thr Glu Gly Asn Thr lie Asn Ser Asp Ala MetAla
555 560565
CAG TTC AAG GAG CAG TTC CTG GAC CGC GAC ATC AAG TTC GAC AGCTAC
Gin Phe Lys Glu Gin Phe Leu Asp Arg Asp He Lys Phe Asp SerTyr
570 575 ,580
CTG GAC ACC CAC CTG ACC GCC CAG CAG GTG AGC AGC AAG GAG CGCGTG
Leu Asp Thr His Leu Thr Ala Gin Gin Val Ser Ser Lys Glu ArqVal <sup>583</sup> 590 595600
ATC CTG AAG GTG ACC GTC CCC AGC GGC AAG GGC AGC ACC ACC CCCACC
He Leu Lys Val Thr Val Pro Ser Gly Lys Gly Ser Thr Thr ProThr <sup>605</sup> . 610 .615
AAG GCC GGC GTG ATC CTG AAC AAC AGC GAG TAC AAG ATG CTG ATCGAC
Lys Ala Gly Val lie Leu Asn Asn Ser Glu Tyr Lys Met Leu HeAsp.
<sup>620</sup> 625630
AAC GGC TAC ATG GTG CAC GTG GAC AAG GTG AGC AAG GTG GTG AAG AAG
Asn Gly Tyr Met Val His Val Asp Lys Val Ser Lys Val Val Lys Lys
635 640645
GGC GTG GAG TGC CTC CAG ATC' GAG GGC ACC CTG AAG AAG AGT CTA GAC
Gly Val Glu Cys teu Gin lie Glu Gly Thr Leu Lys Lys Ser Leu Asp
650 ' 655 660.
TTC AAG AAC GAC ATC AAC GCC GAG GCC. CAC AGC TGG GGC ATG AAG AAC
Phe Lys Asn Asp lie Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn <sup>665</sup>. . <sup>670</sup> 675680'
TAC GAG GAG TGG GCC AAG GAC CTG ACC GAC. AGC CAG CGC GAG GCC CTG
Tyr Glu Glu Trp Ala Lys Asp Leu Thr Asp Ser Gin Arg Glu Ala Leu . 685 690:695
GAC GGC TAC GCC CGC CAG GAC TAC AAG GAG ATC AAC AAC TAC CTG CGC
Asp Gly Tyr Ala Arg Gin Asp Tyr Lys Glu lie Asn Asn 1־y<sub>r</sub> Leu Arq <sup>788</sup> 705710
AAC CAG GGC GGC AGC GGC AAC GAG AAG CTG GAC GCC CAG ATC AAGAAC
Asn Gin Gly Gly Ser Gly Asn Glu Lys Leu Asp Ala Gin He LysAsn <sup>715</sup> 720725
ATC AGC GAC GCC CTG GGC AAG AAG CCC ATC CCC GAG AAC ATC ACCGTG
He Ser Asp Ala Leu Gly Lys Lys Pro He Pro Glu Asn lie ThrVal
730 735'740
<img file="IL115382A_D0009.tif" />
5.6.55
TAC CGC TGG TGC GGC ATG CCC GAG TTC GGC TAC CAG ATC AGC GACCCC
Tyr Arg Trp Cys Gly Met Pro Glu Phe Gly Tyr Gin .lie Ser AspPro . <sup>74</sup>$ 750 755760
CTG CCC AGC CTG AAG GAC TTC GAG GAG CAG TTC CTG AAC ACC ATCAAG
Leu Pro Ser Leu Lys Asp Phe Glu Glu Gin Phe Leu Asn Thr HeLys
775 ׳ 770765
GAG GAC AAG GGC TAC ATG AGC ACC AGC CTG AGC AGC GAG CGC CTG GCC Glu Asp Lys Gly.Tyr Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala
780 785790
GCC TTC GGC AGC CGC AAG ATC ATC CTG CGC CTG CAG GTG CCC AAG GGC
Ala Phe Gly Ser Arg Lys lie lie : Leu Arg Leu Gin Vai Pro Lys Gly <sup>7</sup>95 800805
AGC ACT GGT GCC TAC CTG AGC GCC ATC GGC GGC TTC GCC AGC GAG 'AAG
Ser Thr Gly Ala Tyr Leu Ser Ala He' Gly Gly Phe Ala Ser Glu Lys
810 815820
GAG ATC CTG CTG GAT AAG GAC AGC AAG TAC CAC ATC GAC AAG GTGACC
Glu He Leu Leu Asp Lys Asp Ser Lys Tyr His lie Asp Lys VaiThr <sup>82</sup>5 830 835 .840
GAG GTG ATC ATC AAG GGC GTG AAG CGC TAC GTG GTG GAC GCC ACCCTG
Glu Vai lie He Lys Gly Vai Lys Arg Tyr Vai Vai Asp Ala ThrLeu
845 850855.
CTG ACC AAC TAG
Leu Thr Asn
1058
1106
1154
1202
1250
1298
1346
1358 (2) INFORMATION FOR SEQ ID NO:46:
(i) SEQUENCE CHARACTERISTICS:׳ (A) .LENGTH: 449: amino acids .(B) type: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:
Met . Gly Trp Ser Tip He Phe. Leu Phe Leu Leu Ser Gly Ala Ala Gly <sup>1</sup><sup>5</sup> 1015
Vai His Cys Leu Ser Ser Ser Ser Phe Ala Asp Ser Asn Pro He Ara 20 . 2530
Vai Thr Asp Arg Ala Ala Ser Thr Leu Gin Asn Leu Lys He Thr Asp
׳ 45 4035
Lys Vai Glu Asp Phe Lys Glu' Asp Lys Glu Lys Ala Lys Glu Trp Gly <sup>50</sup> . 5560
203 Π 5 3 8 2 /2
Lys . Glu Lys Glu Lys Glu Tip Lys Leu Thr Ala Thr Glu Lys GlyLys
70 7580
Met Asn Asn Phe Leu Asp Asn Lys Asn Asp He Lys Thr Asn TyrLys . 85 9095
Glu He Thr. Phe Ser He Ala Gly Ser Phe Glu Asp Glu He Lys Asp
100 105 .HO
Leu Lys Glu He Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser 115. 120125
He He Thr Tyr Lys Asn. Vai Glu Pro Thr Thr He Gly Phe Asn Lys 130 135140
Ser Leu Thr Glu Gly Asn Thr He Asn Ser Asp Ala Met Ala GinPhe <sup>145</sup> 150 155 ' .160
Lys Glu Gin Phe Leu Asp Arg Asp lie Lys Phe Asp Ser Tyr LeuAsp
165 170175
Thr His Leu Thr Ala Gin Gin Vai Ser Ser Lys Glu Arg Vai lie Leu 180 . 185190
Lys Vai Thr Vai Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala , 195 200 205'
Gly Vai He Leu Asn Asn Ser Glu Tyr Lys Met Leu lie Asp Asn Gly <sup>210</sup> 215220
Tyr Met Vai His Vai Asp Lys Vai Ser Lys Vai Vai Lys Lys GlyVai <sup>225</sup> . 230 . 235240
Glu Cys Leu.Gin lie Glu Gly Thr Leu Lys Lys Ser Leu Asp PheLys <sup>24</sup>5 . ' 250 .255 '
Asn Asp lie Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu 260 265270
Glu Trp Ala Lys Asp Leu Thr Asp Ser Gin Arg Glu Ala Leu Asp Gly
275 . 280 . '285
Tyr Ala Arg. Gin Asp Tyr Lys Glu He Asn Asn Tyr Leu Arg Asn Gin
290 295 .300
Gly Gly Ser Gly. Asn Glu Lys Leu Asp Ala Gin He Lys Asn lieSer <sup>305</sup> 310 315320
Asp Ala Leu Gly Lys Lys Pro He Pro Glu Asn He Thr. Vai TyrArg
325 330335
Trp Cys Gly Met Pro Glu Phe Gly Tyr Gin lie Ser Asp Pro Leu Pro 340 ’ ' 345350
Ser Leu Lys Asp Phe Glu Glu Gin Phe Leu Asn Thr He Lys Glu Asp <sup>355</sup> 360.365
Lys Gly Tyr Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe <sup>37</sup>;Ο 315380
Gly Ser Arg Lys He lie Leu Arg Leu Gin Val Pro Lys Gly SerThr <sup>385</sup> 390 395400
Gly Ala Tyr Leu Ser Ala He Gly Gly Phe Ala Ser Glu Lys Glulie
405 410415
Leu Leu Asp Lys Asp . Ser Lys Tyr His lie Asp Lys Val Thr GluVal <sup>420</sup> . 425430.
He He Lys Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu LeuThr
435 440445
Asn (2) INFORMATION FOR SEQ ID NO:41:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 16 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide .
(iii) HYPOTHETICAL: NO . (ix) FEATURE:
(A) NAME/KEY.: Peptide (B) LOCATION: 1.16 (D) OTHER INFORMATION: /note־ linker peptide for fusion of VIPlA(a) and VIP2A(a) used to construct pCIB5533 (xi). SEQUENCE. DESCRIPTION: SEQ ID NO:41:
Pro Ser Thr Pro Pro Thr Pro Ser Pro Ser Thr Pro Pro Thr Pro Ser <sup>1</sup> 5 IQ . 15 (2) INFORMATION FOR SEQ ID NO:48:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 66 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single '־. (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid .
(A) DESCRIPTION: /desc - DNA encoding linker peptide used to construct pCIB5533 . (iii) HYPOTHETICAL; NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48: ‘
CCCGGGCCTT CTACTCCCCC AACTCCCTCT CCTAGCACGC CTCCGACACC TAGCGATATC
GGATCC (2) INFORMATION FOR SEQ ID NO:49:
<td></td><td> (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4031 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single <sup>;</sup> (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = Synthetic DNA</td>
<td> 5,6.35</td><td> (iii) HYPOTHETICAL: NO</td>
(ix) FEATURE:
(A) NAME/KEY: CDS (B) LOCATION: 6.4019 (D) OTHER INFORMATION: /note= Maize optimized DNA sequence encoding a VIP2A(a) - VIPlA(a). fusion protein as contained in pCIB5531 (xi) SEQUENCE DESCRIPTION:' SEQ ID NO:49:
GATCC ATG AAG CGC ATG GAG GGC AAG CTG TTC ATG GTG AGC AAG AAG Met Lys Arg Met Glu Gly Lys Leu Phe Met Vai Ser Lys Lvs <sup>450</sup> 455 ' 460'
CTC CAG GTG GTG ACC AAG ACC GTG CTG CTG AGC ACC GTG TTC AGC ATC
Leu Gin Vai Vai Thr Lys Thr Vai Leu Leu Ser Thr Vai Phe Ser lie
475 י. 470 . .,<sup>4</sup>65
AGC CTG CTG AAC . AAC GAG GTG ATC AAG GCC GAG CAG CTG AAC ATC AAC
Ser Leu Leu Asn Asn Glu Vai He Lys Ala Glu Gin Leu Asn lie Asn <sup>480</sup> 485 ' 490 495
AGC CAG AGC AAG TAC ACC AAC CTC CAG AAC CTG AAG ATC ACC GAC AAG
Ser Gin ;Ser Lys Tyr Thr Asn. Leu Gin Asn Leu Lys He Thr Asp Lvs
500 505
GIG GAG GAC TTC AAG GAG GAC AAG GAG AAG GCC AAG GAG TGG GGC AAG
1 5 3 8 2 Ζ
<td> Val</td><td> Glu</td><td> Asp</td><td> Phe</td><td colspan="5"> Lys Glu Asp LysGlu</td><td> Lys</td><td> Ala</td><td colspan="4"> Lys Glu Trp Gly</td><td> Lys</td><td></td>
<td></td><td></td><td></td><td> 515</td><td></td><td></td><td></td><td></td><td> 520</td><td></td><td></td><td></td><td></td><td> 525</td><td></td><td></td><td></td>
<td> GAG</td><td> AAG</td><td> GAG</td><td> AAG</td><td> GAG</td><td> TGG</td><td> AAG</td><td> CTT</td><td> ACC</td><td> GCC</td><td> ACC</td><td colspan="4"> GAG AAG GGC AAG</td><td> ATG .</td><td> 287</td>
<td> Glu</td><td> Lys</td><td> Glu</td><td> Lys</td><td> Glu</td><td> Trp</td><td> Lys</td><td> Leu</td><td> Thr</td><td> Ala</td><td> Thr</td><td> Glu</td><td> Lys</td><td> Gly</td><td> Lys</td><td> Met .</td><td></td>
<td></td><td></td><td> 530</td><td></td><td></td><td></td><td></td><td> 535</td><td></td><td></td><td></td><td></td><td> 540</td><td></td><td></td><td></td><td></td>
<td> AAC</td><td> AAC</td><td> TTC</td><td> CTG</td><td> GAC</td><td> AAC</td><td> AAG</td><td> AAC</td><td colspan="2"> GAC ATC</td><td> AAG</td><td> ACC</td><td> AAC</td><td> TAC</td><td> AAG</td><td> GAG</td><td> 335</td>
<td> Asn</td><td> Asn</td><td> Phe</td><td> Leu</td><td> Asp</td><td> Asn</td><td> Lys</td><td colspan="3"> Asn Asp He</td><td> Lys</td><td> Thr</td><td> Asn</td><td> Tyr</td><td> Lys</td><td> Glu</td><td></td>
<td></td><td> .545</td><td></td><td></td><td></td><td></td><td> 550</td><td></td><td></td><td></td><td></td><td> 555</td><td></td><td></td><td></td><td></td><td></td>
<td> ATC</td><td> ACC</td><td> TTC.</td><td> AGC</td><td> ATA</td><td> GCC</td><td> GGC</td><td> AGC</td><td colspan="2"> TTC GAG</td><td> GAC</td><td> GAG</td><td> ATC</td><td> AAG</td><td> GAC</td><td> CTG</td><td> 383</td>
<td> He</td><td> Thr</td><td> Phe</td><td> Ser</td><td> He</td><td colspan="2"> Ala Gly</td><td> Ser</td><td> Phe</td><td> Glu</td><td colspan="2"> Asp' Glu</td><td> lie</td><td> Lys</td><td> Asp</td><td> Leu,.</td><td></td>
<td> 560</td><td></td><td></td><td></td><td></td><td> 565</td><td></td><td></td><td></td><td></td><td> 570</td><td></td><td></td><td></td><td></td><td> 575</td><td></td>
<td> AAG</td><td colspan="2"> GAG ATC</td><td> GAC</td><td> AAG</td><td> ATG</td><td> TTC</td><td> GAC</td><td> AAG</td><td> ACC</td><td> AAC</td><td colspan="2"> CTG AGC</td><td> AAC</td><td> AGC</td><td> ATC</td><td> . 431</td>
<td> Lys</td><td> Glu</td><td> lie</td><td> Asp</td><td> Lys</td><td> Met</td><td> Phe</td><td> Asp</td><td> Lys</td><td> Thr</td><td> Asn</td><td> Leu</td><td> Ser</td><td> Asn</td><td> Ser</td><td> He .</td><td></td>
<td></td><td></td><td></td><td></td><td> 580</td><td></td><td></td><td></td><td></td><td> 585</td><td></td><td></td><td></td><td></td><td> 590</td><td></td><td></td>
<td> ATC</td><td> ACC</td><td> TAC</td><td> AAG</td><td> AAC</td><td> GTG</td><td> GAG</td><td> CCC</td><td> ACC</td><td> ACC</td><td> ATC</td><td> GGC</td><td> TTC</td><td> AAC</td><td> AAG</td><td> AGC</td><td> 479</td>
<td> He</td><td> Thr</td><td> Tyr</td><td> Lys</td><td> Asn</td><td> Val</td><td> Glu</td><td> Pro</td><td> Thr</td><td> Thr</td><td> He</td><td> Gly</td><td> Phe</td><td> Asn</td><td> Lys</td><td> Ser</td><td></td>
<td></td><td></td><td></td><td> 595</td><td></td><td></td><td></td><td></td><td> 600</td><td></td><td></td><td></td><td></td><td> 605</td><td></td><td></td><td></td>
<td> CTG</td><td> ACC</td><td> GAG</td><td> GGC</td><td> AAC</td><td> ACC</td><td> ATC</td><td> AAC</td><td> AGC</td><td> GAC</td><td> GCC</td><td> ATG</td><td> GCC</td><td> CAG</td><td> TTC</td><td> AAG</td><td> 527</td>
<td> Leu</td><td> Thr</td><td> Glu</td><td> Gly</td><td> Asn</td><td> Thr</td><td> He</td><td> Asn</td><td colspan="2"> Ser Asp</td><td> Ala</td><td> Met</td><td> Ala</td><td> Gin</td><td> Phe</td><td> Lys</td><td></td>
<td></td><td></td><td> 610</td><td></td><td></td><td></td><td></td><td> 615</td><td></td><td></td><td></td><td></td><td> 620</td><td></td><td></td><td></td><td></td>
<td> GAG</td><td> CAG</td><td> TTC</td><td> CTG</td><td> GAC</td><td> CGC</td><td> GAC</td><td> ATC</td><td> AAG</td><td> TTC</td><td> GAC</td><td> AGC</td><td> TAC</td><td> CTG</td><td> GAC</td><td> ACC</td><td> 575</td>
<td> Glu</td><td> Gin</td><td> Phe</td><td> Leu</td><td colspan="3"> Asp Arg Asp</td><td> He</td><td> Lys</td><td> Phe</td><td> Asp</td><td> Ser</td><td> Tyr</td><td> Leu</td><td> Asp</td><td> Thr</td><td></td>
<td></td><td> 625</td><td></td><td></td><td></td><td></td><td> 630</td><td></td><td></td><td></td><td></td><td> 635</td><td></td><td></td><td></td><td></td><td></td>
<td> CAC</td><td> CTG</td><td> ACC</td><td> GCC</td><td> CAG</td><td> CAG</td><td> GTG</td><td> AGC</td><td> AGC</td><td> AAG</td><td> GAG</td><td> CGC</td><td> GTG</td><td> ATC</td><td> CTG</td><td> AAG .</td><td> 623</td>
<td> His</td><td> Leu</td><td> Thr</td><td> Ala</td><td> Gin</td><td> Gin</td><td> Val</td><td> Ser</td><td> Ser</td><td> Lys</td><td> Glu</td><td> Arg</td><td> Val</td><td> He</td><td> Leu</td><td> Lys</td><td></td>
<td> 640</td><td></td><td></td><td></td><td></td><td> 645</td><td></td><td></td><td></td><td></td><td> 650</td><td></td><td></td><td></td><td></td><td> 655</td><td></td>
<td> GTG</td><td> ACC</td><td> GTC</td><td> CCC</td><td> AGC</td><td> GGC</td><td> AAG</td><td colspan="2"> GGC AGC</td><td colspan="3"> ACC ACC CCC</td><td> ACC</td><td> AAG</td><td colspan="2"> GCC GGC '</td><td> ' 671</td>
<td colspan="2"> Val. Thr</td><td> Val</td><td> Pro</td><td> Ser</td><td colspan="2"> Gly Lys</td><td colspan="2"> Gly Ser</td><td> Thr</td><td colspan="2"> Thr: Pro</td><td> Thr</td><td> Lys</td><td colspan="2"> Ala Gly</td><td></td>
<td></td><td></td><td></td><td></td><td> 660</td><td></td><td></td><td></td><td></td><td> 665</td><td></td><td></td><td></td><td></td><td> 670</td><td></td><td></td>
<td colspan="2"> GTG ATC</td><td> CTG</td><td> AAC</td><td colspan="2"> AAC AGC</td><td> GAG</td><td colspan="2"> TAC AAG</td><td> ATG.</td><td colspan="2"> CTG ATC</td><td colspan="2"> GAC AAC</td><td> GGC</td><td> TAC '</td><td> 719</td>
<td> Val</td><td> He</td><td> Leu</td><td> Asn</td><td> Asn</td><td colspan="2"> Ser Glu</td><td colspan="2"> Tyr Lys</td><td> Met</td><td> Leu</td><td> He</td><td> Asp</td><td colspan="3"> Asn. Gly Tyr</td><td></td>
<td></td><td></td><td></td><td> 67.5</td><td></td><td></td><td></td><td></td><td> 680</td><td></td><td></td><td></td><td></td><td> 685</td><td></td><td></td><td></td>
<td> ATG</td><td> GTG</td><td> CAC</td><td> GTG</td><td> GAC</td><td> AAG</td><td> GTG</td><td> AGC</td><td> AAG</td><td> GTG</td><td> GTG</td><td> AAG</td><td> AAG</td><td> GGC</td><td> GTG</td><td> GAG</td><td> 767</td>
<td> Met</td><td> Val</td><td> His</td><td> Val</td><td> Asp</td><td> Lys</td><td> Val</td><td> Ser</td><td> Lys</td><td> Val</td><td> Val</td><td> Lys</td><td> Lys</td><td colspan="2"> Gly Val</td><td> Glu</td><td></td>
<td></td><td></td><td> 690</td><td></td><td></td><td></td><td></td><td> 695</td><td></td><td></td><td></td><td></td><td> 700</td><td></td><td></td><td></td><td></td>
<td> TGC.</td><td> CTC</td><td> CAG</td><td> ATC</td><td> GAG</td><td> GGC</td><td> ACC</td><td> CTG</td><td> AAG</td><td> AAG</td><td> AGT</td><td colspan="2"> CTA GAC</td><td> TTC</td><td> AAG</td><td> AAC .</td><td> 815</td>
<td> Cys</td><td> Leu</td><td> Gin</td><td> He</td><td colspan="2"> Glu Gly</td><td> Thr</td><td> Leu</td><td> Lys</td><td> Lys</td><td> Ser</td><td> Leu</td><td> Asp</td><td> Phe</td><td> Lys</td><td> Asn</td><td></td>
<td></td><td> 705</td><td></td><td></td><td></td><td></td><td> 710</td><td></td><td></td><td></td><td></td><td> 715</td><td></td><td></td><td></td><td></td><td></td>
<td> GAC</td><td> ATC</td><td> AAC</td><td> GCC</td><td> GAG</td><td> GCC</td><td> CAC</td><td> AGC</td><td> TGG</td><td> GGC</td><td> ATG</td><td> AAG</td><td> AAC</td><td> TAC</td><td> GAG</td><td> GAG'</td><td> 863</td>
<td> Asp</td><td> lie</td><td> Asn</td><td> Ala</td><td colspan="2"> Glu Ala</td><td> His</td><td> Ser</td><td colspan="3"> Trp Gly Met</td><td> Lys</td><td> Asn</td><td colspan="2"> Tyr Glu</td><td> Glu</td><td></td>
<td> 720</td><td></td><td></td><td></td><td></td><td> 725</td><td></td><td></td><td></td><td></td><td> 730</td><td></td><td></td><td></td><td></td><td> 735</td><td></td>
«35
<td rowspan="3"> TGG Trp</td><td> GCC AAG GAC CTG ACC GAC</td><td colspan="3"> AGC CAG CGC GAG GCC CTG GAC GGC TAC</td><td rowspan="3"> 911</td>
<td> Ala Lys Asp Leu Thr. Asp</td><td> Ser Gin</td><td> Arg Glu Ala Leu Asp</td><td rowspan="2"> Gly Tyr 750</td>
<td> 740</td><td></td><td> 745</td>
<td> GCC</td><td> CGC CAG GAC TAC AAG GAG</td><td> ATC AAC</td><td> AAC TAC CTG CGC AAC</td><td> CAG GGC.</td><td> ' 959</td>
<td> Ala</td><td> Arg Gin Asp Tyr Lys Glu 755</td><td> He Asn 760</td><td> Asn Tyr Leu Arg Asn 765</td><td> Gin Gly</td><td></td>
<td> GGC</td><td> AGC GGC AAC GAG AAG CTG</td><td> GAC GCC</td><td> CAG ATC AAG AAC ATC</td><td> AGC GAC</td><td> . 1007</td>
<td> Gly</td><td> Ser Gly Asn Glu Lys Leu 770</td><td> Asp Ala 775</td><td> Gin lie Lys Asn Tie ' 780</td><td> Ser Asp</td><td></td>
<td> GCC.</td><td> CTG GGC AAG AAG CCC ATC</td><td> CCC GAG</td><td> AAC ATC ACC GTG TAC</td><td> CGC TGG</td><td> 1055</td>
<td> Ala</td><td> Leu Gly Lys Lys Pro He 785 790</td><td> Pro Glu</td><td> Asn He Thr Vai Tyr 795</td><td> Arg Trp</td><td></td>
<td> TGC</td><td> GGC ATG CCC GAG TTC GGC</td><td> TAC CAG</td><td> ATC AGC GAC CCC CTG</td><td> CCC AGC</td><td> 1103</td>
<td> Cys 800</td><td> Gly Met Pro Glu Phe Gly ' 805</td><td> Tyr Gin</td><td> lie Ser Asp Pro Leu 810</td><td> Pro Ser 815</td><td></td>
<td> CTG</td><td> AAG GAC TTC GAG GAG CAG</td><td> TTC CTG</td><td> AAC ACC ATC AAG GAG</td><td> GAC AAG</td><td> 1151</td>
<td> Leu</td><td> Lys Asp Phe Glu Glu Gin 820 .</td><td> Phe Leu</td><td colspan="2"> Asn Thr He Lys Glu Asp Lys 825 830</td><td></td>
<td> GGC</td><td> TAC ATG AGC ACC AGC CTG</td><td> AGC AGC</td><td> GAG CGC CTG GCC GCC</td><td> TTC GGC</td><td> 1199</td>
<td> Gly</td><td> Tyr Met Ser Thr Ser Leu 835</td><td> Ser Ser 840</td><td> Glu Arg Leu Ala Ala 845</td><td> Phe Gly</td><td></td>
<td> AGC</td><td> CGC AAG ATC ATC CTG CGC</td><td> CTG CAG</td><td> GTG CCC AAG GGC AGC</td><td> ACT GGT</td><td> 1247</td>
<td> Ser</td><td> Arg Lys lie lie Leu Arg . ' 850</td><td> Leu Gin 855</td><td> Vai Pro Lys Gly Ser 860</td><td> Thr Gly</td><td></td>
<td> GCC</td><td> TAC CTG AGC GCC ATC GGC</td><td> GGC TTC</td><td> GCC AGC GAG AAG GAG</td><td> ATC CTG</td><td> . 1295</td>
<td> Ala</td><td> Tyr Leu Ser Ala He Gly 865 870</td><td> Gly Phe</td><td> Ala Ser Glu Lys Glu . 875</td><td> He Leu</td><td></td>
<td> CTG</td><td> GAT AAG GAC.AGC AAG TAC</td><td> CAC ATC</td><td> GAC AAG, GTGACC GAG</td><td> GTG ATC</td><td> . 1343</td>
<td> Leu 880</td><td> Asp Lys Asp Ser Lys Tyr 885</td><td> His He</td><td> Asp Lys Vai Thr Glu 890</td><td> Vai He 8.95 ..</td><td></td>
<td> ATC</td><td> AAG GGC GTG AAG CGC TAC</td><td> GTG GTG.</td><td> GAC GCC ACC CTG CTG</td><td> ACC AAC . .</td><td> '1391</td>
<td> He</td><td> Lys Gly Vai Lys Arg Tyr 900</td><td> Vai Vai</td><td> Asp.Ala Thr Leu Leu 905 '.</td><td> Thr Asn 910</td><td></td>
<td> TOC</td><td> CGG GGG CCT TCT ACT CCC</td><td> CCA ACT</td><td> CCC TCT CCT AGC ACG</td><td> CCT CCG</td><td> 1439</td>
<td> Ser</td><td> Arg Gly Pro Ser Thr Pro 915</td><td> Pro Thr 920</td><td> Pro Ser Pro Ser Thr 925</td><td> Pro Pro</td><td></td>
<td> ACA</td><td> CCT AGC GAT ATC GGA TCC</td><td> ACC ATG</td><td> AAG ACC AAC CAG ATC</td><td> AGC ACC</td><td> 1487</td>
<td> Thr</td><td> Pro Ser Asp He Gly Ser 930</td><td> Thr Met 935</td><td> Lys Thr Asn Gin lie 940</td><td> Ser Thr</td><td></td>
<td> ACC</td><td> CAG AAG AAC CAG CAG AAG</td><td> GAG ATG</td><td> GAC CGC AAG GGC CTG</td><td> CTG GGC</td><td> 1535</td>
<td> Thr</td><td> Gin Lys Asn Gin Gin Lys 945 . 950</td><td> Glu Met</td><td> Asp Arg Lys Gly Leu 955</td><td> Leu Gly</td><td></td>
<td> TAC TAC TTC</td><td> AAG GGC AAG GAC TTC AGC AAC CTG</td><td> ACC ATG TTC GCC CCC</td><td rowspan="3"> 1583</td>
<td> Tyr Tyr . Phe</td><td> Lys Gly Lys Asp Phe Ser Asn Leu</td><td> Thr Met Phe Ala Pro</td>
<td> 960 </td><td> 365 ' / , 970</td><td> 975</td>
<td> ACG CGT GAC</td><td> AGC,ACC CTG ATC TAC GAC CAG CAG</td><td> ACC GCC AAC AAG CTG</td><td> .1631</td>
<td> Thr Arg Asp</td><td> Ser Thr Leu lie Tyr Asp Gin Gin 980 985</td><td> Thr Ala Asn Lys Leu 990</td><td></td>
<td> CTG GAC AAG</td><td> AAG CAG CAG GAG TAC CAG AGC ATC</td><td> CGC TGG ATC GGC CTG</td><td> 1679</td>
<td> Leu Asp Lys</td><td> Lys Gin Gin Glu Tyr Gin Ser lie 995 . 1000 '</td><td> Arg Trp lie Gly Leu 1005</td><td></td>
<td> ATC CAG AGC</td><td> AAG GAG ACC GGC GAC TTC ACC TTC</td><td> AAC CTG AGC GAG GAC</td><td> 1727</td>
<td colspan="2"> lie Gin Ser Lys Glu Thr Gly Asp Phe Thr Phe 1010 1015</td><td> Asn Leu Ser Glu Asp 1020</td><td></td>
<td> GAG CAG GCC</td><td> ATC ATC GAG. ATC AAC GGC AAG ATC</td><td> ATC AGC AAC AAG GGC</td><td> 1775</td>
<td> Glu Gin׳ Ala 1025</td><td> lie lie Glu lie Asn Gly Lys He 1030</td><td> lie Ser Asn Lys Gly 1035</td><td></td>
<td> AAG GAG AAG</td><td> CAG GTG GTG CAC CTG GAG AAG GGC</td><td> AAG CTG GTG CCC ATC</td><td> 1823</td>
<td> Lys Glu Lys 1040.</td><td colspan="2"> Gin Val Val His Leu Glu Lys Gly Lys Leu Val Pro lie 1045 1050 1055</td><td></td>
<td> AAG ATC GAG</td><td> TAC CAG AGC GAC ACC AAG TTC AAC</td><td> ATC GAC AGC AAG ACC</td><td> 1871</td>
<td> Lys He Glu</td><td> Tyr Gin Ser Asp Thr Lys Phe Asn 1060 1065</td><td> He Asp Ser Lys Thr 1070</td><td></td>
<td> TTC AAG GAG</td><td> CTG AAG CTT TTC AAG ATC GAC AGC</td><td> CAG AAC CAG CCC CAG</td><td> 1919</td>
<td> Phe Lys Glu</td><td> Leu Lys Leu Phe Lys He Asp Ser 1075. 1080</td><td> Gin Asn Gin Pro Gin ; 1085</td><td></td>
<td> CAG GTG CAG</td><td> CAG GAC GAG CTG CGC AAC CCC GAG</td><td> TTC AAC AAG AAG GAG</td><td> 1967</td>
<td colspan="2"> Gin Val Gin Gin Asp Glu Leu Arg Asn Pro Glu .1090. 1095</td><td> Phe Asn Lys Lys Glu 1100</td><td></td>
<td> AGC CAG GAG</td><td> TTC CTG GCC AAG CCC AGC AAG ATC</td><td> AAC CTG TTC ACC CAG'</td><td> 2015</td>
<td> Ser Gin Glu 1105</td><td> Phe Leu Ala Lys Pro Set Lys He 1110</td><td> Asn Leu Phe Thr Gin 1115 .</td><td></td>
<td> CAG ATG AAG</td><td> CGC GAG ATC GAC GAG GAC ACC GAC</td><td> ACC GAC GGC GAC AGC</td><td> 2063</td>
<td> Gin Met Lys 1120</td><td colspan="2"> Arg Glu He Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser 1125 / 1130 1135</td><td></td>
<td> ATC CCC GAC</td><td> CTG TGG GAG GAG AAC GGC TAC ACC</td><td> ATC CAG AAC CGC ATC</td><td rowspan="2"> 2111</td>
<td> lie Pro Asp</td><td> Leu Trp Glu Glu Asn Gly Tyr Thr 1140 1145</td><td> lie Gin Asn Arg lie 1150 ,</td>
<td> GCC GTG AAG</td><td> TGG GAC GAC AGC CTG GCT AGC AAG</td><td> GGC TAC ACC AAG TTC</td><td> 2159</td>
<td> Ala Val Lys</td><td> Trp Asp Asp Ser Leu Ala Ser Lys 1155 1160</td><td> Gly Tyr Thr Lys Phe ,. 1165</td><td></td>
<td> GTG AGC AAC</td><td> CCC CTG GAG AGC CAC ACC GTG GGC</td><td> GAC CCC TAC ACC GAC</td><td> 2207</td>
<td> Val Ser Asn</td><td colspan="2"> Pro Leu Glu Ser His Thr Val Gly Asp Pro Tyr Thr Asp</td><td></td>
- 1 1 5 3 8 2 /2
1170 1175 ' 1180
5.635
TAC
Tyr
GAG AAG
Glu Lys
1185
TTC .
Phe . 1200
AAG
Lys
CAC
His
AAC
Asn
GTG
Val
TCG
Ser
GAG GCC
Glu
TAC
Tyr
CCC
Ala
GCC GCC
Ala Ala
CTG GTG
Pro Leu
Val
ATC
He
AGC
Ser
CTG
Leu
CGC GAC CTG GAC CTG
Arg Asp Leu Asp Leu . 1190 '
GCC GCC
Ala Ala 1205
AGC Ser 1220
ACC .
Thr. . 1235
GGC .
Gly 1250
CAG 1
Gin !
1265
CAC
His
AAC
Asn
TTC
Phe
CCC
Pro
AGC
Ser
CCC
Pro
AAC
Asn
GAG
Glu. Asn
AAC
TGG
Trp
AGC
Ser
TAC
Tyr
ATC He
AGC
Ser
GGT
Gly
CCC
Pro
AAG
Lys
GAG
Glu
ACC
Thr
AGC.AAC GCC
Ser Asn Ala
1195
GTG AAC
Val Asn
1210
CTG ־ AGC
Leu Ser 1225.
ACC .
Thr . 1240
GGC .
Gly 1255
GTG Val . 1270
AAC
Asn
ACC
Thr
AAG
Lys
GAG
Glu
ACC
Thr. .
2255
GTG
Val
AGC
Ser
ATG
Met
GAG
Glu 1215
2303
ATC AGC He
GCC CAG
Ala Gin
Ser
TTC
Phe
GAG
Glu
AAC
Asn Ser
AGC
GTG
Val
GAG .
Glu 1230
AGC
Ser
2351
GAG GGC
Glu Gly
GGC GTG Gly
AAC .
Asn ' 1280
ACC
Thr
AGC
Ser
CAG
Gin
TTC AAC ACC Phe
Asn Thr 1285
GCC
Ala
AGC
Ser
GCC
Ala
GTG
Val
CGC
Arg
TAC
Tyr
AAC
Asn
AAC
Asn 1300
GTG
Val
GGC
Gly
ACC
Thr
ACC
Thr
ACC
Thr
TTC
AGC
Ser Phe ' 1315
GTG CTG
Val Leu
AAC
Asn
AAC
Asn
AAG
Lys
TCG
Ser
AAT
Asn 1330
TCC
Ser
ACC GCC CTG
Thr
Ala
Leu
AAG
Lys
AAG
Lys Gly
1345
GGC
CAG
Gin
AAC
Asn
GGC
Gly
GCC Ala 1245
Val
1260
AGC
Ser
AGC
Ser
GTG
Val .GTG
Val
AAC
Asn
2399 .2447
TGG
Trp Gly '
1275
GGC
GGC TAC
Gly Tyr
1290
GGC
Gly Ala He 1305
GCC ATC
GAC ACC
Asp.Thr 1320
AAC ATC
Asn lie 1335
AGC
Ser
TAC
Tyr
ACC AGC
Thr Ser
ACC
Thr
GGC
Gly
2495
CTG AAC GCC
Leu Asn Ala
GAC GTG AAG
Asp Val Lys
ATC lie
GCC
Ala
CCC GGC
Pro
Gly
AGC י Ser 1360
CAC
His
CCC
Pro
ATC ACC lie
Thr
AAC
Asn
AAG
Lys
CCC
Pro
ATG
Met
ATC
AAG
GAC
ACC
ATC 1 lie . 1350
CTG . Leu . 1365
ATG !
Met . 1380
CTG
Leu
CAC GGC
GCC ATC
Ala
AAC AAG
Asn Lys
GAG
Glu
ACC
Thr
AAC
ATC
He
ACC
Thr
AGC
Ser
AAG CAG Lys
Gin
AAC
Asn
GTG
AAC
Asn 1295
2543
CCC
Pro 1310
2591
ACC ATC ACC
Thr lie Thr
1325
GAG AGC
Glu Ser 1340
ATG l Me t . .1355
GAC GAC
Asp Asp
GCC
Ala
2639
TAC
Tyr Pro
CCC
2687
TTC AAC Phe
Asn
2735
GTG GAC
Val Asp
1370
CAG . Gin ' 1385
AAC
Asn
CTG CTG
Leu Leu
AAC
Asn
Ί375
2783
ACC GAC
Thr Asp Gly
GGC
GTC TAC .
Val Tyr :
1390
AAG ' Lys
2831
ACG GGC GGC GAG
TGG AAC GGC
2879 . lie Lys Asp Thr His Gly Asn He Vai.Thr Gly.Gly Glu Trp Asn Gly . ' . 1395 . 1400 1405
GTG ATC CAG CAG ATC AAG GCC AAG ACC GCC AGC ATC ATC GTC GAC. GAC2927
Vai lie Gin Gin lie Lys Ala Lys Thr Ala Ser lie He Vai AspAsp
1410 14151420'
GGC GAG CGC GTG GCC GAG AAG CGC GTG GCC GCC AAG GAC TAC GAG AAC2975
Gly Glu Arg Vai Ala Glu Lys Arg Vai Ala Ala Lys Asp Tyr GluAsn
1425 14301435
CCC GAG GAC AAG ACC CCC AGC CTG ACC CTG AAG GAC GCC CTG AAG CTG3023
Pro Glu Asp Lys Thr Pro Ser Leu Thr Leu Lys Asp Ala Leu LysLeu
1440 1445 ; 1450 '1455
AGC TAC CCC GAC GAG ATC AAG GAG ATC GAG GGC TTG CTG TAC TAC AAG3071
Ser Tyr Pro Asp Glu He Lys Glu lie. Glu Gly Leu Leu Tyr TyrLys <sup>1</sup> 1460 ' 14651470
AAC AAG CCC ATC TAC GAG AGC AGC GTG ATG ACC TAT CTA GAC GAG AAC3119
Asn Lys Pro He Tyr Glu Ser Ser Vai Met Thr Tyr Leu Asp GluAsn
1475 14801485
ACC GCC AAG GAG GTG ACC AAG CAG CTG AAC GAC ACC ACC GGC AAG TTC3167
Thr Ala Lys Glu Vai Thr Lys Gin Leu Asn Asp Thr Thr Gly LysPhe
1490 14951500
AAG GAC GTG AGC CAC CTG TAC GAC GTG AAG CTG ACC CCC AAG ATG AAC3215
Lys Asp Vai Ser His Leu Tyr Asp Vai Lys Leu Thr Pro Lys MetAsn
1505 15101515
GTG ACC ATC AAG CTG AGC ATC CTG TAC GAC AAC GCC GAG AGC AAC .GAC3263
Vai Thr lie Lys Leu Ser He Leu Tyr Asp Asn Ala Glu Ser AsnAsp
1520 1525 15301535
AAC AGC ATC GGC AAG TGG ACC AAC ACC AAC ATC GTG AGC .GGC GGC AAC3311
Asn Ser He Gly Lys Trp Thr Asn Thr Asn He Vai Ser Gly GlyAsn
:. 1540 1545 . 1550
AAC GGC AAG AAG CAG TAC AGC AGC AAC AAC CCC GAC GCC AAC CTG ACC3359
Asn Gly Lys Lys Gin Tyr Ser Ser Asn Asn Pro Asp Ala Asn LeuThr ' .1555 1560: .1565
CTG AAC ACC GAC GCC CAG GAG AAG CTG AAC AAG AAC CGC GAC TAC TAC3407
Leu Asn Thr Asp Ala Gin Glu Lys Leu Asn Lys Asn Arg Asp TyrTyr.
<sup>1</sup> 1570 .1575'1580
ATC AGC CTG TAC ATG AAG AGC. GAG AAG AAC ACC CAG TGC GAG ATC ACC.3455 lie Ser Leu Tyr Met Lys Ser Glu Lys Asn Thr Gin Cys Glu lieThr
1585 . ' 15901595
ATC GAC . GGC GAG ATA TAC CCC ATC ACC ACC AAG ACC GTG AAC GTG AAC3503 lie Asp Gly Glu lie Tyr Pro He Thr Thr Lys Thr Vai Asn VaiAsn
1600 1605 16101615
Λ
<td rowspan="2"> AAG GAC AAC TAC AAG CGC CTG GAC ATC Lys Asp Asn Tyr Lys Arg Leu Asp lie 1620</td><td colspan="2"> ATC GCC CAC AAC ATC AAG AGC</td><td rowspan="2"> 3551</td>
<td> He Ala . His Asn 1625</td><td> lie Lys Ser 1630</td>
<td> AAC CCC ATC AGC AGC CTG CAC ATC AAG</td><td> ACC AAC GAC GAG</td><td> ATC ACC CTG </td><td> 3599</td>
<td> Asn Pro He Ser Ser Leu' His He Lys</td><td> Thr Asn Asp Glu</td><td> He Thr Leu '׳:</td><td></td>
<td colspan="2"> 1635 . 1640 '</td><td> 1645</td><td></td>
<td> TTC TGG GAC GAC ATA TCG ATT ACC GAC</td><td> GTC GCC AGC ATC</td><td> AAG CCC GAG <sup>:</sup></td><td> 3647</td>
<td> Phe Trp Asp Asp He Ser He Thr Asp</td><td> Val Ala Ser He</td><td> Lys Pro Glu</td><td></td>
<td> ., 1650 1655</td><td colspan="2"> 1660</td><td></td>
<td> AAC CTG ACC GAC AGC GAG ATC AAG CAG</td><td> ATA TAC AGT CGC</td><td> TAC GGC ATC</td><td> 3695</td>
<td> Asn Leu Thr. Asp Ser Glu lie Lys Gin</td><td> lie Tyr Ser Arg</td><td> Tyr Gly lie</td><td></td>
<td> 1665 ’ ' 1670</td><td> , 1675 .</td><td></td><td></td>
<td> AAG CTG GAG GAC GGC ATC CTG ATC GAC</td><td> AAG AAA GGC GGC</td><td> ATC CAC TAC</td><td> 3743</td>
<td colspan="2"> Lys Leu Glu Asp Gly He Leu He Asp Lys Lys Gly Gly</td><td> lie His Tyr</td><td></td>
<td> 1680. 1685</td><td> 1690</td><td> 1695</td><td></td>
<td> GGC GAG TTC ATC AAC GAG GCC AGC TTC</td><td> AAC ATC GAG. CCC</td><td> CTG CAG AAC</td><td> 3791</td>
<td> Gly Glu Phe He Asn Glu Ala Ser Phe</td><td> Asn He Glu Pro</td><td> Leu Gin Asn</td><td></td>
1700 1705 1710
TAC GTG ACC AAG TAC GAG GTG ACC TAC AGC AGC GAG CTG GGC CCC AAC3839
Tyr Val Thr Lys Tyr Glu Val Thr Tyr Ser Ser Glu Leu Gly ProAsn
1715 17201725
GTG AGC GAC ACC CTG GAG AGC GAC. AAG ATT TAC AAG GAC GGC ACC ATC3887
Val Ser Asp Thr Leu Glu Ser 'Asp Lys He Tyr Lys Asp Gly Thrlie
1730 1735.1740
AAG TTC GAC TTC ACC AAG TAC AGC AAG AAC GAG CAG GGC CTG TTC TAC3935
Lys Phe Asp Phe Thr Lys Tyr Ser Lys Asn Glu Gin Gly Leu PheTyr
1745 17501755
GAC AGC GGC CTG AAC TGG GAC TTC AAG ATC AAC GCC ATC ACC TAC GAC3983
Asp Ser Gly Leu Asn Trp Asp Phe Lys lie Asn Ala. lie Thr TyrAsp.
1760 1765 ' ' 1770 1775 . . . .
GGC AAG GAG ATG AAC GTG TTC CAC CGC TAC AAC AAG TAGATCTGAG4029
Gly Lys Glu Met Asn Val Phe His Arg Tyr Asn Lys
17801785
CT4031 (2) INFORMATION FOR ,SEQ ID NO:50:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1333 amino. ^eids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein
2125.635 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50:
<td colspan="5"> Met Lys Arg Met Glu Gly Lys Leu Phe Met Vai Ser Lys Lys Leu Gin</td>
<td> 1</td><td> 5</td><td> 10</td><td colspan="2"> 15 </td>
<td> Vai Vai</td><td> Thr Lys Thr. Vai Leu Leu 20</td><td> Ser Thr Vai Phe Ser He 25. . 30</td><td> Ser</td><td> Leu</td>
<td> Leu Asn</td><td> Asn Glu Vai He Lys Ala 35 40</td><td> Glu Gin Leu Asn lie Asn 45</td><td> Ser</td><td> Gin.</td>
<td colspan="2"> Ser Lys Tyr Thr Asn Leu Gin Asn 50 55 '</td><td> Leu Lys He Thr Asp Lys 60</td><td> Vai</td><td> Glu</td>
<td> Asp Phe 65</td><td> Lys Glu Asp Lys Glu Lys .' 70</td><td> Ala Lys Glu Trp Gly Lys 75</td><td> Glu</td><td> Lys 80</td>
<td> Glu Lys</td><td> Glu Trp Lys Leu Thr Ala 85 .</td><td> Thr.Glu Lys Gly Lys Met 90</td><td> Asn .95</td><td> Asn</td>
<td> Phe Leu</td><td> Asp Asn Lys Asn Asp He 100</td><td> Lys Thr Asn Tyr Lys Glu 105 110</td><td> He</td><td> Thr</td>
<td> Phe Ser</td><td> He Ala Gly Ser Phe Glu 115 120</td><td> Asp Glu He Lys Asp Leu 125</td><td> Lys</td><td> Glu</td>
<td> He Asp 130</td><td> Lys Met Phe Asp Lys Thr 135</td><td> Asn Leu Ser Asn Ser He 140</td><td> He</td><td> Thr</td>
<td> Tyr Lys 145</td><td> Asn Vai Glu Pro Thr Thr ׳150</td><td> He Gly Phe Asn Lys Ser 155 </td><td> Leu</td><td> Thr 160</td>
<td> Glu Gly</td><td> Asn Thr lie Asn Ser Asp 165</td><td> Ala Met Ala Gin Phe Lys 170</td><td> Glu 175</td><td> Gin</td>
<td> Phe Leu</td><td> Asp Arg Asp lie Lys Phe 180 ..</td><td> Asp Ser Tyr Leu Asp Thr 185 190</td><td> His</td><td> Leu</td>
<td> Thr Ala</td><td> Gin Gin Vai Ser Ser Lys 195 ' 200.</td><td> Glu Arg Vai He Leu Lys 205</td><td> Vai</td><td> Thr</td>
<td> Vai Pro 210</td><td> Ser Gly Lys Gly Ser Thr 215</td><td> Thr Pro Thr Lys Ala Gly 220</td><td> Vai</td><td> He</td>
<td> Leu Asn 225 <sup>:</sup></td><td> Asn Ser Glu Tyr Lys Met 230</td><td> Leu He Asp Asn Gly Tyr 235</td><td> Met</td><td> Vai 240</td>
<td> His Vai</td><td> Asp Lys Vai Ser Lys Vai 245</td><td> Vai Lys Lys Gly Vai Glu 250</td><td> Cys 255</td><td> Leu׳</td>
<td> Gin He</td><td colspan="2"> Glu Gly Thr Leu Lys Lys Ser Leg Asp.Phe Lys Asn 260 265 <sup>?</sup> 270</td><td colspan="2"> Asp lie</td>
<td> Asn Ala</td><td colspan="2"> Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu</td><td colspan="2"> Trp Ala</td>
-. 275 ' 280. . .285.' .
Lys Asp Leu Thr Asp Ser Gin Arg Glu Ala Leu Asp Gly Tyr Ala Arg . .290 ' 295 300 Λ ;
Gin Asp Tyr Lys Glu lie Asn Asn Tyr Leu Arg Asn Gin Gly Gly Ser
305 310 315 .320
Gly Asn Glu Lys Leu Asp Ala Gin He Lys Asn He Ser Asp AlaLeu . .325 ' ' 330 335
Gly Lys Lys Pro lie Pro Glu Asn He Thr Val Tyr Arg Trp Cys Gly 340 345350 ׳ Met Pro Glu Phe Gly Tyr Gin lie Ser Asp Pro Leu Pro Ser Leu Lys 355 360365
Asp Phe Glu Glu Gin Phe Leu Asn Thr He Lys Glu Asp Lys Gly Tyr 370 375.380
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly SerArg
385 390 395400 ) Lys lie He Leu Arg Leu Gin Val Pro Lys Gly Ser Thr Gly AlaTyr
405 . 410415
Leu Ser Ala He Gly Gly Phe Ala Ser Glu Lys Glu lie Leu Leu Asp . 420 425430'
Lys Asp Ser Lys Tyr His He Asp Lys Val Thr Glu Val lie He Lys 435 . 440 .445
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn Ser Arg 450 455460
Gly Pro Ser Thr Pro Pro Thr Pro Ser Pro Ser Thr Pro Pro Thr Pro
465 . . 470 . . 475480
Ser Asp lie Gly Ser Thr Met Lys Thr Asn Gin He Ser Thr Thr Gin . 485 490495
Lys Asn Gin Gin Lys Glu Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr 500 '505 .,510
Phe Lys Gly Lys Asp Phe Ser Asn Leu Thr Met Phe Ala Pro Thr Arg 515 520525 .
Asp Ser Thr Leu He Tyr Asp Gin Gin Thr Ala Asn Lys Leu Leu Asp 530 535540 .
Lys Lys Gin Gin Glu Tyr Gin Ser He Arg Trp lie Gly Leu lie Gin
560 . 555 . 550 י 545
Ser Lys Glu Thr Gly Asp Phe Thr Phe Asn Leu Ser Glu Asp Glu Gin 565 ' . 570 '575
115382/
<td colspan="3"> Ala lie lie</td><td> Glu 580</td><td colspan="2"> He Asn</td><td colspan="4"> Gly Lys lie He Ser 585</td><td> Asn</td><td colspan="2"> Lys Gly 590</td><td colspan="2"> Lys Glu</td>
<td colspan="3"> Lys Gin Val 595</td><td> Val</td><td> His</td><td> Leu</td><td colspan="3"> Glu Lys Gly Lys 600</td><td> Leu</td><td> Val</td><td> Pro 605</td><td> He</td><td colspan="2"> Lys He</td>
<td> Glu</td><td> Tyr 610</td><td> Gin</td><td colspan="2"> Ser Asp</td><td> Thr</td><td colspan="2"> Lys Phe Asn 615,</td><td> He</td><td> Asp</td><td> Ser 620</td><td colspan="2"> Lys Thr</td><td colspan="2"> Phe Lys</td>
<td> Glu 625</td><td colspan="2"> Leu Lys</td><td colspan="2"> Leu Phe</td><td> Lys 630</td><td colspan="2"> He Asp Ser</td><td> Gin</td><td> Asn 635</td><td> Gin</td><td> Pro</td><td> Gin</td><td> Gin</td><td> Val 640</td>
<td> Gin</td><td> Gin</td><td> Asp</td><td> Glu</td><td> Leu 645</td><td> Arg</td><td> Asn Pro</td><td> Glu</td><td> Phe 650</td><td colspan="2"> Asn Lys</td><td> Lys</td><td> Glu'</td><td colspan="2"> Ser Gin 655</td>
<td colspan="2"> Glu Phe</td><td> Leu</td><td> Ala 660</td><td> Lys</td><td> Pro</td><td> Ser Lys</td><td> He 665</td><td> Asn</td><td colspan="2"> Leu Phe</td><td> Thr</td><td colspan="3"> Gin Gin Met 670</td>
<td colspan="2"> Lys Arg</td><td> Glu 675</td><td> lie</td><td> Asp</td><td> Glu</td><td> Asp Thr 680</td><td> Asp</td><td> Thr</td><td colspan="3"> Asp Gly Asp . 685</td><td> Ser</td><td> He</td><td> Pro</td>
<td> Asp</td><td> Leu 690</td><td colspan="2"> Trp Glu</td><td> Glu</td><td> Asn</td><td> Gly Tyr 6.95</td><td> Thr</td><td> lie</td><td> Gin</td><td> Asn 700</td><td> Arg</td><td> lie</td><td> Ala</td><td> Val</td>
<td> Lys 705</td><td colspan="3"> Trp Asp Asp</td><td> Ser</td><td> Leu 710</td><td> Ala Ser</td><td colspan="3"> Lys Gly Tyr 715</td><td> Thr</td><td> Lys</td><td> Phe</td><td> Val</td><td> Ser 720</td>
<td> Asn</td><td> Pro</td><td colspan="2"> Leu Glu</td><td> Ser 725</td><td> His</td><td> Thr Val</td><td> Gly</td><td> Asp 730</td><td> Pro</td><td> Tyr</td><td> Thr</td><td> Asp</td><td> Tyr 735</td><td> Glu</td>
<td> Lys</td><td> Ala</td><td> Ala</td><td colspan="2"> Arg Asp 740</td><td> Leu</td><td> Asp Leu</td><td colspan="2"> Ser Asn 745</td><td> Ala</td><td> Lys</td><td> Glu</td><td> Thr 750</td><td> Phe.</td><td> Asn</td>
<td> Pro</td><td> Leu</td><td> Val 755</td><td> Ala</td><td> Ala</td><td> Phe</td><td> Pro Ser 760</td><td> Val</td><td> Asn</td><td> Val</td><td> Ser</td><td> Met 765</td><td colspan="2"> Glu Lys</td><td> Val</td>
<td> He</td><td> Leu 770</td><td> Ser</td><td> Pro</td><td> Asn</td><td> Glu</td><td> Asn Leu ׳775</td><td> Ser</td><td> Asn</td><td> Ser</td><td colspan="2"> Val Glu 780</td><td> Ser</td><td> His</td><td> Ser</td>
<td> Ser 785</td><td> Thr</td><td> Asn</td><td> Trp</td><td> Ser</td><td> Tyr. 790</td><td> Thr Asn</td><td> Thr</td><td> Glu</td><td colspan="2"> Gly Ala 795</td><td colspan="3"> Ser Val Glu</td><td> Ala 800</td>
<td colspan="2"> Gly lie</td><td> Gly</td><td> Pro</td><td> Lys 805</td><td> Gly</td><td> lie Ser</td><td> Phe</td><td> Gly 810</td><td> Val</td><td> Ser</td><td> Val</td><td> Asn</td><td> Tyr 815</td><td> Gin</td>
<td> His</td><td> Ser</td><td> Glu</td><td colspan="3"> Thr Val Ala 820</td><td> Gin Glu</td><td colspan="2"> Trp Gly 825</td><td> Thr</td><td> Ser</td><td> Thr</td><td> Gly 830</td><td> Asn</td><td> Thr</td>
<td> Ser</td><td> Gin</td><td> Phe 835</td><td> Asn</td><td> Thr</td><td> Ala</td><td> Ser .Ala 840</td><td colspan="2"> Gly Tyr</td><td> Leu</td><td> Asn</td><td> Ala 845</td><td colspan="2"> Asn Val</td><td> Arg</td>
<td> Tyr</td><td> Asn 850</td><td> Asn</td><td colspan="2"> Val Gly</td><td> Thr</td><td> Gly Ala 855</td><td colspan="3"> He Tyr Asp</td><td colspan="2"> Val Lys 860</td><td> Pro</td><td> Thr</td><td> Thr</td>
5.6.35
<td colspan="2"> Ser Phe 865</td><td colspan="2"> Vai Leu</td><td> Asri</td><td colspan="3"> Asn Asp. Thr' 870 </td><td> lie.</td><td> Ala Thr lie Thr Ala Lys Ser 875 880</td>
<td> Asn</td><td> Ser</td><td colspan="2"> Thr Ala</td><td> Leu 885</td><td> Ash</td><td> lie</td><td> Ser</td><td> Pro</td><td> Gly Glu Ser Tyr Pro Lys Lys 890' . 895</td>
<td> Gly</td><td> Gin</td><td> Asn</td><td> Gly 900</td><td> He</td><td> Ala</td><td> He</td><td> Thr</td><td> Ser 905</td><td> Met Asp Asp Phe.Asn Ser His -910.</td>
<td> Pro</td><td> lie</td><td colspan="4"> Thr Leu Asn Lys 915</td><td> Lys</td><td> Gin 920</td><td> Vai</td><td> Asp Asn Leu Leu Asn Asn Lys 925</td>
<td> Pro</td><td> Met 930</td><td> Met</td><td> Leu</td><td> Glu</td><td> Thr</td><td> Asn 935</td><td> Gin</td><td> Thr</td><td> Asp Gly Vai Tyr Lys He Lys: 940 </td>
<td> Asp 945</td><td> Thr</td><td> His</td><td colspan="2"> Gly Asn</td><td colspan="2"> He Vai 950.</td><td colspan="3"> Thr Gly Gly Glu Trp Asn Gly Vai He : 95.5 960</td>
<td> Gin</td><td> Gin</td><td> lie</td><td> Lys</td><td> Ala 965</td><td> Lys</td><td> Thr</td><td> Ala</td><td> Ser.</td><td> lie lie Vai Asp Asp Gly Glu .970 ' 975</td>
<td> Arg</td><td> Vai</td><td> Ala</td><td> Glu 980</td><td> Lys</td><td> Arg</td><td> Vai</td><td> Ala</td><td> Ala 985</td><td> Lys Asp Tyr Glu Asn Pro Glu 990</td>
<td colspan="2"> Asp Lys</td><td> Thr 995</td><td> Pro</td><td> Ser</td><td> Leu</td><td> Thr</td><td colspan="2"> Leu Lys 1000</td><td> Asp Ala Leu Lys Leu Ser Tyr 1005</td>
<td colspan="3"> Pro Asp Glu 1010</td><td> He</td><td> Lys</td><td> Glu</td><td colspan="2"> lie Glu 1015</td><td> Gly</td><td> Leu Leu Tyr Tyr Lys Asn Lys 1020</td>
<td colspan="2"> Pro. He 1025</td><td> Tyr</td><td> Glu</td><td> Ser</td><td colspan="2"> Ser Vai 1030</td><td> Met</td><td> Thr</td><td> Tyr Leu Asp Glu Asn Thr Ala 1035 . 1040</td>
<td> Lys</td><td> Glu</td><td> Vai</td><td> Thr</td><td colspan="2"> Lys Gin 1045</td><td> Leu</td><td> Asn</td><td> Asp</td><td> Thr Thr Gly Lys Phe Lys Asp 1050 1055</td>
<td> Vai.</td><td> Ser</td><td> His</td><td colspan="4"> Leu Tyr Asp Vai 1060</td><td> Lys</td><td colspan="2"> Leu Thr Pro Lys Met Asn Vai Thr 1065 . 1070</td>
<td> lie</td><td colspan="3"> Lys Leu Ser 1075</td><td> lie</td><td colspan="4"> Leu Tyr Asp Asn .1080.</td><td> Ala Glu Ser Asn Asp Asn Ser 1085</td>
<td> He</td><td colspan="3"> Gly Lys Trp 1090</td><td> Thr</td><td> Asn</td><td colspan="2"> Thr Asn 1095 ,</td><td> He</td><td> Vai Ser Gly Gly Asri Asn Gly 1100</td>
<td colspan="4"> Lys. Lys Gin Tyr 1105</td><td> Ser</td><td colspan="2"> Ser Asn 1110</td><td colspan="2"> Asn Pro</td><td> Asp Ala Asn Leu Thr Leu Asn 1115 . 1120</td>
<td> Thr</td><td colspan="3"> Asp Ala Gin</td><td colspan="2"> Glu Lys 1125 '</td><td> Leu</td><td> Asn</td><td> Lys</td><td> Asn Arg Asp Tyr Tyr lie Ser 1130 1135</td>
<td> Leu</td><td colspan="4"> Tyr Met Lys Ser 1140</td><td> Glu</td><td colspan="2"> Lys Asn</td><td colspan="2"> Thr Gin Cys Glu He Thr He Asp 1145''' . 1150</td>
<td> Gly</td><td> Glu</td><td colspan="4"> lie Tyr Pro. lie</td><td> Thr</td><td> Thr</td><td colspan="2"> Lys Thr Vai Asn Vai Asn Lys Asp</td>
<sup>1155</sup> 1160 <sub>v!</sub>. <sub>VA1(</sub>,. ,1165
Asn Tyr Lys Arg Leu Asp He He Ala His Asn He Lys Ser Asn Pro
־ 1180 11751170 lie Ser Ser Leu His lie Lys Thr Asn Asp Glu He Thr Leu PheTrp
1185 1190 11951200
Asp Asp lie Ser lie Thr Asp Val Ala Ser He Lys Pro Glu AsnLeu
1205 . . 12101215
Thr Asp Ser Glu He Lys Gin He Tyr Ser Arg Tyr Gly He Lys Leu 1220 1225.1230
Glu Asp Gly He Leu He Asp Lys Lys Gly Gly He His Tyr Gly Glu 1235 12401245
Phe lie Asn Glu Ala Ser Phe Asn lie Glu Pro Leu Gin Asn Tyr Val 1250 12551260
Thr Lys Tyr Glu Val Thr Tyr Ser Ser Glu Leu Gly Pro Asn ValSer
1265' 1270 . 1275 . .1280
Asp Thr Leu Glu Ser Asp Lys He Tyr Lys Asp Gly Thr He LysPhe
1285 12901295
Asp Phe Thr Lys Tyr Ser Lys Ash Glu Gin Gly Leu Phe Tyr Asp Ser 1300 13051310
Gly Leu׳ Asn Trp Asp Phe Lys He Asn Ala He Thr Tyr Asp Gly Lys 1315 13201325
Glu Met Asn Val Phe His Arg Tyr Asn Lys 13301335 (2) INFORMATICS for SEQ ID NO :51: .
(i) SEQCENCE CHARACTERISTICS:
(A) LENGTH: 2444 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: ENA (genanic) (iii) HYPOTHETICAL: NO (ix) FEATURE:
(A) NAME/KEY: CDS (B) LOCATION: 17.2444 (D) OTHER INFORMATION; /product3” ״A(a) synthetic :native fusion (5d) SEQUENCE DESCRIPTION: SEQ ID NO:51:
3/ 2 8 3 5 1 ו
GGATCCACCA ATGAAC ATG AAC AAG AAC AAC ACC AAG CTG AGC ACC CGC 49
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg .
5 10
GCC CTG CCG AGC TTC ATC GAC TAC TTC AAC GGC ATC TAC GGC TIC GCC.37
Ala Leu Pro Ser Phe He Asp Tyr Phe A3n Gly He Tyr Gly PheAla
2025
ACC GGC ATC AAG GAC ATC ATG AAC ATG ATC TTC AAG ACC fflC ACC GGC145
Thr Gly He Lys Asp He Met Asn Met He Phe Lys Thr Asp ThrGly . 35 . 40
GGC GAC CTG ACC CTG GAC GAG ATC CTG AAG AAC CAG CAG CTG CTG AAC193
Gly Asp Leu Thr Leu Asp Glu He Leu Lys Asn Gin Gin Leu LeuAan
5055
GAC ATC AGC GGC AAG CTG GAC GGC GTG AAC GGC AGC CTG AAC GAC CTG 241 ׳
Asp He Ser Gly Lys Leu Asp Gly Val Asn Gly Ser Leu Asn AspLeu.
65 7075
ATC GCC CAG GGC AAC CTG AAC ACC GAG CTG AGC AAG GAG ATC CTT AAG289 lie Ala Gin Gly Asn Leu Asn Thr Glu Leu Ser Lys Glu Tie LeuLys
85 .90
ATC GCC AAC GAG CAG AAC CAG GTG CTG AAC ®C GTG AAC AAC AAG CTG337 lie Ala Asn Glu Gin Asn Gin val Leu Asn Asp Val Asn Asn LysLeu
100105
GAC GCC ATC AAC ACC ATG CTG CGC GTG TAC CTG CCG AAG ATC ACC AGC385
Asp Ala He Asn Thr Met Leu Arg Val Tyr Leu Pro Ly3 He Thr Ser
׳ 120 115110
ATG CTG AGC GAC GTG ATG AAG CAG AAC TAC GCC CTG AGC CTG CAG ATC'433
Met Leu Ser Asp Val Met Lys Gin Asn Tyr Ala Leu Ser Leu GinHe
125 130 .135
GAG TAC CTG AGC AAG CAG CTG CAG GAG ATC AGC GAC AAG CTG GAC ATC481
Glu Tyr Leu Ser Lys Gin Leu Gin Glu lie Ser Asp Lys Leu AspHe !40 145 150155
ATC AAC GIG. AAC GTC CIG ATC AAC AGC ACC CTG ACC GAG ATC ACC CCG. 529 lie Asn Val Asn Val leu lie Asn Ser Thr Leu Thr Glu He Thr Pro
160 165170
GCC TAC CAG CGC ATC AAG TAC GTG AAC GAG AAG TTC GAA GAG CTG ACC577
Ala Tyr gin Arg He Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr 175 180185
TTC GCCACCGAGACCAGCAGCAAGGTGAAGAAGGACGGCAGCCCGGCC 625
Phe Ala Thr Glu Thr Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala 190 195200
GAC ATC CTG GAC GAG CTG ACC GAG 01¢ ACC GAG CTG GCC AiG AGC GTG 673 Asp lie Leu Asp Glu Leu Thr Glu Leu Thr Glu Leu Ala Ly3 Ser Val .
V
205 210215
ACC AAG AAC GAC GTG GAC GGC TIC GAG TTC TAG CTG AAC ACC TTCCAC
Thr Lys Asn Asp. Val Asp Gly Phe Glu Phe Tyr leu Asn Thr PheHis
220 225 . 230235
GAC GTG ATG GTG GGC AAC AAC CTG TTC GGC CGC AGC GCC CTG AAGACC
Asp Val Met Val Gly . Asn Asn Leu Phe Gly Arg Ser Ala Leu LysThr
240 245250
GCC AGC GftG CTG ATC ACC AAG GAG AAC GTG AAG ACC AGC GGC AGCGAG
Ala Ser Glu Leu lie Thr Lys Glu Asn Val Lys Thr Ser Gly SerGlu
255 260265
GTG GGC AAC GTG TAC AAC TTC CTG ATC GIG CTG ACC GCC CTG CAGGCC
Val Gly Asn Val Tyr Asn Phe Leu lie Val Leu Thr Ala leu GinAla
270 275.280
CAG GCC TTC CTG ACC CTG ACC ACC TCT CGC AAG CTG CTG GGC CTGGCC
Gin Ala Phe Leu Thr Leu Thr Thr Cys Arg Lye Leu Leu Gly LeuAla
285 290295
GAC ATC GAC TAC t£C AGC ATC ATG AAC GAG CAC TTG AAC AAG GAGAAG
Asp lie Asp Tyr Thr Ser lie Met Asn Glu His Leu Asn Lys GluLys
300 305 310315
GAG GAG TTC CGC GTG AAC ATC CTG CCG ACC CTG AGC AAC ACC TICAGC
Glu Glu Phe Arg Val Asn lie Leu Pro Thr Leu Ser Asn Thr PheSer
320 325330
AAC CCG MC TAC GCC AAG GTG AAG GGC AGC GAC GAG GAC GCC AAGATG
Asn Pro Asn Tyr Ala Lys Val Lys Gly Ser Asp Glu Asp Ala Ly3Met
335 340. 345
ATC GTG GAG GCT AAG CCG GGC CAC GCG TTG ATC GGC TTC GAG ATCAGC.
He Val Ghi Ala Lys Pro Gly His Ala Leu He Gly Phe Glu lieSer
350 355360
1009
1057
1105
AAC <SAC AGC ATC ACC GTG CTG AAG CTG TAC GAG GCC AAG CTG AAG CAGH53
Asn Asp Ser Tie Thr Val Leu Lys Val Tyr Glu Ala Lys Leu LysGin
365 370375
AAC TAC CAG. GTG GAC AAG GAC AGC TTG AGC GAG GTG ATC TAC GGC GAC1201
Asn Tyr Gin Val Asp Lys Asp Sex Leu Ser Glu Val He Tyr GlyAsp
380 385 390395
ATG GAS AAG CTG CTG TGT CXJG GAC CAG WX) GAG CAA ATC TAC TAC ACC1249
Met Asp Lys Leu Leu Cys Pro Asp Gin Ser Glu Gin He Tyr TyzThr
400 405. 410
AAC AAC ATC CTG TTC CCG AAC GAG TAC GTG ATC ACC AAG ATC GAC TTC1297
Asn Asn lie Val Phe Pro Asn Glu Tyr Val He Thr Lys He AspPhe
415 420 .425
ACC AAG AAG ATG AAG ACC CTG CGC TAC GAG GTG ACC GCC AAC TTC TAC 1345
5382/3 1 1 .9מThr Lys Lys Met Lys Thr Leu Arg Tyr Glu Vai Thr Ala Asn Phe Tyr
430 435440
GAC AGC AGC ACC GGC GAG ATC GAC CTG AAC AAG AAG AAG GTG GAG AGC .1393
Asp Ser Ser Thr Gly Glu He Asp Leu Asn Lys Lys Lys Vai Glu Ser 445 450455
AGC GAG GCC GAG TAC CGC ACC CTG AGC GCG AAC GAC GAC GGC GTC TAC1441
Set Glu Ala Glu Tyr Arg Thr Leu Ser Ala Asn Asp Asp Gly VaiTyr
460 465 470475
ATG CCA CTG GGC GTC ATC AGC GAG ACC TTC CTG ACC CCG ATC AAC GGC .1489
Met Pro Leu Gly Vai He Ser Glu Thr Phe leu Thr Pro He AsnGly:
480 485.490 ־m . GGC CTG CAG GCC GAC GAG AAC AGC CGC CTC ATC ACC CTG ACC TCT1537
Phe Gly Leu Gin Ala Asp Glu Asn Ser Arg Leu He Thr leu Thr . Cys . 495 500 .'505
AAG AGC TAC CTG CGC GAG CTG CTG CTA GCC ACC (SC CTG AGC AAC AAG . . 1585
Lys Ser Tyr Leu Arg Glu Leu Leu leu Ala <sup>,</sup>Sir Asp Leu Ser Asn Lys
510 515520
GAG ACC AAG CTG ATC GTC CCA CCG AGC GGC TTC ATC AGC AAC ATC GTG 1633
Glu Thr Lys Leu He Vai Pro Pro Ser . Gly Phe He Ser Asn He Vai
525 530535 gagaacggcagcatcgaggaggacaacctggagccgtggaaggccaac1681
Glu Asn Gly Ser He Glu Glu Asp Asn Leu Glu Pro Tip Lys Ala Asn
540 545 550555
AAC AAG AAC GCC TAC GTCGACCACACCGGCGGCGTCAACGGCAOCAAG1729
Asn Lys Asn Ala Tyr Vai Asp His Thr Gly Gly Vai Asn Gly Thr Lys
560 565 570
GCC CTG TAC'GTG CAC AAG GAC GGC GGC ATC AGC CAG TTC ATC GGC GAC1777
Ala Leu Tyr Vai Bis Lys Asp Gly Gly He Ser Gin phe He GlyAsp
575 580585
AAG CTG AAG CCG AAG ACC ΘΜ5 TAC GTG ATC CAG TAC ACC GTG AAG GGC1825
Lys Leu Lys Pro Lys Thr Glu Tyr Vai He Gin Tyr Thr Vai LysGly ;590 595600
AAG CCATCGATTCACCTCAAGGACGAGAACACCGGCmCATCCACTAC 1873
Lys Pro Ser He His Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr 605 610615
GAG GAC ACC AAC AAC AAC CTG OG GAC TAC CAG ACC ATC AAC AAG CGC1921
Glu Asp Thr Asn Asn Asn Leu Glu Asp Tyr Gin Kir He Asn LysArg
620 625 630635.
TTC ACC ACC GGC ACC GAC CTG AAG GGC GTC TAC CTG ATC CTG AAG AGC1969
Phe Thr Thr Gly Thr Asp Leu Lys Gly Vai Tyr Leu He Leu LysSer
64Q 645650 ־220CAG AAC GGC t3\C GAG GCC TGG GGC GAC AAC TTC ATC ATC CTG GAG ATC 2017
Gin Asn Gly Asp Glu Ala Trp Gly Asp Asn Phe He lie Leu Glu lie
655 660 <sup>665</sup>
AGC CCG AGC GAG AAG CTG CTG AGC CCG GAG CTG ATC AAC ACC AAC AAC2065
Ser Pro Ser Glu Lys Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn
670 . 675 680 ' .
TGG ACC AGC ACC GGC AGC ACC AAC ATC AGC GGC AAC ACC CTG ACC CTG2113 רו׳ ם־יז. Ser Thr Gly Ser Thr Aan lie Ser Gly fen Thr Leu Thr Leu
685 . 690\ 695
TAC CAG GGC GGC CGG GGG ATT CTA AAA CAA AAC CTT CAA TEA GAT AGT2161
Tyr Gin Gly Gly Arg Gly Tie Leu Lys Gin Asn Leu Gin Leu Asp Ser
700 705 710.715 .
TTT TCA ACT TAT AGA GTG TAT TTT TCT GTG TCC GGA GAT GCT AAT GTA2209
Phe Ser Thr Tyr Arg Val Tyr Phe Ser Val Ser Gly Asp Ala AsnVal
720 . ' 725730
AGG ATT AGA AAT TCT AGG GAA GTG TTA TTT GAA AAA ΝΆ TAT ATG AGC2257
Arg lie Arg Asn Ser Arg Glu Val Leu Phe Glu Lys Arg Tyr MetSer
735 740745
GGT GCT AAA GAT GTT TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT2305
Glv Ala Lys Asp Val Ser Glu Met Phe Thr Thr Ly3 Phe Glu Lys Asp
750 755760
AAC TTT TAT ATA GAG CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT2353
Asn Phe Tyr He Glu Leu Ser Gin Gly fen Asn Leu Tyr Gly Gly Pro
765 770775
ATT GTA.CAT TTT TAC GAT GTC TCT ATT AAG NAA GAT CGG GAT CTA ATA2401
He Val His Phe Tyr Asp Val Ser lie Lys Xfe Asp Arg Asp Leu He
780 785 790795
TTA AC^ GTT TTT AAA AGC NAA TTC TTG TAT AAT GTC CTT GAT T2444
Leu Thr Val Phe Lys Ser Xaa Phe Leu Tyr Asn Val Leu Asp < 800805 (2) jOIFCRMATION FOR SEQ ID NO:52:.
.(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 809 amino acids (B) TYPE; amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52:
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe
5 ו IS lie Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly lie Lys Asp
20. 2530 lie Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu
45 . 40יי 35
Asp Glu lie Leu Lys Asn Gin Gin Leu Leu Asn Asp He Ser Gly Lys
5560
Leu Asp Gly Val Asn Gly Ser Leu Aan Asp Leu He Ala Gin Gly Asn
70 . <sup>7580</sup>
Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin
95 .־ 90 ' .85 .
Asn Gin . Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr 100 105HO
Met Leu Ara Val Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120
Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys
130 135140
Gin Leu Gin Glu lie Ser Asp Lys Leu Asp He He Asn Val AsnVal
145 150 . 155160
Leu lie Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin ArgHe
155 no
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr ; 180 185190
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu !95 200205
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215220
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe Bia ASp Val Met ValGly
225 230 235240
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Sex Glu Leulie
245 250.255
Thr Lys Glu Asn val Lys Thr Sex Gly Ser Glu Val Gly Asn Val Tyr
70־2 265260
Asn Phe Leu He val Leu Thr Ala Leu Gin Ala Gin Ala Phe Leu Thr 275 280285
Leu Thr Thr Cys Arg Lys Leu. Leu Gly leu Ala Asp He Asp Tyr Thr 290 295 .300
Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
Λ 305 i
Asn He Leu Pro —
325 <sub>m</sub> Thr lcu Sat to! Tte »0 Ser ton Pro to» Tyr A־.־»
Lys Vai Lys Gly Ser Asp Glu Asp Ala Lys
340 <sup>345</sup>
Pro Gly. His Ala Leu lie Gly Phe Glu He
355 <sup>360</sup>
Met He Vai Glu Ala LyS
Ser Asn Asp Ser He Thr
Vai Leu
Ly3 Vai Tyr
Gin Asn Tyr Gin Vai Asp
Lys Asp
Ser Uu Ser
Cy3 Pro Asp Gin Ser
Glu Ala Lys Leu Ly3
Glu Vai He Tyr Gly Asp Met Asp Lys leu Leu
390 . 395 ^0
Glu Gin He Tyr Tyr Thr Asn Asn Ila Vai Phe ;
410 <sup>415</sup>
Pro Asn
Glu Tyr Vai
Ila
Thr Lys lie Asp Phe.Thr Lys Lys Met Lys
425 430 .
Thr,Leu
Tyr Glu
Vai
Thr Ala
Asn ?he Tyr Asp
Ser Ser Thr Gly 445
Glu lie
Leu Asn
Lys
Lys lys
Vai Glu Ser Ser .460
Glu Ala Glu Tyr lie
Thr Leu
Ser Ala Asn Asp Asp Gly Vai Tyr Het
470 <sup>475</sup>
Pro Leu Gly Vai
Ser Glu Thr Ph־ leu Thr Pro Π־ Λβϊ 7« *י־
Glu ton set tog leu He Thr leu Thr Cys ty־ Ser Tyx leu Arg 500 <sup>505</sup> .
Glu Leu Leu
Leu Ala Thr Asp
Leu Ser Asn 520
Lys Glu Thr Lys Leu
He
Vai Pro Pro
Ser Gly Phe
He
Ser Asn
He
Vai Glu Asn Gly Ser
540 lie
Glu Glu Asp Asn Leu 545
Glu
Pro
Trp Lys
Ala
Asn Asn Lys Asn Ala 555
Tyr
Vai Asp His Thr Gly
Gly
Vai Asn
Gly Thr Lys Ala Leu Tyr Vai
570 <sup>575</sup>
H13
Lys Asp Gly Gly lie
Ser Gin Phe
He Gly Asp <sup>L</sup>Y<sup>3 1</sup>«ο <sup>1</sup>Y<sup>3 Pr0 1</sup>׳Y<sup>3</sup>
585 590
Thr Glu Tyr Vai He Gin Tyr W val Lys Gly <sup>Sar :le His </sup>595
Ash Leu Glu Asp Ty<sup>E</sup> Gin Thx 625 630 lie Asn Lys Arg Phe Thr Thr Gly Thr
635 640
צדד המשפטים
זמך זה הינו העתק שנסרק בשלמותו ביום ובשעה המצוינים
)ריקה ממוחשבת מהימנה מהמסמך המצוי בתיק, תאם לנוהל הבדיקות במשרד המשפטים.
u t «תום
משרד המשפטים (חתימה מוסדית).
ί
<img file="IL115382A_D0010.tif" />
where underlined
5.6.1995 where doubleunderlined
27.9.1995
Contents1682
12 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12
117 members in 34 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 31459494 | United States of America | A | |
| 31459494 | United States of America | A | |
| 46348395 | United States of America | A | |
| 46348395 | United States of America | A | |
| 314594 | – | – | – |
| 463483 | – | – | – |
| US19940314594 | – | – | – |
| US19950463483 | – | – | – |
Members117
| Document | Office | Kind | |
|---|---|---|---|
| CA2157297A1 | Canada | A1 | |
| WO9421795A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6414294A | Australia | A | |
| HU9502466D0 | Hungary | D0 | |
| IL115382D0 | Israel | D0 | |
| BR9406484A | Brazil | A | |
| EP0690916A1 | European Patent Office (EPO) | A1 | |
| CZ247695A3 | Czechia | A3 | |
| CN1119877A | China | A | |
| SK117695A3 | Slovakia | A3 | |
| CA2199049A1 | Canada | A1 | |
| WO9610083A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3743395A | Australia | A | |
| ZA958121B | South Africa | B | |
| TR199501182A2 | Türkiye | A2 | |
| HUT73337A | Hungary | A | |
| JPH08508164A | Japan | A | |
| NZ263445A | New Zealand | A | |
| BG100000A | Bulgaria | A | |
| MX9702212A | Mexico | A | |
| CO4480060A1 | Colombia | A1 | |
| EP0792363A1 | European Patent Office (EPO) | A1 | |
| CN1160420A | China | A | |
| BR9509099A | Brazil | A | |
| BG101384A | Bulgaria | A | |
| AU684068B2 | Australia | B2 | |
| HUT77449A | Hungary | A | |
| AU692934B2 | Australia | B2 | |
| US5770696A | United States of America | A | |
| JPH10506532A | Japan | A | |
| ZA982801B | South Africa | B | |
| CA2286284A1 | Canada | A1 | |
| WO9844137A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6832598A | Australia | A | |
| US5840868A | United States of America | A | |
| US5849870A | United States of America | A | |
| WO9844137A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5866326A | United States of America | A | |
| US5872212A | United States of America | A | |
| US5877012A | United States of America | A | |
| US5888801A | United States of America | A | |
| US5889174A | United States of America | A | |
| US5990383A | United States of America | A | |
| MX9909043A | Mexico | A | |
| EP0972062A2 | European Patent Office (EPO) | A2 | |
| CZ90897A3 | Czechia | A3 | |
| BR9808483A | Brazil | A | |
| US6066783A | United States of America | A | |
| HU0000295A2 | Hungary | A2 | |
| HUP0000295A2 | Hungary | A2 | |
| PL336081A1 | Poland | A1 | |
| CN1256712A | China | A | |
| TR199902426T2 | Türkiye | T2 | |
| US6107279A | United States of America | A | |
| AR012219A1 | Argentina | A1 | |
| US6137033A | United States of America | A | |
| AU727218B2 | Australia | B2 | |
| KR20010006015A | Republic of Korea | A | |
| IL132039D0 | Israel | D0 | |
| US6291156B1 | United States of America | B1 | |
| BG63313B1 | Bulgaria | B1 | |
| RO117111B1 | Romania | B1 | |
| JP2001524817A | Japan | A | |
| HU0000295A3 | Hungary | A3 | |
| HUP0000295A3 | Hungary | A3 | |
| SG49845A1 | Singapore | A1 | |
| HU220714B1 | Hungary | B1 | |
| US2002078473A1 | United States of America | A1 | |
| CZ290301B6 | Czechia | B6 | |
| IL146109D0 | Israel | D0 | |
| TW496896B | Taiwan Province of China | B | |
| US6429360B1 | United States of America | B1 | |
| PH11995051386B1 | Philippines | B1 | |
| CZ290801B6 | Czechia | B6 | |
| UA52579C2 | Ukraine | C2 | |
| RU2196824C2 | Russian Federation | C2 | |
| HU222264B1 | Hungary | B1 | |
| SK283509B6 | Slovakia | B6 | |
| EP0792363B1 | European Patent Office (EPO) | B1 | |
| AT256743T | Austria | T | |
| ATE256743T1 | Austria | T1 | |
| EP1382611A2 | European Patent Office (EPO) | A2 | |
| PH12002000307B1 | Philippines | B1 | |
| RU2222597C2 | Russian Federation | C2 | |
| DE69532333D1 | Germany | D1 | |
| MX219628B | Mexico | B | |
| EP1382611A3 | European Patent Office (EPO) | A3 | |
| DK0792363T3 | Denmark | T3 | |
| SI0792363T1 | Slovenia | T1 | |
| PT792363E | Portugal | E | |
| KR100419438B1 | Republic of Korea | B1 | |
| ES2213162T3 | Spain | T3 | |
| UA68345C2 | Ukraine | C2 | |
| DE69532333T2 | Germany | T2 | |
| EP1471145A2 | European Patent Office (EPO) | A2 | |
| EP0690916B1 | European Patent Office (EPO) | B1 | |
| IN710CH1998A | India | A | |
| AT290083T | Austria | T | |
| ATE290083T1 | Austria | T1 | |
| DE69434283D1 | Germany | D1 |
5 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent expiredExpiredEXP | EXP | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF | |
| Patent renewedKB | KB | |
| Change in proprietorshipHP | HP |
Numbers
- Publication, DOCDB
- 115382
- Publication, EPODOC
- IL115382
- Application
- 115382
- Application, DOCDB
- 11538295
- Application, EPODOC
- IL19950115382
Titles
- English
- PESTICIDAL PROTEINS AND STRAINS
Classification
- CPC, 14
- C07K14/32
- C07K14/325
- C07K14/415
- C07K14/43563
- C07K2319/00
- C07K2319/02
- C12N15/8285
- C12N15/8286
- Y10S530/825
- Y02A40/146
- A01N63/50
- C12R2001/075
- C12N1/205
- C12R2001/07
- IPC, 31
- A01H5 00
- A01N63 00
- A01N63 02
- C07K
- C07K14 32
- C07K14 325
- C07K14 415
- C07K14 435
- C07K16 00
- C12N1 11
- C12N1 12
- C12N1 13
- C12N1 19
- C12N1 21
- C12N5 10
- C12N7 00
- C12N15 09
- C12N15 11
- C12N15 31
- C12N15 32
- C12N15 62
- C12N15 82
- C12N15 84
- C12P21 02
- C12Q1 02
- C12Q1 68
- C12R1 07
- C12R1 085
- C12R1 19
- C12R1 91
- G01N33 00
